\PassOptionsToPackage{unicode=true}{hyperref} % options for packages loaded elsewhere
\PassOptionsToPackage{hyphens}{url}
\PassOptionsToPackage{dvipsnames,svgnames*,x11names*}{xcolor}
%
\documentclass[]{book}
\usepackage{lmodern}
\usepackage{amssymb,amsmath}
\usepackage{ifxetex,ifluatex}
\usepackage{fixltx2e} % provides \textsubscript
\ifnum 0\ifxetex 1\fi\ifluatex 1\fi=0 % if pdftex
  \usepackage[T1]{fontenc}
  \usepackage[utf8]{inputenc}
  \usepackage{textcomp} % provides euro and other symbols
\else % if luatex or xelatex
  \usepackage{unicode-math}
  \defaultfontfeatures{Ligatures=TeX,Scale=MatchLowercase}
\fi
% use upquote if available, for straight quotes in verbatim environments
\IfFileExists{upquote.sty}{\usepackage{upquote}}{}
% use microtype if available
\IfFileExists{microtype.sty}{%
\usepackage[]{microtype}
\UseMicrotypeSet[protrusion]{basicmath} % disable protrusion for tt fonts
}{}
\IfFileExists{parskip.sty}{%
\usepackage{parskip}
}{% else
\setlength{\parindent}{0pt}
\setlength{\parskip}{6pt plus 2pt minus 1pt}
}
\usepackage{xcolor}
\usepackage{hyperref}
\hypersetup{
            pdftitle={COVID-19 Immunogenicity Analysis Report},
            pdfauthor={USG COVID-19 Response Biostatistics Team},
            colorlinks=true,
            linkcolor=Maroon,
            citecolor=Blue,
            urlcolor=Blue,
            breaklinks=true}
\urlstyle{same}  % don't use monospace font for urls
\usepackage{longtable,booktabs}
% Fix footnotes in tables (requires footnote package)
\IfFileExists{footnote.sty}{\usepackage{footnote}\makesavenoteenv{longtable}}{}
\usepackage{graphicx,grffile}
\makeatletter
\def\maxwidth{\ifdim\Gin@nat@width>\linewidth\linewidth\else\Gin@nat@width\fi}
\def\maxheight{\ifdim\Gin@nat@height>\textheight\textheight\else\Gin@nat@height\fi}
\makeatother
% Scale images if necessary, so that they will not overflow the page
% margins by default, and it is still possible to overwrite the defaults
% using explicit options in \includegraphics[width, height, ...]{}
\setkeys{Gin}{width=\maxwidth,height=\maxheight,keepaspectratio}
\setlength{\emergencystretch}{3em}  % prevent overfull lines
\providecommand{\tightlist}{%
  \setlength{\itemsep}{0pt}\setlength{\parskip}{0pt}}
\setcounter{secnumdepth}{5}
% Redefines (sub)paragraphs to behave more like sections
\ifx\paragraph\undefined\else
\let\oldparagraph\paragraph
\renewcommand{\paragraph}[1]{\oldparagraph{#1}\mbox{}}
\fi
\ifx\subparagraph\undefined\else
\let\oldsubparagraph\subparagraph
\renewcommand{\subparagraph}[1]{\oldsubparagraph{#1}\mbox{}}
\fi

% set default figure placement to htbp
\makeatletter
\def\fps@figure{htbp}
\makeatother

%\usepackage[maxfloats=256]{morefloats}
\maxdeadcycles=1000
\usepackage[margin=1in]{geometry}
\usepackage{float}
\usepackage{booktabs}
\usepackage[inline]{enumitem}
\usepackage{mathtools}
\usepackage{graphicx}
\usepackage[round]{natbib}
\usepackage{tikz}
\usepackage[english]{babel}
\usepackage{longtable}
\usepackage{color}
\usepackage{amssymb,amsmath,amsthm}
\usepackage{multirow}
\usepackage[titletoc,title]{appendix}
\usepackage{authblk}
\usepackage{setspace}
\usepackage{dsfont}
\usepackage[OT1]{fontenc}
\usepackage{subcaption}
\usepackage{refcount}

\newtheorem*{remark}{Remark}
\newtheorem{theorem}{Theorem}
\AtEndDocument{\refstepcounter{theorem}\label{finalthm}}
{
  \theoremstyle{definition}
  \newtheorem{assumption}{}
}
{
  \theoremstyle{definition}
  \newtheorem{assumptioniden}{}
}
{
  \theoremstyle{definition}
  \newtheorem{example}{Example}[section]
}
\DeclareMathOperator{\opt}{opt}
\DeclareMathOperator{\dr}{IF}
\newcommand{\hopt}{\hat h_{\opt}}
\newcommand{\supp}{\mathop{\mathrm{supp}}}
\renewcommand\theassumptioniden{{A}\arabic{assumptioniden}}
\renewcommand\theassumption{{C}\arabic{assumption}}
\renewcommand\theexample{\arabic{example}}

\newtheorem{lemma}{Lemma} \newtheorem{coro}{Corollary}
\newtheorem{definition}{Definition}
\DeclareMathOperator{\expit}{expit}
\DeclareMathOperator{\bern}{Bern}
\DeclareMathOperator{\logit}{logit} \DeclareMathOperator{\var}{Var}
\DeclareMathOperator{\Rem}{Rem} \newcommand{\pt}{\mbox{$p_0$}}
\newcommand{\Pt}{\mbox{$P_0$}} \newcommand{\pl}{\parallel}
\newcommand{\indep}{\mbox{$\perp\!\!\!\perp$}} \newcommand{\rs}{R}
\newcommand{\ds}{D^\dag} \newcommand{\dd}{\mathrm{d}}
\newcommand{\Pn}{\mathbb{P}_{n}}
\newcommand{\mut}{\mu_0}
\newcommand{\thetasub}{\hat\theta_{\mbox{\scriptsize sub}}(\delta)}
\newcommand{\thetare}{\hat\theta_{\mbox{\scriptsize re}}(\delta)}
\newcommand{\thetatmle}{\hat\theta_{\mbox{\scriptsize tmle}}(\delta)}
\newcommand{\thetaaipw}{\hat\theta(\delta)}
\newcommand{\hgd}{\hat g_\delta} \newcommand{\hm}{\hat m}
\newcommand{\one}{\mathds{1}} \renewcommand{\P}{\mathbb{P}}
\newcommand{\R}{\mathbb{R}} \renewcommand{\rmdefault}{ptm}
\newcommand{\E}{\mathbb{E}}
\newcommand{\M}{\mathcal{M}}
\newcommand{\1}{\mathbbm{1}}
\newcommand{\prob}{\mathbb{P}}
\renewenvironment{proof}{{\it Proof }}{\qed \\}
\DeclareMathOperator*{\argmin}{\arg\!\min}
\DeclarePairedDelimiterX{\norm}[1]{\lVert}{\rVert}{#1}
\usepackage{eso-pic,graphicx,transparent}
\usepackage{etoolbox}
\makeatletter
\providecommand{\subtitle}[1]{% add subtitle to \maketitle
  \apptocmd{\@title}{\par {\large #1 \par}}{}{}
}
\makeatother
\usepackage{float}
\usepackage{flafter}
\usepackage{booktabs}
\usepackage{longtable}
\usepackage{array}
\usepackage{multirow}
\usepackage{wrapfig}
\usepackage{colortbl}
\usepackage{pdflscape}
\usepackage{tabu}
\usepackage{threeparttable}
\usepackage{threeparttablex}
\usepackage[normalem]{ulem}
\usepackage{makecell}
\usepackage{xcolor}
\usepackage[]{natbib}
\bibliographystyle{apalike}

\title{COVID-19 Immunogenicity Analysis Report}
\providecommand{\subtitle}[1]{}
\subtitle{mock Study}
\author{USG COVID-19 Response Biostatistics Team}
\date{March 29, 2021}

\begin{document}
\maketitle

{
\hypersetup{linkcolor=}
\setcounter{tocdepth}{1}
\tableofcontents
}
\listoftables
\listoffigures
\AddToShipoutPictureFG{
  \AtPageCenter{
    \makebox[0pt]{\rotatebox[origin=c]{45}{
      \scalebox{10}{\texttransparent{0.3}{MOCK}}}}}}

\hypertarget{immuno-tabular}{%
\chapter{Tabular Description of Immunogenicity Data}\label{immuno-tabular}}

\captionsetup{justification=raggedright,singlelinecheck=false}

\captionsetup[table]{labelformat=empty}

\begin{ThreePartTable}
\begin{TableNotes}
\item This table summarises the random subcohort, which
      was randomly sampled from the per-protocol individuals without a COVID failure
      event $<$ 7 days post Day 57. The sampling was stratified by the key baseline 
      covariates: assigned treatment arm, baseline SARS-CoV-2 status 
      (defined by serostatus and possibly also NAAT and/or RNA PCR testing), 
      any additional important demographic factors such as the randomization strata 
      (e.g., defined by age and/or co-morbidities).
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{7cm}lll}
\caption{\label{tab:tabs}Table 1. Demographic and Clinical Characteristics at Baseline in 
      the baseline SARS-CoV-2 negative per-protocol cohort}\\
\toprule
Characteristics & \makecell[l]{Vaccine\\(N = 914)} & \makecell[l]{Placebo\\(N = 163)} & \makecell[l]{Total\\(N = 1077)}\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Characteristics & \makecell[l]{Vaccine\\(N = 914)} & \makecell[l]{Placebo\\(N = 163)} & \makecell[l]{Total\\(N = 1077)}\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{4}{l}{\textbf{Age}}\\
\hspace{1em}Age $<$ 65 & 432 (47.3\%) & 80 (49.1\%) & 512 (47.5\%)\\
\hspace{1em}Age $\geq$ 65 & 482 (52.7\%) & 83 (50.9\%) & 565 \vphantom{1} (52.5\%)\\
\hspace{1em}Mean (Range) & 58.6 (18.0, 85.0) & 59.0 (18.0, 85.0) & 58.7 (18.0, 85.0)\\
\addlinespace[0.3em]
\multicolumn{4}{l}{\textbf{BMI}}\\
\hspace{1em}Mean $\pm$ SD & 30.1 $\pm$ 7.0 & 29.6 $\pm$ 7.2 & 30.0 $\pm$ 7.0\\
\addlinespace[0.3em]
\multicolumn{4}{l}{\textbf{Sex}}\\
\hspace{1em}Female & 519 (56.8\%) & 87 (53.4\%) & 606 (56.3\%)\\
\hspace{1em}Male & 395 (43.2\%) & 76 (46.6\%) & 471 (43.7\%)\\
\addlinespace[0.3em]
\multicolumn{4}{l}{\textbf{Race}}\\
\hspace{1em}White Non-Hispanic & 362 (43.8\%) & 67 (44.7\%) & 429 (43.9\%)\\
\hspace{1em}Black or African American & 195 (23.6\%) & 39 (26.0\%) & 234 (24.0\%)\\
\hspace{1em}Asian & 67 (8.1\%) & 12 (8.0\%) & 79 (8.1\%)\\
\hspace{1em}American Indian or Alaska Native & 13 (1.6\%) & 5 (3.3\%) & 18 (1.8\%)\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & 17 (2.1\%) & 1 (0.7\%) & 18 (1.8\%)\\
\hspace{1em}Multiracial & 52 (6.3\%) & 8 (5.3\%) & 60 (6.1\%)\\
\hspace{1em}Other & 34 (4.1\%) & 4 (2.7\%) & 38 (3.9\%)\\
\hspace{1em}Not reported and unknown & 87 (10.5\%) & 14 (9.3\%) & 101 (10.3\%)\\
\hspace{1em}Communities of Color & 420 (53.7\%) & 73 (52.1\%) & 493 (53.5\%)\\
\addlinespace[0.3em]
\multicolumn{4}{l}{\textbf{Hispanic or Latino ethnicity}}\\
\hspace{1em}Hispanic or Latino & 136 (14.9\%) & 20 (12.3\%) & 156 (14.5\%)\\
\hspace{1em}Not Hispanic or Latino & 690 (75.5\%) & 130 (79.8\%) & 820 (76.1\%)\\
\hspace{1em}Not reported and unknown & 88 (9.6\%) & 13 (8.0\%) & 101 (9.4\%)\\
\addlinespace[0.3em]
\multicolumn{4}{l}{\textbf{Risk for Severe Covid-19}}\\
\hspace{1em}At-risk & 469 (51.3\%) & 84 (51.5\%) & 553 (51.3\%)\\
\hspace{1em}Not at-risk & 445 (48.7\%) & 79 (48.5\%) & 524 (48.7\%)\\
\addlinespace[0.3em]
\multicolumn{4}{l}{\textbf{Age, Risk for Severe Covid-19}}\\
\hspace{1em}Age $\geq$ 65 & 482 (52.7\%) & 83 (50.9\%) & 565 (52.5\%)\\
\hspace{1em}Age $<$ 65 At-risk & 214 (23.4\%) & 40 (24.5\%) & 254 (23.6\%)\\
\hspace{1em}Age $<$ 65 Not at-risk & 218 (23.9\%) & 40 (24.5\%) & 258 (24.0\%)\\*
\end{longtable}
\end{ThreePartTable}

\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item This table summarises the random subcohort, which
      was randomly sampled from the per-protocol individuals without a COVID failure
      event $<$ 7 days post Day 57. The sampling was stratified by the key baseline 
      covariates: assigned treatment arm, baseline SARS-CoV-2 status 
      (defined by serostatus and possibly also NAAT and/or RNA PCR testing), 
      any additional important demographic factors such as the randomization strata 
      (e.g., defined by age and/or co-morbidities).
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{7cm}lll}
\caption{\label{tab:tabs}Table 2. Demographic and Clinical Characteristics at Baseline in 
      the baseline SARS-CoV-2 positive per-protocol cohort}\\
\toprule
Characteristics & \makecell[l]{Vaccine\\(N = 274)} & \makecell[l]{Placebo\\(N = 270)} & \makecell[l]{Total\\(N = 544)}\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Characteristics & \makecell[l]{Vaccine\\(N = 274)} & \makecell[l]{Placebo\\(N = 270)} & \makecell[l]{Total\\(N = 544)}\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{4}{l}{\textbf{Age}}\\
\hspace{1em}Age $<$ 65 & 146 (53.3\%) & 147 (54.4\%) & 293 (53.9\%)\\
\hspace{1em}Age $\geq$ 65 & 128 (46.7\%) & 123 (45.6\%) & 251 \vphantom{1} (46.1\%)\\
\hspace{1em}Mean (Range) & 56.0 (18.0, 85.0) & 55.8 (18.0, 85.0) & 55.9 (18.0, 85.0)\\
\addlinespace[0.3em]
\multicolumn{4}{l}{\textbf{BMI}}\\
\hspace{1em}Mean $\pm$ SD & 30.7 $\pm$ 6.8 & 30.1 $\pm$ 7.2 & 30.4 $\pm$ 7.0\\
\addlinespace[0.3em]
\multicolumn{4}{l}{\textbf{Sex}}\\
\hspace{1em}Female & 153 (55.8\%) & 155 (57.4\%) & 308 (56.6\%)\\
\hspace{1em}Male & 121 (44.2\%) & 115 (42.6\%) & 236 (43.4\%)\\
\addlinespace[0.3em]
\multicolumn{4}{l}{\textbf{Race}}\\
\hspace{1em}White Non-Hispanic & 125 (49.8\%) & 121 (49.0\%) & 246 (49.4\%)\\
\hspace{1em}Black or African American & 52 (20.7\%) & 60 (24.3\%) & 112 (22.5\%)\\
\hspace{1em}Asian & 24 (9.6\%) & 13 (5.3\%) & 37 (7.4\%)\\
\hspace{1em}American Indian or Alaska Native & 6 (2.4\%) & 4 (1.6\%) & 10 (2.0\%)\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & 5 (2.0\%) & 1 (0.4\%) & 6 (1.2\%)\\
\hspace{1em}Multiracial & 12 (4.8\%) & 19 (7.7\%) & 31 (6.2\%)\\
\hspace{1em}Other & 7 (2.8\%) & 5 (2.0\%) & 12 (2.4\%)\\
\hspace{1em}Not reported and unknown & 20 (8.0\%) & 24 (9.7\%) & 44 (8.8\%)\\
\hspace{1em}Communities of Color & 120 (49.0\%) & 111 (47.8\%) & 231 (48.4\%)\\
\addlinespace[0.3em]
\multicolumn{4}{l}{\textbf{Hispanic or Latino ethnicity}}\\
\hspace{1em}Hispanic or Latino & 35 (12.8\%) & 38 (14.1\%) & 73 (13.4\%)\\
\hspace{1em}Not Hispanic or Latino & 217 (79.2\%) & 214 (79.3\%) & 431 (79.2\%)\\
\hspace{1em}Not reported and unknown & 22 (8.0\%) & 18 (6.7\%) & 40 (7.4\%)\\
\addlinespace[0.3em]
\multicolumn{4}{l}{\textbf{Risk for Severe Covid-19}}\\
\hspace{1em}At-risk & 125 (45.6\%) & 123 (45.6\%) & 248 (45.6\%)\\
\hspace{1em}Not at-risk & 149 (54.4\%) & 147 (54.4\%) & 296 (54.4\%)\\
\addlinespace[0.3em]
\multicolumn{4}{l}{\textbf{Age, Risk for Severe Covid-19}}\\
\hspace{1em}Age $\geq$ 65 & 128 (46.7\%) & 123 (45.6\%) & 251 (46.1\%)\\
\hspace{1em}Age $<$ 65 At-risk & 73 (26.6\%) & 75 (27.8\%) & 148 (27.2\%)\\
\hspace{1em}Age $<$ 65 Not at-risk & 73 (26.6\%) & 72 (26.7\%) & 145 (26.7\%)\\*
\end{longtable}
\end{ThreePartTable}

\clearpage

\newgeometry{top=0.08in, bottom=0.08in}

\begin{landscape}

\begin{ThreePartTable}
\begin{TableNotes}
\item Binding Antibody Responders are defined as participants who had
        baseline values below the LLOD with detectable antibody concentration
        above the assay LLOD, or as participants with baseline values above
        the LLOD with a 4-fold increase in antibody concentration.
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{2.7cm}llllllll}
\caption{\label{tab:tabs}Table 3a. Percentage of responders, and participants
      with concentrations $\geq$ 2 x LLOD or $\geq$ 4 x LLOD for binding antibody
      markers by All participants}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% Greater than 2xLLOD & \% Greater than 4xLLOD\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% Greater than 2xLLOD & \% Greater than 4xLLOD\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{9}{l}{\textbf{All participants}}\\
\hspace{1em} & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 914 & \makecell[l]{13295/13295 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{13295/13295 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{13295/13295 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em} & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 914 & \makecell[l]{13295/13295 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{13295/13295 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{13295/13295 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em} & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 274 & \makecell[l]{1432/1432 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1432/1432 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1432/1432 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em} & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 274 & \makecell[l]{1432/1432 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1432/1432 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1432/1432 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em} & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 163 & \makecell[l]{0/13359 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/13359 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/13359 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em} & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 163 & \makecell[l]{0/13359 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/13359 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/13359 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em} & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 270 & \makecell[l]{1357/1357 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1357/1357 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1357/1357 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em} & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 270 & \makecell[l]{1357/1357 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1357/1357 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1357/1357 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em} & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 914 & \makecell[l]{13295/13295 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{13295/13295 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{13295/13295 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em} & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 914 & \makecell[l]{13295/13295 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{13295/13295 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{13295/13295 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em} & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 274 & \makecell[l]{1432/1432 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1432/1432 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1432/1432 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em} & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 274 & \makecell[l]{1432/1432 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1432/1432 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1432/1432 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em} & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 163 & \makecell[l]{76.3/13359 = 0.6\%\\(0.1\%, 4.0\%)} & \makecell[l]{0/13359 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/13359 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em} & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 163 & \makecell[l]{0/13359 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/13359 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/13359 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em} & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 270 & \makecell[l]{1357/1357 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1357/1357 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1357/1357 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em} & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 270 & \makecell[l]{1357/1357 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1357/1357 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1357/1357 = 100.0\%\\(100.0\%, 100.0\%)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item Binding Antibody Responders are defined as participants who had
        baseline values below the LLOD with detectable antibody concentration
        above the assay LLOD, or as participants with baseline values above
        the LLOD with a 4-fold increase in antibody concentration.
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{2.7cm}llllllll}
\caption{\label{tab:tabs}Table 3b. Percentage of responders, and participants
      with concentrations $\geq$ 2 x LLOD or $\geq$ 4 x LLOD for binding antibody
      markers by Age}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% Greater than 2xLLOD & \% Greater than 4xLLOD\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% Greater than 2xLLOD & \% Greater than 4xLLOD\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{9}{l}{\textbf{Age}}\\
\hspace{1em}Age $<$ 65 & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 432 & \makecell[l]{10518/10518 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{10518/10518 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{10518/10518 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 432 & \makecell[l]{10518/10518 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{10518/10518 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{10518/10518 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 146 & \makecell[l]{1145/1145 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1145/1145 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1145/1145 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 146 & \makecell[l]{1145/1145 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1145/1145 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1145/1145 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 80 & \makecell[l]{0/10234 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/10234 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/10234 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 80 & \makecell[l]{0/10234 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/10234 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/10234 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 147 & \makecell[l]{1098/1098 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1098/1098 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1098/1098 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 147 & \makecell[l]{1098/1098 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1098/1098 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1098/1098 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 432 & \makecell[l]{10518/10518 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{10518/10518 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{10518/10518 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 432 & \makecell[l]{10518/10518 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{10518/10518 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{10518/10518 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 146 & \makecell[l]{1145/1145 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1145/1145 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1145/1145 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 146 & \makecell[l]{1145/1145 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1145/1145 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1145/1145 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 80 & \makecell[l]{76.3/10234 = 0.7\%\\(0.1\%, 5.3\%)} & \makecell[l]{0/10234 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/10234 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 80 & \makecell[l]{0/10234 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/10234 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/10234 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 147 & \makecell[l]{1098/1098 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1098/1098 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1098/1098 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 147 & \makecell[l]{1098/1098 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1098/1098 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1098/1098 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 482 & \makecell[l]{2777/2777 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{2777/2777 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{2777/2777 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 482 & \makecell[l]{2777/2777 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{2777/2777 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{2777/2777 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 128 & \makecell[l]{287/287 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{287/287 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{287/287 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 128 & \makecell[l]{287/287 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{287/287 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{287/287 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 83 & \makecell[l]{0/3125 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/3125 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/3125 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 83 & \makecell[l]{0/3125 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/3125 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/3125 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 123 & \makecell[l]{259/259 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{259/259 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{259/259 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 123 & \makecell[l]{259/259 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{259/259 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{259/259 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 482 & \makecell[l]{2777/2777 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{2777/2777 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{2777/2777 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 482 & \makecell[l]{2777/2777 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{2777/2777 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{2777/2777 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 128 & \makecell[l]{287/287 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{287/287 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{287/287 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 128 & \makecell[l]{287/287 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{287/287 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{287/287 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 83 & \makecell[l]{0/3125 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/3125 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/3125 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 83 & \makecell[l]{0/3125 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/3125 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/3125 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 123 & \makecell[l]{259/259 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{259/259 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{259/259 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 123 & \makecell[l]{259/259 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{259/259 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{259/259 = 100.0\%\\(100.0\%, 100.0\%)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item Binding Antibody Responders are defined as participants who had
        baseline values below the LLOD with detectable antibody concentration
        above the assay LLOD, or as participants with baseline values above
        the LLOD with a 4-fold increase in antibody concentration.
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{2.7cm}llllllll}
\caption{\label{tab:tabs}Table 3c. Percentage of responders, and participants
      with concentrations $\geq$ 2 x LLOD or $\geq$ 4 x LLOD for binding antibody
      markers by Risk for Severe Covid-19}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% Greater than 2xLLOD & \% Greater than 4xLLOD\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% Greater than 2xLLOD & \% Greater than 4xLLOD\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{9}{l}{\textbf{Risk for Severe Covid-19}}\\
\hspace{1em}At-risk & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 469 & \makecell[l]{3736.6/3736.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{3736.6/3736.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{3736.6/3736.6 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}At-risk & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 469 & \makecell[l]{3736.6/3736.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{3736.6/3736.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{3736.6/3736.6 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}At-risk & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 125 & \makecell[l]{368.8/368.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{368.8/368.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{368.8/368.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}At-risk & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 125 & \makecell[l]{368.8/368.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{368.8/368.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{368.8/368.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}At-risk & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 84 & \makecell[l]{0/4096.4 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/4096.4 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/4096.4 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}At-risk & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 84 & \makecell[l]{0/4096.4 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/4096.4 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/4096.4 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}At-risk & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 123 & \makecell[l]{331.2/331.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{331.2/331.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{331.2/331.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}At-risk & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 123 & \makecell[l]{331.2/331.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{331.2/331.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{331.2/331.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}At-risk & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 469 & \makecell[l]{3736.6/3736.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{3736.6/3736.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{3736.6/3736.6 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}At-risk & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 469 & \makecell[l]{3736.6/3736.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{3736.6/3736.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{3736.6/3736.6 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}At-risk & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 125 & \makecell[l]{368.8/368.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{368.8/368.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{368.8/368.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}At-risk & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 125 & \makecell[l]{368.8/368.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{368.8/368.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{368.8/368.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}At-risk & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 84 & \makecell[l]{76.3/4096.4 = 1.9\%\\(0.2\%, 12.6\%)} & \makecell[l]{0/4096.4 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/4096.4 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}At-risk & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 84 & \makecell[l]{0/4096.4 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/4096.4 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/4096.4 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}At-risk & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 123 & \makecell[l]{331.2/331.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{331.2/331.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{331.2/331.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}At-risk & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 123 & \makecell[l]{331.2/331.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{331.2/331.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{331.2/331.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not at-risk & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 445 & \makecell[l]{9558.4/9558.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{9558.4/9558.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{9558.4/9558.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not at-risk & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 445 & \makecell[l]{9558.4/9558.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{9558.4/9558.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{9558.4/9558.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not at-risk & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 149 & \makecell[l]{1063.2/1063.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1063.2/1063.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1063.2/1063.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not at-risk & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 149 & \makecell[l]{1063.2/1063.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1063.2/1063.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1063.2/1063.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not at-risk & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 79 & \makecell[l]{0/9262.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/9262.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/9262.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Not at-risk & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 79 & \makecell[l]{0/9262.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/9262.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/9262.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Not at-risk & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 147 & \makecell[l]{1025.8/1025.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1025.8/1025.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1025.8/1025.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not at-risk & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 147 & \makecell[l]{1025.8/1025.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1025.8/1025.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1025.8/1025.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not at-risk & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 445 & \makecell[l]{9558.4/9558.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{9558.4/9558.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{9558.4/9558.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not at-risk & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 445 & \makecell[l]{9558.4/9558.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{9558.4/9558.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{9558.4/9558.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not at-risk & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 149 & \makecell[l]{1063.2/1063.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1063.2/1063.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1063.2/1063.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not at-risk & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 149 & \makecell[l]{1063.2/1063.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1063.2/1063.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1063.2/1063.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not at-risk & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 79 & \makecell[l]{0/9262.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/9262.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/9262.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Not at-risk & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 79 & \makecell[l]{0/9262.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/9262.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/9262.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Not at-risk & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 147 & \makecell[l]{1025.8/1025.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1025.8/1025.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1025.8/1025.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not at-risk & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 147 & \makecell[l]{1025.8/1025.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1025.8/1025.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1025.8/1025.8 = 100.0\%\\(100.0\%, 100.0\%)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item Binding Antibody Responders are defined as participants who had
        baseline values below the LLOD with detectable antibody concentration
        above the assay LLOD, or as participants with baseline values above
        the LLOD with a 4-fold increase in antibody concentration.
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{2.7cm}llllllll}
\caption{\label{tab:tabs}Table 3d. Percentage of responders, and participants
      with concentrations $\geq$ 2 x LLOD or $\geq$ 4 x LLOD for binding antibody
      markers by Age, Risk for Severe Covid-19}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% Greater than 2xLLOD & \% Greater than 4xLLOD\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% Greater than 2xLLOD & \% Greater than 4xLLOD\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{9}{l}{\textbf{Age, Risk for Severe Covid-19}}\\
\hspace{1em}Age $<$ 65 At-risk & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 214 & \makecell[l]{2279/2279 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{2279/2279 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{2279/2279 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 214 & \makecell[l]{2279/2279 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{2279/2279 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{2279/2279 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 73 & \makecell[l]{248/248 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{248/248 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{248/248 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 73 & \makecell[l]{248/248 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{248/248 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{248/248 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 40 & \makecell[l]{0/2454 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/2454 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/2454 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 40 & \makecell[l]{0/2454 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/2454 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/2454 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 75 & \makecell[l]{226/226 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{226/226 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{226/226 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 75 & \makecell[l]{226/226 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{226/226 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{226/226 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 214 & \makecell[l]{2279/2279 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{2279/2279 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{2279/2279 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 214 & \makecell[l]{2279/2279 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{2279/2279 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{2279/2279 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 73 & \makecell[l]{248/248 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{248/248 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{248/248 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 73 & \makecell[l]{248/248 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{248/248 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{248/248 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 40 & \makecell[l]{76.3/2454 = 3.1\%\\(0.4\%, 20.6\%)} & \makecell[l]{0/2454 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/2454 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 40 & \makecell[l]{0/2454 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/2454 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/2454 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 75 & \makecell[l]{226/226 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{226/226 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{226/226 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 75 & \makecell[l]{226/226 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{226/226 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{226/226 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 218 & \makecell[l]{8239/8239 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{8239/8239 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{8239/8239 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 218 & \makecell[l]{8239/8239 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{8239/8239 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{8239/8239 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 73 & \makecell[l]{897/897 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{897/897 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{897/897 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 73 & \makecell[l]{897/897 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{897/897 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{897/897 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 40 & \makecell[l]{0/7780 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/7780 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/7780 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 40 & \makecell[l]{0/7780 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/7780 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/7780 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 72 & \makecell[l]{872/872 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{872/872 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{872/872 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 72 & \makecell[l]{872/872 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{872/872 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{872/872 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 218 & \makecell[l]{8239/8239 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{8239/8239 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{8239/8239 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 218 & \makecell[l]{8239/8239 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{8239/8239 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{8239/8239 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 73 & \makecell[l]{897/897 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{897/897 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{897/897 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 73 & \makecell[l]{897/897 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{897/897 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{897/897 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 40 & \makecell[l]{0/7780 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/7780 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/7780 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 40 & \makecell[l]{0/7780 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/7780 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/7780 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 72 & \makecell[l]{872/872 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{872/872 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{872/872 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 72 & \makecell[l]{872/872 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{872/872 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{872/872 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 255 & \makecell[l]{1457.6/1457.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1457.6/1457.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1457.6/1457.6 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 255 & \makecell[l]{1457.6/1457.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1457.6/1457.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1457.6/1457.6 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 52 & \makecell[l]{120.8/120.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{120.8/120.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{120.8/120.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 52 & \makecell[l]{120.8/120.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{120.8/120.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{120.8/120.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 44 & \makecell[l]{0/1642.4 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1642.4 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1642.4 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 44 & \makecell[l]{0/1642.4 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1642.4 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1642.4 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 48 & \makecell[l]{105.2/105.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{105.2/105.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{105.2/105.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 48 & \makecell[l]{105.2/105.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{105.2/105.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{105.2/105.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 255 & \makecell[l]{1457.6/1457.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1457.6/1457.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1457.6/1457.6 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 255 & \makecell[l]{1457.6/1457.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1457.6/1457.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1457.6/1457.6 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 52 & \makecell[l]{120.8/120.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{120.8/120.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{120.8/120.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 52 & \makecell[l]{120.8/120.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{120.8/120.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{120.8/120.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 44 & \makecell[l]{0/1642.4 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1642.4 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1642.4 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 44 & \makecell[l]{0/1642.4 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1642.4 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1642.4 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 48 & \makecell[l]{105.2/105.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{105.2/105.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{105.2/105.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 48 & \makecell[l]{105.2/105.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{105.2/105.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{105.2/105.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 227 & \makecell[l]{1319.4/1319.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1319.4/1319.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1319.4/1319.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 227 & \makecell[l]{1319.4/1319.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1319.4/1319.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1319.4/1319.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 76 & \makecell[l]{166.2/166.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{166.2/166.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{166.2/166.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 76 & \makecell[l]{166.2/166.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{166.2/166.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{166.2/166.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 39 & \makecell[l]{0/1482.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1482.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1482.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 39 & \makecell[l]{0/1482.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1482.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1482.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 75 & \makecell[l]{153.8/153.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{153.8/153.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{153.8/153.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 75 & \makecell[l]{153.8/153.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{153.8/153.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{153.8/153.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 227 & \makecell[l]{1319.4/1319.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1319.4/1319.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1319.4/1319.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 227 & \makecell[l]{1319.4/1319.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1319.4/1319.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1319.4/1319.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 76 & \makecell[l]{166.2/166.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{166.2/166.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{166.2/166.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 76 & \makecell[l]{166.2/166.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{166.2/166.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{166.2/166.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 39 & \makecell[l]{0/1482.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1482.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1482.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 39 & \makecell[l]{0/1482.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1482.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1482.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 75 & \makecell[l]{153.8/153.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{153.8/153.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{153.8/153.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 75 & \makecell[l]{153.8/153.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{153.8/153.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{153.8/153.8 = 100.0\%\\(100.0\%, 100.0\%)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item Binding Antibody Responders are defined as participants who had
        baseline values below the LLOD with detectable antibody concentration
        above the assay LLOD, or as participants with baseline values above
        the LLOD with a 4-fold increase in antibody concentration.
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{2.7cm}llllllll}
\caption{\label{tab:tabs}Table 3e. Percentage of responders, and participants
      with concentrations $\geq$ 2 x LLOD or $\geq$ 4 x LLOD for binding antibody
      markers by Sex}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% Greater than 2xLLOD & \% Greater than 4xLLOD\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% Greater than 2xLLOD & \% Greater than 4xLLOD\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{9}{l}{\textbf{Sex}}\\
\hspace{1em}Male & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 395 & \makecell[l]{5298.6/5298.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{5298.6/5298.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{5298.6/5298.6 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Male & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 395 & \makecell[l]{5298.6/5298.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{5298.6/5298.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{5298.6/5298.6 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Male & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 121 & \makecell[l]{564.7/564.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{564.7/564.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{564.7/564.7 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Male & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 121 & \makecell[l]{564.7/564.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{564.7/564.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{564.7/564.7 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Male & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 76 & \makecell[l]{0/4771.7 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/4771.7 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/4771.7 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Male & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 76 & \makecell[l]{0/4771.7 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/4771.7 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/4771.7 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Male & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 115 & \makecell[l]{529.2/529.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{529.2/529.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{529.2/529.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Male & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 115 & \makecell[l]{529.2/529.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{529.2/529.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{529.2/529.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Male & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 395 & \makecell[l]{5298.6/5298.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{5298.6/5298.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{5298.6/5298.6 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Male & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 395 & \makecell[l]{5298.6/5298.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{5298.6/5298.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{5298.6/5298.6 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Male & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 121 & \makecell[l]{564.7/564.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{564.7/564.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{564.7/564.7 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Male & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 121 & \makecell[l]{564.7/564.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{564.7/564.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{564.7/564.7 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Male & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 76 & \makecell[l]{76.3/4771.7 = 1.6\%\\(0.2\%, 11.0\%)} & \makecell[l]{0/4771.7 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/4771.7 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Male & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 76 & \makecell[l]{0/4771.7 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/4771.7 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/4771.7 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Male & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 115 & \makecell[l]{529.2/529.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{529.2/529.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{529.2/529.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Male & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 115 & \makecell[l]{529.2/529.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{529.2/529.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{529.2/529.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Female & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 519 & \makecell[l]{7996.4/7996.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{7996.4/7996.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{7996.4/7996.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Female & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 519 & \makecell[l]{7996.4/7996.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{7996.4/7996.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{7996.4/7996.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Female & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 153 & \makecell[l]{867.3/867.3 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{867.3/867.3 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{867.3/867.3 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Female & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 153 & \makecell[l]{867.3/867.3 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{867.3/867.3 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{867.3/867.3 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Female & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 87 & \makecell[l]{0/8587.3 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/8587.3 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/8587.3 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Female & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 87 & \makecell[l]{0/8587.3 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/8587.3 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/8587.3 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Female & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 155 & \makecell[l]{827.8/827.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{827.8/827.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{827.8/827.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Female & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 155 & \makecell[l]{827.8/827.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{827.8/827.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{827.8/827.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Female & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 519 & \makecell[l]{7996.4/7996.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{7996.4/7996.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{7996.4/7996.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Female & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 519 & \makecell[l]{7996.4/7996.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{7996.4/7996.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{7996.4/7996.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Female & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 153 & \makecell[l]{867.3/867.3 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{867.3/867.3 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{867.3/867.3 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Female & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 153 & \makecell[l]{867.3/867.3 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{867.3/867.3 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{867.3/867.3 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Female & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 87 & \makecell[l]{0/8587.3 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/8587.3 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/8587.3 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Female & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 87 & \makecell[l]{0/8587.3 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/8587.3 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/8587.3 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Female & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 155 & \makecell[l]{827.8/827.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{827.8/827.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{827.8/827.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Female & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 155 & \makecell[l]{827.8/827.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{827.8/827.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{827.8/827.8 = 100.0\%\\(100.0\%, 100.0\%)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item Binding Antibody Responders are defined as participants who had
        baseline values below the LLOD with detectable antibody concentration
        above the assay LLOD, or as participants with baseline values above
        the LLOD with a 4-fold increase in antibody concentration.
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{2.7cm}llllllll}
\caption{\label{tab:tabs}Table 3f. Percentage of responders, and participants
      with concentrations $\geq$ 2 x LLOD or $\geq$ 4 x LLOD for binding antibody
      markers by Age, sex}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% Greater than 2xLLOD & \% Greater than 4xLLOD\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% Greater than 2xLLOD & \% Greater than 4xLLOD\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{9}{l}{\textbf{Age, sex}}\\
\hspace{1em}Age $<$ 65 Female & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 269 & \makecell[l]{6524.4/6524.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{6524.4/6524.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{6524.4/6524.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Female & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 269 & \makecell[l]{6524.4/6524.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{6524.4/6524.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{6524.4/6524.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Female & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 79 & \makecell[l]{701.8/701.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{701.8/701.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{701.8/701.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Female & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 79 & \makecell[l]{701.8/701.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{701.8/701.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{701.8/701.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Female & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 52 & \makecell[l]{0/7188.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/7188.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/7188.8 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 Female & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 52 & \makecell[l]{0/7188.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/7188.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/7188.8 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 Female & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 83 & \makecell[l]{673.1/673.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{673.1/673.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{673.1/673.1 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Female & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 83 & \makecell[l]{673.1/673.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{673.1/673.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{673.1/673.1 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Female & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 269 & \makecell[l]{6524.4/6524.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{6524.4/6524.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{6524.4/6524.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Female & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 269 & \makecell[l]{6524.4/6524.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{6524.4/6524.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{6524.4/6524.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Female & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 79 & \makecell[l]{701.8/701.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{701.8/701.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{701.8/701.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Female & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 79 & \makecell[l]{701.8/701.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{701.8/701.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{701.8/701.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Female & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 52 & \makecell[l]{0/7188.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/7188.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/7188.8 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 Female & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 52 & \makecell[l]{0/7188.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/7188.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/7188.8 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 Female & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 83 & \makecell[l]{673.1/673.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{673.1/673.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{673.1/673.1 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Female & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 83 & \makecell[l]{673.1/673.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{673.1/673.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{673.1/673.1 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Male & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 163 & \makecell[l]{3993.6/3993.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{3993.6/3993.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{3993.6/3993.6 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Male & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 163 & \makecell[l]{3993.6/3993.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{3993.6/3993.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{3993.6/3993.6 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Male & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 67 & \makecell[l]{443.2/443.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{443.2/443.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{443.2/443.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Male & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 67 & \makecell[l]{443.2/443.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{443.2/443.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{443.2/443.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Male & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 28 & \makecell[l]{0/3045.2 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/3045.2 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/3045.2 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 Male & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 28 & \makecell[l]{0/3045.2 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/3045.2 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/3045.2 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 Male & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 64 & \makecell[l]{424.9/424.9 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{424.9/424.9 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{424.9/424.9 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Male & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 64 & \makecell[l]{424.9/424.9 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{424.9/424.9 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{424.9/424.9 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Male & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 163 & \makecell[l]{3993.6/3993.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{3993.6/3993.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{3993.6/3993.6 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Male & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 163 & \makecell[l]{3993.6/3993.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{3993.6/3993.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{3993.6/3993.6 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Male & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 67 & \makecell[l]{443.2/443.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{443.2/443.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{443.2/443.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Male & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 67 & \makecell[l]{443.2/443.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{443.2/443.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{443.2/443.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Male & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 28 & \makecell[l]{76.3/3045.2 = 2.5\%\\(0.3\%, 17.6\%)} & \makecell[l]{0/3045.2 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/3045.2 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 Male & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 28 & \makecell[l]{0/3045.2 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/3045.2 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/3045.2 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 Male & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 64 & \makecell[l]{424.9/424.9 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{424.9/424.9 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{424.9/424.9 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Male & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 64 & \makecell[l]{424.9/424.9 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{424.9/424.9 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{424.9/424.9 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 232 & \makecell[l]{1305/1305 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1305/1305 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1305/1305 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 232 & \makecell[l]{1305/1305 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1305/1305 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1305/1305 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 54 & \makecell[l]{121.5/121.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{121.5/121.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{121.5/121.5 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 54 & \makecell[l]{121.5/121.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{121.5/121.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{121.5/121.5 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 48 & \makecell[l]{0/1726.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1726.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1726.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 48 & \makecell[l]{0/1726.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1726.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1726.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 51 & \makecell[l]{104.4/104.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{104.4/104.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{104.4/104.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 51 & \makecell[l]{104.4/104.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{104.4/104.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{104.4/104.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 232 & \makecell[l]{1305/1305 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1305/1305 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1305/1305 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 232 & \makecell[l]{1305/1305 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1305/1305 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1305/1305 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 54 & \makecell[l]{121.5/121.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{121.5/121.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{121.5/121.5 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 54 & \makecell[l]{121.5/121.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{121.5/121.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{121.5/121.5 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 48 & \makecell[l]{0/1726.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1726.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1726.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 48 & \makecell[l]{0/1726.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1726.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1726.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 51 & \makecell[l]{104.4/104.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{104.4/104.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{104.4/104.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 51 & \makecell[l]{104.4/104.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{104.4/104.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{104.4/104.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 250 & \makecell[l]{1472/1472 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1472/1472 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1472/1472 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 250 & \makecell[l]{1472/1472 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1472/1472 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1472/1472 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 74 & \makecell[l]{165.5/165.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{165.5/165.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{165.5/165.5 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 74 & \makecell[l]{165.5/165.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{165.5/165.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{165.5/165.5 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 35 & \makecell[l]{0/1398.4 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1398.4 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1398.4 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 35 & \makecell[l]{0/1398.4 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1398.4 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1398.4 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 72 & \makecell[l]{154.6/154.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{154.6/154.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{154.6/154.6 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 72 & \makecell[l]{154.6/154.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{154.6/154.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{154.6/154.6 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 250 & \makecell[l]{1472/1472 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1472/1472 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1472/1472 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 250 & \makecell[l]{1472/1472 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1472/1472 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1472/1472 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 74 & \makecell[l]{165.5/165.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{165.5/165.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{165.5/165.5 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 74 & \makecell[l]{165.5/165.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{165.5/165.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{165.5/165.5 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 35 & \makecell[l]{0/1398.4 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1398.4 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1398.4 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 35 & \makecell[l]{0/1398.4 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1398.4 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1398.4 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 72 & \makecell[l]{154.6/154.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{154.6/154.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{154.6/154.6 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 72 & \makecell[l]{154.6/154.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{154.6/154.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{154.6/154.6 = 100.0\%\\(100.0\%, 100.0\%)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item Binding Antibody Responders are defined as participants who had
        baseline values below the LLOD with detectable antibody concentration
        above the assay LLOD, or as participants with baseline values above
        the LLOD with a 4-fold increase in antibody concentration.
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{2.7cm}llllllll}
\caption{\label{tab:tabs}Table 3g. Percentage of responders, and participants
      with concentrations $\geq$ 2 x LLOD or $\geq$ 4 x LLOD for binding antibody
      markers by Hispanic or Latino ethnicity}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% Greater than 2xLLOD & \% Greater than 4xLLOD\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% Greater than 2xLLOD & \% Greater than 4xLLOD\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{9}{l}{\textbf{Hispanic or Latino ethnicity}}\\
\hspace{1em}Hispanic or Latino & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 136 & \makecell[l]{1363.4/1363.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1363.4/1363.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1363.4/1363.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Hispanic or Latino & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 136 & \makecell[l]{1363.4/1363.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1363.4/1363.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1363.4/1363.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Hispanic or Latino & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 35 & \makecell[l]{145.7/145.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{145.7/145.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{145.7/145.7 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Hispanic or Latino & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 35 & \makecell[l]{145.7/145.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{145.7/145.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{145.7/145.7 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Hispanic or Latino & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 20 & \makecell[l]{0/1237.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1237.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1237.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Hispanic or Latino & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 20 & \makecell[l]{0/1237.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1237.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1237.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Hispanic or Latino & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 38 & \makecell[l]{133.7/133.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{133.7/133.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{133.7/133.7 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Hispanic or Latino & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 38 & \makecell[l]{133.7/133.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{133.7/133.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{133.7/133.7 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Hispanic or Latino & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 136 & \makecell[l]{1363.4/1363.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1363.4/1363.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1363.4/1363.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Hispanic or Latino & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 136 & \makecell[l]{1363.4/1363.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1363.4/1363.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1363.4/1363.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Hispanic or Latino & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 35 & \makecell[l]{145.7/145.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{145.7/145.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{145.7/145.7 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Hispanic or Latino & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 35 & \makecell[l]{145.7/145.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{145.7/145.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{145.7/145.7 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Hispanic or Latino & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 20 & \makecell[l]{0/1237.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1237.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1237.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Hispanic or Latino & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 20 & \makecell[l]{0/1237.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1237.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1237.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Hispanic or Latino & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 38 & \makecell[l]{133.7/133.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{133.7/133.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{133.7/133.7 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Hispanic or Latino & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 38 & \makecell[l]{133.7/133.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{133.7/133.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{133.7/133.7 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not Hispanic or Latino & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 690 & \makecell[l]{10481.2/10481.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{10481.2/10481.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{10481.2/10481.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not Hispanic or Latino & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 690 & \makecell[l]{10481.2/10481.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{10481.2/10481.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{10481.2/10481.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not Hispanic or Latino & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 217 & \makecell[l]{1162.3/1162.3 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1162.3/1162.3 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1162.3/1162.3 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not Hispanic or Latino & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 217 & \makecell[l]{1162.3/1162.3 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1162.3/1162.3 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1162.3/1162.3 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not Hispanic or Latino & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 130 & \makecell[l]{0/10828.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/10828.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/10828.8 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Not Hispanic or Latino & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 130 & \makecell[l]{0/10828.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/10828.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/10828.8 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Not Hispanic or Latino & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 214 & \makecell[l]{1121.8/1121.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1121.8/1121.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1121.8/1121.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not Hispanic or Latino & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 214 & \makecell[l]{1121.8/1121.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1121.8/1121.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1121.8/1121.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not Hispanic or Latino & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 690 & \makecell[l]{10481.2/10481.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{10481.2/10481.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{10481.2/10481.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not Hispanic or Latino & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 690 & \makecell[l]{10481.2/10481.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{10481.2/10481.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{10481.2/10481.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not Hispanic or Latino & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 217 & \makecell[l]{1162.3/1162.3 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1162.3/1162.3 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1162.3/1162.3 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not Hispanic or Latino & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 217 & \makecell[l]{1162.3/1162.3 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1162.3/1162.3 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1162.3/1162.3 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not Hispanic or Latino & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 130 & \makecell[l]{76.3/10828.8 = 0.7\%\\(0.1\%, 4.9\%)} & \makecell[l]{0/10828.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/10828.8 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Not Hispanic or Latino & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 130 & \makecell[l]{0/10828.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/10828.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/10828.8 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Not Hispanic or Latino & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 214 & \makecell[l]{1121.8/1121.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1121.8/1121.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1121.8/1121.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not Hispanic or Latino & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 214 & \makecell[l]{1121.8/1121.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1121.8/1121.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1121.8/1121.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not reported and unknown & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 88 & \makecell[l]{1450.4/1450.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1450.4/1450.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1450.4/1450.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not reported and unknown & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 88 & \makecell[l]{1450.4/1450.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1450.4/1450.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1450.4/1450.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not reported and unknown & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 22 & \makecell[l]{124/124 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{124/124 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{124/124 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not reported and unknown & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 22 & \makecell[l]{124/124 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{124/124 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{124/124 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not reported and unknown & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 13 & \makecell[l]{0/1292.7 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1292.7 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1292.7 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Not reported and unknown & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 13 & \makecell[l]{0/1292.7 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1292.7 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1292.7 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Not reported and unknown & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 18 & \makecell[l]{101.5/101.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{101.5/101.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{101.5/101.5 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not reported and unknown & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 18 & \makecell[l]{101.5/101.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{101.5/101.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{101.5/101.5 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not reported and unknown & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 88 & \makecell[l]{1450.4/1450.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1450.4/1450.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1450.4/1450.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not reported and unknown & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 88 & \makecell[l]{1450.4/1450.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1450.4/1450.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1450.4/1450.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not reported and unknown & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 22 & \makecell[l]{124/124 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{124/124 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{124/124 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not reported and unknown & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 22 & \makecell[l]{124/124 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{124/124 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{124/124 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not reported and unknown & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 13 & \makecell[l]{0/1292.7 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1292.7 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1292.7 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Not reported and unknown & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 13 & \makecell[l]{0/1292.7 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1292.7 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1292.7 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Not reported and unknown & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 18 & \makecell[l]{101.5/101.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{101.5/101.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{101.5/101.5 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not reported and unknown & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 18 & \makecell[l]{101.5/101.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{101.5/101.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{101.5/101.5 = 100.0\%\\(100.0\%, 100.0\%)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item Binding Antibody Responders are defined as participants who had
        baseline values below the LLOD with detectable antibody concentration
        above the assay LLOD, or as participants with baseline values above
        the LLOD with a 4-fold increase in antibody concentration.
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{2.7cm}llllllll}
\caption{\label{tab:tabs}Table 3h. Percentage of responders, and participants
      with concentrations $\geq$ 2 x LLOD or $\geq$ 4 x LLOD for binding antibody
      markers by Race}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% Greater than 2xLLOD & \% Greater than 4xLLOD\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% Greater than 2xLLOD & \% Greater than 4xLLOD\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{9}{l}{\textbf{Race}}\\
\hspace{1em}White Non-Hispanic & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 362 & \makecell[l]{6597/6597 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{6597/6597 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{6597/6597 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 362 & \makecell[l]{6597/6597 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{6597/6597 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{6597/6597 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 125 & \makecell[l]{773.8/773.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{773.8/773.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{773.8/773.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 125 & \makecell[l]{773.8/773.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{773.8/773.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{773.8/773.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 67 & \makecell[l]{0/6586.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/6586.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/6586.8 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 67 & \makecell[l]{0/6586.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/6586.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/6586.8 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 121 & \makecell[l]{666.4/666.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{666.4/666.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{666.4/666.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 121 & \makecell[l]{666.4/666.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{666.4/666.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{666.4/666.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 362 & \makecell[l]{6597/6597 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{6597/6597 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{6597/6597 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 362 & \makecell[l]{6597/6597 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{6597/6597 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{6597/6597 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 125 & \makecell[l]{773.8/773.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{773.8/773.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{773.8/773.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 125 & \makecell[l]{773.8/773.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{773.8/773.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{773.8/773.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 67 & \makecell[l]{76.3/6586.8 = 1.2\%\\(0.2\%, 8.1\%)} & \makecell[l]{0/6586.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/6586.8 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 67 & \makecell[l]{0/6586.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/6586.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/6586.8 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 121 & \makecell[l]{666.4/666.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{666.4/666.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{666.4/666.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 121 & \makecell[l]{666.4/666.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{666.4/666.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{666.4/666.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Black or African American & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 195 & \makecell[l]{2012.2/2012.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{2012.2/2012.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{2012.2/2012.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Black or African American & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 195 & \makecell[l]{2012.2/2012.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{2012.2/2012.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{2012.2/2012.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Black or African American & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 52 & \makecell[l]{195.6/195.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{195.6/195.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{195.6/195.6 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Black or African American & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 52 & \makecell[l]{195.6/195.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{195.6/195.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{195.6/195.6 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Black or African American & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 39 & \makecell[l]{0/2311.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/2311.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/2311.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Black or African American & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 39 & \makecell[l]{0/2311.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/2311.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/2311.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Black or African American & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 60 & \makecell[l]{265.1/265.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{265.1/265.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{265.1/265.1 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Black or African American & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 60 & \makecell[l]{265.1/265.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{265.1/265.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{265.1/265.1 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Black or African American & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 195 & \makecell[l]{2012.2/2012.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{2012.2/2012.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{2012.2/2012.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Black or African American & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 195 & \makecell[l]{2012.2/2012.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{2012.2/2012.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{2012.2/2012.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Black or African American & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 52 & \makecell[l]{195.6/195.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{195.6/195.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{195.6/195.6 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Black or African American & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 52 & \makecell[l]{195.6/195.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{195.6/195.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{195.6/195.6 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Black or African American & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 39 & \makecell[l]{0/2311.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/2311.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/2311.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Black or African American & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 39 & \makecell[l]{0/2311.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/2311.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/2311.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Black or African American & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 60 & \makecell[l]{265.1/265.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{265.1/265.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{265.1/265.1 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Black or African American & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 60 & \makecell[l]{265.1/265.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{265.1/265.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{265.1/265.1 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Asian & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 67 & \makecell[l]{673.6/673.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{673.6/673.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{673.6/673.6 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Asian & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 67 & \makecell[l]{673.6/673.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{673.6/673.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{673.6/673.6 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Asian & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 24 & \makecell[l]{81.1/81.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{81.1/81.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{81.1/81.1 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Asian & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 24 & \makecell[l]{81.1/81.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{81.1/81.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{81.1/81.1 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Asian & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 12 & \makecell[l]{0/609.1 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/609.1 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/609.1 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Asian & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 12 & \makecell[l]{0/609.1 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/609.1 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/609.1 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Asian & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 13 & \makecell[l]{48.4/48.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{48.4/48.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{48.4/48.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Asian & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 13 & \makecell[l]{48.4/48.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{48.4/48.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{48.4/48.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Asian & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 67 & \makecell[l]{673.6/673.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{673.6/673.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{673.6/673.6 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Asian & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 67 & \makecell[l]{673.6/673.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{673.6/673.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{673.6/673.6 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Asian & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 24 & \makecell[l]{81.1/81.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{81.1/81.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{81.1/81.1 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Asian & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 24 & \makecell[l]{81.1/81.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{81.1/81.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{81.1/81.1 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Asian & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 12 & \makecell[l]{0/609.1 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/609.1 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/609.1 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Asian & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 12 & \makecell[l]{0/609.1 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/609.1 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/609.1 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Asian & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 13 & \makecell[l]{48.4/48.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{48.4/48.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{48.4/48.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Asian & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 13 & \makecell[l]{48.4/48.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{48.4/48.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{48.4/48.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}American Indian or Alaska Native & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 13 & \makecell[l]{151.4/151.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{151.4/151.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{151.4/151.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}American Indian or Alaska Native & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 13 & \makecell[l]{151.4/151.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{151.4/151.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{151.4/151.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}American Indian or Alaska Native & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 6 & \makecell[l]{31.1/31.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{31.1/31.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{31.1/31.1 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}American Indian or Alaska Native & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 6 & \makecell[l]{31.1/31.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{31.1/31.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{31.1/31.1 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}American Indian or Alaska Native & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 5 & \makecell[l]{0/247.2 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/247.2 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/247.2 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}American Indian or Alaska Native & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 5 & \makecell[l]{0/247.2 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/247.2 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/247.2 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}American Indian or Alaska Native & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 4 & 15.3/15.3 = 100.0\% & 15.3/15.3 = 100.0\% & 15.3/15.3 = 100.0\%\\
\hspace{1em}American Indian or Alaska Native & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 4 & 15.3/15.3 = 100.0\% & 15.3/15.3 = 100.0\% & 15.3/15.3 = 100.0\%\\
\hspace{1em}American Indian or Alaska Native & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 13 & \makecell[l]{151.4/151.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{151.4/151.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{151.4/151.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}American Indian or Alaska Native & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 13 & \makecell[l]{151.4/151.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{151.4/151.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{151.4/151.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}American Indian or Alaska Native & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 6 & \makecell[l]{31.1/31.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{31.1/31.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{31.1/31.1 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}American Indian or Alaska Native & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 6 & \makecell[l]{31.1/31.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{31.1/31.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{31.1/31.1 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}American Indian or Alaska Native & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 5 & \makecell[l]{0/247.2 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/247.2 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/247.2 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}American Indian or Alaska Native & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 5 & \makecell[l]{0/247.2 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/247.2 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/247.2 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}American Indian or Alaska Native & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 4 & 15.3/15.3 = 100.0\% & 15.3/15.3 = 100.0\% & 15.3/15.3 = 100.0\%\\
\hspace{1em}American Indian or Alaska Native & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 4 & 15.3/15.3 = 100.0\% & 15.3/15.3 = 100.0\% & 15.3/15.3 = 100.0\%\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 17 & \makecell[l]{98.2/98.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{98.2/98.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{98.2/98.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 17 & \makecell[l]{98.2/98.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{98.2/98.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{98.2/98.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 5 & \makecell[l]{23/23 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{23/23 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{23/23 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 5 & \makecell[l]{23/23 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{23/23 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{23/23 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 1 & 0/28.8 = 0.0\% & 0/28.8 = 0.0\% & 0/28.8 = 0.0\%\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 1 & 0/28.8 = 0.0\% & 0/28.8 = 0.0\% & 0/28.8 = 0.0\%\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 1 & 2.5/2.5 = 100.0\% & 2.5/2.5 = 100.0\% & 2.5/2.5 = 100.0\%\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 1 & 2.5/2.5 = 100.0\% & 2.5/2.5 = 100.0\% & 2.5/2.5 = 100.0\%\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 17 & \makecell[l]{98.2/98.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{98.2/98.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{98.2/98.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 17 & \makecell[l]{98.2/98.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{98.2/98.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{98.2/98.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 5 & \makecell[l]{23/23 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{23/23 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{23/23 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 5 & \makecell[l]{23/23 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{23/23 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{23/23 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 1 & 0/28.8 = 0.0\% & 0/28.8 = 0.0\% & 0/28.8 = 0.0\%\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 1 & 0/28.8 = 0.0\% & 0/28.8 = 0.0\% & 0/28.8 = 0.0\%\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 1 & 2.5/2.5 = 100.0\% & 2.5/2.5 = 100.0\% & 2.5/2.5 = 100.0\%\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 1 & 2.5/2.5 = 100.0\% & 2.5/2.5 = 100.0\% & 2.5/2.5 = 100.0\%\\
\hspace{1em}Multiracial & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 52 & \makecell[l]{498.5/498.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{498.5/498.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{498.5/498.5 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Multiracial & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 52 & \makecell[l]{498.5/498.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{498.5/498.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{498.5/498.5 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Multiracial & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 12 & \makecell[l]{56.4/56.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{56.4/56.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{56.4/56.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Multiracial & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 12 & \makecell[l]{56.4/56.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{56.4/56.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{56.4/56.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Multiracial & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 8 & \makecell[l]{0/554 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/554 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/554 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Multiracial & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 8 & \makecell[l]{0/554 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/554 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/554 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Multiracial & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 19 & \makecell[l]{61.4/61.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{61.4/61.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{61.4/61.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Multiracial & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 19 & \makecell[l]{61.4/61.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{61.4/61.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{61.4/61.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Multiracial & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 52 & \makecell[l]{498.5/498.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{498.5/498.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{498.5/498.5 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Multiracial & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 52 & \makecell[l]{498.5/498.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{498.5/498.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{498.5/498.5 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Multiracial & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 12 & \makecell[l]{56.4/56.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{56.4/56.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{56.4/56.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Multiracial & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 12 & \makecell[l]{56.4/56.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{56.4/56.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{56.4/56.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Multiracial & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 8 & \makecell[l]{0/554 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/554 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/554 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Multiracial & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 8 & \makecell[l]{0/554 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/554 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/554 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Multiracial & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 19 & \makecell[l]{61.4/61.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{61.4/61.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{61.4/61.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Multiracial & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 19 & \makecell[l]{61.4/61.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{61.4/61.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{61.4/61.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Other & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 34 & \makecell[l]{469.2/469.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{469.2/469.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{469.2/469.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Other & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 34 & \makecell[l]{469.2/469.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{469.2/469.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{469.2/469.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Other & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 7 & \makecell[l]{13.8/13.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{13.8/13.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{13.8/13.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Other & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 7 & \makecell[l]{13.8/13.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{13.8/13.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{13.8/13.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Other & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 4 & 0/232.6 = 0.0\% & 0/232.6 = 0.0\% & 0/232.6 = 0.0\%\\
\hspace{1em}Other & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 4 & 0/232.6 = 0.0\% & 0/232.6 = 0.0\% & 0/232.6 = 0.0\%\\
\hspace{1em}Other & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 5 & \makecell[l]{24.1/24.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{24.1/24.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{24.1/24.1 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Other & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 5 & \makecell[l]{24.1/24.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{24.1/24.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{24.1/24.1 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Other & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 34 & \makecell[l]{469.2/469.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{469.2/469.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{469.2/469.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Other & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 34 & \makecell[l]{469.2/469.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{469.2/469.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{469.2/469.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Other & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 7 & \makecell[l]{13.8/13.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{13.8/13.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{13.8/13.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Other & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 7 & \makecell[l]{13.8/13.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{13.8/13.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{13.8/13.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Other & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 4 & 0/232.6 = 0.0\% & 0/232.6 = 0.0\% & 0/232.6 = 0.0\%\\
\hspace{1em}Other & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 4 & 0/232.6 = 0.0\% & 0/232.6 = 0.0\% & 0/232.6 = 0.0\%\\
\hspace{1em}Other & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 5 & \makecell[l]{24.1/24.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{24.1/24.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{24.1/24.1 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Other & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 5 & \makecell[l]{24.1/24.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{24.1/24.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{24.1/24.1 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not reported and unknown & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 87 & \makecell[l]{1413.2/1413.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1413.2/1413.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1413.2/1413.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not reported and unknown & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 87 & \makecell[l]{1413.2/1413.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1413.2/1413.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1413.2/1413.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not reported and unknown & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 20 & \makecell[l]{155/155 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{155/155 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{155/155 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not reported and unknown & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 20 & \makecell[l]{155/155 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{155/155 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{155/155 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not reported and unknown & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 14 & \makecell[l]{0/1337.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1337.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1337.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Not reported and unknown & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 14 & \makecell[l]{0/1337.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1337.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1337.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Not reported and unknown & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 24 & \makecell[l]{165.4/165.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{165.4/165.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{165.4/165.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not reported and unknown & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 24 & \makecell[l]{165.4/165.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{165.4/165.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{165.4/165.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not reported and unknown & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 87 & \makecell[l]{1413.2/1413.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1413.2/1413.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1413.2/1413.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not reported and unknown & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 87 & \makecell[l]{1413.2/1413.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1413.2/1413.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1413.2/1413.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not reported and unknown & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 20 & \makecell[l]{155/155 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{155/155 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{155/155 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not reported and unknown & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 20 & \makecell[l]{155/155 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{155/155 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{155/155 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not reported and unknown & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 14 & \makecell[l]{0/1337.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1337.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1337.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Not reported and unknown & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 14 & \makecell[l]{0/1337.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1337.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1337.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Not reported and unknown & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 24 & \makecell[l]{165.4/165.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{165.4/165.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{165.4/165.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not reported and unknown & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 24 & \makecell[l]{165.4/165.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{165.4/165.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{165.4/165.4 = 100.0\%\\(100.0\%, 100.0\%)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item Binding Antibody Responders are defined as participants who had
        baseline values below the LLOD with detectable antibody concentration
        above the assay LLOD, or as participants with baseline values above
        the LLOD with a 4-fold increase in antibody concentration.
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{2.7cm}llllllll}
\caption{\label{tab:tabs}Table 3i. Percentage of responders, and participants
      with concentrations $\geq$ 2 x LLOD or $\geq$ 4 x LLOD for binding antibody
      markers by Underrepresented minority status}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% Greater than 2xLLOD & \% Greater than 4xLLOD\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% Greater than 2xLLOD & \% Greater than 4xLLOD\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{9}{l}{\textbf{Underrepresented minority status}}\\
\hspace{1em}Communities of Color & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 420 & \makecell[l]{4289/4289 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{4289/4289 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{4289/4289 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Communities of Color & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 420 & \makecell[l]{4289/4289 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{4289/4289 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{4289/4289 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Communities of Color & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 120 & \makecell[l]{462/462 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{462/462 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{462/462 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Communities of Color & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 120 & \makecell[l]{462/462 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{462/462 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{462/462 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Communities of Color & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 73 & \makecell[l]{0/4319 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/4319 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/4319 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Communities of Color & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 73 & \makecell[l]{0/4319 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/4319 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/4319 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Communities of Color & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 111 & \makecell[l]{439/439 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{439/439 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{439/439 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Communities of Color & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 111 & \makecell[l]{439/439 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{439/439 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{439/439 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Communities of Color & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 420 & \makecell[l]{4289/4289 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{4289/4289 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{4289/4289 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Communities of Color & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 420 & \makecell[l]{4289/4289 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{4289/4289 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{4289/4289 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Communities of Color & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 120 & \makecell[l]{462/462 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{462/462 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{462/462 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Communities of Color & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 120 & \makecell[l]{462/462 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{462/462 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{462/462 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Communities of Color & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 73 & \makecell[l]{0/4319 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/4319 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/4319 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Communities of Color & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 73 & \makecell[l]{0/4319 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/4319 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/4319 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Communities of Color & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 111 & \makecell[l]{439/439 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{439/439 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{439/439 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Communities of Color & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 111 & \makecell[l]{439/439 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{439/439 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{439/439 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 362 & \makecell[l]{6597/6597 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{6597/6597 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{6597/6597 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 362 & \makecell[l]{6597/6597 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{6597/6597 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{6597/6597 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 125 & \makecell[l]{773.8/773.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{773.8/773.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{773.8/773.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 125 & \makecell[l]{773.8/773.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{773.8/773.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{773.8/773.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 67 & \makecell[l]{0/6586.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/6586.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/6586.8 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 67 & \makecell[l]{0/6586.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/6586.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/6586.8 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 121 & \makecell[l]{666.4/666.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{666.4/666.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{666.4/666.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 121 & \makecell[l]{666.4/666.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{666.4/666.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{666.4/666.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 362 & \makecell[l]{6597/6597 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{6597/6597 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{6597/6597 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 362 & \makecell[l]{6597/6597 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{6597/6597 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{6597/6597 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 125 & \makecell[l]{773.8/773.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{773.8/773.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{773.8/773.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 125 & \makecell[l]{773.8/773.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{773.8/773.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{773.8/773.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 67 & \makecell[l]{76.3/6586.8 = 1.2\%\\(0.2\%, 8.1\%)} & \makecell[l]{0/6586.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/6586.8 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 67 & \makecell[l]{0/6586.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/6586.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/6586.8 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 121 & \makecell[l]{666.4/666.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{666.4/666.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{666.4/666.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 121 & \makecell[l]{666.4/666.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{666.4/666.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{666.4/666.4 = 100.0\%\\(100.0\%, 100.0\%)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item Binding Antibody Responders are defined as participants who had
        baseline values below the LLOD with detectable antibody concentration
        above the assay LLOD, or as participants with baseline values above
        the LLOD with a 4-fold increase in antibody concentration.
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{2.7cm}llllllll}
\caption{\label{tab:tabs}Table 3j. Percentage of responders, and participants
      with concentrations $\geq$ 2 x LLOD or $\geq$ 4 x LLOD for binding antibody
      markers by Age, Underrepresented minority status}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% Greater than 2xLLOD & \% Greater than 4xLLOD\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% Greater than 2xLLOD & \% Greater than 4xLLOD\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{9}{l}{\textbf{Age, Underrepresented minority status}}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 192 & \makecell[l]{3386/3386 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{3386/3386 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{3386/3386 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 192 & \makecell[l]{3386/3386 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{3386/3386 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{3386/3386 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 69 & \makecell[l]{375/375 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{375/375 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{375/375 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 69 & \makecell[l]{375/375 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{375/375 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{375/375 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 37 & \makecell[l]{0/3281 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/3281 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/3281 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 37 & \makecell[l]{0/3281 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/3281 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/3281 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 61 & \makecell[l]{361/361 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{361/361 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{361/361 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 61 & \makecell[l]{361/361 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{361/361 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{361/361 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 192 & \makecell[l]{3386/3386 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{3386/3386 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{3386/3386 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 192 & \makecell[l]{3386/3386 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{3386/3386 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{3386/3386 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 69 & \makecell[l]{375/375 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{375/375 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{375/375 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 69 & \makecell[l]{375/375 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{375/375 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{375/375 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 37 & \makecell[l]{0/3281 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/3281 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/3281 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 37 & \makecell[l]{0/3281 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/3281 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/3281 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 61 & \makecell[l]{361/361 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{361/361 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{361/361 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 61 & \makecell[l]{361/361 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{361/361 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{361/361 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 175 & \makecell[l]{5217.3/5217.3 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{5217.3/5217.3 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{5217.3/5217.3 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 175 & \makecell[l]{5217.3/5217.3 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{5217.3/5217.3 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{5217.3/5217.3 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 59 & \makecell[l]{602.4/602.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{602.4/602.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{602.4/602.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 59 & \makecell[l]{602.4/602.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{602.4/602.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{602.4/602.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 31 & \makecell[l]{0/4988.2 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/4988.2 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/4988.2 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 31 & \makecell[l]{0/4988.2 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/4988.2 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/4988.2 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 61 & \makecell[l]{517.6/517.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{517.6/517.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{517.6/517.6 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 61 & \makecell[l]{517.6/517.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{517.6/517.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{517.6/517.6 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 175 & \makecell[l]{5217.3/5217.3 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{5217.3/5217.3 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{5217.3/5217.3 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 175 & \makecell[l]{5217.3/5217.3 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{5217.3/5217.3 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{5217.3/5217.3 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 59 & \makecell[l]{602.4/602.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{602.4/602.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{602.4/602.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 59 & \makecell[l]{602.4/602.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{602.4/602.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{602.4/602.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 31 & \makecell[l]{76.3/4988.2 = 1.5\%\\(0.2\%, 11.0\%)} & \makecell[l]{0/4988.2 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/4988.2 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 31 & \makecell[l]{0/4988.2 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/4988.2 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/4988.2 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 61 & \makecell[l]{517.6/517.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{517.6/517.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{517.6/517.6 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 61 & \makecell[l]{517.6/517.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{517.6/517.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{517.6/517.6 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 228 & \makecell[l]{903/903 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{903/903 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{903/903 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 228 & \makecell[l]{903/903 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{903/903 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{903/903 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 51 & \makecell[l]{87/87 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{87/87 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{87/87 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 51 & \makecell[l]{87/87 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{87/87 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{87/87 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 36 & \makecell[l]{0/1038 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1038 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1038 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 36 & \makecell[l]{0/1038 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1038 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1038 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 50 & \makecell[l]{78/78 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{78/78 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{78/78 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 50 & \makecell[l]{78/78 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{78/78 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{78/78 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 228 & \makecell[l]{903/903 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{903/903 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{903/903 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 228 & \makecell[l]{903/903 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{903/903 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{903/903 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 51 & \makecell[l]{87/87 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{87/87 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{87/87 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 51 & \makecell[l]{87/87 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{87/87 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{87/87 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 36 & \makecell[l]{0/1038 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1038 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1038 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 36 & \makecell[l]{0/1038 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1038 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1038 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 50 & \makecell[l]{78/78 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{78/78 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{78/78 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 50 & \makecell[l]{78/78 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{78/78 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{78/78 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 187 & \makecell[l]{1379.7/1379.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1379.7/1379.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1379.7/1379.7 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 187 & \makecell[l]{1379.7/1379.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1379.7/1379.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1379.7/1379.7 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 66 & \makecell[l]{171.4/171.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{171.4/171.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{171.4/171.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 66 & \makecell[l]{171.4/171.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{171.4/171.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{171.4/171.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 36 & \makecell[l]{0/1598.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1598.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1598.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 36 & \makecell[l]{0/1598.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1598.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1598.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 60 & \makecell[l]{148.8/148.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{148.8/148.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{148.8/148.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 60 & \makecell[l]{148.8/148.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{148.8/148.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{148.8/148.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 187 & \makecell[l]{1379.7/1379.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1379.7/1379.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1379.7/1379.7 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 187 & \makecell[l]{1379.7/1379.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1379.7/1379.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1379.7/1379.7 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 66 & \makecell[l]{171.4/171.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{171.4/171.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{171.4/171.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 66 & \makecell[l]{171.4/171.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{171.4/171.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{171.4/171.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 36 & \makecell[l]{0/1598.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1598.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1598.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 36 & \makecell[l]{0/1598.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1598.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1598.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 60 & \makecell[l]{148.8/148.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{148.8/148.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{148.8/148.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 60 & \makecell[l]{148.8/148.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{148.8/148.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{148.8/148.8 = 100.0\%\\(100.0\%, 100.0\%)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item Neutralization Responders are defined as participants who had baseline
        values below the lower limit of detection (LLOD) with detectable
        ID50 neutralization titer above the assay LLOD, or as participants with
        baseline values above the LLOD with a 4-fold increase in ID50.
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{2.7cm}llllllll}
\caption{\label{tab:tabs}Table 4a. Percentage of responders, and participants
      participants with 2-fold rise, and participants with 4-fold rise for 
      ID50 pseudo-virus neutralization antibody markers by All participants}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% 2-Fold Rise & \% 4-Fold Rise\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% 2-Fold Rise & \% 4-Fold Rise\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{9}{l}{\textbf{All participants}}\\
\hspace{1em} & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 914 & \makecell[l]{11733.1/13295 = 88.3\%\\(84.7\%, 91.0\%)} & \makecell[l]{11787.2/13295 = 88.7\%\\(85.2\%, 91.4\%)} & \makecell[l]{10870.9/13295 = 81.8\%\\(77.9\%, 85.1\%)}\\
\hspace{1em} & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 274 & \makecell[l]{1383.1/1432 = 96.6\%\\(91.6\%, 98.7\%)} & \makecell[l]{1383.1/1432 = 96.6\%\\(91.6\%, 98.7\%)} & \makecell[l]{1287.8/1432 = 89.9\%\\(83.3\%, 94.1\%)}\\
\hspace{1em} & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 163 & \makecell[l]{149.5/13359 = 1.1\%\\(0.3\%, 3.8\%)} & \makecell[l]{149.5/13359 = 1.1\%\\(0.3\%, 3.8\%)} & \makecell[l]{0/13359 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em} & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 270 & \makecell[l]{1139.8/1357 = 84.0\%\\(76.8\%, 89.3\%)} & \makecell[l]{1143.2/1357 = 84.2\%\\(77.0\%, 89.5\%)} & \makecell[l]{906/1357 = 66.8\%\\(58.6\%, 74.0\%)}\\
\hspace{1em} & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 914 & \makecell[l]{13159.4/13295 = 99.0\%\\(98.0\%, 99.5\%)} & \makecell[l]{13159.4/13295 = 99.0\%\\(98.0\%, 99.5\%)} & \makecell[l]{12955/13295 = 97.4\%\\(95.6\%, 98.5\%)}\\
\hspace{1em} & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 274 & \makecell[l]{1432/1432 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1432/1432 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1432/1432 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em} & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 163 & \makecell[l]{131.9/13359 = 1.0\%\\(0.3\%, 3.0\%)} & \makecell[l]{131.9/13359 = 1.0\%\\(0.3\%, 3.0\%)} & \makecell[l]{0/13359 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em} & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 270 & \makecell[l]{1301.8/1357 = 95.9\%\\(90.6\%, 98.3\%)} & \makecell[l]{1301.8/1357 = 95.9\%\\(90.6\%, 98.3\%)} & \makecell[l]{1253.1/1357 = 92.3\%\\(86.0\%, 95.9\%)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item Neutralization Responders are defined as participants who had baseline
        values below the lower limit of detection (LLOD) with detectable
        ID50 neutralization titer above the assay LLOD, or as participants with
        baseline values above the LLOD with a 4-fold increase in ID50.
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{2.7cm}llllllll}
\caption{\label{tab:tabs}Table 4b. Percentage of responders, and participants
      participants with 2-fold rise, and participants with 4-fold rise for 
      ID50 pseudo-virus neutralization antibody markers by Age}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% 2-Fold Rise & \% 4-Fold Rise\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% 2-Fold Rise & \% 4-Fold Rise\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{9}{l}{\textbf{Age}}\\
\hspace{1em}Age $<$ 65 & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 432 & \makecell[l]{9050.2/10518 = 86.0\%\\(81.6\%, 89.5\%)} & \makecell[l]{9096.9/10518 = 86.5\%\\(82.1\%, 89.9\%)} & \makecell[l]{8317.2/10518 = 79.1\%\\(74.2\%, 83.2\%)}\\
\hspace{1em}Age $<$ 65 & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 146 & \makecell[l]{1103/1145 = 96.3\%\\(89.7\%, 98.7\%)} & \makecell[l]{1103/1145 = 96.3\%\\(89.7\%, 98.7\%)} & \makecell[l]{1010.3/1145 = 88.2\%\\(80.0\%, 93.4\%)}\\
\hspace{1em}Age $<$ 65 & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 80 & \makecell[l]{76.3/10234 = 0.7\%\\(0.1\%, 5.3\%)} & \makecell[l]{76.3/10234 = 0.7\%\\(0.1\%, 5.3\%)} & \makecell[l]{0/10234 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 147 & \makecell[l]{896.3/1098 = 81.6\%\\(72.7\%, 88.1\%)} & \makecell[l]{899.7/1098 = 81.9\%\\(73.1\%, 88.4\%)} & \makecell[l]{682.7/1098 = 62.2\%\\(52.3\%, 71.1\%)}\\
\hspace{1em}Age $<$ 65 & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 432 & \makecell[l]{10405/10518 = 98.9\%\\(97.6\%, 99.5\%)} & \makecell[l]{10405/10518 = 98.9\%\\(97.6\%, 99.5\%)} & \makecell[l]{10226.7/10518 = 97.2\%\\(94.8\%, 98.5\%)}\\
\hspace{1em}Age $<$ 65 & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 146 & \makecell[l]{1145/1145 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1145/1145 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1145/1145 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 80 & \makecell[l]{43.1/10234 = 0.4\%\\(0.1\%, 3.0\%)} & \makecell[l]{43.1/10234 = 0.4\%\\(0.1\%, 3.0\%)} & \makecell[l]{0/10234 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 147 & \makecell[l]{1042.8/1098 = 95.0\%\\(88.4\%, 97.9\%)} & \makecell[l]{1042.8/1098 = 95.0\%\\(88.4\%, 97.9\%)} & \makecell[l]{995.7/1098 = 90.7\%\\(82.9\%, 95.1\%)}\\
\hspace{1em}Age $\geq$ 65 & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 482 & \makecell[l]{2682.9/2777 = 96.6\%\\(94.4\%, 98.0\%)} & \makecell[l]{2690.3/2777 = 96.9\%\\(94.8\%, 98.2\%)} & \makecell[l]{2553.6/2777 = 92.0\%\\(89.1\%, 94.1\%)}\\
\hspace{1em}Age $\geq$ 65 & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 128 & \makecell[l]{280.1/287 = 97.6\%\\(92.6\%, 99.3\%)} & \makecell[l]{280.1/287 = 97.6\%\\(92.6\%, 99.3\%)} & \makecell[l]{277.5/287 = 96.7\%\\(91.3\%, 98.8\%)}\\
\hspace{1em}Age $\geq$ 65 & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 83 & \makecell[l]{73.2/3125 = 2.3\%\\(0.5\%, 9.5\%)} & \makecell[l]{73.2/3125 = 2.3\%\\(0.5\%, 9.5\%)} & \makecell[l]{0/3125 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 123 & \makecell[l]{243.5/259 = 94.0\%\\(87.7\%, 97.2\%)} & \makecell[l]{243.5/259 = 94.0\%\\(87.7\%, 97.2\%)} & \makecell[l]{223.3/259 = 86.2\%\\(78.6\%, 91.4\%)}\\
\hspace{1em}Age $\geq$ 65 & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 482 & \makecell[l]{2754.3/2777 = 99.2\%\\(97.7\%, 99.7\%)} & \makecell[l]{2754.3/2777 = 99.2\%\\(97.7\%, 99.7\%)} & \makecell[l]{2728.2/2777 = 98.2\%\\(96.4\%, 99.1\%)}\\
\hspace{1em}Age $\geq$ 65 & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 128 & \makecell[l]{287/287 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{287/287 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{287/287 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 83 & \makecell[l]{88.8/3125 = 2.8\%\\(0.7\%, 10.9\%)} & \makecell[l]{88.8/3125 = 2.8\%\\(0.7\%, 10.9\%)} & \makecell[l]{0/3125 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 123 & \makecell[l]{259/259 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{259/259 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{257.4/259 = 99.4\%\\(95.7\%, 99.9\%)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item Neutralization Responders are defined as participants who had baseline
        values below the lower limit of detection (LLOD) with detectable
        ID50 neutralization titer above the assay LLOD, or as participants with
        baseline values above the LLOD with a 4-fold increase in ID50.
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{2.7cm}llllllll}
\caption{\label{tab:tabs}Table 4c. Percentage of responders, and participants
      participants with 2-fold rise, and participants with 4-fold rise for 
      ID50 pseudo-virus neutralization antibody markers by Risk for Severe Covid-19}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% 2-Fold Rise & \% 4-Fold Rise\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% 2-Fold Rise & \% 4-Fold Rise\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{9}{l}{\textbf{Risk for Severe Covid-19}}\\
\hspace{1em}At-risk & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 469 & \makecell[l]{3353.3/3736.6 = 89.7\%\\(86.3\%, 92.4\%)} & \makecell[l]{3360.6/3736.6 = 89.9\%\\(86.6\%, 92.5\%)} & \makecell[l]{3035.3/3736.6 = 81.2\%\\(77.1\%, 84.8\%)}\\
\hspace{1em}At-risk & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 125 & \makecell[l]{355.1/368.8 = 96.3\%\\(90.0\%, 98.7\%)} & \makecell[l]{355.1/368.8 = 96.3\%\\(90.0\%, 98.7\%)} & \makecell[l]{332.9/368.8 = 90.3\%\\(82.5\%, 94.8\%)}\\
\hspace{1em}At-risk & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 84 & \makecell[l]{149.5/4096.4 = 3.6\%\\(1.0\%, 12.0\%)} & \makecell[l]{149.5/4096.4 = 3.6\%\\(1.0\%, 12.0\%)} & \makecell[l]{0/4096.4 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}At-risk & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 123 & \makecell[l]{284.5/331.2 = 85.9\%\\(78.4\%, 91.1\%)} & \makecell[l]{287.9/331.2 = 86.9\%\\(79.6\%, 91.9\%)} & \makecell[l]{248.5/331.2 = 75.0\%\\(66.5\%, 82.0\%)}\\
\hspace{1em}At-risk & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 469 & \makecell[l]{3654.9/3736.6 = 97.8\%\\(95.6\%, 98.9\%)} & \makecell[l]{3654.9/3736.6 = 97.8\%\\(95.6\%, 98.9\%)} & \makecell[l]{3597.8/3736.6 = 96.3\%\\(93.7\%, 97.8\%)}\\
\hspace{1em}At-risk & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 125 & \makecell[l]{368.8/368.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{368.8/368.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{368.8/368.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}At-risk & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 84 & \makecell[l]{43.1/4096.4 = 1.1\%\\(0.1\%, 7.4\%)} & \makecell[l]{43.1/4096.4 = 1.1\%\\(0.1\%, 7.4\%)} & \makecell[l]{0/4096.4 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}At-risk & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 123 & \makecell[l]{322.9/331.2 = 97.5\%\\(92.2\%, 99.2\%)} & \makecell[l]{322.9/331.2 = 97.5\%\\(92.2\%, 99.2\%)} & \makecell[l]{317/331.2 = 95.7\%\\(89.9\%, 98.2\%)}\\
\hspace{1em}Not at-risk & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 445 & \makecell[l]{8379.9/9558.4 = 87.7\%\\(82.8\%, 91.3\%)} & \makecell[l]{8426.5/9558.4 = 88.2\%\\(83.4\%, 91.7\%)} & \makecell[l]{7835.6/9558.4 = 82.0\%\\(76.7\%, 86.3\%)}\\
\hspace{1em}Not at-risk & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 149 & \makecell[l]{1028/1063.2 = 96.7\%\\(89.2\%, 99.0\%)} & \makecell[l]{1028/1063.2 = 96.7\%\\(89.2\%, 99.0\%)} & \makecell[l]{954.9/1063.2 = 89.8\%\\(80.7\%, 94.9\%)}\\
\hspace{1em}Not at-risk & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 79 & \makecell[l]{0/9262.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/9262.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/9262.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Not at-risk & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 147 & \makecell[l]{855.3/1025.8 = 83.4\%\\(73.8\%, 89.9\%)} & \makecell[l]{855.3/1025.8 = 83.4\%\\(73.8\%, 89.9\%)} & \makecell[l]{657.5/1025.8 = 64.1\%\\(53.6\%, 73.4\%)}\\
\hspace{1em}Not at-risk & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 445 & \makecell[l]{9504.5/9558.4 = 99.4\%\\(97.8\%, 99.9\%)} & \makecell[l]{9504.5/9558.4 = 99.4\%\\(97.8\%, 99.9\%)} & \makecell[l]{9357.2/9558.4 = 97.9\%\\(95.0\%, 99.1\%)}\\
\hspace{1em}Not at-risk & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 149 & \makecell[l]{1063.2/1063.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1063.2/1063.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1063.2/1063.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not at-risk & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 79 & \makecell[l]{88.8/9262.6 = 1.0\%\\(0.2\%, 3.7\%)} & \makecell[l]{88.8/9262.6 = 1.0\%\\(0.2\%, 3.7\%)} & \makecell[l]{0/9262.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Not at-risk & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 147 & \makecell[l]{978.9/1025.8 = 95.4\%\\(88.1\%, 98.3\%)} & \makecell[l]{978.9/1025.8 = 95.4\%\\(88.1\%, 98.3\%)} & \makecell[l]{936.2/1025.8 = 91.3\%\\(82.8\%, 95.8\%)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item Neutralization Responders are defined as participants who had baseline
        values below the lower limit of detection (LLOD) with detectable
        ID50 neutralization titer above the assay LLOD, or as participants with
        baseline values above the LLOD with a 4-fold increase in ID50.
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{2.7cm}llllllll}
\caption{\label{tab:tabs}Table 4d. Percentage of responders, and participants
      participants with 2-fold rise, and participants with 4-fold rise for 
      ID50 pseudo-virus neutralization antibody markers by Age, Risk for Severe Covid-19}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% 2-Fold Rise & \% 4-Fold Rise\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% 2-Fold Rise & \% 4-Fold Rise\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{9}{l}{\textbf{Age, Risk for Severe Covid-19}}\\
\hspace{1em}Age $<$ 65 At-risk & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 214 & \makecell[l]{1967.1/2279 = 86.3\%\\(81.1\%, 90.3\%)} & \makecell[l]{1967.1/2279 = 86.3\%\\(81.1\%, 90.3\%)} & \makecell[l]{1729.6/2279 = 75.9\%\\(69.6\%, 81.2\%)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 73 & \makecell[l]{236.9/248 = 95.5\%\\(86.2\%, 98.7\%)} & \makecell[l]{236.9/248 = 95.5\%\\(86.2\%, 98.7\%)} & \makecell[l]{214.7/248 = 86.6\%\\(75.4\%, 93.1\%)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 40 & \makecell[l]{76.3/2454 = 3.1\%\\(0.4\%, 20.6\%)} & \makecell[l]{76.3/2454 = 3.1\%\\(0.4\%, 20.6\%)} & \makecell[l]{0/2454 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 75 & \makecell[l]{186.7/226 = 82.6\%\\(72.4\%, 89.6\%)} & \makecell[l]{190.1/226 = 84.1\%\\(74.3\%, 90.7\%)} & \makecell[l]{160.7/226 = 71.1\%\\(59.9\%, 80.2\%)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 214 & \makecell[l]{2219.9/2279 = 97.4\%\\(93.8\%, 98.9\%)} & \makecell[l]{2219.9/2279 = 97.4\%\\(93.8\%, 98.9\%)} & \makecell[l]{2181.6/2279 = 95.7\%\\(91.6\%, 97.9\%)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 73 & \makecell[l]{248/248 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{248/248 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{248/248 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 40 & \makecell[l]{43.1/2454 = 1.8\%\\(0.2\%, 12.3\%)} & \makecell[l]{43.1/2454 = 1.8\%\\(0.2\%, 12.3\%)} & \makecell[l]{0/2454 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 75 & \makecell[l]{217.6/226 = 96.3\%\\(88.7\%, 98.9\%)} & \makecell[l]{217.6/226 = 96.3\%\\(88.7\%, 98.9\%)} & \makecell[l]{211.8/226 = 93.7\%\\(85.3\%, 97.4\%)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 218 & \makecell[l]{7083.2/8239 = 86.0\%\\(80.3\%, 90.2\%)} & \makecell[l]{7129.8/8239 = 86.5\%\\(81.0\%, 90.7\%)} & \makecell[l]{6587.7/8239 = 80.0\%\\(73.8\%, 85.0\%)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 73 & \makecell[l]{866.1/897 = 96.6\%\\(86.9\%, 99.2\%)} & \makecell[l]{866.1/897 = 96.6\%\\(86.9\%, 99.2\%)} & \makecell[l]{795.6/897 = 88.7\%\\(77.8\%, 94.6\%)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 40 & \makecell[l]{0/7780 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/7780 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/7780 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 72 & \makecell[l]{709.6/872 = 81.4\%\\(70.1\%, 89.1\%)} & \makecell[l]{709.6/872 = 81.4\%\\(70.1\%, 89.1\%)} & \makecell[l]{522.1/872 = 59.9\%\\(47.7\%, 70.9\%)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 218 & \makecell[l]{8185.1/8239 = 99.3\%\\(97.4\%, 99.8\%)} & \makecell[l]{8185.1/8239 = 99.3\%\\(97.4\%, 99.8\%)} & \makecell[l]{8045.2/8239 = 97.6\%\\(94.3\%, 99.1\%)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 73 & \makecell[l]{897/897 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{897/897 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{897/897 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 40 & \makecell[l]{0/7780 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/7780 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/7780 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 72 & \makecell[l]{825.1/872 = 94.6\%\\(86.0\%, 98.1\%)} & \makecell[l]{825.1/872 = 94.6\%\\(86.0\%, 98.1\%)} & \makecell[l]{783.9/872 = 89.9\%\\(79.8\%, 95.2\%)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 255 & \makecell[l]{1386.2/1457.6 = 95.1\%\\(91.4\%, 97.3\%)} & \makecell[l]{1393.5/1457.6 = 95.6\%\\(92.0\%, 97.6\%)} & \makecell[l]{1305.7/1457.6 = 89.6\%\\(85.0\%, 92.9\%)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 52 & \makecell[l]{118.2/120.8 = 97.8\%\\(85.4\%, 99.7\%)} & \makecell[l]{118.2/120.8 = 97.8\%\\(85.4\%, 99.7\%)} & \makecell[l]{118.2/120.8 = 97.8\%\\(85.4\%, 99.7\%)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 44 & \makecell[l]{73.2/1642.4 = 4.5\%\\(1.0\%, 17.7\%)} & \makecell[l]{73.2/1642.4 = 4.5\%\\(1.0\%, 17.7\%)} & \makecell[l]{0/1642.4 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 48 & \makecell[l]{97.8/105.2 = 92.9\%\\(79.7\%, 97.8\%)} & \makecell[l]{97.8/105.2 = 92.9\%\\(79.7\%, 97.8\%)} & \makecell[l]{87.9/105.2 = 83.5\%\\(69.0\%, 92.0\%)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 255 & \makecell[l]{1434.9/1457.6 = 98.4\%\\(95.7\%, 99.4\%)} & \makecell[l]{1434.9/1457.6 = 98.4\%\\(95.7\%, 99.4\%)} & \makecell[l]{1416.2/1457.6 = 97.2\%\\(94.0\%, 98.7\%)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 52 & \makecell[l]{120.8/120.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{120.8/120.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{120.8/120.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 44 & \makecell[l]{0/1642.4 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1642.4 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1642.4 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 48 & \makecell[l]{105.2/105.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{105.2/105.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{105.2/105.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 227 & \makecell[l]{1296.7/1319.4 = 98.3\%\\(95.3\%, 99.4\%)} & \makecell[l]{1296.7/1319.4 = 98.3\%\\(95.3\%, 99.4\%)} & \makecell[l]{1247.9/1319.4 = 94.6\%\\(90.5\%, 97.0\%)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 76 & \makecell[l]{161.9/166.2 = 97.4\%\\(89.6\%, 99.4\%)} & \makecell[l]{161.9/166.2 = 97.4\%\\(89.6\%, 99.4\%)} & \makecell[l]{159.3/166.2 = 95.8\%\\(87.3\%, 98.7\%)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 39 & \makecell[l]{0/1482.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1482.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1482.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 75 & \makecell[l]{145.7/153.8 = 94.7\%\\(86.2\%, 98.1\%)} & \makecell[l]{145.7/153.8 = 94.7\%\\(86.2\%, 98.1\%)} & \makecell[l]{135.4/153.8 = 88.1\%\\(78.7\%, 93.6\%)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 227 & \makecell[l]{1319.4/1319.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1319.4/1319.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1312/1319.4 = 99.4\%\\(96.1\%, 99.9\%)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 76 & \makecell[l]{166.2/166.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{166.2/166.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{166.2/166.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 39 & \makecell[l]{88.8/1482.6 = 6.0\%\\(1.4\%, 22.0\%)} & \makecell[l]{88.8/1482.6 = 6.0\%\\(1.4\%, 22.0\%)} & \makecell[l]{0/1482.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 75 & \makecell[l]{153.8/153.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{153.8/153.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{152.2/153.8 = 99.0\%\\(92.9\%, 99.9\%)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item Neutralization Responders are defined as participants who had baseline
        values below the lower limit of detection (LLOD) with detectable
        ID50 neutralization titer above the assay LLOD, or as participants with
        baseline values above the LLOD with a 4-fold increase in ID50.
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{2.7cm}llllllll}
\caption{\label{tab:tabs}Table 4e. Percentage of responders, and participants
      participants with 2-fold rise, and participants with 4-fold rise for 
      ID50 pseudo-virus neutralization antibody markers by Sex}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% 2-Fold Rise & \% 4-Fold Rise\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% 2-Fold Rise & \% 4-Fold Rise\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{9}{l}{\textbf{Sex}}\\
\hspace{1em}Male & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 395 & \makecell[l]{4737.9/5298.6 = 89.4\%\\(83.8\%, 93.2\%)} & \makecell[l]{4745.3/5298.6 = 89.6\%\\(83.9\%, 93.4\%)} & \makecell[l]{4439.5/5298.6 = 83.8\%\\(77.6\%, 88.5\%)}\\
\hspace{1em}Male & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 121 & \makecell[l]{557.7/564.7 = 98.8\%\\(94.9\%, 99.7\%)} & \makecell[l]{557.7/564.7 = 98.8\%\\(94.9\%, 99.7\%)} & \makecell[l]{522.3/564.7 = 92.5\%\\(83.1\%, 96.9\%)}\\
\hspace{1em}Male & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 76 & \makecell[l]{105.1/4771.7 = 2.2\%\\(0.5\%, 9.9\%)} & \makecell[l]{105.1/4771.7 = 2.2\%\\(0.5\%, 9.9\%)} & \makecell[l]{0/4771.7 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Male & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 115 & \makecell[l]{433.2/529.2 = 81.9\%\\(69.1\%, 90.1\%)} & \makecell[l]{433.2/529.2 = 81.9\%\\(69.1\%, 90.1\%)} & \makecell[l]{328.3/529.2 = 62.0\%\\(49.2\%, 73.4\%)}\\
\hspace{1em}Male & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 395 & \makecell[l]{5254.4/5298.6 = 99.2\%\\(97.9\%, 99.7\%)} & \makecell[l]{5254.4/5298.6 = 99.2\%\\(97.9\%, 99.7\%)} & \makecell[l]{5101.6/5298.6 = 96.3\%\\(91.7\%, 98.4\%)}\\
\hspace{1em}Male & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 121 & \makecell[l]{564.7/564.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{564.7/564.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{564.7/564.7 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Male & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 76 & \makecell[l]{44.4/4771.7 = 0.9\%\\(0.1\%, 6.6\%)} & \makecell[l]{44.4/4771.7 = 0.9\%\\(0.1\%, 6.6\%)} & \makecell[l]{0/4771.7 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Male & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 115 & \makecell[l]{517/529.2 = 97.7\%\\(88.9\%, 99.6\%)} & \makecell[l]{517/529.2 = 97.7\%\\(88.9\%, 99.6\%)} & \makecell[l]{483.7/529.2 = 91.4\%\\(79.2\%, 96.7\%)}\\
\hspace{1em}Female & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 519 & \makecell[l]{6995.2/7996.4 = 87.5\%\\(82.6\%, 91.1\%)} & \makecell[l]{7041.9/7996.4 = 88.1\%\\(83.3\%, 91.6\%)} & \makecell[l]{6431.3/7996.4 = 80.4\%\\(75.1\%, 84.8\%)}\\
\hspace{1em}Female & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 153 & \makecell[l]{825.4/867.3 = 95.2\%\\(86.7\%, 98.3\%)} & \makecell[l]{825.4/867.3 = 95.2\%\\(86.7\%, 98.3\%)} & \makecell[l]{765.4/867.3 = 88.3\%\\(78.1\%, 94.1\%)}\\
\hspace{1em}Female & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 87 & \makecell[l]{44.4/8587.3 = 0.5\%\\(0.1\%, 3.7\%)} & \makecell[l]{44.4/8587.3 = 0.5\%\\(0.1\%, 3.7\%)} & \makecell[l]{0/8587.3 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Female & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 155 & \makecell[l]{706.6/827.8 = 85.4\%\\(75.6\%, 91.7\%)} & \makecell[l]{710/827.8 = 85.8\%\\(76.0\%, 92.0\%)} & \makecell[l]{577.7/827.8 = 69.8\%\\(58.8\%, 78.9\%)}\\
\hspace{1em}Female & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 519 & \makecell[l]{7905/7996.4 = 98.9\%\\(97.2\%, 99.5\%)} & \makecell[l]{7905/7996.4 = 98.9\%\\(97.2\%, 99.5\%)} & \makecell[l]{7853.4/7996.4 = 98.2\%\\(96.6\%, 99.1\%)}\\
\hspace{1em}Female & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 153 & \makecell[l]{867.3/867.3 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{867.3/867.3 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{867.3/867.3 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Female & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 87 & \makecell[l]{87.5/8587.3 = 1.0\%\\(0.2\%, 4.1\%)} & \makecell[l]{87.5/8587.3 = 1.0\%\\(0.2\%, 4.1\%)} & \makecell[l]{0/8587.3 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Female & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 155 & \makecell[l]{784.7/827.8 = 94.8\%\\(86.4\%, 98.1\%)} & \makecell[l]{784.7/827.8 = 94.8\%\\(86.4\%, 98.1\%)} & \makecell[l]{769.4/827.8 = 93.0\%\\(84.0\%, 97.1\%)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item Neutralization Responders are defined as participants who had baseline
        values below the lower limit of detection (LLOD) with detectable
        ID50 neutralization titer above the assay LLOD, or as participants with
        baseline values above the LLOD with a 4-fold increase in ID50.
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{2.7cm}llllllll}
\caption{\label{tab:tabs}Table 4f. Percentage of responders, and participants
      participants with 2-fold rise, and participants with 4-fold rise for 
      ID50 pseudo-virus neutralization antibody markers by Age, sex}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% 2-Fold Rise & \% 4-Fold Rise\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% 2-Fold Rise & \% 4-Fold Rise\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{9}{l}{\textbf{Age, sex}}\\
\hspace{1em}Age $<$ 65 Female & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 269 & \makecell[l]{5560.6/6524.4 = 85.2\%\\(79.3\%, 89.7\%)} & \makecell[l]{5607.3/6524.4 = 85.9\%\\(80.1\%, 90.3\%)} & \makecell[l]{5076.7/6524.4 = 77.8\%\\(71.3\%, 83.2\%)}\\
\hspace{1em}Age $<$ 65 Female & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 79 & \makecell[l]{664.2/701.8 = 94.6\%\\(83.7\%, 98.4\%)} & \makecell[l]{664.2/701.8 = 94.6\%\\(83.7\%, 98.4\%)} & \makecell[l]{606.9/701.8 = 86.5\%\\(73.8\%, 93.5\%)}\\
\hspace{1em}Age $<$ 65 Female & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 52 & \makecell[l]{0/7188.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/7188.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/7188.8 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 Female & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 83 & \makecell[l]{561/673.1 = 83.3\%\\(71.3\%, 91.0\%)} & \makecell[l]{564.4/673.1 = 83.8\%\\(71.8\%, 91.4\%)} & \makecell[l]{437.7/673.1 = 65.0\%\\(51.8\%, 76.3\%)}\\
\hspace{1em}Age $<$ 65 Female & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 269 & \makecell[l]{6437/6524.4 = 98.7\%\\(96.5\%, 99.5\%)} & \makecell[l]{6437/6524.4 = 98.7\%\\(96.5\%, 99.5\%)} & \makecell[l]{6411.4/6524.4 = 98.3\%\\(96.2\%, 99.2\%)}\\
\hspace{1em}Age $<$ 65 Female & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 79 & \makecell[l]{701.8/701.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{701.8/701.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{701.8/701.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Female & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 52 & \makecell[l]{43.1/7188.8 = 0.6\%\\(0.1\%, 4.4\%)} & \makecell[l]{43.1/7188.8 = 0.6\%\\(0.1\%, 4.4\%)} & \makecell[l]{0/7188.8 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 Female & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 83 & \makecell[l]{630.1/673.1 = 93.6\%\\(83.3\%, 97.7\%)} & \makecell[l]{630.1/673.1 = 93.6\%\\(83.3\%, 97.7\%)} & \makecell[l]{616.4/673.1 = 91.6\%\\(80.5\%, 96.6\%)}\\
\hspace{1em}Age $<$ 65 Male & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 163 & \makecell[l]{3489.6/3993.6 = 87.4\%\\(79.9\%, 92.3\%)} & \makecell[l]{3489.6/3993.6 = 87.4\%\\(79.9\%, 92.3\%)} & \makecell[l]{3240.5/3993.6 = 81.1\%\\(73.0\%, 87.2\%)}\\
\hspace{1em}Age $<$ 65 Male & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 67 & \makecell[l]{438.8/443.2 = 99.0\%\\(93.0\%, 99.9\%)} & \makecell[l]{438.8/443.2 = 99.0\%\\(93.0\%, 99.9\%)} & \makecell[l]{403.4/443.2 = 91.0\%\\(79.0\%, 96.5\%)}\\
\hspace{1em}Age $<$ 65 Male & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 28 & \makecell[l]{76.3/3045.2 = 2.5\%\\(0.3\%, 17.6\%)} & \makecell[l]{76.3/3045.2 = 2.5\%\\(0.3\%, 17.6\%)} & \makecell[l]{0/3045.2 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 Male & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 64 & \makecell[l]{335.3/424.9 = 78.9\%\\(63.2\%, 89.1\%)} & \makecell[l]{335.3/424.9 = 78.9\%\\(63.2\%, 89.1\%)} & \makecell[l]{245/424.9 = 57.7\%\\(42.2\%, 71.8\%)}\\
\hspace{1em}Age $<$ 65 Male & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 163 & \makecell[l]{3968.1/3993.6 = 99.4\%\\(97.5\%, 99.8\%)} & \makecell[l]{3968.1/3993.6 = 99.4\%\\(97.5\%, 99.8\%)} & \makecell[l]{3815.3/3993.6 = 95.5\%\\(89.2\%, 98.2\%)}\\
\hspace{1em}Age $<$ 65 Male & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 67 & \makecell[l]{443.2/443.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{443.2/443.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{443.2/443.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Male & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 28 & \makecell[l]{0/3045.2 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/3045.2 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/3045.2 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 Male & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 64 & \makecell[l]{412.7/424.9 = 97.1\%\\(86.1\%, 99.5\%)} & \makecell[l]{412.7/424.9 = 97.1\%\\(86.1\%, 99.5\%)} & \makecell[l]{379.3/424.9 = 89.3\%\\(74.3\%, 96.0\%)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 232 & \makecell[l]{1248.3/1305 = 95.7\%\\(91.9\%, 97.7\%)} & \makecell[l]{1255.7/1305 = 96.2\%\\(92.6\%, 98.1\%)} & \makecell[l]{1199/1305 = 91.9\%\\(87.3\%, 94.9\%)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 54 & \makecell[l]{118.9/121.5 = 97.9\%\\(85.5\%, 99.7\%)} & \makecell[l]{118.9/121.5 = 97.9\%\\(85.5\%, 99.7\%)} & \makecell[l]{118.9/121.5 = 97.9\%\\(85.5\%, 99.7\%)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 48 & \makecell[l]{28.8/1726.6 = 1.7\%\\(0.2\%, 11.6\%)} & \makecell[l]{28.8/1726.6 = 1.7\%\\(0.2\%, 11.6\%)} & \makecell[l]{0/1726.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 51 & \makecell[l]{97.9/104.4 = 93.8\%\\(81.3\%, 98.1\%)} & \makecell[l]{97.9/104.4 = 93.8\%\\(81.3\%, 98.1\%)} & \makecell[l]{83.3/104.4 = 79.8\%\\(65.3\%, 89.2\%)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 232 & \makecell[l]{1286.3/1305 = 98.6\%\\(95.4\%, 99.6\%)} & \makecell[l]{1286.3/1305 = 98.6\%\\(95.4\%, 99.6\%)} & \makecell[l]{1286.3/1305 = 98.6\%\\(95.4\%, 99.6\%)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 54 & \makecell[l]{121.5/121.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{121.5/121.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{121.5/121.5 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 48 & \makecell[l]{44.4/1726.6 = 2.6\%\\(0.3\%, 17.2\%)} & \makecell[l]{44.4/1726.6 = 2.6\%\\(0.3\%, 17.2\%)} & \makecell[l]{0/1726.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 51 & \makecell[l]{104.4/104.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{104.4/104.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{104.4/104.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 250 & \makecell[l]{1434.6/1472 = 97.5\%\\(94.3\%, 98.9\%)} & \makecell[l]{1434.6/1472 = 97.5\%\\(94.3\%, 98.9\%)} & \makecell[l]{1354.6/1472 = 92.0\%\\(87.8\%, 94.9\%)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 74 & \makecell[l]{161.2/165.5 = 97.4\%\\(89.5\%, 99.4\%)} & \makecell[l]{161.2/165.5 = 97.4\%\\(89.5\%, 99.4\%)} & \makecell[l]{158.6/165.5 = 95.8\%\\(87.3\%, 98.7\%)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 35 & \makecell[l]{44.4/1398.4 = 3.2\%\\(0.4\%, 21.1\%)} & \makecell[l]{44.4/1398.4 = 3.2\%\\(0.4\%, 21.1\%)} & \makecell[l]{0/1398.4 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 72 & \makecell[l]{145.6/154.6 = 94.2\%\\(84.9\%, 97.9\%)} & \makecell[l]{145.6/154.6 = 94.2\%\\(84.9\%, 97.9\%)} & \makecell[l]{140/154.6 = 90.6\%\\(80.8\%, 95.6\%)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 250 & \makecell[l]{1468/1472 = 99.7\%\\(98.1\%, 100.0\%)} & \makecell[l]{1468/1472 = 99.7\%\\(98.1\%, 100.0\%)} & \makecell[l]{1441.9/1472 = 98.0\%\\(95.0\%, 99.2\%)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 74 & \makecell[l]{165.5/165.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{165.5/165.5 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{165.5/165.5 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 35 & \makecell[l]{44.4/1398.4 = 3.2\%\\(0.4\%, 21.1\%)} & \makecell[l]{44.4/1398.4 = 3.2\%\\(0.4\%, 21.1\%)} & \makecell[l]{0/1398.4 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 72 & \makecell[l]{154.6/154.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{154.6/154.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{153.1/154.6 = 99.0\%\\(92.9\%, 99.9\%)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item Neutralization Responders are defined as participants who had baseline
        values below the lower limit of detection (LLOD) with detectable
        ID50 neutralization titer above the assay LLOD, or as participants with
        baseline values above the LLOD with a 4-fold increase in ID50.
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{2.7cm}llllllll}
\caption{\label{tab:tabs}Table 4g. Percentage of responders, and participants
      participants with 2-fold rise, and participants with 4-fold rise for 
      ID50 pseudo-virus neutralization antibody markers by Hispanic or Latino ethnicity}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% 2-Fold Rise & \% 4-Fold Rise\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% 2-Fold Rise & \% 4-Fold Rise\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{9}{l}{\textbf{Hispanic or Latino ethnicity}}\\
\hspace{1em}Hispanic or Latino & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 136 & \makecell[l]{1226.3/1363.4 = 89.9\%\\(81.7\%, 94.7\%)} & \makecell[l]{1226.3/1363.4 = 89.9\%\\(81.7\%, 94.7\%)} & \makecell[l]{1109.8/1363.4 = 81.4\%\\(71.0\%, 88.7\%)}\\
\hspace{1em}Hispanic or Latino & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 35 & \makecell[l]{144/145.7 = 98.8\%\\(91.4\%, 99.9\%)} & \makecell[l]{144/145.7 = 98.8\%\\(91.4\%, 99.9\%)} & \makecell[l]{141.7/145.7 = 97.2\%\\(88.7\%, 99.4\%)}\\
\hspace{1em}Hispanic or Latino & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 20 & \makecell[l]{28.8/1237.6 = 2.3\%\\(0.3\%, 17.1\%)} & \makecell[l]{28.8/1237.6 = 2.3\%\\(0.3\%, 17.1\%)} & \makecell[l]{0/1237.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Hispanic or Latino & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 38 & \makecell[l]{125.7/133.7 = 94.0\%\\(84.6\%, 97.8\%)} & \makecell[l]{125.7/133.7 = 94.0\%\\(84.6\%, 97.8\%)} & \makecell[l]{90/133.7 = 67.3\%\\(42.1\%, 85.3\%)}\\
\hspace{1em}Hispanic or Latino & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 136 & \makecell[l]{1328.6/1363.4 = 97.4\%\\(88.5\%, 99.5\%)} & \makecell[l]{1328.6/1363.4 = 97.4\%\\(88.5\%, 99.5\%)} & \makecell[l]{1328.6/1363.4 = 97.4\%\\(88.5\%, 99.5\%)}\\
\hspace{1em}Hispanic or Latino & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 35 & \makecell[l]{145.7/145.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{145.7/145.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{145.7/145.7 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Hispanic or Latino & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 20 & \makecell[l]{0/1237.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1237.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1237.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Hispanic or Latino & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 38 & \makecell[l]{133.7/133.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{133.7/133.7 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{129.7/133.7 = 97.0\%\\(87.6\%, 99.3\%)}\\
\hspace{1em}Not Hispanic or Latino & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 690 & \makecell[l]{9218.1/10481.2 = 87.9\%\\(83.8\%, 91.2\%)} & \makecell[l]{9272.1/10481.2 = 88.5\%\\(84.4\%, 91.6\%)} & \makecell[l]{8529.4/10481.2 = 81.4\%\\(76.8\%, 85.2\%)}\\
\hspace{1em}Not Hispanic or Latino & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 217 & \makecell[l]{1119.5/1162.3 = 96.3\%\\(90.0\%, 98.7\%)} & \makecell[l]{1119.5/1162.3 = 96.3\%\\(90.0\%, 98.7\%)} & \makecell[l]{1030.9/1162.3 = 88.7\%\\(80.6\%, 93.7\%)}\\
\hspace{1em}Not Hispanic or Latino & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 130 & \makecell[l]{120.7/10828.8 = 1.1\%\\(0.3\%, 4.6\%)} & \makecell[l]{120.7/10828.8 = 1.1\%\\(0.3\%, 4.6\%)} & \makecell[l]{0/10828.8 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Not Hispanic or Latino & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 214 & \makecell[l]{941.9/1121.8 = 84.0\%\\(75.7\%, 89.8\%)} & \makecell[l]{945.4/1121.8 = 84.3\%\\(76.0\%, 90.1\%)} & \makecell[l]{743.9/1121.8 = 66.3\%\\(57.1\%, 74.4\%)}\\
\hspace{1em}Not Hispanic or Latino & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 690 & \makecell[l]{10380.4/10481.2 = 99.0\%\\(97.9\%, 99.6\%)} & \makecell[l]{10380.4/10481.2 = 99.0\%\\(97.9\%, 99.6\%)} & \makecell[l]{10269.3/10481.2 = 98.0\%\\(96.3\%, 98.9\%)}\\
\hspace{1em}Not Hispanic or Latino & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 217 & \makecell[l]{1162.3/1162.3 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1162.3/1162.3 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1162.3/1162.3 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not Hispanic or Latino & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 130 & \makecell[l]{87.5/10828.8 = 0.8\%\\(0.2\%, 3.2\%)} & \makecell[l]{87.5/10828.8 = 0.8\%\\(0.2\%, 3.2\%)} & \makecell[l]{0/10828.8 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Not Hispanic or Latino & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 214 & \makecell[l]{1076.3/1121.8 = 95.9\%\\(89.7\%, 98.5\%)} & \makecell[l]{1076.3/1121.8 = 95.9\%\\(89.7\%, 98.5\%)} & \makecell[l]{1048.8/1121.8 = 93.5\%\\(86.3\%, 97.0\%)}\\
\hspace{1em}Not reported and unknown & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 88 & \makecell[l]{1288.7/1450.4 = 88.9\%\\(74.6\%, 95.6\%)} & \makecell[l]{1288.7/1450.4 = 88.9\%\\(74.6\%, 95.6\%)} & \makecell[l]{1231.7/1450.4 = 84.9\%\\(71.6\%, 92.6\%)}\\
\hspace{1em}Not reported and unknown & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 22 & \makecell[l]{119.6/124 = 96.5\%\\(75.1\%, 99.6\%)} & \makecell[l]{119.6/124 = 96.5\%\\(75.1\%, 99.6\%)} & \makecell[l]{115.2/124 = 92.9\%\\(75.0\%, 98.3\%)}\\
\hspace{1em}Not reported and unknown & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 13 & \makecell[l]{0/1292.7 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1292.7 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1292.7 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Not reported and unknown & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 18 & \makecell[l]{72.2/101.5 = 71.1\%\\(32.1\%, 92.8\%)} & \makecell[l]{72.2/101.5 = 71.1\%\\(32.1\%, 92.8\%)} & \makecell[l]{72.2/101.5 = 71.1\%\\(32.1\%, 92.8\%)}\\
\hspace{1em}Not reported and unknown & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 88 & \makecell[l]{1450.4/1450.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1450.4/1450.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1357.1/1450.4 = 93.6\%\\(77.2\%, 98.4\%)}\\
\hspace{1em}Not reported and unknown & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 22 & \makecell[l]{124/124 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{124/124 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{124/124 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not reported and unknown & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 13 & \makecell[l]{44.4/1292.7 = 3.4\%\\(0.3\%, 28.0\%)} & \makecell[l]{44.4/1292.7 = 3.4\%\\(0.3\%, 28.0\%)} & \makecell[l]{0/1292.7 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Not reported and unknown & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 18 & \makecell[l]{91.8/101.5 = 90.4\%\\(52.1\%, 98.8\%)} & \makecell[l]{91.8/101.5 = 90.4\%\\(52.1\%, 98.8\%)} & \makecell[l]{74.6/101.5 = 73.5\%\\(32.9\%, 94.0\%)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item Neutralization Responders are defined as participants who had baseline
        values below the lower limit of detection (LLOD) with detectable
        ID50 neutralization titer above the assay LLOD, or as participants with
        baseline values above the LLOD with a 4-fold increase in ID50.
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{2.7cm}llllllll}
\caption{\label{tab:tabs}Table 4h. Percentage of responders, and participants
      participants with 2-fold rise, and participants with 4-fold rise for 
      ID50 pseudo-virus neutralization antibody markers by Race}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% 2-Fold Rise & \% 4-Fold Rise\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% 2-Fold Rise & \% 4-Fold Rise\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{9}{l}{\textbf{Race}}\\
\hspace{1em}White Non-Hispanic & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 362 & \makecell[l]{5915.2/6597 = 89.7\%\\(84.2\%, 93.4\%)} & \makecell[l]{5922.6/6597 = 89.8\%\\(84.3\%, 93.5\%)} & \makecell[l]{5515.3/6597 = 83.6\%\\(77.6\%, 88.3\%)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 125 & \makecell[l]{733.3/773.8 = 94.8\%\\(85.2\%, 98.3\%)} & \makecell[l]{733.3/773.8 = 94.8\%\\(85.2\%, 98.3\%)} & \makecell[l]{671.1/773.8 = 86.7\%\\(75.6\%, 93.2\%)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 67 & \makecell[l]{44.4/6586.8 = 0.7\%\\(0.1\%, 4.8\%)} & \makecell[l]{44.4/6586.8 = 0.7\%\\(0.1\%, 4.8\%)} & \makecell[l]{0/6586.8 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 121 & \makecell[l]{546.7/666.4 = 82.0\%\\(70.0\%, 90.0\%)} & \makecell[l]{550.2/666.4 = 82.6\%\\(70.5\%, 90.4\%)} & \makecell[l]{458.9/666.4 = 68.9\%\\(56.4\%, 79.1\%)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 362 & \makecell[l]{6531.1/6597 = 99.0\%\\(97.8\%, 99.6\%)} & \makecell[l]{6531.1/6597 = 99.0\%\\(97.8\%, 99.6\%)} & \makecell[l]{6436.8/6597 = 97.6\%\\(95.1\%, 98.8\%)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 125 & \makecell[l]{773.8/773.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{773.8/773.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{773.8/773.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 67 & \makecell[l]{0/6586.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/6586.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/6586.8 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 121 & \makecell[l]{652.7/666.4 = 97.9\%\\(86.3\%, 99.7\%)} & \makecell[l]{652.7/666.4 = 97.9\%\\(86.3\%, 99.7\%)} & \makecell[l]{625.2/666.4 = 93.8\%\\(82.4\%, 98.0\%)}\\
\hspace{1em}Black or African American & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 195 & \makecell[l]{1743.5/2012.2 = 86.6\%\\(78.6\%, 92.0\%)} & \makecell[l]{1743.5/2012.2 = 86.6\%\\(78.6\%, 92.0\%)} & \makecell[l]{1549.3/2012.2 = 77.0\%\\(67.8\%, 84.2\%)}\\
\hspace{1em}Black or African American & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 52 & \makecell[l]{195.6/195.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{195.6/195.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{187/195.6 = 95.6\%\\(72.5\%, 99.4\%)}\\
\hspace{1em}Black or African American & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 39 & \makecell[l]{0/2311.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/2311.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/2311.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Black or African American & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 60 & \makecell[l]{220.4/265.1 = 83.2\%\\(66.7\%, 92.4\%)} & \makecell[l]{220.4/265.1 = 83.2\%\\(66.7\%, 92.4\%)} & \makecell[l]{154/265.1 = 58.1\%\\(40.8\%, 73.6\%)}\\
\hspace{1em}Black or African American & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 195 & \makecell[l]{1977.3/2012.2 = 98.3\%\\(91.8\%, 99.7\%)} & \makecell[l]{1977.3/2012.2 = 98.3\%\\(91.8\%, 99.7\%)} & \makecell[l]{1977.3/2012.2 = 98.3\%\\(91.8\%, 99.7\%)}\\
\hspace{1em}Black or African American & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 52 & \makecell[l]{195.6/195.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{195.6/195.6 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{195.6/195.6 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Black or African American & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 39 & \makecell[l]{43.1/2311.6 = 1.9\%\\(0.2\%, 13.1\%)} & \makecell[l]{43.1/2311.6 = 1.9\%\\(0.2\%, 13.1\%)} & \makecell[l]{0/2311.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Black or African American & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 60 & \makecell[l]{243.2/265.1 = 91.7\%\\(74.1\%, 97.7\%)} & \makecell[l]{243.2/265.1 = 91.7\%\\(74.1\%, 97.7\%)} & \makecell[l]{241.6/265.1 = 91.1\%\\(74.1\%, 97.4\%)}\\
\hspace{1em}Asian & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 67 & \makecell[l]{653.8/673.6 = 97.1\%\\(91.8\%, 99.0\%)} & \makecell[l]{653.8/673.6 = 97.1\%\\(91.8\%, 99.0\%)} & \makecell[l]{630/673.6 = 93.5\%\\(87.7\%, 96.7\%)}\\
\hspace{1em}Asian & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 24 & \makecell[l]{78.8/81.1 = 97.1\%\\(80.0\%, 99.7\%)} & \makecell[l]{78.8/81.1 = 97.1\%\\(80.0\%, 99.7\%)} & \makecell[l]{76.5/81.1 = 94.3\%\\(79.4\%, 98.6\%)}\\
\hspace{1em}Asian & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 12 & \makecell[l]{28.8/609.1 = 4.7\%\\(0.5\%, 34.8\%)} & \makecell[l]{28.8/609.1 = 4.7\%\\(0.5\%, 34.8\%)} & \makecell[l]{0/609.1 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Asian & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 13 & \makecell[l]{45.9/48.4 = 94.9\%\\(64.0\%, 99.5\%)} & \makecell[l]{45.9/48.4 = 94.9\%\\(64.0\%, 99.5\%)} & \makecell[l]{31.3/48.4 = 64.6\%\\(19.5\%, 93.2\%)}\\
\hspace{1em}Asian & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 67 & \makecell[l]{669.7/673.6 = 99.4\%\\(95.8\%, 99.9\%)} & \makecell[l]{669.7/673.6 = 99.4\%\\(95.8\%, 99.9\%)} & \makecell[l]{665.7/673.6 = 98.8\%\\(95.4\%, 99.7\%)}\\
\hspace{1em}Asian & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 24 & \makecell[l]{81.1/81.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{81.1/81.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{81.1/81.1 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Asian & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 12 & \makecell[l]{0/609.1 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/609.1 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/609.1 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Asian & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 13 & \makecell[l]{45.9/48.4 = 94.9\%\\(64.0\%, 99.5\%)} & \makecell[l]{45.9/48.4 = 94.9\%\\(64.0\%, 99.5\%)} & \makecell[l]{45.9/48.4 = 94.9\%\\(64.0\%, 99.5\%)}\\
\hspace{1em}American Indian or Alaska Native & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 13 & \makecell[l]{151.4/151.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{151.4/151.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{139.5/151.4 = 92.1\%\\(65.9\%, 98.6\%)}\\
\hspace{1em}American Indian or Alaska Native & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 6 & \makecell[l]{31.1/31.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{31.1/31.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{31.1/31.1 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}American Indian or Alaska Native & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 5 & \makecell[l]{0/247.2 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/247.2 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/247.2 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}American Indian or Alaska Native & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 4 & 5.6/15.3 = 36.5\% & 5.6/15.3 = 36.5\% & 3.1/15.3 = 20.4\%\\
\hspace{1em}American Indian or Alaska Native & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 13 & \makecell[l]{151.4/151.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{151.4/151.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{151.4/151.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}American Indian or Alaska Native & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 6 & \makecell[l]{31.1/31.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{31.1/31.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{31.1/31.1 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}American Indian or Alaska Native & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 5 & \makecell[l]{0/247.2 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/247.2 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/247.2 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}American Indian or Alaska Native & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 4 & 15.3/15.3 = 100.0\% & 15.3/15.3 = 100.0\% & 15.3/15.3 = 100.0\%\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 17 & \makecell[l]{98.2/98.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{98.2/98.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{94.3/98.2 = 96.0\%\\(70.1\%, 99.6\%)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 5 & \makecell[l]{23/23 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{23/23 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{23/23 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 1 & 0/28.8 = 0.0\% & 0/28.8 = 0.0\% & 0/28.8 = 0.0\%\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 1 & 0/2.5 = 0.0\% & 0/2.5 = 0.0\% & 0/2.5 = 0.0\%\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 17 & \makecell[l]{98.2/98.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{98.2/98.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{98.2/98.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 5 & \makecell[l]{23/23 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{23/23 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{23/23 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 1 & 0/28.8 = 0.0\% & 0/28.8 = 0.0\% & 0/28.8 = 0.0\%\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 1 & 2.5/2.5 = 100.0\% & 2.5/2.5 = 100.0\% & 2.5/2.5 = 100.0\%\\
\hspace{1em}Multiracial & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 52 & \makecell[l]{416.8/498.5 = 83.6\%\\(62.3\%, 94.0\%)} & \makecell[l]{416.8/498.5 = 83.6\%\\(62.3\%, 94.0\%)} & \makecell[l]{382/498.5 = 76.6\%\\(54.9\%, 89.8\%)}\\
\hspace{1em}Multiracial & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 12 & \makecell[l]{56.4/56.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{56.4/56.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{56.4/56.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Multiracial & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 8 & \makecell[l]{0/554 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/554 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/554 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Multiracial & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 19 & \makecell[l]{56.5/61.4 = 92.0\%\\(71.7\%, 98.1\%)} & \makecell[l]{56.5/61.4 = 92.0\%\\(71.7\%, 98.1\%)} & \makecell[l]{45.2/61.4 = 73.6\%\\(30.6\%, 94.6\%)}\\
\hspace{1em}Multiracial & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 52 & \makecell[l]{494.5/498.5 = 99.2\%\\(94.3\%, 99.9\%)} & \makecell[l]{494.5/498.5 = 99.2\%\\(94.3\%, 99.9\%)} & \makecell[l]{494.5/498.5 = 99.2\%\\(94.3\%, 99.9\%)}\\
\hspace{1em}Multiracial & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 12 & \makecell[l]{56.4/56.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{56.4/56.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{56.4/56.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Multiracial & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 8 & \makecell[l]{0/554 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/554 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/554 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Multiracial & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 19 & \makecell[l]{61.4/61.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{61.4/61.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{58.9/61.4 = 96.0\%\\(72.4\%, 99.5\%)}\\
\hspace{1em}Other & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 34 & \makecell[l]{426.4/469.2 = 90.9\%\\(68.6\%, 97.8\%)} & \makecell[l]{426.4/469.2 = 90.9\%\\(68.6\%, 97.8\%)} & \makecell[l]{383.6/469.2 = 81.8\%\\(59.3\%, 93.2\%)}\\
\hspace{1em}Other & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 7 & \makecell[l]{13.8/13.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{13.8/13.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{11.5/13.8 = 83.2\%\\(18.4\%, 99.1\%)}\\
\hspace{1em}Other & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 4 & 0/232.6 = 0.0\% & 0/232.6 = 0.0\% & 0/232.6 = 0.0\%\\
\hspace{1em}Other & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 5 & \makecell[l]{24.1/24.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{24.1/24.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{22.6/24.1 = 93.5\%\\(32.5\%, 99.8\%)}\\
\hspace{1em}Other & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 34 & \makecell[l]{469.2/469.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{469.2/469.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{469.2/469.2 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Other & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 7 & \makecell[l]{13.8/13.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{13.8/13.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{13.8/13.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Other & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 4 & 0/232.6 = 0.0\% & 0/232.6 = 0.0\% & 0/232.6 = 0.0\%\\
\hspace{1em}Other & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 5 & \makecell[l]{24.1/24.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{24.1/24.1 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{24.1/24.1 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not reported and unknown & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 87 & \makecell[l]{1107.8/1413.2 = 78.4\%\\(61.9\%, 89.0\%)} & \makecell[l]{1154.4/1413.2 = 81.7\%\\(65.2\%, 91.4\%)} & \makecell[l]{1014/1413.2 = 71.8\%\\(55.6\%, 83.7\%)}\\
\hspace{1em}Not reported and unknown & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 20 & \makecell[l]{155/155 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{155/155 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{139.5/155 = 90.0\%\\(45.7\%, 99.0\%)}\\
\hspace{1em}Not reported and unknown & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 14 & \makecell[l]{76.3/1337.6 = 5.7\%\\(0.6\%, 38.4\%)} & \makecell[l]{76.3/1337.6 = 5.7\%\\(0.6\%, 38.4\%)} & \makecell[l]{0/1337.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Not reported and unknown & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 24 & \makecell[l]{149.2/165.4 = 90.2\%\\(55.7\%, 98.5\%)} & \makecell[l]{149.2/165.4 = 90.2\%\\(55.7\%, 98.5\%)} & \makecell[l]{103.1/165.4 = 62.3\%\\(33.5\%, 84.4\%)}\\
\hspace{1em}Not reported and unknown & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 87 & \makecell[l]{1413.2/1413.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1413.2/1413.2 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{1400.5/1413.2 = 99.1\%\\(93.6\%, 99.9\%)}\\
\hspace{1em}Not reported and unknown & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 20 & \makecell[l]{155/155 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{155/155 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{155/155 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Not reported and unknown & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 14 & \makecell[l]{44.4/1337.6 = 3.3\%\\(0.4\%, 25.1\%)} & \makecell[l]{44.4/1337.6 = 3.3\%\\(0.4\%, 25.1\%)} & \makecell[l]{0/1337.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Not reported and unknown & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 24 & \makecell[l]{148.3/165.4 = 89.6\%\\(55.9\%, 98.3\%)} & \makecell[l]{148.3/165.4 = 89.6\%\\(55.9\%, 98.3\%)} & \makecell[l]{148.3/165.4 = 89.6\%\\(55.9\%, 98.3\%)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item Neutralization Responders are defined as participants who had baseline
        values below the lower limit of detection (LLOD) with detectable
        ID50 neutralization titer above the assay LLOD, or as participants with
        baseline values above the LLOD with a 4-fold increase in ID50.
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{2.7cm}llllllll}
\caption{\label{tab:tabs}Table 4i. Percentage of responders, and participants
      participants with 2-fold rise, and participants with 4-fold rise for 
      ID50 pseudo-virus neutralization antibody markers by Underrepresented minority status}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% 2-Fold Rise & \% 4-Fold Rise\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% 2-Fold Rise & \% 4-Fold Rise\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{9}{l}{\textbf{Underrepresented minority status}}\\
\hspace{1em}Communities of Color & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 420 & \makecell[l]{3833.3/4289 = 89.4\%\\(84.6\%, 92.8\%)} & \makecell[l]{3833.3/4289 = 89.4\%\\(84.6\%, 92.8\%)} & \makecell[l]{3490.9/4289 = 81.4\%\\(75.8\%, 86.0\%)}\\
\hspace{1em}Communities of Color & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 120 & \makecell[l]{458/462 = 99.1\%\\(96.5\%, 99.8\%)} & \makecell[l]{458/462 = 99.1\%\\(96.5\%, 99.8\%)} & \makecell[l]{444.7/462 = 96.3\%\\(89.1\%, 98.8\%)}\\
\hspace{1em}Communities of Color & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 73 & \makecell[l]{28.8/4319 = 0.7\%\\(0.1\%, 4.8\%)} & \makecell[l]{28.8/4319 = 0.7\%\\(0.1\%, 4.8\%)} & \makecell[l]{0/4319 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Communities of Color & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 111 & \makecell[l]{374.8/439 = 85.4\%\\(74.2\%, 92.2\%)} & \makecell[l]{374.8/439 = 85.4\%\\(74.2\%, 92.2\%)} & \makecell[l]{276.8/439 = 63.1\%\\(50.1\%, 74.4\%)}\\
\hspace{1em}Communities of Color & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 420 & \makecell[l]{4219.3/4289 = 98.4\%\\(95.2\%, 99.5\%)} & \makecell[l]{4219.3/4289 = 98.4\%\\(95.2\%, 99.5\%)} & \makecell[l]{4215.3/4289 = 98.3\%\\(95.2\%, 99.4\%)}\\
\hspace{1em}Communities of Color & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 120 & \makecell[l]{462/462 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{462/462 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{462/462 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Communities of Color & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 73 & \makecell[l]{43.1/4319 = 1.0\%\\(0.1\%, 7.0\%)} & \makecell[l]{43.1/4319 = 1.0\%\\(0.1\%, 7.0\%)} & \makecell[l]{0/4319 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Communities of Color & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 111 & \makecell[l]{414.6/439 = 94.4\%\\(83.7\%, 98.3\%)} & \makecell[l]{414.6/439 = 94.4\%\\(83.7\%, 98.3\%)} & \makecell[l]{410.6/439 = 93.5\%\\(83.4\%, 97.7\%)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 362 & \makecell[l]{5915.2/6597 = 89.7\%\\(84.2\%, 93.4\%)} & \makecell[l]{5922.6/6597 = 89.8\%\\(84.3\%, 93.5\%)} & \makecell[l]{5515.3/6597 = 83.6\%\\(77.6\%, 88.3\%)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 125 & \makecell[l]{733.3/773.8 = 94.8\%\\(85.2\%, 98.3\%)} & \makecell[l]{733.3/773.8 = 94.8\%\\(85.2\%, 98.3\%)} & \makecell[l]{671.1/773.8 = 86.7\%\\(75.6\%, 93.2\%)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 67 & \makecell[l]{44.4/6586.8 = 0.7\%\\(0.1\%, 4.8\%)} & \makecell[l]{44.4/6586.8 = 0.7\%\\(0.1\%, 4.8\%)} & \makecell[l]{0/6586.8 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 121 & \makecell[l]{546.7/666.4 = 82.0\%\\(70.0\%, 90.0\%)} & \makecell[l]{550.2/666.4 = 82.6\%\\(70.5\%, 90.4\%)} & \makecell[l]{458.9/666.4 = 68.9\%\\(56.4\%, 79.1\%)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 362 & \makecell[l]{6531.1/6597 = 99.0\%\\(97.8\%, 99.6\%)} & \makecell[l]{6531.1/6597 = 99.0\%\\(97.8\%, 99.6\%)} & \makecell[l]{6436.8/6597 = 97.6\%\\(95.1\%, 98.8\%)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 125 & \makecell[l]{773.8/773.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{773.8/773.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{773.8/773.8 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 67 & \makecell[l]{0/6586.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/6586.8 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/6586.8 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 121 & \makecell[l]{652.7/666.4 = 97.9\%\\(86.3\%, 99.7\%)} & \makecell[l]{652.7/666.4 = 97.9\%\\(86.3\%, 99.7\%)} & \makecell[l]{625.2/666.4 = 93.8\%\\(82.4\%, 98.0\%)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item Neutralization Responders are defined as participants who had baseline
        values below the lower limit of detection (LLOD) with detectable
        ID50 neutralization titer above the assay LLOD, or as participants with
        baseline values above the LLOD with a 4-fold increase in ID50.
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{2.7cm}llllllll}
\caption{\label{tab:tabs}Table 4j. Percentage of responders, and participants
      participants with 2-fold rise, and participants with 4-fold rise for 
      ID50 pseudo-virus neutralization antibody markers by Age, Underrepresented minority status}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% 2-Fold Rise & \% 4-Fold Rise\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & Responder & \% 2-Fold Rise & \% 4-Fold Rise\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{9}{l}{\textbf{Age, Underrepresented minority status}}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 192 & \makecell[l]{2958/3386 = 87.4\%\\(81.4\%, 91.6\%)} & \makecell[l]{2958/3386 = 87.4\%\\(81.4\%, 91.6\%)} & \makecell[l]{2671.1/3386 = 78.9\%\\(71.8\%, 84.6\%)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 69 & \makecell[l]{372.7/375 = 99.4\%\\(95.6\%, 99.9\%)} & \makecell[l]{372.7/375 = 99.4\%\\(95.6\%, 99.9\%)} & \makecell[l]{359.4/375 = 95.8\%\\(86.7\%, 98.8\%)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 37 & \makecell[l]{0/3281 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/3281 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/3281 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 61 & \makecell[l]{299.9/361 = 83.1\%\\(69.5\%, 91.4\%)} & \makecell[l]{299.9/361 = 83.1\%\\(69.5\%, 91.4\%)} & \makecell[l]{209.7/361 = 58.1\%\\(42.8\%, 72.0\%)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 192 & \makecell[l]{3324.2/3386 = 98.2\%\\(93.9\%, 99.5\%)} & \makecell[l]{3324.2/3386 = 98.2\%\\(93.9\%, 99.5\%)} & \makecell[l]{3324.2/3386 = 98.2\%\\(93.9\%, 99.5\%)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 69 & \makecell[l]{375/375 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{375/375 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{375/375 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 37 & \makecell[l]{43.1/3281 = 1.3\%\\(0.2\%, 9.4\%)} & \makecell[l]{43.1/3281 = 1.3\%\\(0.2\%, 9.4\%)} & \makecell[l]{0/3281 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 61 & \makecell[l]{336.6/361 = 93.2\%\\(80.2\%, 97.9\%)} & \makecell[l]{336.6/361 = 93.2\%\\(80.2\%, 97.9\%)} & \makecell[l]{334.1/361 = 92.6\%\\(80.0\%, 97.5\%)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 175 & \makecell[l]{4601.9/5217.3 = 88.2\%\\(81.3\%, 92.8\%)} & \makecell[l]{4601.9/5217.3 = 88.2\%\\(81.3\%, 92.8\%)} & \makecell[l]{4253.6/5217.3 = 81.5\%\\(73.9\%, 87.3\%)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 59 & \makecell[l]{567/602.4 = 94.1\%\\(81.1\%, 98.4\%)} & \makecell[l]{567/602.4 = 94.1\%\\(81.1\%, 98.4\%)} & \makecell[l]{507.5/602.4 = 84.2\%\\(69.9\%, 92.5\%)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 31 & \makecell[l]{0/4988.2 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/4988.2 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/4988.2 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 61 & \makecell[l]{407.9/517.6 = 78.8\%\\(63.4\%, 88.9\%)} & \makecell[l]{411.3/517.6 = 79.5\%\\(64.0\%, 89.4\%)} & \makecell[l]{332.4/517.6 = 64.2\%\\(48.6\%, 77.4\%)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 175 & \makecell[l]{5166.2/5217.3 = 99.0\%\\(97.4\%, 99.6\%)} & \makecell[l]{5166.2/5217.3 = 99.0\%\\(97.4\%, 99.6\%)} & \makecell[l]{5094/5217.3 = 97.6\%\\(94.3\%, 99.0\%)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 59 & \makecell[l]{602.4/602.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{602.4/602.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{602.4/602.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 31 & \makecell[l]{0/4988.2 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/4988.2 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/4988.2 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 61 & \makecell[l]{503.9/517.6 = 97.3\%\\(82.5\%, 99.7\%)} & \makecell[l]{503.9/517.6 = 97.3\%\\(82.5\%, 99.7\%)} & \makecell[l]{476.4/517.6 = 92.0\%\\(77.5\%, 97.5\%)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 228 & \makecell[l]{875.3/903 = 96.9\%\\(93.7\%, 98.5\%)} & \makecell[l]{875.3/903 = 96.9\%\\(93.7\%, 98.5\%)} & \makecell[l]{819.8/903 = 90.8\%\\(86.2\%, 93.9\%)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 51 & \makecell[l]{85.3/87 = 98.0\%\\(86.6\%, 99.7\%)} & \makecell[l]{85.3/87 = 98.0\%\\(86.6\%, 99.7\%)} & \makecell[l]{85.3/87 = 98.0\%\\(86.6\%, 99.7\%)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 36 & \makecell[l]{28.8/1038 = 2.8\%\\(0.4\%, 18.7\%)} & \makecell[l]{28.8/1038 = 2.8\%\\(0.4\%, 18.7\%)} & \makecell[l]{0/1038 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 50 & \makecell[l]{74.9/78 = 96.0\%\\(84.7\%, 99.0\%)} & \makecell[l]{74.9/78 = 96.0\%\\(84.7\%, 99.0\%)} & \makecell[l]{67.1/78 = 86.0\%\\(72.9\%, 93.4\%)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 228 & \makecell[l]{895.1/903 = 99.1\%\\(96.5\%, 99.8\%)} & \makecell[l]{895.1/903 = 99.1\%\\(96.5\%, 99.8\%)} & \makecell[l]{891.1/903 = 98.7\%\\(96.0\%, 99.6\%)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 51 & \makecell[l]{87/87 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{87/87 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{87/87 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 36 & \makecell[l]{0/1038 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1038 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1038 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 50 & \makecell[l]{78/78 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{78/78 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{76.4/78 = 98.0\%\\(86.3\%, 99.7\%)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 187 & \makecell[l]{1313.3/1379.7 = 95.2\%\\(91.0\%, 97.5\%)} & \makecell[l]{1320.7/1379.7 = 95.7\%\\(91.6\%, 97.9\%)} & \makecell[l]{1261.6/1379.7 = 91.4\%\\(86.4\%, 94.7\%)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 66 & \makecell[l]{166.2/171.4 = 97.0\%\\(88.3\%, 99.3\%)} & \makecell[l]{166.2/171.4 = 97.0\%\\(88.3\%, 99.3\%)} & \makecell[l]{163.6/171.4 = 95.5\%\\(86.5\%, 98.6\%)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 36 & \makecell[l]{44.4/1598.6 = 2.8\%\\(0.4\%, 18.7\%)} & \makecell[l]{44.4/1598.6 = 2.8\%\\(0.4\%, 18.7\%)} & \makecell[l]{0/1598.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 60 & \makecell[l]{138.8/148.8 = 93.3\%\\(83.1\%, 97.5\%)} & \makecell[l]{138.8/148.8 = 93.3\%\\(83.1\%, 97.5\%)} & \makecell[l]{126.5/148.8 = 85.0\%\\(73.2\%, 92.2\%)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 187 & \makecell[l]{1364.9/1379.7 = 98.9\%\\(95.8\%, 99.7\%)} & \makecell[l]{1364.9/1379.7 = 98.9\%\\(95.8\%, 99.7\%)} & \makecell[l]{1342.8/1379.7 = 97.3\%\\(93.7\%, 98.9\%)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 66 & \makecell[l]{171.4/171.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{171.4/171.4 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{171.4/171.4 = 100.0\%\\(100.0\%, 100.0\%)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 36 & \makecell[l]{0/1598.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1598.6 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{0/1598.6 = 0.0\%\\(0.0\%, 0.0\%)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 60 & \makecell[l]{148.8/148.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{148.8/148.8 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{148.8/148.8 = 100.0\%\\(100.0\%, 100.0\%)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item 
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{7cm}llllll}
\caption{\label{tab:tabs}Table 5a. Geometric mean titers (GMTs) and geometric mean
      concentrations (GMCs) by All participants}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & GMT/GMC\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & GMT/GMC\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{7}{l}{\textbf{All participants}}\\
\hspace{1em} & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 914 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em} & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 914 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em} & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 914 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em} & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 914 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em} & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 274 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em} & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 274 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em} & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 274 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em} & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 274 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em} & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 163 & \makecell[l]{10\\(10, 11)}\\
\hspace{1em} & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 163 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em} & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & 163 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em} & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & 163 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em} & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 270 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em} & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 270 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em} & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & 270 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em} & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & 270 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em} & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 914 & \makecell[l]{22926\\(19863, 26460)}\\
\hspace{1em} & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 914 & \makecell[l]{40963\\(36741, 45671)}\\
\hspace{1em} & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 914 & \makecell[l]{106\\(91, 125)}\\
\hspace{1em} & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & 914 & \makecell[l]{189\\(161, 222)}\\
\hspace{1em} & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 274 & \makecell[l]{36133\\(28182, 46328)}\\
\hspace{1em} & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 274 & \makecell[l]{79981\\(65041, 98352)}\\
\hspace{1em} & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 274 & \makecell[l]{186\\(142, 243)}\\
\hspace{1em} & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & 274 & \makecell[l]{420\\(314, 560)}\\
\hspace{1em} & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 163 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em} & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 163 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em} & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 163 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em} & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & 163 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em} & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 270 & \makecell[l]{12861\\(10150, 16296)}\\
\hspace{1em} & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 270 & \makecell[l]{18191\\(15159, 21829)}\\
\hspace{1em} & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 270 & \makecell[l]{51\\(40, 66)}\\
\hspace{1em} & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & 270 & \makecell[l]{129\\(98, 169)}\\
\hspace{1em} & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 914 & \makecell[l]{966160\\(823437, 1133621)}\\
\hspace{1em} & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 914 & \makecell[l]{2087965\\(1831068, 2380904)}\\
\hspace{1em} & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 914 & \makecell[l]{1497\\(1228, 1825)}\\
\hspace{1em} & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & 914 & \makecell[l]{2223\\(1809, 2733)}\\
\hspace{1em} & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 274 & \makecell[l]{2298869\\(1785648, 2959596)}\\
\hspace{1em} & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 274 & \makecell[l]{5346334\\(4339333, 6587023)}\\
\hspace{1em} & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 274 & \makecell[l]{5680\\(3863, 8351)}\\
\hspace{1em} & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & 274 & \makecell[l]{7837\\(5545, 11076)}\\
\hspace{1em} & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 163 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em} & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 163 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em} & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 163 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em} & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & 163 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em} & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 270 & \makecell[l]{382614\\(299829, 488256)}\\
\hspace{1em} & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 270 & \makecell[l]{676872\\(531354, 862241)}\\
\hspace{1em} & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 270 & \makecell[l]{566\\(409, 783)}\\
\hspace{1em} & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & 270 & \makecell[l]{1324\\(937, 1870)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item 
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{7cm}llllll}
\caption{\label{tab:tabs}Table 5b. Geometric mean titers (GMTs) and geometric mean
      concentrations (GMCs) by Age}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & GMT/GMC\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & GMT/GMC\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{7}{l}{\textbf{Age}}\\
\hspace{1em}Age $<$ 65 & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 432 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 432 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 432 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 432 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 146 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 146 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 146 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 146 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 80 & \makecell[l]{10\\(10, 11)}\\
\hspace{1em}Age $<$ 65 & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 80 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & 80 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & 80 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 147 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 147 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & 147 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & 147 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 432 & \makecell[l]{17393\\(14565, 20770)}\\
\hspace{1em}Age $<$ 65 & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 432 & \makecell[l]{31397\\(27475, 35879)}\\
\hspace{1em}Age $<$ 65 & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 432 & \makecell[l]{85\\(69, 103)}\\
\hspace{1em}Age $<$ 65 & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & 432 & \makecell[l]{157\\(129, 192)}\\
\hspace{1em}Age $<$ 65 & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 146 & \makecell[l]{24939\\(18393, 33814)}\\
\hspace{1em}Age $<$ 65 & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 146 & \makecell[l]{59400\\(46119, 76506)}\\
\hspace{1em}Age $<$ 65 & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 146 & \makecell[l]{144\\(104, 198)}\\
\hspace{1em}Age $<$ 65 & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & 146 & \makecell[l]{339\\(238, 482)}\\
\hspace{1em}Age $<$ 65 & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 80 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 80 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 80 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & 80 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 147 & \makecell[l]{9737\\(7318, 12957)}\\
\hspace{1em}Age $<$ 65 & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 147 & \makecell[l]{13380\\(10752, 16650)}\\
\hspace{1em}Age $<$ 65 & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 147 & \makecell[l]{40\\(29, 54)}\\
\hspace{1em}Age $<$ 65 & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & 147 & \makecell[l]{106\\(76, 147)}\\
\hspace{1em}Age $<$ 65 & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 432 & \makecell[l]{737116\\(604473, 898866)}\\
\hspace{1em}Age $<$ 65 & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 432 & \makecell[l]{1643373\\(1397160, 1932976)}\\
\hspace{1em}Age $<$ 65 & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 432 & \makecell[l]{1136\\(890, 1449)}\\
\hspace{1em}Age $<$ 65 & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & 432 & \makecell[l]{1750\\(1355, 2260)}\\
\hspace{1em}Age $<$ 65 & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 146 & \makecell[l]{1708031\\(1250384, 2333179)}\\
\hspace{1em}Age $<$ 65 & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 146 & \makecell[l]{4266733\\(3292306, 5529560)}\\
\hspace{1em}Age $<$ 65 & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 146 & \makecell[l]{4061\\(2527, 6527)}\\
\hspace{1em}Age $<$ 65 & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & 146 & \makecell[l]{6238\\(4090, 9513)}\\
\hspace{1em}Age $<$ 65 & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 80 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 80 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 80 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & 80 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 147 & \makecell[l]{270061\\(201183, 362521)}\\
\hspace{1em}Age $<$ 65 & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 147 & \makecell[l]{484596\\(361146, 650244)}\\
\hspace{1em}Age $<$ 65 & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 147 & \makecell[l]{387\\(262, 572)}\\
\hspace{1em}Age $<$ 65 & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & 147 & \makecell[l]{1009\\(665, 1531)}\\
\hspace{1em}Age $\geq$ 65 & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 482 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 482 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 482 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 482 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 128 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 128 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 128 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 128 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 83 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 83 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & 83 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & 83 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 123 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 123 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & 123 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & 123 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 482 & \makecell[l]{65260\\(56734, 75068)}\\
\hspace{1em}Age $\geq$ 65 & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 482 & \makecell[l]{112166\\(98902, 127209)}\\
\hspace{1em}Age $\geq$ 65 & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 482 & \makecell[l]{254\\(214, 300)}\\
\hspace{1em}Age $\geq$ 65 & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & 482 & \makecell[l]{381\\(321, 451)}\\
\hspace{1em}Age $\geq$ 65 & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 128 & \makecell[l]{158619\\(123545, 203649)}\\
\hspace{1em}Age $\geq$ 65 & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 128 & \makecell[l]{262073\\(211994, 323982)}\\
\hspace{1em}Age $\geq$ 65 & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 128 & \makecell[l]{522\\(373, 731)}\\
\hspace{1em}Age $\geq$ 65 & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & 128 & \makecell[l]{988\\(733, 1331)}\\
\hspace{1em}Age $\geq$ 65 & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 83 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 83 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 83 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & 83 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 123 & \makecell[l]{41836\\(32047, 54614)}\\
\hspace{1em}Age $\geq$ 65 & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 123 & \makecell[l]{66891\\(53117, 84238)}\\
\hspace{1em}Age $\geq$ 65 & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 123 & \makecell[l]{156\\(112, 216)}\\
\hspace{1em}Age $\geq$ 65 & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & 123 & \makecell[l]{301\\(219, 413)}\\
\hspace{1em}Age $\geq$ 65 & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 482 & \makecell[l]{2692372\\(2329146, 3112243)}\\
\hspace{1em}Age $\geq$ 65 & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 482 & \makecell[l]{5171042\\(4536102, 5894857)}\\
\hspace{1em}Age $\geq$ 65 & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 482 & \makecell[l]{4259\\(3414, 5312)}\\
\hspace{1em}Age $\geq$ 65 & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & 482 & \makecell[l]{5506\\(4535, 6685)}\\
\hspace{1em}Age $\geq$ 65 & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 128 & \makecell[l]{7520373\\(6146909, 9200723)}\\
\hspace{1em}Age $\geq$ 65 & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 128 & \makecell[l]{13148461\\(11661345, 14825221)}\\
\hspace{1em}Age $\geq$ 65 & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 128 & \makecell[l]{21658\\(15437, 30385)}\\
\hspace{1em}Age $\geq$ 65 & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & 128 & \makecell[l]{19480\\(13318, 28494)}\\
\hspace{1em}Age $\geq$ 65 & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 83 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 83 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 83 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & 83 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 123 & \makecell[l]{1675605\\(1276999, 2198632)}\\
\hspace{1em}Age $\geq$ 65 & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 123 & \makecell[l]{2790960\\(2209589, 3525298)}\\
\hspace{1em}Age $\geq$ 65 & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 123 & \makecell[l]{2827\\(1887, 4233)}\\
\hspace{1em}Age $\geq$ 65 & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & 123 & \makecell[l]{4185\\(2859, 6127)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item 
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{7cm}llllll}
\caption{\label{tab:tabs}Table 5c. Geometric mean titers (GMTs) and geometric mean
      concentrations (GMCs) by Risk for Severe Covid-19}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & GMT/GMC\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & GMT/GMC\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{7}{l}{\textbf{Risk for Severe Covid-19}}\\
\hspace{1em}At-risk & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 469 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}At-risk & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 469 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}At-risk & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 469 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}At-risk & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 469 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}At-risk & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 125 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}At-risk & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 125 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}At-risk & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 125 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}At-risk & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 125 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}At-risk & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 84 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}At-risk & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 84 & \makecell[l]{10\\(10, 11)}\\
\hspace{1em}At-risk & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & 84 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}At-risk & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & 84 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}At-risk & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 123 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}At-risk & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 123 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}At-risk & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & 123 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}At-risk & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & 123 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}At-risk & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 469 & \makecell[l]{26276\\(22610, 30535)}\\
\hspace{1em}At-risk & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 469 & \makecell[l]{45842\\(40067, 52448)}\\
\hspace{1em}At-risk & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 469 & \makecell[l]{103\\(87, 122)}\\
\hspace{1em}At-risk & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & 469 & \makecell[l]{215\\(180, 258)}\\
\hspace{1em}At-risk & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 125 & \makecell[l]{55528\\(43641, 70653)}\\
\hspace{1em}At-risk & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 125 & \makecell[l]{103862\\(82479, 130788)}\\
\hspace{1em}At-risk & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 125 & \makecell[l]{220\\(161, 302)}\\
\hspace{1em}At-risk & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & 125 & \makecell[l]{443\\(318, 617)}\\
\hspace{1em}At-risk & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 84 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}At-risk & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 84 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}At-risk & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 84 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}At-risk & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & 84 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}At-risk & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 123 & \makecell[l]{16713\\(12642, 22096)}\\
\hspace{1em}At-risk & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 123 & \makecell[l]{26705\\(21285, 33505)}\\
\hspace{1em}At-risk & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 123 & \makecell[l]{69\\(52, 93)}\\
\hspace{1em}At-risk & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & 123 & \makecell[l]{180\\(133, 243)}\\
\hspace{1em}At-risk & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 469 & \makecell[l]{1142597\\(961925, 1357205)}\\
\hspace{1em}At-risk & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 469 & \makecell[l]{2144439\\(1840509, 2498559)}\\
\hspace{1em}At-risk & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 469 & \makecell[l]{1796\\(1424, 2264)}\\
\hspace{1em}At-risk & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & 469 & \makecell[l]{2766\\(2265, 3377)}\\
\hspace{1em}At-risk & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 125 & \makecell[l]{2930270\\(2216035, 3874704)}\\
\hspace{1em}At-risk & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 125 & \makecell[l]{6396516\\(5214355, 7846688)}\\
\hspace{1em}At-risk & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 125 & \makecell[l]{6128\\(4355, 8625)}\\
\hspace{1em}At-risk & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & 125 & \makecell[l]{11182\\(7684, 16271)}\\
\hspace{1em}At-risk & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 84 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}At-risk & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 84 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}At-risk & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 84 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}At-risk & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & 84 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}At-risk & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 123 & \makecell[l]{663561\\(492320, 894363)}\\
\hspace{1em}At-risk & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 123 & \makecell[l]{1012116\\(794913, 1288669)}\\
\hspace{1em}At-risk & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 123 & \makecell[l]{931\\(651, 1331)}\\
\hspace{1em}At-risk & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & 123 & \makecell[l]{2086\\(1418, 3067)}\\
\hspace{1em}Not at-risk & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 445 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not at-risk & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 445 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not at-risk & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 445 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not at-risk & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 445 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not at-risk & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 149 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not at-risk & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 149 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not at-risk & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 149 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not at-risk & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 149 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not at-risk & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 79 & \makecell[l]{10\\(10, 11)}\\
\hspace{1em}Not at-risk & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 79 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not at-risk & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & 79 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not at-risk & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & 79 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not at-risk & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 147 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not at-risk & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 147 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not at-risk & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & 147 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not at-risk & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & 147 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not at-risk & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 445 & \makecell[l]{21736\\(17965, 26298)}\\
\hspace{1em}Not at-risk & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 445 & \makecell[l]{39200\\(34023, 45165)}\\
\hspace{1em}Not at-risk & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 445 & \makecell[l]{108\\(87, 133)}\\
\hspace{1em}Not at-risk & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & 445 & \makecell[l]{180\\(145, 223)}\\
\hspace{1em}Not at-risk & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 149 & \makecell[l]{31130\\(22510, 43050)}\\
\hspace{1em}Not at-risk & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 149 & \makecell[l]{73051\\(55946, 95386)}\\
\hspace{1em}Not at-risk & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 149 & \makecell[l]{175\\(124, 247)}\\
\hspace{1em}Not at-risk & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & 149 & \makecell[l]{412\\(284, 597)}\\
\hspace{1em}Not at-risk & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 79 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not at-risk & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 79 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not at-risk & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 79 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not at-risk & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & 79 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not at-risk & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 147 & \makecell[l]{11818\\(8756, 15950)}\\
\hspace{1em}Not at-risk & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 147 & \makecell[l]{16070\\(12770, 20222)}\\
\hspace{1em}Not at-risk & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 147 & \makecell[l]{47\\(34, 64)}\\
\hspace{1em}Not at-risk & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & 147 & \makecell[l]{116\\(82, 164)}\\
\hspace{1em}Not at-risk & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 445 & \makecell[l]{904842\\(732112, 1118324)}\\
\hspace{1em}Not at-risk & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 445 & \makecell[l]{2066294\\(1739231, 2454861)}\\
\hspace{1em}Not at-risk & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 445 & \makecell[l]{1394\\(1075, 1808)}\\
\hspace{1em}Not at-risk & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & 445 & \makecell[l]{2041\\(1549, 2690)}\\
\hspace{1em}Not at-risk & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 149 & \makecell[l]{2113273\\(1525010, 2928453)}\\
\hspace{1em}Not at-risk & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 149 & \makecell[l]{5023873\\(3827375, 6594416)}\\
\hspace{1em}Not at-risk & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 149 & \makecell[l]{5532\\(3337, 9171)}\\
\hspace{1em}Not at-risk & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & 149 & \makecell[l]{6928\\(4429, 10838)}\\
\hspace{1em}Not at-risk & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 79 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not at-risk & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 79 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not at-risk & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 79 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not at-risk & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & 79 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not at-risk & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 147 & \makecell[l]{320294\\(235413, 435781)}\\
\hspace{1em}Not at-risk & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 147 & \makecell[l]{594413\\(435730, 810886)}\\
\hspace{1em}Not at-risk & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 147 & \makecell[l]{482\\(318, 728)}\\
\hspace{1em}Not at-risk & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & 147 & \makecell[l]{1143\\(737, 1774)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item 
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{7cm}llllll}
\caption{\label{tab:tabs}Table 5d. Geometric mean titers (GMTs) and geometric mean
      concentrations (GMCs) by Age, Risk for Severe Covid-19}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & GMT/GMC\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & GMT/GMC\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{7}{l}{\textbf{Age, Risk for Severe Covid-19}}\\
\hspace{1em}Age $<$ 65 At-risk & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 214 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 214 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 214 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 214 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 73 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 73 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 73 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 73 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 40 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 40 & \makecell[l]{10\\(10, 11)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & 40 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & 40 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 75 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 75 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & 75 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & 75 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 214 & \makecell[l]{16530\\(13368, 20441)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 214 & \makecell[l]{31028\\(25725, 37423)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 214 & \makecell[l]{68\\(54, 85)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & 214 & \makecell[l]{159\\(123, 204)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 73 & \makecell[l]{30603\\(22501, 41623)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 73 & \makecell[l]{62641\\(46271, 84801)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 73 & \makecell[l]{142\\(95, 213)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & 73 & \makecell[l]{291\\(187, 453)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 40 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 40 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 40 & \makecell[l]{5\\(5, 6)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & 40 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 75 & \makecell[l]{10221\\(7219, 14470)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 75 & \makecell[l]{16112\\(12299, 21107)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 75 & \makecell[l]{48\\(34, 67)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & 75 & \makecell[l]{127\\(87, 186)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 214 & \makecell[l]{761200\\(595277, 973370)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 214 & \makecell[l]{1498825\\(1211392, 1854460)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 214 & \makecell[l]{1203\\(876, 1652)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & 214 & \makecell[l]{2067\\(1571, 2720)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 73 & \makecell[l]{1815884\\(1228679, 2683724)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 73 & \makecell[l]{4547755\\(3405518, 6073108)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 73 & \makecell[l]{2953\\(1859, 4690)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & 73 & \makecell[l]{7954\\(4852, 13039)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 40 & \makecell[l]{10\\(10, 11)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 40 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 40 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & 40 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 75 & \makecell[l]{417627\\(286526, 608715)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 75 & \makecell[l]{575539\\(423609, 781958)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 75 & \makecell[l]{502\\(325, 776)}\\
\hspace{1em}Age $<$ 65 At-risk & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & 75 & \makecell[l]{1382\\(851, 2245)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 218 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 218 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 218 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 218 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 73 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 73 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 73 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 73 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 40 & \makecell[l]{10\\(10, 11)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 40 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & 40 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & 40 & \makecell[l]{5\\(5, 6)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 72 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 72 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & 72 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & 72 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 218 & \makecell[l]{17639\\(14174, 21953)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 218 & \makecell[l]{31500\\(26782, 37050)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 218 & \makecell[l]{90\\(70, 115)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & 218 & \makecell[l]{157\\(122, 200)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 73 & \makecell[l]{23567\\(16129, 34434)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 73 & \makecell[l]{58534\\(42846, 79967)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 73 & \makecell[l]{144\\(97, 214)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & 73 & \makecell[l]{353\\(229, 545)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 40 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 40 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 40 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & 40 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 72 & \makecell[l]{9616\\(6788, 13622)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 72 & \makecell[l]{12751\\(9770, 16642)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 72 & \makecell[l]{38\\(26, 55)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & 72 & \makecell[l]{101\\(68, 150)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 218 & \makecell[l]{730590\\(572430, 932450)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 218 & \makecell[l]{1685764\\(1382036, 2056240)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 218 & \makecell[l]{1118\\(830, 1506)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & 218 & \makecell[l]{1671\\(1216, 2295)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 73 & \makecell[l]{1679359\\(1144789, 2463552)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 73 & \makecell[l]{4192147\\(3040678, 5779665)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 73 & \makecell[l]{4435\\(2453, 8017)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & 73 & \makecell[l]{5833\\(3464, 9821)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 40 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 40 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 40 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & 40 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 72 & \makecell[l]{241209\\(168681, 344922)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 72 & \makecell[l]{463469\\(322830, 665378)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 72 & \makecell[l]{362\\(224, 583)}\\
\hspace{1em}Age $<$ 65 Not at-risk & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & 72 & \makecell[l]{930\\(559, 1549)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 255 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 255 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 255 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 255 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 52 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 52 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 52 & \makecell[l]{5\\(5, 6)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 52 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 44 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 44 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & 44 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & 44 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 48 & \makecell[l]{10\\(10, 11)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 48 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & 48 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & 48 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 255 & \makecell[l]{54232\\(44615, 65922)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 255 & \makecell[l]{84391\\(70325, 101269)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 255 & \makecell[l]{199\\(157, 252)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & 255 & \makecell[l]{348\\(276, 438)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 52 & \makecell[l]{188670\\(129392, 275106)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 52 & \makecell[l]{293282\\(210942, 407763)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 52 & \makecell[l]{541\\(337, 870)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & 52 & \makecell[l]{1052\\(680, 1627)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 44 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 44 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 44 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & 44 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 48 & \makecell[l]{48060\\(30237, 76388)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 48 & \makecell[l]{79058\\(52125, 119908)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 48 & \makecell[l]{155\\(89, 270)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & 48 & \makecell[l]{378\\(233, 613)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 255 & \makecell[l]{2156196\\(1736284, 2677662)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 255 & \makecell[l]{3754377\\(3053564, 4616033)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 255 & \makecell[l]{3359\\(2423, 4656)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & 255 & \makecell[l]{4361\\(3299, 5763)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 52 & \makecell[l]{7826271\\(5853680, 10463591)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 52 & \makecell[l]{12884976\\(10641883, 15600868)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 52 & \makecell[l]{27431\\(17819, 42227)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & 52 & \makecell[l]{22502\\(13237, 38254)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 44 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 44 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 44 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & 44 & \makecell[l]{5\\(5, 6)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 48 & \makecell[l]{1793880\\(1112795, 2891824)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 48 & \makecell[l]{3402410\\(2325361, 4978321)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 48 & \makecell[l]{3501\\(1863, 6577)}\\
\hspace{1em}Age $\geq$ 65 At-risk & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & 48 & \makecell[l]{5048\\(2709, 9408)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 227 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 227 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 227 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 227 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 76 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 76 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 76 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 76 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 39 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 39 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & 39 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & 39 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 75 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 75 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & 75 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & 75 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 227 & \makecell[l]{80069\\(65707, 97571)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 227 & \makecell[l]{153593\\(130667, 180543)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 227 & \makecell[l]{332\\(263, 418)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & 227 & \makecell[l]{421\\(328, 540)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 76 & \makecell[l]{139826\\(99996, 195520)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 76 & \makecell[l]{241494\\(182978, 318724)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 76 & \makecell[l]{508\\(317, 815)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & 76 & \makecell[l]{944\\(626, 1422)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 39 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 39 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 39 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & 39 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 75 & \makecell[l]{38048\\(27669, 52321)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 75 & \makecell[l]{59664\\(45819, 77691)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 75 & \makecell[l]{156\\(105, 232)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & 75 & \makecell[l]{257\\(170, 390)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 227 & \makecell[l]{3441017\\(2860842, 4138850)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 227 & \makecell[l]{7365218\\(6408010, 8465410)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 227 & \makecell[l]{5534\\(4137, 7404)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & 227 & \makecell[l]{7125\\(5468, 9285)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 76 & \makecell[l]{7305563\\(5522547, 9664247)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 76 & \makecell[l]{13343347\\(11421210, 15588971)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 76 & \makecell[l]{18240\\(11134, 29880)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & 76 & \makecell[l]{17541\\(10280, 29932)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 39 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 39 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 39 & \makecell[l]{5\\(5, 6)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & 39 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 75 & \makecell[l]{1599200\\(1156266, 2211811)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 75 & \makecell[l]{2437171\\(1815977, 3270859)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 75 & \makecell[l]{2442\\(1442, 4134)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & 75 & \makecell[l]{3681\\(2278, 5949)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item 
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{7cm}llllll}
\caption{\label{tab:tabs}Table 5e. Geometric mean titers (GMTs) and geometric mean
      concentrations (GMCs) by Sex}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & GMT/GMC\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & GMT/GMC\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{7}{l}{\textbf{Sex}}\\
\hspace{1em}Male & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 395 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Male & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 395 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Male & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 395 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Male & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 395 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Male & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 121 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Male & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 121 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Male & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 121 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Male & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 121 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Male & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 76 & \makecell[l]{11\\(9, 12)}\\
\hspace{1em}Male & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 76 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Male & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & 76 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Male & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & 76 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Male & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 115 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Male & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 115 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Male & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & 115 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Male & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & 115 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Male & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 395 & \makecell[l]{25738\\(20110, 32941)}\\
\hspace{1em}Male & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 395 & \makecell[l]{40290\\(34397, 47193)}\\
\hspace{1em}Male & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 395 & \makecell[l]{121\\(93, 157)}\\
\hspace{1em}Male & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & 395 & \makecell[l]{207\\(158, 272)}\\
\hspace{1em}Male & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 121 & \makecell[l]{43301\\(30763, 60949)}\\
\hspace{1em}Male & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 121 & \makecell[l]{83762\\(65541, 107048)}\\
\hspace{1em}Male & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 121 & \makecell[l]{223\\(158, 315)}\\
\hspace{1em}Male & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & 121 & \makecell[l]{449\\(303, 666)}\\
\hspace{1em}Male & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 76 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Male & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 76 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Male & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 76 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Male & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & 76 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Male & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 115 & \makecell[l]{12838\\(8743, 18852)}\\
\hspace{1em}Male & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 115 & \makecell[l]{16359\\(12044, 22219)}\\
\hspace{1em}Male & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 115 & \makecell[l]{43\\(29, 63)}\\
\hspace{1em}Male & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & 115 & \makecell[l]{100\\(68, 146)}\\
\hspace{1em}Male & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 395 & \makecell[l]{1032572\\(803692, 1326633)}\\
\hspace{1em}Male & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 395 & \makecell[l]{2448348\\(1992531, 3008439)}\\
\hspace{1em}Male & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 395 & \makecell[l]{1983\\(1427, 2754)}\\
\hspace{1em}Male & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & 395 & \makecell[l]{2322\\(1694, 3181)}\\
\hspace{1em}Male & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 121 & \makecell[l]{2628794\\(1842173, 3751308)}\\
\hspace{1em}Male & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 121 & \makecell[l]{5518909\\(4222583, 7213204)}\\
\hspace{1em}Male & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 121 & \makecell[l]{5567\\(3235, 9581)}\\
\hspace{1em}Male & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & 121 & \makecell[l]{9590\\(6259, 14696)}\\
\hspace{1em}Male & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 76 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Male & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 76 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Male & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 76 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Male & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & 76 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Male & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 115 & \makecell[l]{361345\\(243436, 536364)}\\
\hspace{1em}Male & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 115 & \makecell[l]{578439\\(406742, 822616)}\\
\hspace{1em}Male & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 115 & \makecell[l]{606\\(358, 1023)}\\
\hspace{1em}Male & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & 115 & \makecell[l]{930\\(554, 1559)}\\
\hspace{1em}Female & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 519 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Female & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 519 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Female & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 519 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Female & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 519 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Female & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 153 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Female & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 153 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Female & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 153 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Female & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 153 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Female & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 87 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Female & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 87 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Female & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & 87 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Female & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & 87 & \makecell[l]{5\\(5, 6)}\\
\hspace{1em}Female & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 155 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Female & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 155 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Female & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & 155 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Female & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & 155 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Female & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 519 & \makecell[l]{21234\\(17837, 25278)}\\
\hspace{1em}Female & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 519 & \makecell[l]{41415\\(35725, 48012)}\\
\hspace{1em}Female & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 519 & \makecell[l]{98\\(80, 120)}\\
\hspace{1em}Female & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & 519 & \makecell[l]{178\\(145, 218)}\\
\hspace{1em}Female & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 153 & \makecell[l]{32117\\(22658, 45526)}\\
\hspace{1em}Female & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 153 & \makecell[l]{77611\\(57216, 105276)}\\
\hspace{1em}Female & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 153 & \makecell[l]{165\\(113, 242)}\\
\hspace{1em}Female & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & 153 & \makecell[l]{401\\(268, 602)}\\
\hspace{1em}Female & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 87 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Female & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 87 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Female & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 87 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Female & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & 87 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Female & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 155 & \makecell[l]{12876\\(9489, 17472)}\\
\hspace{1em}Female & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 155 & \makecell[l]{19468\\(15496, 24459)}\\
\hspace{1em}Female & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 155 & \makecell[l]{58\\(42, 81)}\\
\hspace{1em}Female & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & 155 & \makecell[l]{152\\(105, 219)}\\
\hspace{1em}Female & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 519 & \makecell[l]{924524\\(750510, 1138886)}\\
\hspace{1em}Female & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 519 & \makecell[l]{1878895\\(1586011, 2225864)}\\
\hspace{1em}Female & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 519 & \makecell[l]{1243\\(972, 1588)}\\
\hspace{1em}Female & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & 519 & \makecell[l]{2160\\(1643, 2840)}\\
\hspace{1em}Female & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 153 & \makecell[l]{2106655\\(1490680, 2977161)}\\
\hspace{1em}Female & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 153 & \makecell[l]{5236885\\(3880756, 7066912)}\\
\hspace{1em}Female & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 153 & \makecell[l]{5754\\(3356, 9868)}\\
\hspace{1em}Female & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & 153 & \makecell[l]{6872\\(4174, 11314)}\\
\hspace{1em}Female & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 87 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Female & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 87 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Female & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 87 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Female & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & 87 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Female & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 155 & \makecell[l]{396863\\(289955, 543189)}\\
\hspace{1em}Female & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 155 & \makecell[l]{748414\\(540245, 1036794)}\\
\hspace{1em}Female & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 155 & \makecell[l]{541\\(355, 825)}\\
\hspace{1em}Female & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & 155 & \makecell[l]{1659\\(1064, 2588)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item 
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{7cm}llllll}
\caption{\label{tab:tabs}Table 5f. Geometric mean titers (GMTs) and geometric mean
      concentrations (GMCs) by Age, sex}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & GMT/GMC\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & GMT/GMC\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{7}{l}{\textbf{Age, sex}}\\
\hspace{1em}Age $<$ 65 Female & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 269 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Female & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 269 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Female & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 269 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Female & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 269 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Female & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 79 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Female & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 79 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Female & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 79 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Female & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 79 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Female & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 52 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Female & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 52 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Female & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & 52 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Female & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & 52 & \makecell[l]{5\\(5, 6)}\\
\hspace{1em}Age $<$ 65 Female & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 83 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Female & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 83 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Female & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & 83 & \makecell[l]{5\\(5, 6)}\\
\hspace{1em}Age $<$ 65 Female & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & 83 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Female & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 269 & \makecell[l]{16543\\(13418, 20396)}\\
\hspace{1em}Age $<$ 65 Female & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 269 & \makecell[l]{32705\\(27399, 39039)}\\
\hspace{1em}Age $<$ 65 Female & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 269 & \makecell[l]{79\\(62, 101)}\\
\hspace{1em}Age $<$ 65 Female & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & 269 & \makecell[l]{150\\(118, 191)}\\
\hspace{1em}Age $<$ 65 Female & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 79 & \makecell[l]{21789\\(14248, 33321)}\\
\hspace{1em}Age $<$ 65 Female & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 79 & \makecell[l]{56962\\(39317, 82526)}\\
\hspace{1em}Age $<$ 65 Female & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 79 & \makecell[l]{124\\(78, 197)}\\
\hspace{1em}Age $<$ 65 Female & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & 79 & \makecell[l]{319\\(195, 522)}\\
\hspace{1em}Age $<$ 65 Female & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 52 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Female & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 52 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Female & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 52 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Female & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & 52 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Female & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 83 & \makecell[l]{10100\\(6984, 14608)}\\
\hspace{1em}Age $<$ 65 Female & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 83 & \makecell[l]{14961\\(11369, 19689)}\\
\hspace{1em}Age $<$ 65 Female & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 83 & \makecell[l]{46\\(31, 69)}\\
\hspace{1em}Age $<$ 65 Female & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & 83 & \makecell[l]{133\\(86, 207)}\\
\hspace{1em}Age $<$ 65 Female & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 269 & \makecell[l]{725439\\(563976, 933126)}\\
\hspace{1em}Age $<$ 65 Female & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 269 & \makecell[l]{1494002\\(1218429, 1831901)}\\
\hspace{1em}Age $<$ 65 Female & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 269 & \makecell[l]{946\\(706, 1267)}\\
\hspace{1em}Age $<$ 65 Female & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & 269 & \makecell[l]{1691\\(1216, 2352)}\\
\hspace{1em}Age $<$ 65 Female & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 79 & \makecell[l]{1557246\\(1019727, 2378101)}\\
\hspace{1em}Age $<$ 65 Female & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 79 & \makecell[l]{4234642\\(2930914, 6118296)}\\
\hspace{1em}Age $<$ 65 Female & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 79 & \makecell[l]{4195\\(2173, 8100)}\\
\hspace{1em}Age $<$ 65 Female & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & 79 & \makecell[l]{5422\\(2964, 9918)}\\
\hspace{1em}Age $<$ 65 Female & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 52 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Female & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 52 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Female & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 52 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Female & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & 52 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Female & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 83 & \makecell[l]{293632\\(201048, 428852)}\\
\hspace{1em}Age $<$ 65 Female & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 83 & \makecell[l]{571578\\(384900, 848795)}\\
\hspace{1em}Age $<$ 65 Female & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 83 & \makecell[l]{387\\(233, 641)}\\
\hspace{1em}Age $<$ 65 Female & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & 83 & \makecell[l]{1375\\(804, 2349)}\\
\hspace{1em}Age $<$ 65 Male & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 163 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Male & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 163 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Male & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 163 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Male & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 163 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Male & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 67 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Male & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 67 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Male & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 67 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Male & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 67 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Male & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 28 & \makecell[l]{11\\(9, 13)}\\
\hspace{1em}Age $<$ 65 Male & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 28 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Male & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & 28 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Male & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & 28 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Male & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 64 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Male & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 64 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Male & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & 64 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Male & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & 64 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Male & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 163 & \makecell[l]{18877\\(13705, 26001)}\\
\hspace{1em}Age $<$ 65 Male & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 163 & \makecell[l]{29372\\(24030, 35901)}\\
\hspace{1em}Age $<$ 65 Male & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 163 & \makecell[l]{94\\(67, 132)}\\
\hspace{1em}Age $<$ 65 Male & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & 163 & \makecell[l]{169\\(118, 240)}\\
\hspace{1em}Age $<$ 65 Male & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 67 & \makecell[l]{30884\\(20281, 47031)}\\
\hspace{1em}Age $<$ 65 Male & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 67 & \makecell[l]{63477\\(47023, 85688)}\\
\hspace{1em}Age $<$ 65 Male & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 67 & \makecell[l]{180\\(119, 274)}\\
\hspace{1em}Age $<$ 65 Male & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & 67 & \makecell[l]{372\\(229, 604)}\\
\hspace{1em}Age $<$ 65 Male & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 28 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Male & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 28 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Male & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 28 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Male & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & 28 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Male & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 64 & \makecell[l]{9188\\(5784, 14598)}\\
\hspace{1em}Age $<$ 65 Male & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 64 & \makecell[l]{11210\\(7775, 16161)}\\
\hspace{1em}Age $<$ 65 Male & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 64 & \makecell[l]{31\\(20, 50)}\\
\hspace{1em}Age $<$ 65 Male & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & 64 & \makecell[l]{73\\(47, 115)}\\
\hspace{1em}Age $<$ 65 Male & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 163 & \makecell[l]{756600\\(546757, 1046981)}\\
\hspace{1em}Age $<$ 65 Male & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 163 & \makecell[l]{1920202\\(1472176, 2504576)}\\
\hspace{1em}Age $<$ 65 Male & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 163 & \makecell[l]{1532\\(1004, 2337)}\\
\hspace{1em}Age $<$ 65 Male & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & 163 & \makecell[l]{1850\\(1231, 2781)}\\
\hspace{1em}Age $<$ 65 Male & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 67 & \makecell[l]{1977267\\(1268954, 3080952)}\\
\hspace{1em}Age $<$ 65 Male & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 67 & \makecell[l]{4318054\\(3077671, 6058343)}\\
\hspace{1em}Age $<$ 65 Male & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 67 & \makecell[l]{3857\\(1960, 7590)}\\
\hspace{1em}Age $<$ 65 Male & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & 67 & \makecell[l]{7789\\(4625, 13117)}\\
\hspace{1em}Age $<$ 65 Male & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 28 & \makecell[l]{10\\(10, 11)}\\
\hspace{1em}Age $<$ 65 Male & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 28 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Male & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 28 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Male & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & 28 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Male & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 64 & \makecell[l]{236528\\(146661, 381460)}\\
\hspace{1em}Age $<$ 65 Male & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 64 & \makecell[l]{373064\\(243212, 572245)}\\
\hspace{1em}Age $<$ 65 Male & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 64 & \makecell[l]{387\\(206, 728)}\\
\hspace{1em}Age $<$ 65 Male & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & 64 & \makecell[l]{618\\(331, 1154)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 232 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 232 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 232 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 232 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 54 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 54 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 54 & \makecell[l]{5\\(5, 6)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 54 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 48 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 48 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & 48 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & 48 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 51 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 51 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & 51 & \makecell[l]{5\\(5, 6)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & 51 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 232 & \makecell[l]{66467\\(53933, 81913)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 232 & \makecell[l]{105989\\(87935, 127749)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 232 & \makecell[l]{259\\(203, 330)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & 232 & \makecell[l]{390\\(306, 496)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 54 & \makecell[l]{148457\\(98119, 224620)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 54 & \makecell[l]{230231\\(167261, 316907)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 54 & \makecell[l]{482\\(286, 812)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & 54 & \makecell[l]{895\\(560, 1432)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 48 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 48 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 48 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & 48 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 51 & \makecell[l]{50082\\(30542, 82125)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 51 & \makecell[l]{76189\\(49115, 118188)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 51 & \makecell[l]{147\\(82, 263)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & 51 & \makecell[l]{350\\(196, 626)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 232 & \makecell[l]{2674328\\(2152728, 3322311)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 232 & \makecell[l]{5149990\\(4231902, 6267253)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 232 & \makecell[l]{4362\\(3133, 6074)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & 232 & \makecell[l]{4649\\(3501, 6173)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 54 & \makecell[l]{7426127\\(5296972, 10411111)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 54 & \makecell[l]{13502491\\(11607977, 15706205)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 54 & \makecell[l]{21221\\(12633, 35647)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & 54 & \makecell[l]{20477\\(11619, 36087)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 48 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 48 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 48 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & 48 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 51 & \makecell[l]{2027539\\(1259961, 3262731)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 51 & \makecell[l]{3447429\\(2322804, 5116559)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 51 & \makecell[l]{3730\\(1880, 7401)}\\
\hspace{1em}Age $\geq$ 65 Male & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & 51 & \makecell[l]{4892\\(2560, 9348)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 250 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 250 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 250 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 250 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 74 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 74 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 74 & \makecell[l]{5\\(5, 6)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 74 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 35 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 35 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & 35 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & 35 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 72 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 72 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & 72 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & 72 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 250 & \makecell[l]{64209\\(53151, 77567)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 250 & \makecell[l]{117943\\(99447, 139878)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 250 & \makecell[l]{249\\(197, 315)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & 250 & \makecell[l]{373\\(294, 474)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 74 & \makecell[l]{166523\\(121761, 227741)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 74 & \makecell[l]{288235\\(216852, 383115)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 74 & \makecell[l]{553\\(354, 864)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & 74 & \makecell[l]{1062\\(720, 1566)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 35 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 35 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 35 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & 35 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 72 & \makecell[l]{37051\\(27449, 50013)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 72 & \makecell[l]{61265\\(47638, 78789)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 72 & \makecell[l]{162\\(110, 238)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & 72 & \makecell[l]{271\\(188, 392)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 250 & \makecell[l]{2708471\\(2228982, 3291105)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 250 & \makecell[l]{5189777\\(4355492, 6183867)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 250 & \makecell[l]{4169\\(3097, 5612)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & 250 & \makecell[l]{6397\\(4907, 8340)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 74 & \makecell[l]{7590360\\(5921961, 9728799)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 74 & \makecell[l]{12894340\\(10799304, 15395807)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 74 & \makecell[l]{21984\\(13986, 34558)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & 74 & \makecell[l]{18779\\(11189, 31518)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 35 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 35 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 35 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & 35 & \makecell[l]{5\\(5, 6)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 72 & \makecell[l]{1473236\\(1067157, 2033836)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 72 & \makecell[l]{2420004\\(1820068, 3217693)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 72 & \makecell[l]{2344\\(1427, 3849)}\\
\hspace{1em}Age $\geq$ 65 Female & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & 72 & \makecell[l]{3767\\(2352, 6032)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item 
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{7cm}llllll}
\caption{\label{tab:tabs}Table 5g. Geometric mean titers (GMTs) and geometric mean
      concentrations (GMCs) by Hispanic or Latino ethnicity}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & GMT/GMC\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & GMT/GMC\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{7}{l}{\textbf{Hispanic or Latino ethnicity}}\\
\hspace{1em}Hispanic or Latino & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 136 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Hispanic or Latino & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 136 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Hispanic or Latino & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 136 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Hispanic or Latino & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 136 & \makecell[l]{5\\(5, 6)}\\
\hspace{1em}Hispanic or Latino & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 35 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Hispanic or Latino & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 35 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Hispanic or Latino & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 35 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Hispanic or Latino & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 35 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Hispanic or Latino & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 20 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Hispanic or Latino & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 20 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Hispanic or Latino & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & 20 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Hispanic or Latino & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & 20 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Hispanic or Latino & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 38 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Hispanic or Latino & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 38 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Hispanic or Latino & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & 38 & \makecell[l]{6\\(5, 7)}\\
\hspace{1em}Hispanic or Latino & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & 38 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Hispanic or Latino & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 136 & \makecell[l]{22266\\(15847, 31284)}\\
\hspace{1em}Hispanic or Latino & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 136 & \makecell[l]{41773\\(31562, 55289)}\\
\hspace{1em}Hispanic or Latino & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 136 & \makecell[l]{101\\(67, 152)}\\
\hspace{1em}Hispanic or Latino & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & 136 & \makecell[l]{190\\(126, 284)}\\
\hspace{1em}Hispanic or Latino & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 35 & \makecell[l]{57339\\(30559, 107588)}\\
\hspace{1em}Hispanic or Latino & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 35 & \makecell[l]{90332\\(50343, 162084)}\\
\hspace{1em}Hispanic or Latino & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 35 & \makecell[l]{254\\(155, 417)}\\
\hspace{1em}Hispanic or Latino & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & 35 & \makecell[l]{498\\(236, 1049)}\\
\hspace{1em}Hispanic or Latino & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 20 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Hispanic or Latino & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 20 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Hispanic or Latino & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 20 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Hispanic or Latino & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & 20 & \makecell[l]{6\\(4, 8)}\\
\hspace{1em}Hispanic or Latino & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 38 & \makecell[l]{34815\\(16110, 75239)}\\
\hspace{1em}Hispanic or Latino & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 38 & \makecell[l]{26708\\(12585, 56680)}\\
\hspace{1em}Hispanic or Latino & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 38 & \makecell[l]{118\\(42, 327)}\\
\hspace{1em}Hispanic or Latino & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & 38 & \makecell[l]{351\\(151, 818)}\\
\hspace{1em}Hispanic or Latino & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 136 & \makecell[l]{1087406\\(737091, 1604213)}\\
\hspace{1em}Hispanic or Latino & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 136 & \makecell[l]{2082654\\(1564176, 2772993)}\\
\hspace{1em}Hispanic or Latino & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 136 & \makecell[l]{1727\\(1013, 2946)}\\
\hspace{1em}Hispanic or Latino & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & 136 & \makecell[l]{2444\\(1373, 4350)}\\
\hspace{1em}Hispanic or Latino & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 35 & \makecell[l]{2735111\\(1368395, 5466868)}\\
\hspace{1em}Hispanic or Latino & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 35 & \makecell[l]{7578287\\(5040721, 11393296)}\\
\hspace{1em}Hispanic or Latino & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 35 & \makecell[l]{7727\\(2908, 20532)}\\
\hspace{1em}Hispanic or Latino & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & 35 & \makecell[l]{10208\\(4492, 23195)}\\
\hspace{1em}Hispanic or Latino & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 20 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Hispanic or Latino & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 20 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Hispanic or Latino & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 20 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Hispanic or Latino & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & 20 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Hispanic or Latino & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 38 & \makecell[l]{747435\\(391924, 1425424)}\\
\hspace{1em}Hispanic or Latino & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 38 & \makecell[l]{1403460\\(609038, 3234119)}\\
\hspace{1em}Hispanic or Latino & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 38 & \makecell[l]{1522\\(466, 4976)}\\
\hspace{1em}Hispanic or Latino & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & 38 & \makecell[l]{3063\\(1057, 8877)}\\
\hspace{1em}Not Hispanic or Latino & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 690 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not Hispanic or Latino & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 690 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not Hispanic or Latino & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 690 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not Hispanic or Latino & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 690 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not Hispanic or Latino & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 217 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not Hispanic or Latino & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 217 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not Hispanic or Latino & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 217 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not Hispanic or Latino & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 217 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not Hispanic or Latino & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 130 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not Hispanic or Latino & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 130 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not Hispanic or Latino & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & 130 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not Hispanic or Latino & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & 130 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not Hispanic or Latino & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 214 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not Hispanic or Latino & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 214 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not Hispanic or Latino & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & 214 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not Hispanic or Latino & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & 214 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not Hispanic or Latino & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 690 & \makecell[l]{23020\\(19425, 27280)}\\
\hspace{1em}Not Hispanic or Latino & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 690 & \makecell[l]{39694\\(35055, 44946)}\\
\hspace{1em}Not Hispanic or Latino & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 690 & \makecell[l]{104\\(86, 125)}\\
\hspace{1em}Not Hispanic or Latino & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & 690 & \makecell[l]{191\\(158, 230)}\\
\hspace{1em}Not Hispanic or Latino & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 217 & \makecell[l]{35344\\(26390, 47337)}\\
\hspace{1em}Not Hispanic or Latino & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 217 & \makecell[l]{83383\\(65546, 106075)}\\
\hspace{1em}Not Hispanic or Latino & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 217 & \makecell[l]{183\\(133, 251)}\\
\hspace{1em}Not Hispanic or Latino & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & 217 & \makecell[l]{411\\(294, 575)}\\
\hspace{1em}Not Hispanic or Latino & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 130 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not Hispanic or Latino & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 130 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not Hispanic or Latino & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 130 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not Hispanic or Latino & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & 130 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not Hispanic or Latino & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 214 & \makecell[l]{11608\\(9046, 14896)}\\
\hspace{1em}Not Hispanic or Latino & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 214 & \makecell[l]{18056\\(14910, 21865)}\\
\hspace{1em}Not Hispanic or Latino & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 214 & \makecell[l]{48\\(37, 63)}\\
\hspace{1em}Not Hispanic or Latino & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & 214 & \makecell[l]{123\\(92, 165)}\\
\hspace{1em}Not Hispanic or Latino & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 690 & \makecell[l]{987977\\(822264, 1187086)}\\
\hspace{1em}Not Hispanic or Latino & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 690 & \makecell[l]{2063432\\(1775937, 2397468)}\\
\hspace{1em}Not Hispanic or Latino & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 690 & \makecell[l]{1500\\(1191, 1888)}\\
\hspace{1em}Not Hispanic or Latino & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & 690 & \makecell[l]{2270\\(1788, 2883)}\\
\hspace{1em}Not Hispanic or Latino & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 217 & \makecell[l]{2315554\\(1731123, 3097290)}\\
\hspace{1em}Not Hispanic or Latino & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 217 & \makecell[l]{5301268\\(4150604, 6770929)}\\
\hspace{1em}Not Hispanic or Latino & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 217 & \makecell[l]{5224\\(3348, 8151)}\\
\hspace{1em}Not Hispanic or Latino & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & 217 & \makecell[l]{7937\\(5300, 11886)}\\
\hspace{1em}Not Hispanic or Latino & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 130 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not Hispanic or Latino & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 130 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not Hispanic or Latino & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 130 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not Hispanic or Latino & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & 130 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not Hispanic or Latino & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 214 & \makecell[l]{381696\\(293138, 497006)}\\
\hspace{1em}Not Hispanic or Latino & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 214 & \makecell[l]{648311\\(505732, 831086)}\\
\hspace{1em}Not Hispanic or Latino & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 214 & \makecell[l]{555\\(395, 782)}\\
\hspace{1em}Not Hispanic or Latino & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & 214 & \makecell[l]{1324\\(921, 1904)}\\
\hspace{1em}Not reported and unknown & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 88 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not reported and unknown & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 88 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not reported and unknown & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 88 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not reported and unknown & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 88 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not reported and unknown & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 22 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not reported and unknown & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 22 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not reported and unknown & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 22 & \makecell[l]{6\\(4, 7)}\\
\hspace{1em}Not reported and unknown & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 22 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not reported and unknown & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 13 & \makecell[l]{12\\(8, 18)}\\
\hspace{1em}Not reported and unknown & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 13 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not reported and unknown & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & 13 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not reported and unknown & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & 13 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not reported and unknown & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 18 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not reported and unknown & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 18 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not reported and unknown & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & 18 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not reported and unknown & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & 18 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not reported and unknown & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 88 & \makecell[l]{22876\\(15904, 32905)}\\
\hspace{1em}Not reported and unknown & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 88 & \makecell[l]{50488\\(35885, 71034)}\\
\hspace{1em}Not reported and unknown & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 88 & \makecell[l]{133\\(84, 213)}\\
\hspace{1em}Not reported and unknown & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & 88 & \makecell[l]{174\\(106, 287)}\\
\hspace{1em}Not reported and unknown & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 22 & \makecell[l]{25827\\(18334, 36382)}\\
\hspace{1em}Not reported and unknown & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 22 & \makecell[l]{46903\\(33825, 65038)}\\
\hspace{1em}Not reported and unknown & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 22 & \makecell[l]{154\\(91, 259)}\\
\hspace{1em}Not reported and unknown & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & 22 & \makecell[l]{420\\(198, 891)}\\
\hspace{1em}Not reported and unknown & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 13 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not reported and unknown & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 13 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not reported and unknown & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 13 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not reported and unknown & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & 13 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not reported and unknown & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 18 & \makecell[l]{10750\\(3611, 32001)}\\
\hspace{1em}Not reported and unknown & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 18 & \makecell[l]{11909\\(5649, 25107)}\\
\hspace{1em}Not reported and unknown & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 18 & \makecell[l]{37\\(15, 93)}\\
\hspace{1em}Not reported and unknown & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & 18 & \makecell[l]{58\\(19, 177)}\\
\hspace{1em}Not reported and unknown & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 88 & \makecell[l]{735710\\(462524, 1170251)}\\
\hspace{1em}Not reported and unknown & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 88 & \makecell[l]{2279592\\(1446853, 3591615)}\\
\hspace{1em}Not reported and unknown & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 88 & \makecell[l]{1291\\(765, 2178)}\\
\hspace{1em}Not reported and unknown & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & 88 & \makecell[l]{1748\\(990, 3088)}\\
\hspace{1em}Not reported and unknown & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 22 & \makecell[l]{1751283\\(872333, 3515850)}\\
\hspace{1em}Not reported and unknown & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 22 & \makecell[l]{3840709\\(2197166, 6713669)}\\
\hspace{1em}Not reported and unknown & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 22 & \makecell[l]{8669\\(2979, 25223)}\\
\hspace{1em}Not reported and unknown & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & 22 & \makecell[l]{5104\\(2140, 12175)}\\
\hspace{1em}Not reported and unknown & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 13 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not reported and unknown & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 13 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not reported and unknown & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 13 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not reported and unknown & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & 13 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not reported and unknown & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 18 & \makecell[l]{162620\\(55659, 475135)}\\
\hspace{1em}Not reported and unknown & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 18 & \makecell[l]{417076\\(107739, 1614570)}\\
\hspace{1em}Not reported and unknown & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 18 & \makecell[l]{188\\(46, 766)}\\
\hspace{1em}Not reported and unknown & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & 18 & \makecell[l]{437\\(69, 2773)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item 
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{7cm}llllll}
\caption{\label{tab:tabs}Table 5h. Geometric mean titers (GMTs) and geometric mean
      concentrations (GMCs) by Race}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & GMT/GMC\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & GMT/GMC\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{7}{l}{\textbf{Race}}\\
\hspace{1em}White Non-Hispanic & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 362 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}White Non-Hispanic & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 362 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}White Non-Hispanic & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 362 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}White Non-Hispanic & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 362 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}White Non-Hispanic & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 125 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}White Non-Hispanic & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 125 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}White Non-Hispanic & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 125 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}White Non-Hispanic & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 125 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}White Non-Hispanic & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 67 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}White Non-Hispanic & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 67 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}White Non-Hispanic & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & 67 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}White Non-Hispanic & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & 67 & \makecell[l]{5\\(5, 6)}\\
\hspace{1em}White Non-Hispanic & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 121 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}White Non-Hispanic & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 121 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}White Non-Hispanic & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & 121 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}White Non-Hispanic & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & 121 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 362 & \makecell[l]{23438\\(18669, 29425)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 362 & \makecell[l]{40376\\(34349, 47460)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 362 & \makecell[l]{115\\(90, 147)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & 362 & \makecell[l]{188\\(146, 241)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 125 & \makecell[l]{30985\\(21434, 44793)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 125 & \makecell[l]{72481\\(53061, 99008)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 125 & \makecell[l]{148\\(104, 211)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & 125 & \makecell[l]{348\\(226, 535)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 67 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 67 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 67 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & 67 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 121 & \makecell[l]{10931\\(7560, 15804)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 121 & \makecell[l]{18868\\(14808, 24043)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 121 & \makecell[l]{52\\(37, 74)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & 121 & \makecell[l]{107\\(76, 150)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 362 & \makecell[l]{1035293\\(809568, 1323956)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 362 & \makecell[l]{2145772\\(1770774, 2600184)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 362 & \makecell[l]{1376\\(1010, 1874)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & 362 & \makecell[l]{2011\\(1465, 2761)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 125 & \makecell[l]{1943813\\(1349835, 2799166)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 125 & \makecell[l]{4608987\\(3338577, 6362819)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 125 & \makecell[l]{4550\\(2471, 8378)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & 125 & \makecell[l]{7994\\(4646, 13757)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 67 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 67 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 67 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & 67 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 121 & \makecell[l]{393045\\(287516, 537306)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 121 & \makecell[l]{674526\\(485396, 937351)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 121 & \makecell[l]{575\\(371, 892)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & 121 & \makecell[l]{1478\\(953, 2292)}\\
\hspace{1em}Black or African American & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 195 & \makecell[l]{10\\(10, 11)}\\
\hspace{1em}Black or African American & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 195 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Black or African American & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 195 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Black or African American & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 195 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Black or African American & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 52 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Black or African American & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 52 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Black or African American & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 52 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Black or African American & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 52 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Black or African American & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 39 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Black or African American & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 39 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Black or African American & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & 39 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Black or African American & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & 39 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Black or African American & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 60 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Black or African American & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 60 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Black or African American & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & 60 & \makecell[l]{5\\(5, 6)}\\
\hspace{1em}Black or African American & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & 60 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Black or African American & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 195 & \makecell[l]{18966\\(14305, 25146)}\\
\hspace{1em}Black or African American & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 195 & \makecell[l]{33478\\(26923, 41629)}\\
\hspace{1em}Black or African American & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 195 & \makecell[l]{80\\(57, 111)}\\
\hspace{1em}Black or African American & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & 195 & \makecell[l]{168\\(116, 244)}\\
\hspace{1em}Black or African American & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 52 & \makecell[l]{49806\\(32279, 76849)}\\
\hspace{1em}Black or African American & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 52 & \makecell[l]{92510\\(63827, 134083)}\\
\hspace{1em}Black or African American & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 52 & \makecell[l]{240\\(126, 455)}\\
\hspace{1em}Black or African American & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & 52 & \makecell[l]{595\\(282, 1255)}\\
\hspace{1em}Black or African American & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 39 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Black or African American & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 39 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Black or African American & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 39 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Black or African American & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & 39 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Black or African American & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 60 & \makecell[l]{13142\\(8909, 19387)}\\
\hspace{1em}Black or African American & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 60 & \makecell[l]{17281\\(11001, 27148)}\\
\hspace{1em}Black or African American & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 60 & \makecell[l]{44\\(24, 81)}\\
\hspace{1em}Black or African American & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & 60 & \makecell[l]{170\\(88, 328)}\\
\hspace{1em}Black or African American & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 195 & \makecell[l]{700976\\(482795, 1017755)}\\
\hspace{1em}Black or African American & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 195 & \makecell[l]{1698222\\(1265203, 2279444)}\\
\hspace{1em}Black or African American & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 195 & \makecell[l]{1634\\(1060, 2520)}\\
\hspace{1em}Black or African American & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & 195 & \makecell[l]{2461\\(1568, 3861)}\\
\hspace{1em}Black or African American & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 52 & \makecell[l]{3863173\\(2496394, 5978266)}\\
\hspace{1em}Black or African American & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 52 & \makecell[l]{5233980\\(3292870, 8319352)}\\
\hspace{1em}Black or African American & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 52 & \makecell[l]{9353\\(5430, 16111)}\\
\hspace{1em}Black or African American & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & 52 & \makecell[l]{10207\\(5426, 19200)}\\
\hspace{1em}Black or African American & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 39 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Black or African American & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 39 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Black or African American & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 39 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Black or African American & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & 39 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Black or African American & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 60 & \makecell[l]{304404\\(168043, 551417)}\\
\hspace{1em}Black or African American & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 60 & \makecell[l]{604842\\(358324, 1020956)}\\
\hspace{1em}Black or African American & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 60 & \makecell[l]{572\\(270, 1213)}\\
\hspace{1em}Black or African American & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & 60 & \makecell[l]{1276\\(599, 2723)}\\
\hspace{1em}Asian & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 67 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Asian & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 67 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Asian & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 67 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Asian & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 67 & \makecell[l]{5\\(5, 6)}\\
\hspace{1em}Asian & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 24 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Asian & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 24 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Asian & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 24 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Asian & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 24 & \makecell[l]{6\\(5, 7)}\\
\hspace{1em}Asian & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 12 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Asian & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 12 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Asian & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & 12 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Asian & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & 12 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Asian & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 13 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Asian & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 13 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Asian & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & 13 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Asian & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & 13 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Asian & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 67 & \makecell[l]{33349\\(22259, 49964)}\\
\hspace{1em}Asian & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 67 & \makecell[l]{63758\\(45931, 88504)}\\
\hspace{1em}Asian & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 67 & \makecell[l]{144\\(92, 225)}\\
\hspace{1em}Asian & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & 67 & \makecell[l]{330\\(204, 534)}\\
\hspace{1em}Asian & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 24 & \makecell[l]{24553\\(12536, 48091)}\\
\hspace{1em}Asian & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 24 & \makecell[l]{49522\\(26709, 91821)}\\
\hspace{1em}Asian & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 24 & \makecell[l]{174\\(94, 325)}\\
\hspace{1em}Asian & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & 24 & \makecell[l]{368\\(184, 735)}\\
\hspace{1em}Asian & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 12 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Asian & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 12 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Asian & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 12 & \makecell[l]{5\\(5, 6)}\\
\hspace{1em}Asian & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & 12 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Asian & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 13 & \makecell[l]{27396\\(5431, 138186)}\\
\hspace{1em}Asian & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 13 & \makecell[l]{12500\\(4740, 32962)}\\
\hspace{1em}Asian & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 13 & \makecell[l]{65\\(17, 245)}\\
\hspace{1em}Asian & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & 13 & \makecell[l]{146\\(18, 1215)}\\
\hspace{1em}Asian & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 67 & \makecell[l]{1685637\\(1167594, 2433528)}\\
\hspace{1em}Asian & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 67 & \makecell[l]{2633046\\(1864450, 3718486)}\\
\hspace{1em}Asian & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 67 & \makecell[l]{2850\\(1578, 5149)}\\
\hspace{1em}Asian & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & 67 & \makecell[l]{3805\\(1835, 7889)}\\
\hspace{1em}Asian & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 24 & \makecell[l]{2094481\\(742718, 5906481)}\\
\hspace{1em}Asian & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 24 & \makecell[l]{4848443\\(2478358, 9485072)}\\
\hspace{1em}Asian & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 24 & \makecell[l]{6020\\(2360, 15360)}\\
\hspace{1em}Asian & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & 24 & \makecell[l]{8404\\(2608, 27081)}\\
\hspace{1em}Asian & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 12 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Asian & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 12 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Asian & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 12 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Asian & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & 12 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Asian & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 13 & \makecell[l]{750472\\(176753, 3186420)}\\
\hspace{1em}Asian & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 13 & \makecell[l]{859200\\(168867, 4371633)}\\
\hspace{1em}Asian & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 13 & \makecell[l]{482\\(269, 862)}\\
\hspace{1em}Asian & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & 13 & \makecell[l]{1167\\(203, 6693)}\\
\hspace{1em}American Indian or Alaska Native & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 13 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}American Indian or Alaska Native & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 13 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}American Indian or Alaska Native & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 13 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}American Indian or Alaska Native & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 13 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}American Indian or Alaska Native & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 6 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}American Indian or Alaska Native & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 6 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}American Indian or Alaska Native & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 6 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}American Indian or Alaska Native & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 6 & \makecell[l]{7\\(4, 14)}\\
\hspace{1em}American Indian or Alaska Native & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 5 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}American Indian or Alaska Native & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 5 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}American Indian or Alaska Native & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & 5 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}American Indian or Alaska Native & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & 5 & \makecell[l]{5\\(5, 7)}\\
\hspace{1em}American Indian or Alaska Native & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 4 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}American Indian or Alaska Native & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 4 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}American Indian or Alaska Native & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & 4 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}American Indian or Alaska Native & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & 4 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}American Indian or Alaska Native & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 13 & \makecell[l]{42283\\(20288, 88120)}\\
\hspace{1em}American Indian or Alaska Native & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 13 & \makecell[l]{30785\\(13439, 70516)}\\
\hspace{1em}American Indian or Alaska Native & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 13 & \makecell[l]{186\\(63, 554)}\\
\hspace{1em}American Indian or Alaska Native & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & 13 & \makecell[l]{309\\(55, 1753)}\\
\hspace{1em}American Indian or Alaska Native & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 6 & \makecell[l]{22761\\(8134, 63689)}\\
\hspace{1em}American Indian or Alaska Native & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 6 & \makecell[l]{85898\\(68138, 108288)}\\
\hspace{1em}American Indian or Alaska Native & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 6 & \makecell[l]{244\\(182, 327)}\\
\hspace{1em}American Indian or Alaska Native & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & 6 & \makecell[l]{1338\\(620, 2888)}\\
\hspace{1em}American Indian or Alaska Native & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 5 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}American Indian or Alaska Native & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 5 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}American Indian or Alaska Native & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 5 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}American Indian or Alaska Native & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & 5 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}American Indian or Alaska Native & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 4 & \makecell[l]{7559\\(3837, 14892)}\\
\hspace{1em}American Indian or Alaska Native & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 4 & \makecell[l]{5348\\(1735, 16488)}\\
\hspace{1em}American Indian or Alaska Native & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 4 & \makecell[l]{13\\(4, 46)}\\
\hspace{1em}American Indian or Alaska Native & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & 4 & \makecell[l]{79\\(32, 190)}\\
\hspace{1em}American Indian or Alaska Native & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 13 & \makecell[l]{836025\\(283249, 2467576)}\\
\hspace{1em}American Indian or Alaska Native & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 13 & \makecell[l]{4760602\\(2359191, 9606399)}\\
\hspace{1em}American Indian or Alaska Native & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 13 & \makecell[l]{3381\\(548, 20856)}\\
\hspace{1em}American Indian or Alaska Native & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & 13 & \makecell[l]{4097\\(1137, 14766)}\\
\hspace{1em}American Indian or Alaska Native & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 6 & \makecell[l]{2320038\\(501453, 10733961)}\\
\hspace{1em}American Indian or Alaska Native & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 6 & \makecell[l]{7507181\\(3379449, 16676615)}\\
\hspace{1em}American Indian or Alaska Native & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 6 & \makecell[l]{8919\\(1502, 52953)}\\
\hspace{1em}American Indian or Alaska Native & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & 6 & \makecell[l]{9789\\(1020, 93964)}\\
\hspace{1em}American Indian or Alaska Native & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 5 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}American Indian or Alaska Native & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 5 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}American Indian or Alaska Native & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 5 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}American Indian or Alaska Native & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & 5 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}American Indian or Alaska Native & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 4 & \makecell[l]{272152\\(65917, 1123631)}\\
\hspace{1em}American Indian or Alaska Native & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 4 & \makecell[l]{677711\\(214540, 2140827)}\\
\hspace{1em}American Indian or Alaska Native & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 4 & \makecell[l]{126\\(26, 608)}\\
\hspace{1em}American Indian or Alaska Native & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & 4 & \makecell[l]{520\\(61, 4436)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 17 & \makecell[l]{11\\(9, 14)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 17 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 17 & \makecell[l]{6\\(4, 8)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 17 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 5 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 5 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 5 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 5 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 1 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 1 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & 1 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & 1 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 1 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 1 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & 1 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & 1 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 17 & \makecell[l]{114776\\(53301, 247155)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 17 & \makecell[l]{116196\\(67714, 199391)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 17 & \makecell[l]{381\\(198, 736)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & 17 & \makecell[l]{982\\(339, 2849)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 5 & \makecell[l]{44998\\(2885, 701952)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 5 & \makecell[l]{107953\\(71167, 163752)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 5 & \makecell[l]{227\\(17, 2989)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & 5 & \makecell[l]{489\\(239, 1000)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 1 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 1 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 1 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & 1 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 1 & \makecell[l]{6237\\(6237, 6237)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 1 & \makecell[l]{10844\\(10844, 10844)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 1 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & 1 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 17 & \makecell[l]{5533419\\(2490433, 12294540)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 17 & \makecell[l]{7662810\\(3323463, 17667914)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 17 & \makecell[l]{10464\\(2274, 48150)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & 17 & \makecell[l]{4635\\(2089, 10284)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 5 & \makecell[l]{1828480\\(947016, 3530396)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 5 & \makecell[l]{5139344\\(595014, 44390337)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 5 & \makecell[l]{2545\\(185, 35084)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & 5 & \makecell[l]{1804\\(213, 15248)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 1 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 1 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 1 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & 1 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 1 & \makecell[l]{4780\\(4780, 4780)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 1 & \makecell[l]{61376\\(61376, 61376)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 1 & \makecell[l]{44\\(44, 44)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & 1 & \makecell[l]{144\\(144, 144)}\\
\hspace{1em}Multiracial & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 52 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Multiracial & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 52 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Multiracial & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 52 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Multiracial & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 52 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Multiracial & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 12 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Multiracial & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 12 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Multiracial & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 12 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Multiracial & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 12 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Multiracial & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 8 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Multiracial & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 8 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Multiracial & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & 8 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Multiracial & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & 8 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Multiracial & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 19 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Multiracial & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 19 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Multiracial & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & 19 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Multiracial & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & 19 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Multiracial & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 52 & \makecell[l]{21505\\(13701, 33755)}\\
\hspace{1em}Multiracial & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 52 & \makecell[l]{45067\\(27165, 74765)}\\
\hspace{1em}Multiracial & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 52 & \makecell[l]{71\\(38, 130)}\\
\hspace{1em}Multiracial & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & 52 & \makecell[l]{135\\(82, 222)}\\
\hspace{1em}Multiracial & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 12 & \makecell[l]{55196\\(16260, 187371)}\\
\hspace{1em}Multiracial & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 12 & \makecell[l]{155885\\(67996, 357377)}\\
\hspace{1em}Multiracial & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 12 & \makecell[l]{398\\(197, 804)}\\
\hspace{1em}Multiracial & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & 12 & \makecell[l]{277\\(153, 502)}\\
\hspace{1em}Multiracial & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 8 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Multiracial & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 8 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Multiracial & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 8 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Multiracial & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & 8 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Multiracial & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 19 & \makecell[l]{24792\\(13458, 45670)}\\
\hspace{1em}Multiracial & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 19 & \makecell[l]{25261\\(11298, 56479)}\\
\hspace{1em}Multiracial & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 19 & \makecell[l]{51\\(28, 93)}\\
\hspace{1em}Multiracial & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & 19 & \makecell[l]{190\\(60, 600)}\\
\hspace{1em}Multiracial & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 52 & \makecell[l]{1262157\\(710446, 2242309)}\\
\hspace{1em}Multiracial & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 52 & \makecell[l]{2195866\\(1476648, 3265387)}\\
\hspace{1em}Multiracial & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 52 & \makecell[l]{1524\\(697, 3334)}\\
\hspace{1em}Multiracial & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & 52 & \makecell[l]{1963\\(778, 4953)}\\
\hspace{1em}Multiracial & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 12 & \makecell[l]{3777504\\(1786314, 7988255)}\\
\hspace{1em}Multiracial & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 12 & \makecell[l]{8118223\\(3167974, 20803689)}\\
\hspace{1em}Multiracial & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 12 & \makecell[l]{2411\\(687, 8455)}\\
\hspace{1em}Multiracial & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & 12 & \makecell[l]{10135\\(6049, 16979)}\\
\hspace{1em}Multiracial & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 8 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Multiracial & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 8 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Multiracial & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 8 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Multiracial & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & 8 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Multiracial & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 19 & \makecell[l]{693982\\(285837, 1684912)}\\
\hspace{1em}Multiracial & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 19 & \makecell[l]{791515\\(327732, 1911609)}\\
\hspace{1em}Multiracial & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 19 & \makecell[l]{1034\\(211, 5057)}\\
\hspace{1em}Multiracial & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & 19 & \makecell[l]{2744\\(676, 11140)}\\
\hspace{1em}Other & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 34 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Other & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 34 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Other & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 34 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Other & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 34 & \makecell[l]{6\\(5, 7)}\\
\hspace{1em}Other & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 7 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Other & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 7 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Other & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 7 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Other & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 7 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Other & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 4 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Other & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 4 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Other & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & 4 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Other & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & 4 & \makecell[l]{6\\(4, 8)}\\
\hspace{1em}Other & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 5 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Other & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 5 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Other & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & 5 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Other & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & 5 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Other & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 34 & \makecell[l]{22295\\(11570, 42963)}\\
\hspace{1em}Other & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 34 & \makecell[l]{38007\\(21259, 67950)}\\
\hspace{1em}Other & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 34 & \makecell[l]{118\\(54, 259)}\\
\hspace{1em}Other & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & 34 & \makecell[l]{254\\(100, 650)}\\
\hspace{1em}Other & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 7 & \makecell[l]{18039\\(7489, 43449)}\\
\hspace{1em}Other & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 7 & \makecell[l]{75844\\(32129, 179037)}\\
\hspace{1em}Other & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 7 & \makecell[l]{63\\(18, 221)}\\
\hspace{1em}Other & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & 7 & \makecell[l]{283\\(86, 936)}\\
\hspace{1em}Other & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 4 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Other & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 4 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Other & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 4 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Other & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & 4 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Other & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 5 & \makecell[l]{49870\\(993, 2505753)}\\
\hspace{1em}Other & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 5 & \makecell[l]{40496\\(1871, 876366)}\\
\hspace{1em}Other & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 5 & \makecell[l]{221\\(12, 4185)}\\
\hspace{1em}Other & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & 5 & \makecell[l]{295\\(27, 3229)}\\
\hspace{1em}Other & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 34 & \makecell[l]{959325\\(467189, 1969877)}\\
\hspace{1em}Other & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 34 & \makecell[l]{2238776\\(1221484, 4103302)}\\
\hspace{1em}Other & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 34 & \makecell[l]{1974\\(715, 5452)}\\
\hspace{1em}Other & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & 34 & \makecell[l]{3391\\(1017, 11315)}\\
\hspace{1em}Other & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 7 & \makecell[l]{4612046\\(1663462, 12787169)}\\
\hspace{1em}Other & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 7 & \makecell[l]{5745695\\(3340937, 9881364)}\\
\hspace{1em}Other & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 7 & \makecell[l]{2543\\(573, 11275)}\\
\hspace{1em}Other & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & 7 & \makecell[l]{4503\\(1467, 13817)}\\
\hspace{1em}Other & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 4 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Other & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 4 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Other & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 4 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Other & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & 4 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Other & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 5 & \makecell[l]{390164\\(12362, 12313729)}\\
\hspace{1em}Other & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 5 & \makecell[l]{1950467\\(62864, 60516607)}\\
\hspace{1em}Other & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 5 & \makecell[l]{6112\\(27, 1395272)}\\
\hspace{1em}Other & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & 5 & \makecell[l]{1609\\(34, 75283)}\\
\hspace{1em}Not reported and unknown & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 87 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not reported and unknown & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 87 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not reported and unknown & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 87 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not reported and unknown & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 87 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not reported and unknown & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 20 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not reported and unknown & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 20 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not reported and unknown & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 20 & \makecell[l]{6\\(5, 7)}\\
\hspace{1em}Not reported and unknown & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 20 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not reported and unknown & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 14 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not reported and unknown & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 14 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not reported and unknown & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & 14 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not reported and unknown & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & 14 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not reported and unknown & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 24 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not reported and unknown & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 24 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not reported and unknown & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & 24 & \makecell[l]{6\\(5, 7)}\\
\hspace{1em}Not reported and unknown & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & 24 & \makecell[l]{5\\(5, 6)}\\
\hspace{1em}Not reported and unknown & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 87 & \makecell[l]{19972\\(12070, 33047)}\\
\hspace{1em}Not reported and unknown & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 87 & \makecell[l]{41499\\(27382, 62895)}\\
\hspace{1em}Not reported and unknown & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 87 & \makecell[l]{85\\(51, 144)}\\
\hspace{1em}Not reported and unknown & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & 87 & \makecell[l]{167\\(114, 245)}\\
\hspace{1em}Not reported and unknown & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 20 & \makecell[l]{57668\\(23639, 140684)}\\
\hspace{1em}Not reported and unknown & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 20 & \makecell[l]{112437\\(52711, 239834)}\\
\hspace{1em}Not reported and unknown & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 20 & \makecell[l]{348\\(94, 1295)}\\
\hspace{1em}Not reported and unknown & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & 20 & \makecell[l]{581\\(199, 1695)}\\
\hspace{1em}Not reported and unknown & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 14 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not reported and unknown & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 14 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not reported and unknown & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 14 & \makecell[l]{5\\(5, 6)}\\
\hspace{1em}Not reported and unknown & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & 14 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not reported and unknown & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 24 & \makecell[l]{11890\\(6465, 21867)}\\
\hspace{1em}Not reported and unknown & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 24 & \makecell[l]{17779\\(10512, 30069)}\\
\hspace{1em}Not reported and unknown & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 24 & \makecell[l]{46\\(19, 111)}\\
\hspace{1em}Not reported and unknown & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & 24 & \makecell[l]{168\\(59, 476)}\\
\hspace{1em}Not reported and unknown & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 87 & \makecell[l]{958206\\(602856, 1523015)}\\
\hspace{1em}Not reported and unknown & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 87 & \makecell[l]{1898203\\(1201387, 2999181)}\\
\hspace{1em}Not reported and unknown & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 87 & \makecell[l]{1331\\(758, 2339)}\\
\hspace{1em}Not reported and unknown & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & 87 & \makecell[l]{2345\\(1156, 4755)}\\
\hspace{1em}Not reported and unknown & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 20 & \makecell[l]{3239260\\(1199389, 8748461)}\\
\hspace{1em}Not reported and unknown & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 20 & \makecell[l]{9280577\\(5784309, 14890128)}\\
\hspace{1em}Not reported and unknown & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 20 & \makecell[l]{11045\\(3104, 39295)}\\
\hspace{1em}Not reported and unknown & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & 20 & \makecell[l]{5210\\(1481, 18320)}\\
\hspace{1em}Not reported and unknown & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 14 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not reported and unknown & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 14 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Not reported and unknown & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 14 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not reported and unknown & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & 14 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Not reported and unknown & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 24 & \makecell[l]{401782\\(153583, 1051084)}\\
\hspace{1em}Not reported and unknown & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 24 & \makecell[l]{645039\\(295340, 1408800)}\\
\hspace{1em}Not reported and unknown & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 24 & \makecell[l]{485\\(159, 1481)}\\
\hspace{1em}Not reported and unknown & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & 24 & \makecell[l]{1124\\(299, 4219)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item 
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{7cm}llllll}
\caption{\label{tab:tabs}Table 5i. Geometric mean titers (GMTs) and geometric mean
      concentrations (GMCs) by Underrepresented minority status}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & GMT/GMC\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & GMT/GMC\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{7}{l}{\textbf{Underrepresented minority status}}\\
\hspace{1em}Communities of Color & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 420 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Communities of Color & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 420 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Communities of Color & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 420 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Communities of Color & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 420 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Communities of Color & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 120 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Communities of Color & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 120 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Communities of Color & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 120 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Communities of Color & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 120 & \makecell[l]{5\\(5, 6)}\\
\hspace{1em}Communities of Color & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 73 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Communities of Color & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 73 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Communities of Color & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & 73 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Communities of Color & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & 73 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Communities of Color & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 111 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Communities of Color & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 111 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Communities of Color & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & 111 & \makecell[l]{5\\(5, 6)}\\
\hspace{1em}Communities of Color & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & 111 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Communities of Color & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 420 & \makecell[l]{23355\\(19242, 28347)}\\
\hspace{1em}Communities of Color & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 420 & \makecell[l]{40216\\(34320, 47124)}\\
\hspace{1em}Communities of Color & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 420 & \makecell[l]{99\\(79, 124)}\\
\hspace{1em}Communities of Color & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & 420 & \makecell[l]{208\\(163, 266)}\\
\hspace{1em}Communities of Color & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 120 & \makecell[l]{44605\\(32113, 61955)}\\
\hspace{1em}Communities of Color & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 120 & \makecell[l]{90964\\(70627, 117156)}\\
\hspace{1em}Communities of Color & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 120 & \makecell[l]{238\\(171, 332)}\\
\hspace{1em}Communities of Color & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & 120 & \makecell[l]{545\\(371, 802)}\\
\hspace{1em}Communities of Color & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 73 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Communities of Color & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 73 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Communities of Color & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 73 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Communities of Color & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & 73 & \makecell[l]{5\\(5, 6)}\\
\hspace{1em}Communities of Color & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 111 & \makecell[l]{17596\\(12331, 25109)}\\
\hspace{1em}Communities of Color & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 111 & \makecell[l]{18884\\(13334, 26743)}\\
\hspace{1em}Communities of Color & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 111 & \makecell[l]{54\\(34, 84)}\\
\hspace{1em}Communities of Color & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & 111 & \makecell[l]{178\\(110, 288)}\\
\hspace{1em}Communities of Color & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 420 & \makecell[l]{977894\\(775549, 1233031)}\\
\hspace{1em}Communities of Color & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 420 & \makecell[l]{2083276\\(1732503, 2505069)}\\
\hspace{1em}Communities of Color & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 420 & \makecell[l]{1903\\(1416, 2557)}\\
\hspace{1em}Communities of Color & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & 420 & \makecell[l]{2744\\(2021, 3725)}\\
\hspace{1em}Communities of Color & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 120 & \makecell[l]{3146770\\(2273084, 4356267)}\\
\hspace{1em}Communities of Color & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 120 & \makecell[l]{5991417\\(4527248, 7929117)}\\
\hspace{1em}Communities of Color & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 120 & \makecell[l]{7086\\(4582, 10956)}\\
\hspace{1em}Communities of Color & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & 120 & \makecell[l]{8885\\(5903, 13374)}\\
\hspace{1em}Communities of Color & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 73 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Communities of Color & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 73 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Communities of Color & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 73 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Communities of Color & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & 73 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Communities of Color & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 111 & \makecell[l]{397884\\(256621, 616908)}\\
\hspace{1em}Communities of Color & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 111 & \makecell[l]{734879\\(489927, 1102301)}\\
\hspace{1em}Communities of Color & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 111 & \makecell[l]{684\\(382, 1222)}\\
\hspace{1em}Communities of Color & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & 111 & \makecell[l]{1409\\(809, 2454)}\\
\hspace{1em}White Non-Hispanic & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 362 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}White Non-Hispanic & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 362 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}White Non-Hispanic & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 362 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}White Non-Hispanic & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 362 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}White Non-Hispanic & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 125 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}White Non-Hispanic & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 125 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}White Non-Hispanic & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 125 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}White Non-Hispanic & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 125 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}White Non-Hispanic & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 67 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}White Non-Hispanic & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 67 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}White Non-Hispanic & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & 67 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}White Non-Hispanic & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & 67 & \makecell[l]{5\\(5, 6)}\\
\hspace{1em}White Non-Hispanic & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 121 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}White Non-Hispanic & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 121 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}White Non-Hispanic & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & 121 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}White Non-Hispanic & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & 121 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 362 & \makecell[l]{23438\\(18669, 29425)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 362 & \makecell[l]{40376\\(34349, 47460)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 362 & \makecell[l]{115\\(90, 147)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & 362 & \makecell[l]{188\\(146, 241)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 125 & \makecell[l]{30985\\(21434, 44793)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 125 & \makecell[l]{72481\\(53061, 99008)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 125 & \makecell[l]{148\\(104, 211)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & 125 & \makecell[l]{348\\(226, 535)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 67 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 67 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 67 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & 67 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 121 & \makecell[l]{10931\\(7560, 15804)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 121 & \makecell[l]{18868\\(14808, 24043)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 121 & \makecell[l]{52\\(37, 74)}\\
\hspace{1em}White Non-Hispanic & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & 121 & \makecell[l]{107\\(76, 150)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 362 & \makecell[l]{1035293\\(809568, 1323956)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 362 & \makecell[l]{2145772\\(1770774, 2600184)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 362 & \makecell[l]{1376\\(1010, 1874)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & 362 & \makecell[l]{2011\\(1465, 2761)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 125 & \makecell[l]{1943813\\(1349835, 2799166)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 125 & \makecell[l]{4608987\\(3338577, 6362819)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 125 & \makecell[l]{4550\\(2471, 8378)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & 125 & \makecell[l]{7994\\(4646, 13757)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 67 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 67 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 67 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & 67 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 121 & \makecell[l]{393045\\(287516, 537306)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 121 & \makecell[l]{674526\\(485396, 937351)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 121 & \makecell[l]{575\\(371, 892)}\\
\hspace{1em}White Non-Hispanic & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & 121 & \makecell[l]{1478\\(953, 2292)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item 
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{7cm}llllll}
\caption{\label{tab:tabs}Table 5j. Geometric mean titers (GMTs) and geometric mean
      concentrations (GMCs) by Age, Underrepresented minority status}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & GMT/GMC\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & GMT/GMC\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{7}{l}{\textbf{Age, Underrepresented minority status}}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 192 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 192 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 192 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 192 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 69 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 69 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 69 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 69 & \makecell[l]{5\\(5, 6)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 37 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 37 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & 37 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & 37 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 61 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 61 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & 61 & \makecell[l]{5\\(5, 6)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & 61 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 192 & \makecell[l]{17593\\(13852, 22344)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 192 & \makecell[l]{30531\\(25113, 37119)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 192 & \makecell[l]{76\\(58, 101)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & 192 & \makecell[l]{174\\(128, 236)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 69 & \makecell[l]{34937\\(23612, 51692)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 69 & \makecell[l]{70998\\(52424, 96153)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 69 & \makecell[l]{209\\(141, 310)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & 69 & \makecell[l]{484\\(305, 768)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 37 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 37 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 37 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & 37 & \makecell[l]{5\\(5, 6)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 61 & \makecell[l]{13618\\(8923, 20783)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 61 & \makecell[l]{13717\\(9065, 20756)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 61 & \makecell[l]{42\\(25, 72)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & 61 & \makecell[l]{150\\(84, 267)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 192 & \makecell[l]{741900\\(555661, 990562)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 192 & \makecell[l]{1629402\\(1297120, 2046806)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 192 & \makecell[l]{1435\\(996, 2067)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & 192 & \makecell[l]{2230\\(1526, 3260)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 69 & \makecell[l]{2542683\\(1712040, 3776334)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 69 & \makecell[l]{5081700\\(3610831, 7151727)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 69 & \makecell[l]{5550\\(3299, 9337)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & 69 & \makecell[l]{7380\\(4562, 11940)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 37 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 37 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 37 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & 37 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 61 & \makecell[l]{277278\\(163947, 468952)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 61 & \makecell[l]{543679\\(333997, 884998)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 61 & \makecell[l]{466\\(233, 933)}\\
\hspace{1em}Age $<$ 65 Communities of Color & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & 61 & \makecell[l]{1073\\(554, 2078)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 175 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 175 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 175 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 175 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 59 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 59 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 59 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 59 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 31 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 31 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & 31 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & 31 & \makecell[l]{5\\(5, 6)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 61 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 61 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & 61 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & 61 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 175 & \makecell[l]{18239\\(13758, 24181)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 175 & \makecell[l]{31442\\(25791, 38330)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 175 & \makecell[l]{98\\(72, 132)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & 175 & \makecell[l]{163\\(120, 222)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 59 & \makecell[l]{19045\\(11981, 30275)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 59 & \makecell[l]{50450\\(34089, 74664)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 59 & \makecell[l]{100\\(65, 155)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & 59 & \makecell[l]{255\\(148, 438)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 31 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 31 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 31 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & 31 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 61 & \makecell[l]{7844\\(4943, 12447)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 61 & \makecell[l]{13337\\(9897, 17972)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 61 & \makecell[l]{38\\(25, 58)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & 61 & \makecell[l]{78\\(51, 118)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 175 & \makecell[l]{821667\\(605817, 1114423)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 175 & \makecell[l]{1724310\\(1360533, 2185355)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 175 & \makecell[l]{1085\\(742, 1587)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & 175 & \makecell[l]{1624\\(1097, 2405)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 59 & \makecell[l]{1330657\\(839177, 2109982)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 59 & \makecell[l]{3419951\\(2265916, 5161739)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 59 & \makecell[l]{2838\\(1308, 6159)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & 59 & \makecell[l]{6125\\(3095, 12121)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 31 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 31 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 31 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & 31 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 61 & \makecell[l]{264698\\(179593, 390131)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 61 & \makecell[l]{451492\\(299075, 681584)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 61 & \makecell[l]{376\\(219, 646)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & 61 & \makecell[l]{1102\\(639, 1903)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 228 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 228 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 228 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 228 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 51 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 51 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 51 & \makecell[l]{5\\(5, 6)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 51 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 36 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 36 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & 36 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & 36 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 50 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 50 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & 50 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & 50 & \makecell[l]{5\\(5, 6)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 228 & \makecell[l]{67566\\(54928, 83111)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 228 & \makecell[l]{113000\\(94968, 134457)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 228 & \makecell[l]{263\\(208, 334)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & 228 & \makecell[l]{409\\(322, 520)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 51 & \makecell[l]{127850\\(82403, 198362)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 51 & \makecell[l]{264698\\(193965, 361225)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 51 & \makecell[l]{414\\(254, 674)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & 51 & \makecell[l]{911\\(557, 1491)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 36 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 36 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 36 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & 36 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 50 & \makecell[l]{57615\\(37847, 87707)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 50 & \makecell[l]{82913\\(55530, 123801)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 50 & \makecell[l]{167\\(101, 276)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & 50 & \makecell[l]{390\\(234, 650)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 228 & \makecell[l]{2754587\\(2268630, 3344640)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 228 & \makecell[l]{5234940\\(4335352, 6321193)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 228 & \makecell[l]{5478\\(4015, 7473)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & 228 & \makecell[l]{5966\\(4475, 7954)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 51 & \makecell[l]{7886529\\(5982602, 10396367)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 51 & \makecell[l]{12184499\\(9858697, 15058989)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 51 & \makecell[l]{20307\\(11438, 36054)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & 51 & \makecell[l]{19769\\(10376, 37665)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 36 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 36 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 36 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & 36 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 50 & \makecell[l]{2116643\\(1388474, 3226693)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 50 & \makecell[l]{2964324\\(2089369, 4205680)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 50 & \makecell[l]{4026\\(2199, 7373)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & 50 & \makecell[l]{4985\\(2691, 9234)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 187 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 187 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 187 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 187 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 66 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 66 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 66 & \makecell[l]{5\\(5, 6)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 66 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 36 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 36 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & 36 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & 36 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 60 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 60 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & 60 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & 60 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 187 & \makecell[l]{60501\\(48781, 75037)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 187 & \makecell[l]{103956\\(85919, 125780)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & 187 & \makecell[l]{214\\(164, 280)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & 187 & \makecell[l]{317\\(243, 412)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 66 & \makecell[l]{171330\\(122104, 240402)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 66 & \makecell[l]{258922\\(193660, 346179)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & 66 & \makecell[l]{575\\(355, 932)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & 66 & \makecell[l]{1037\\(709, 1518)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & 36 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & 36 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & 36 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & 36 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & 60 & \makecell[l]{34684\\(23682, 50795)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & 60 & \makecell[l]{63090\\(45886, 86746)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & 60 & \makecell[l]{160\\(99, 257)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & 60 & \makecell[l]{323\\(207, 502)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 187 & \makecell[l]{2480906\\(1963293, 3134986)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 187 & \makecell[l]{4905828\\(4009921, 6001900)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & 187 & \makecell[l]{3376\\(2393, 4763)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & 187 & \makecell[l]{4511\\(3339, 6096)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 66 & \makecell[l]{7361735\\(5495760, 9861264)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 66 & \makecell[l]{13150407\\(11178796, 15469753)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & 66 & \makecell[l]{23885\\(15539, 36713)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & 66 & \makecell[l]{20383\\(12350, 33642)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & 36 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & 36 & \makecell[l]{10\\(10, 10)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & 36 & \makecell[l]{5\\(5, 5)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & 36 & \makecell[l]{5\\(5, 6)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & 60 & \makecell[l]{1555275\\(1070146, 2260326)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & 60 & \makecell[l]{2726537\\(1931325, 3849174)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & 60 & \makecell[l]{2516\\(1427, 4435)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & 60 & \makecell[l]{4096\\(2471, 6792)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item  
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{2.7cm}llllllll}
\caption{\label{tab:tabs}Table 6a. Geometric mean titer ratios (GMTRs) or geometric mean
      concentration ratios (GMCRs) between post-vaccinations/pre-vaccination by All participants}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & \makecell[l]{Baseline\\GMT/GMC} & \makecell[l]{Post Baseline\\GMT/GMC} & GMTR/GMCR\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & \makecell[l]{Baseline\\GMT/GMC} & \makecell[l]{Post Baseline\\GMT/GMC} & GMTR/GMCR\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{9}{l}{\textbf{All participants}}\\
\hspace{1em} & D29 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 914 & \makecell[l]{10\\(10, 10)} & \makecell[l]{22926\\(19863, 26460)} & \makecell[l]{2279.09\\(1975.09, 2629.88)}\\
\hspace{1em} & D29 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 914 & \makecell[l]{10\\(10, 10)} & \makecell[l]{40963\\(36741, 45671)} & \makecell[l]{4091.68\\(3670.04, 4561.76)}\\
\hspace{1em} & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 914 & \makecell[l]{5\\(5, 5)} & \makecell[l]{106\\(91, 125)} & \makecell[l]{21.01\\(17.90, 24.67)}\\
\hspace{1em} & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 914 & \makecell[l]{5\\(5, 5)} & \makecell[l]{189\\(161, 222)} & \makecell[l]{37.28\\(31.71, 43.83)}\\
\hspace{1em} & D29 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 274 & \makecell[l]{10\\(10, 10)} & \makecell[l]{36133\\(28182, 46328)} & \makecell[l]{3613.33\\(2818.21, 4632.79)}\\
\hspace{1em} & D29 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 274 & \makecell[l]{10\\(10, 10)} & \makecell[l]{79981\\(65041, 98352)} & \makecell[l]{7998.08\\(6504.13, 9835.19)}\\
\hspace{1em} & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 274 & \makecell[l]{5\\(5, 5)} & \makecell[l]{186\\(142, 243)} & \makecell[l]{36.50\\(27.92, 47.71)}\\
\hspace{1em} & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 274 & \makecell[l]{5\\(5, 5)} & \makecell[l]{420\\(314, 560)} & \makecell[l]{82.61\\(61.87, 110.32)}\\
\hspace{1em} & D29 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 163 & \makecell[l]{10\\(10, 11)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.98\\(0.95, 1.02)}\\
\hspace{1em} & D29 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 163 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.99\\(0.98, 1.01)}\\
\hspace{1em} & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 163 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.01\\(0.99, 1.02)}\\
\hspace{1em} & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 163 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.95, 1.04)}\\
\hspace{1em} & D29 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 270 & \makecell[l]{10\\(10, 10)} & \makecell[l]{12861\\(10150, 16296)} & \makecell[l]{1284.22\\(1013.60, 1627.09)}\\
\hspace{1em} & D29 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 270 & \makecell[l]{10\\(10, 10)} & \makecell[l]{18191\\(15159, 21829)} & \makecell[l]{1819.07\\(1515.87, 2182.92)}\\
\hspace{1em} & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 270 & \makecell[l]{5\\(5, 5)} & \makecell[l]{51\\(40, 66)} & \makecell[l]{9.99\\(7.85, 12.73)}\\
\hspace{1em} & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 270 & \makecell[l]{5\\(5, 5)} & \makecell[l]{129\\(98, 169)} & \makecell[l]{25.46\\(19.48, 33.27)}\\
\hspace{1em} & D57 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 914 & \makecell[l]{10\\(10, 10)} & \makecell[l]{966160\\(823437, 1133621)} & \makecell[l]{96047.59\\(81866.19, 112685.58)}\\
\hspace{1em} & D57 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 914 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2087965\\(1831068, 2380904)} & \makecell[l]{208560.44\\(182899.78, 237821.27)}\\
\hspace{1em} & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 914 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1497\\(1228, 1825)} & \makecell[l]{295.67\\(242.59, 360.37)}\\
\hspace{1em} & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 914 & \makecell[l]{5\\(5, 5)} & \makecell[l]{2223\\(1809, 2733)} & \makecell[l]{438.66\\(357.19, 538.72)}\\
\hspace{1em} & D57 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 274 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2298869\\(1785648, 2959596)} & \makecell[l]{229886.89\\(178564.83, 295959.65)}\\
\hspace{1em} & D57 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 274 & \makecell[l]{10\\(10, 10)} & \makecell[l]{5346334\\(4339333, 6587023)} & \makecell[l]{534633.43\\(433933.34, 658702.34)}\\
\hspace{1em} & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 274 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5680\\(3863, 8351)} & \makecell[l]{1114.53\\(761.21, 1631.83)}\\
\hspace{1em} & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 274 & \makecell[l]{5\\(5, 5)} & \makecell[l]{7837\\(5545, 11076)} & \makecell[l]{1542.78\\(1091.92, 2179.81)}\\
\hspace{1em} & D57 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 163 & \makecell[l]{10\\(10, 11)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.99\\(0.95, 1.02)}\\
\hspace{1em} & D57 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 163 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.99\\(0.98, 1.01)}\\
\hspace{1em} & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 163 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(0.99, 1.02)}\\
\hspace{1em} & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 163 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.95, 1.03)}\\
\hspace{1em} & D57 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 270 & \makecell[l]{10\\(10, 10)} & \makecell[l]{382614\\(299829, 488256)} & \makecell[l]{38205.28\\(29939.10, 48753.76)}\\
\hspace{1em} & D57 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 270 & \makecell[l]{10\\(10, 10)} & \makecell[l]{676872\\(531354, 862241)} & \makecell[l]{67687.19\\(53135.41, 86224.15)}\\
\hspace{1em} & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 270 & \makecell[l]{5\\(5, 5)} & \makecell[l]{566\\(409, 783)} & \makecell[l]{109.82\\(79.77, 151.19)}\\
\hspace{1em} & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 270 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1324\\(937, 1870)} & \makecell[l]{261.17\\(185.46, 367.79)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item  
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{2.7cm}llllllll}
\caption{\label{tab:tabs}Table 6b. Geometric mean titer ratios (GMTRs) or geometric mean
      concentration ratios (GMCRs) between post-vaccinations/pre-vaccination by Age}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & \makecell[l]{Baseline\\GMT/GMC} & \makecell[l]{Post Baseline\\GMT/GMC} & GMTR/GMCR\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & \makecell[l]{Baseline\\GMT/GMC} & \makecell[l]{Post Baseline\\GMT/GMC} & GMTR/GMCR\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{9}{l}{\textbf{Age}}\\
\hspace{1em}Age $<$ 65 & D29 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 432 & \makecell[l]{10\\(10, 10)} & \makecell[l]{17393\\(14565, 20770)} & \makecell[l]{1728.59\\(1447.96, 2063.60)}\\
\hspace{1em}Age $<$ 65 & D29 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 432 & \makecell[l]{10\\(10, 10)} & \makecell[l]{31397\\(27475, 35879)} & \makecell[l]{3139.72\\(2747.52, 3587.91)}\\
\hspace{1em}Age $<$ 65 & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 432 & \makecell[l]{5\\(5, 5)} & \makecell[l]{85\\(69, 103)} & \makecell[l]{16.72\\(13.72, 20.38)}\\
\hspace{1em}Age $<$ 65 & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 432 & \makecell[l]{5\\(5, 5)} & \makecell[l]{157\\(129, 192)} & \makecell[l]{31.07\\(25.45, 37.94)}\\
\hspace{1em}Age $<$ 65 & D29 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 146 & \makecell[l]{10\\(10, 10)} & \makecell[l]{24939\\(18393, 33814)} & \makecell[l]{2493.88\\(1839.31, 3381.39)}\\
\hspace{1em}Age $<$ 65 & D29 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 146 & \makecell[l]{10\\(10, 10)} & \makecell[l]{59400\\(46119, 76506)} & \makecell[l]{5940.04\\(4611.93, 7650.60)}\\
\hspace{1em}Age $<$ 65 & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 146 & \makecell[l]{5\\(5, 5)} & \makecell[l]{144\\(104, 198)} & \makecell[l]{28.34\\(20.48, 39.21)}\\
\hspace{1em}Age $<$ 65 & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 146 & \makecell[l]{5\\(5, 5)} & \makecell[l]{339\\(238, 482)} & \makecell[l]{66.39\\(46.61, 94.58)}\\
\hspace{1em}Age $<$ 65 & D29 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 80 & \makecell[l]{10\\(10, 11)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.98\\(0.93, 1.02)}\\
\hspace{1em}Age $<$ 65 & D29 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 80 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.99\\(0.98, 1.01)}\\
\hspace{1em}Age $<$ 65 & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(0.98, 1.03)}\\
\hspace{1em}Age $<$ 65 & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.93, 1.06)}\\
\hspace{1em}Age $<$ 65 & D29 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 147 & \makecell[l]{10\\(10, 10)} & \makecell[l]{9737\\(7318, 12957)} & \makecell[l]{973.73\\(731.75, 1295.73)}\\
\hspace{1em}Age $<$ 65 & D29 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 147 & \makecell[l]{10\\(10, 10)} & \makecell[l]{13380\\(10752, 16650)} & \makecell[l]{1337.99\\(1075.18, 1665.05)}\\
\hspace{1em}Age $<$ 65 & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 147 & \makecell[l]{5\\(5, 5)} & \makecell[l]{40\\(29, 54)} & \makecell[l]{7.70\\(5.77, 10.28)}\\
\hspace{1em}Age $<$ 65 & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 147 & \makecell[l]{5\\(5, 5)} & \makecell[l]{106\\(76, 147)} & \makecell[l]{20.88\\(15.13, 28.82)}\\
\hspace{1em}Age $<$ 65 & D57 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 432 & \makecell[l]{10\\(10, 10)} & \makecell[l]{737116\\(604473, 898866)} & \makecell[l]{73258.07\\(60080.95, 89325.22)}\\
\hspace{1em}Age $<$ 65 & D57 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 432 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1643373\\(1397160, 1932976)} & \makecell[l]{164337.35\\(139715.98, 193297.60)}\\
\hspace{1em}Age $<$ 65 & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 432 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1136\\(890, 1449)} & \makecell[l]{224.61\\(176.12, 286.46)}\\
\hspace{1em}Age $<$ 65 & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 432 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1750\\(1355, 2260)} & \makecell[l]{346.17\\(268.34, 446.58)}\\
\hspace{1em}Age $<$ 65 & D57 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 146 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1708031\\(1250384, 2333179)} & \makecell[l]{170803.11\\(125038.42, 233317.89)}\\
\hspace{1em}Age $<$ 65 & D57 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 146 & \makecell[l]{10\\(10, 10)} & \makecell[l]{4266733\\(3292306, 5529560)} & \makecell[l]{426673.25\\(329230.63, 552956.04)}\\
\hspace{1em}Age $<$ 65 & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 146 & \makecell[l]{5\\(5, 5)} & \makecell[l]{4061\\(2527, 6527)} & \makecell[l]{801.35\\(501.10, 1281.50)}\\
\hspace{1em}Age $<$ 65 & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 146 & \makecell[l]{5\\(5, 5)} & \makecell[l]{6238\\(4090, 9513)} & \makecell[l]{1223.09\\(802.31, 1864.58)}\\
\hspace{1em}Age $<$ 65 & D57 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 80 & \makecell[l]{10\\(10, 11)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.98\\(0.93, 1.03)}\\
\hspace{1em}Age $<$ 65 & D57 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 80 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.99\\(0.98, 1.01)}\\
\hspace{1em}Age $<$ 65 & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(0.98, 1.01)}\\
\hspace{1em}Age $<$ 65 & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.98\\(0.93, 1.03)}\\
\hspace{1em}Age $<$ 65 & D57 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 147 & \makecell[l]{10\\(10, 10)} & \makecell[l]{270061\\(201183, 362521)} & \makecell[l]{27006.13\\(20118.30, 36252.12)}\\
\hspace{1em}Age $<$ 65 & D57 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 147 & \makecell[l]{10\\(10, 10)} & \makecell[l]{484596\\(361146, 650244)} & \makecell[l]{48459.60\\(36114.65, 65024.40)}\\
\hspace{1em}Age $<$ 65 & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 147 & \makecell[l]{5\\(5, 5)} & \makecell[l]{387\\(262, 572)} & \makecell[l]{75.13\\(51.19, 110.26)}\\
\hspace{1em}Age $<$ 65 & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 147 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1009\\(665, 1531)} & \makecell[l]{199.32\\(131.81, 301.41)}\\
\hspace{1em}Age $\geq$ 65 & D29 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 482 & \makecell[l]{10\\(10, 10)} & \makecell[l]{65260\\(56734, 75068)} & \makecell[l]{6494.31\\(5646.18, 7469.84)}\\
\hspace{1em}Age $\geq$ 65 & D29 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 482 & \makecell[l]{10\\(10, 10)} & \makecell[l]{112166\\(98902, 127209)} & \makecell[l]{11156.00\\(9843.59, 12643.39)}\\
\hspace{1em}Age $\geq$ 65 & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 482 & \makecell[l]{5\\(5, 5)} & \makecell[l]{254\\(214, 300)} & \makecell[l]{49.89\\(42.15, 59.05)}\\
\hspace{1em}Age $\geq$ 65 & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 482 & \makecell[l]{5\\(5, 5)} & \makecell[l]{381\\(321, 451)} & \makecell[l]{74.35\\(62.85, 87.96)}\\
\hspace{1em}Age $\geq$ 65 & D29 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 128 & \makecell[l]{10\\(10, 10)} & \makecell[l]{158619\\(123545, 203649)} & \makecell[l]{15861.86\\(12354.53, 20364.88)}\\
\hspace{1em}Age $\geq$ 65 & D29 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 128 & \makecell[l]{10\\(10, 10)} & \makecell[l]{262073\\(211994, 323982)} & \makecell[l]{26207.29\\(21199.35, 32398.25)}\\
\hspace{1em}Age $\geq$ 65 & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 128 & \makecell[l]{5\\(5, 5)} & \makecell[l]{522\\(373, 731)} & \makecell[l]{100.15\\(72.09, 139.12)}\\
\hspace{1em}Age $\geq$ 65 & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 128 & \makecell[l]{5\\(5, 5)} & \makecell[l]{988\\(733, 1331)} & \makecell[l]{197.60\\(146.66, 266.24)}\\
\hspace{1em}Age $\geq$ 65 & D29 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 83 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $\geq$ 65 & D29 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 83 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $\geq$ 65 & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 83 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.02\\(0.99, 1.04)}\\
\hspace{1em}Age $\geq$ 65 & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 83 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(0.98, 1.03)}\\
\hspace{1em}Age $\geq$ 65 & D29 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 123 & \makecell[l]{10\\(10, 10)} & \makecell[l]{41836\\(32047, 54614)} & \makecell[l]{4151.56\\(3184.55, 5412.22)}\\
\hspace{1em}Age $\geq$ 65 & D29 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 123 & \makecell[l]{10\\(10, 10)} & \makecell[l]{66891\\(53117, 84238)} & \makecell[l]{6689.12\\(5311.68, 8423.77)}\\
\hspace{1em}Age $\geq$ 65 & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 123 & \makecell[l]{5\\(5, 5)} & \makecell[l]{156\\(112, 216)} & \makecell[l]{30.24\\(21.85, 41.85)}\\
\hspace{1em}Age $\geq$ 65 & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 123 & \makecell[l]{5\\(5, 5)} & \makecell[l]{301\\(219, 413)} & \makecell[l]{59.03\\(43.06, 80.92)}\\
\hspace{1em}Age $\geq$ 65 & D57 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 482 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2692372\\(2329146, 3112243)} & \makecell[l]{267928.32\\(231855.79, 309613.08)}\\
\hspace{1em}Age $\geq$ 65 & D57 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 482 & \makecell[l]{10\\(10, 10)} & \makecell[l]{5171042\\(4536102, 5894857)} & \makecell[l]{514311.17\\(451159.38, 586302.75)}\\
\hspace{1em}Age $\geq$ 65 & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 482 & \makecell[l]{5\\(5, 5)} & \makecell[l]{4259\\(3414, 5312)} & \makecell[l]{837.43\\(671.41, 1044.49)}\\
\hspace{1em}Age $\geq$ 65 & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 482 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5506\\(4535, 6685)} & \makecell[l]{1075.58\\(887.15, 1304.01)}\\
\hspace{1em}Age $\geq$ 65 & D57 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 128 & \makecell[l]{10\\(10, 10)} & \makecell[l]{7520373\\(6146909, 9200723)} & \makecell[l]{752037.26\\(614690.86, 920072.32)}\\
\hspace{1em}Age $\geq$ 65 & D57 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 128 & \makecell[l]{10\\(10, 10)} & \makecell[l]{13148461\\(11661345, 14825221)} & \makecell[l]{1314846.07\\(1166134.50, 1482522.12)}\\
\hspace{1em}Age $\geq$ 65 & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 128 & \makecell[l]{5\\(5, 5)} & \makecell[l]{21658\\(15437, 30385)} & \makecell[l]{4155.93\\(2979.90, 5796.08)}\\
\hspace{1em}Age $\geq$ 65 & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 128 & \makecell[l]{5\\(5, 5)} & \makecell[l]{19480\\(13318, 28494)} & \makecell[l]{3896.02\\(2663.58, 5698.73)}\\
\hspace{1em}Age $\geq$ 65 & D57 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 83 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $\geq$ 65 & D57 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 83 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $\geq$ 65 & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 83 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.02\\(0.99, 1.05)}\\
\hspace{1em}Age $\geq$ 65 & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 83 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.01\\(0.97, 1.05)}\\
\hspace{1em}Age $\geq$ 65 & D57 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 123 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1675605\\(1276999, 2198632)} & \makecell[l]{166277.45\\(126741.57, 218146.20)}\\
\hspace{1em}Age $\geq$ 65 & D57 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 123 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2790960\\(2209589, 3525298)} & \makecell[l]{279096.04\\(220958.92, 352529.78)}\\
\hspace{1em}Age $\geq$ 65 & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 123 & \makecell[l]{5\\(5, 5)} & \makecell[l]{2827\\(1887, 4233)} & \makecell[l]{549.05\\(368.08, 818.99)}\\
\hspace{1em}Age $\geq$ 65 & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 123 & \makecell[l]{5\\(5, 5)} & \makecell[l]{4185\\(2859, 6127)} & \makecell[l]{821.36\\(562.39, 1199.58)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item  
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{2.7cm}llllllll}
\caption{\label{tab:tabs}Table 6c. Geometric mean titer ratios (GMTRs) or geometric mean
      concentration ratios (GMCRs) between post-vaccinations/pre-vaccination by Risk for Severe Covid-19}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & \makecell[l]{Baseline\\GMT/GMC} & \makecell[l]{Post Baseline\\GMT/GMC} & GMTR/GMCR\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & \makecell[l]{Baseline\\GMT/GMC} & \makecell[l]{Post Baseline\\GMT/GMC} & GMTR/GMCR\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{9}{l}{\textbf{Risk for Severe Covid-19}}\\
\hspace{1em}At-risk & D29 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 469 & \makecell[l]{10\\(10, 10)} & \makecell[l]{26276\\(22610, 30535)} & \makecell[l]{2615.50\\(2250.98, 3039.05)}\\
\hspace{1em}At-risk & D29 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 469 & \makecell[l]{10\\(10, 10)} & \makecell[l]{45842\\(40067, 52448)} & \makecell[l]{4565.75\\(3992.37, 5221.47)}\\
\hspace{1em}At-risk & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 469 & \makecell[l]{5\\(5, 5)} & \makecell[l]{103\\(87, 122)} & \makecell[l]{20.04\\(16.98, 23.65)}\\
\hspace{1em}At-risk & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 469 & \makecell[l]{5\\(5, 5)} & \makecell[l]{215\\(180, 258)} & \makecell[l]{42.59\\(35.64, 50.91)}\\
\hspace{1em}At-risk & D29 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 125 & \makecell[l]{10\\(10, 10)} & \makecell[l]{55528\\(43641, 70653)} & \makecell[l]{5552.80\\(4364.10, 7065.28)}\\
\hspace{1em}At-risk & D29 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 125 & \makecell[l]{10\\(10, 10)} & \makecell[l]{103862\\(82479, 130788)} & \makecell[l]{10386.18\\(8247.90, 13078.81)}\\
\hspace{1em}At-risk & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 125 & \makecell[l]{5\\(5, 5)} & \makecell[l]{220\\(161, 302)} & \makecell[l]{43.07\\(31.58, 58.75)}\\
\hspace{1em}At-risk & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 125 & \makecell[l]{5\\(5, 5)} & \makecell[l]{443\\(318, 617)} & \makecell[l]{87.77\\(62.95, 122.37)}\\
\hspace{1em}At-risk & D29 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 84 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}At-risk & D29 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 84 & \makecell[l]{10\\(10, 11)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.98\\(0.94, 1.02)}\\
\hspace{1em}At-risk & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 84 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.02\\(0.96, 1.08)}\\
\hspace{1em}At-risk & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 84 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(0.98, 1.02)}\\
\hspace{1em}At-risk & D29 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 123 & \makecell[l]{10\\(10, 10)} & \makecell[l]{16713\\(12642, 22096)} & \makecell[l]{1661.32\\(1257.58, 2194.67)}\\
\hspace{1em}At-risk & D29 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 123 & \makecell[l]{10\\(10, 10)} & \makecell[l]{26705\\(21285, 33505)} & \makecell[l]{2670.50\\(2128.48, 3350.54)}\\
\hspace{1em}At-risk & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 123 & \makecell[l]{5\\(5, 5)} & \makecell[l]{69\\(52, 93)} & \makecell[l]{13.57\\(10.16, 18.12)}\\
\hspace{1em}At-risk & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 123 & \makecell[l]{5\\(5, 5)} & \makecell[l]{180\\(133, 243)} & \makecell[l]{35.50\\(26.16, 48.18)}\\
\hspace{1em}At-risk & D57 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 469 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1142597\\(961925, 1357205)} & \makecell[l]{113734.61\\(95775.71, 135060.99)}\\
\hspace{1em}At-risk & D57 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 469 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2144439\\(1840509, 2498559)} & \makecell[l]{213582.55\\(183324.98, 248834.09)}\\
\hspace{1em}At-risk & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 469 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1796\\(1424, 2264)} & \makecell[l]{349.12\\(277.06, 439.92)}\\
\hspace{1em}At-risk & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 469 & \makecell[l]{5\\(5, 5)} & \makecell[l]{2766\\(2265, 3377)} & \makecell[l]{546.96\\(448.44, 667.12)}\\
\hspace{1em}At-risk & D57 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 125 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2930270\\(2216035, 3874704)} & \makecell[l]{293027.00\\(221603.54, 387470.44)}\\
\hspace{1em}At-risk & D57 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 125 & \makecell[l]{10\\(10, 10)} & \makecell[l]{6396516\\(5214355, 7846688)} & \makecell[l]{639651.59\\(521435.48, 784668.81)}\\
\hspace{1em}At-risk & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 125 & \makecell[l]{5\\(5, 5)} & \makecell[l]{6128\\(4355, 8625)} & \makecell[l]{1197.37\\(852.46, 1681.83)}\\
\hspace{1em}At-risk & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 125 & \makecell[l]{5\\(5, 5)} & \makecell[l]{11182\\(7684, 16271)} & \makecell[l]{2214.72\\(1523.03, 3220.55)}\\
\hspace{1em}At-risk & D57 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 84 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.01\\(0.99, 1.04)}\\
\hspace{1em}At-risk & D57 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 84 & \makecell[l]{10\\(10, 11)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.98\\(0.94, 1.02)}\\
\hspace{1em}At-risk & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 84 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.96, 1.03)}\\
\hspace{1em}At-risk & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 84 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.02\\(0.98, 1.07)}\\
\hspace{1em}At-risk & D57 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 123 & \makecell[l]{10\\(10, 10)} & \makecell[l]{663561\\(492320, 894363)} & \makecell[l]{65958.42\\(48940.12, 88894.61)}\\
\hspace{1em}At-risk & D57 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 123 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1012116\\(794913, 1288669)} & \makecell[l]{101211.63\\(79491.29, 128866.87)}\\
\hspace{1em}At-risk & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 123 & \makecell[l]{5\\(5, 5)} & \makecell[l]{931\\(651, 1331)} & \makecell[l]{182.03\\(127.42, 260.06)}\\
\hspace{1em}At-risk & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 123 & \makecell[l]{5\\(5, 5)} & \makecell[l]{2086\\(1418, 3067)} & \makecell[l]{412.34\\(280.42, 606.33)}\\
\hspace{1em}Not at-risk & D29 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 445 & \makecell[l]{10\\(10, 10)} & \makecell[l]{21736\\(17965, 26298)} & \makecell[l]{2159.67\\(1785.56, 2612.16)}\\
\hspace{1em}Not at-risk & D29 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 445 & \makecell[l]{10\\(10, 10)} & \makecell[l]{39200\\(34023, 45165)} & \makecell[l]{3920.03\\(3402.34, 4516.49)}\\
\hspace{1em}Not at-risk & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 445 & \makecell[l]{5\\(5, 5)} & \makecell[l]{108\\(87, 133)} & \makecell[l]{21.41\\(17.29, 26.50)}\\
\hspace{1em}Not at-risk & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 445 & \makecell[l]{5\\(5, 5)} & \makecell[l]{180\\(145, 223)} & \makecell[l]{35.39\\(28.57, 43.84)}\\
\hspace{1em}Not at-risk & D29 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 149 & \makecell[l]{10\\(10, 10)} & \makecell[l]{31130\\(22510, 43050)} & \makecell[l]{3113.00\\(2251.05, 4305.00)}\\
\hspace{1em}Not at-risk & D29 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 149 & \makecell[l]{10\\(10, 10)} & \makecell[l]{73051\\(55946, 95386)} & \makecell[l]{7305.09\\(5594.58, 9538.58)}\\
\hspace{1em}Not at-risk & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 149 & \makecell[l]{5\\(5, 5)} & \makecell[l]{175\\(124, 247)} & \makecell[l]{34.46\\(24.42, 48.63)}\\
\hspace{1em}Not at-risk & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 149 & \makecell[l]{5\\(5, 5)} & \makecell[l]{412\\(284, 597)} & \makecell[l]{80.90\\(55.76, 117.37)}\\
\hspace{1em}Not at-risk & D29 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 79 & \makecell[l]{10\\(10, 11)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.97\\(0.92, 1.03)}\\
\hspace{1em}Not at-risk & D29 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 79 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Not at-risk & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 79 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Not at-risk & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 79 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.92, 1.06)}\\
\hspace{1em}Not at-risk & D29 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 147 & \makecell[l]{10\\(10, 10)} & \makecell[l]{11818\\(8756, 15950)} & \makecell[l]{1181.77\\(875.58, 1595.05)}\\
\hspace{1em}Not at-risk & D29 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 147 & \makecell[l]{10\\(10, 10)} & \makecell[l]{16070\\(12770, 20222)} & \makecell[l]{1606.98\\(1277.02, 2022.19)}\\
\hspace{1em}Not at-risk & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 147 & \makecell[l]{5\\(5, 5)} & \makecell[l]{47\\(34, 64)} & \makecell[l]{9.06\\(6.67, 12.30)}\\
\hspace{1em}Not at-risk & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 147 & \makecell[l]{5\\(5, 5)} & \makecell[l]{116\\(82, 164)} & \makecell[l]{22.87\\(16.28, 32.13)}\\
\hspace{1em}Not at-risk & D57 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 445 & \makecell[l]{10\\(10, 10)} & \makecell[l]{904842\\(732112, 1118324)} & \makecell[l]{89906.29\\(72750.39, 111107.87)}\\
\hspace{1em}Not at-risk & D57 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 445 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2066294\\(1739231, 2454861)} & \makecell[l]{206629.43\\(173923.14, 245486.15)}\\
\hspace{1em}Not at-risk & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 445 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1394\\(1075, 1808)} & \makecell[l]{277.07\\(213.65, 359.32)}\\
\hspace{1em}Not at-risk & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 445 & \makecell[l]{5\\(5, 5)} & \makecell[l]{2041\\(1549, 2690)} & \makecell[l]{402.41\\(305.66, 529.78)}\\
\hspace{1em}Not at-risk & D57 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 149 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2113273\\(1525010, 2928453)} & \makecell[l]{211327.27\\(152501.04, 292845.31)}\\
\hspace{1em}Not at-risk & D57 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 149 & \makecell[l]{10\\(10, 10)} & \makecell[l]{5023873\\(3827375, 6594416)} & \makecell[l]{502387.34\\(382737.50, 659441.62)}\\
\hspace{1em}Not at-risk & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 149 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5532\\(3337, 9171)} & \makecell[l]{1087.15\\(659.48, 1792.15)}\\
\hspace{1em}Not at-risk & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 149 & \makecell[l]{5\\(5, 5)} & \makecell[l]{6928\\(4429, 10838)} & \makecell[l]{1360.94\\(870.25, 2128.30)}\\
\hspace{1em}Not at-risk & D57 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 79 & \makecell[l]{10\\(10, 11)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.97\\(0.92, 1.03)}\\
\hspace{1em}Not at-risk & D57 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 79 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Not at-risk & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 79 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.01\\(1.00, 1.02)}\\
\hspace{1em}Not at-risk & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 79 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.97\\(0.92, 1.03)}\\
\hspace{1em}Not at-risk & D57 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 147 & \makecell[l]{10\\(10, 10)} & \makecell[l]{320294\\(235413, 435781)} & \makecell[l]{32029.42\\(23541.29, 43578.07)}\\
\hspace{1em}Not at-risk & D57 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 147 & \makecell[l]{10\\(10, 10)} & \makecell[l]{594413\\(435730, 810886)} & \makecell[l]{59441.32\\(43572.97, 81088.58)}\\
\hspace{1em}Not at-risk & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 147 & \makecell[l]{5\\(5, 5)} & \makecell[l]{482\\(318, 728)} & \makecell[l]{93.28\\(62.10, 140.13)}\\
\hspace{1em}Not at-risk & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 147 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1143\\(737, 1774)} & \makecell[l]{225.36\\(145.81, 348.33)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item  
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{2.7cm}llllllll}
\caption{\label{tab:tabs}Table 6d. Geometric mean titer ratios (GMTRs) or geometric mean
      concentration ratios (GMCRs) between post-vaccinations/pre-vaccination by Age, Risk for Severe Covid-19}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & \makecell[l]{Baseline\\GMT/GMC} & \makecell[l]{Post Baseline\\GMT/GMC} & GMTR/GMCR\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & \makecell[l]{Baseline\\GMT/GMC} & \makecell[l]{Post Baseline\\GMT/GMC} & GMTR/GMCR\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{9}{l}{\textbf{Age, Risk for Severe Covid-19}}\\
\hspace{1em}Age $<$ 65 At-risk & D29 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 214 & \makecell[l]{10\\(10, 10)} & \makecell[l]{16530\\(13368, 20441)} & \makecell[l]{1647.12\\(1332.23, 2036.44)}\\
\hspace{1em}Age $<$ 65 At-risk & D29 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 214 & \makecell[l]{10\\(10, 10)} & \makecell[l]{31028\\(25725, 37423)} & \makecell[l]{3102.75\\(2572.47, 3742.34)}\\
\hspace{1em}Age $<$ 65 At-risk & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 214 & \makecell[l]{5\\(5, 5)} & \makecell[l]{68\\(54, 85)} & \makecell[l]{13.04\\(10.42, 16.32)}\\
\hspace{1em}Age $<$ 65 At-risk & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 214 & \makecell[l]{5\\(5, 5)} & \makecell[l]{159\\(123, 204)} & \makecell[l]{31.54\\(24.49, 40.62)}\\
\hspace{1em}Age $<$ 65 At-risk & D29 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 73 & \makecell[l]{10\\(10, 10)} & \makecell[l]{30603\\(22501, 41623)} & \makecell[l]{3060.34\\(2250.14, 4162.27)}\\
\hspace{1em}Age $<$ 65 At-risk & D29 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 73 & \makecell[l]{10\\(10, 10)} & \makecell[l]{62641\\(46271, 84801)} & \makecell[l]{6264.08\\(4627.13, 8480.14)}\\
\hspace{1em}Age $<$ 65 At-risk & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 73 & \makecell[l]{5\\(5, 5)} & \makecell[l]{142\\(95, 213)} & \makecell[l]{28.47\\(19.00, 42.66)}\\
\hspace{1em}Age $<$ 65 At-risk & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 73 & \makecell[l]{5\\(5, 5)} & \makecell[l]{291\\(187, 453)} & \makecell[l]{57.32\\(36.68, 89.56)}\\
\hspace{1em}Age $<$ 65 At-risk & D29 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 40 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $<$ 65 At-risk & D29 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 40 & \makecell[l]{10\\(10, 11)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.97\\(0.91, 1.03)}\\
\hspace{1em}Age $<$ 65 At-risk & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 40 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 6)} & \makecell[l]{1.01\\(0.92, 1.11)}\\
\hspace{1em}Age $<$ 65 At-risk & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 40 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.96, 1.01)}\\
\hspace{1em}Age $<$ 65 At-risk & D29 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 75 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10221\\(7219, 14470)} & \makecell[l]{1022.09\\(721.94, 1447.04)}\\
\hspace{1em}Age $<$ 65 At-risk & D29 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 75 & \makecell[l]{10\\(10, 10)} & \makecell[l]{16112\\(12299, 21107)} & \makecell[l]{1611.16\\(1229.86, 2110.68)}\\
\hspace{1em}Age $<$ 65 At-risk & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 75 & \makecell[l]{5\\(5, 5)} & \makecell[l]{48\\(34, 67)} & \makecell[l]{9.40\\(6.70, 13.17)}\\
\hspace{1em}Age $<$ 65 At-risk & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 75 & \makecell[l]{5\\(5, 5)} & \makecell[l]{127\\(87, 186)} & \makecell[l]{25.12\\(17.07, 36.96)}\\
\hspace{1em}Age $<$ 65 At-risk & D57 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 214 & \makecell[l]{10\\(10, 10)} & \makecell[l]{761200\\(595277, 973370)} & \makecell[l]{75848.48\\(59325.91, 96972.66)}\\
\hspace{1em}Age $<$ 65 At-risk & D57 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 214 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1498825\\(1211392, 1854460)} & \makecell[l]{149882.51\\(121139.16, 185445.96)}\\
\hspace{1em}Age $<$ 65 At-risk & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 214 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1203\\(876, 1652)} & \makecell[l]{231.86\\(169.01, 318.08)}\\
\hspace{1em}Age $<$ 65 At-risk & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 214 & \makecell[l]{5\\(5, 5)} & \makecell[l]{2067\\(1571, 2720)} & \makecell[l]{411.15\\(312.79, 540.45)}\\
\hspace{1em}Age $<$ 65 At-risk & D57 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 73 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1815884\\(1228679, 2683724)} & \makecell[l]{181588.39\\(122867.87, 268372.40)}\\
\hspace{1em}Age $<$ 65 At-risk & D57 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 73 & \makecell[l]{10\\(10, 10)} & \makecell[l]{4547755\\(3405518, 6073108)} & \makecell[l]{454775.50\\(340551.75, 607310.79)}\\
\hspace{1em}Age $<$ 65 At-risk & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 73 & \makecell[l]{5\\(5, 5)} & \makecell[l]{2953\\(1859, 4690)} & \makecell[l]{590.64\\(371.88, 938.10)}\\
\hspace{1em}Age $<$ 65 At-risk & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 73 & \makecell[l]{5\\(5, 5)} & \makecell[l]{7954\\(4852, 13039)} & \makecell[l]{1567.92\\(957.49, 2567.49)}\\
\hspace{1em}Age $<$ 65 At-risk & D57 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 40 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 11)} & \makecell[l]{1.02\\(0.98, 1.07)}\\
\hspace{1em}Age $<$ 65 At-risk & D57 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 40 & \makecell[l]{10\\(10, 11)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.97\\(0.91, 1.03)}\\
\hspace{1em}Age $<$ 65 At-risk & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 40 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.93, 1.05)}\\
\hspace{1em}Age $<$ 65 At-risk & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 40 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.01\\(0.96, 1.07)}\\
\hspace{1em}Age $<$ 65 At-risk & D57 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 75 & \makecell[l]{10\\(10, 10)} & \makecell[l]{417627\\(286526, 608715)} & \makecell[l]{41762.73\\(28652.58, 60871.51)}\\
\hspace{1em}Age $<$ 65 At-risk & D57 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 75 & \makecell[l]{10\\(10, 10)} & \makecell[l]{575539\\(423609, 781958)} & \makecell[l]{57553.86\\(42360.90, 78195.85)}\\
\hspace{1em}Age $<$ 65 At-risk & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 75 & \makecell[l]{5\\(5, 5)} & \makecell[l]{502\\(325, 776)} & \makecell[l]{98.87\\(64.02, 152.71)}\\
\hspace{1em}Age $<$ 65 At-risk & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 75 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1382\\(851, 2245)} & \makecell[l]{273.33\\(168.28, 443.96)}\\
\hspace{1em}Age $<$ 65 Not at-risk & D29 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 218 & \makecell[l]{10\\(10, 10)} & \makecell[l]{17639\\(14174, 21953)} & \makecell[l]{1751.83\\(1408.13, 2179.42)}\\
\hspace{1em}Age $<$ 65 Not at-risk & D29 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 218 & \makecell[l]{10\\(10, 10)} & \makecell[l]{31500\\(26782, 37050)} & \makecell[l]{3150.02\\(2678.20, 3704.97)}\\
\hspace{1em}Age $<$ 65 Not at-risk & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 218 & \makecell[l]{5\\(5, 5)} & \makecell[l]{90\\(70, 115)} & \makecell[l]{17.91\\(14.03, 22.88)}\\
\hspace{1em}Age $<$ 65 Not at-risk & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 218 & \makecell[l]{5\\(5, 5)} & \makecell[l]{157\\(122, 200)} & \makecell[l]{30.94\\(24.21, 39.54)}\\
\hspace{1em}Age $<$ 65 Not at-risk & D29 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 73 & \makecell[l]{10\\(10, 10)} & \makecell[l]{23567\\(16129, 34434)} & \makecell[l]{2356.67\\(1612.92, 3443.37)}\\
\hspace{1em}Age $<$ 65 Not at-risk & D29 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 73 & \makecell[l]{10\\(10, 10)} & \makecell[l]{58534\\(42846, 79967)} & \makecell[l]{5853.44\\(4284.64, 7996.66)}\\
\hspace{1em}Age $<$ 65 Not at-risk & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 73 & \makecell[l]{5\\(5, 5)} & \makecell[l]{144\\(97, 214)} & \makecell[l]{28.30\\(18.99, 42.19)}\\
\hspace{1em}Age $<$ 65 Not at-risk & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 73 & \makecell[l]{5\\(5, 5)} & \makecell[l]{353\\(229, 545)} & \makecell[l]{69.15\\(44.78, 106.78)}\\
\hspace{1em}Age $<$ 65 Not at-risk & D29 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 40 & \makecell[l]{10\\(10, 11)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.97\\(0.91, 1.03)}\\
\hspace{1em}Age $<$ 65 Not at-risk & D29 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 40 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $<$ 65 Not at-risk & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 40 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $<$ 65 Not at-risk & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 40 & \makecell[l]{5\\(5, 6)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.91, 1.08)}\\
\hspace{1em}Age $<$ 65 Not at-risk & D29 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 72 & \makecell[l]{10\\(10, 10)} & \makecell[l]{9616\\(6788, 13622)} & \makecell[l]{961.58\\(678.78, 1362.18)}\\
\hspace{1em}Age $<$ 65 Not at-risk & D29 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 72 & \makecell[l]{10\\(10, 10)} & \makecell[l]{12751\\(9770, 16642)} & \makecell[l]{1275.09\\(976.97, 1664.19)}\\
\hspace{1em}Age $<$ 65 Not at-risk & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 72 & \makecell[l]{5\\(5, 5)} & \makecell[l]{38\\(26, 55)} & \makecell[l]{7.31\\(5.13, 10.41)}\\
\hspace{1em}Age $<$ 65 Not at-risk & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 72 & \makecell[l]{5\\(5, 5)} & \makecell[l]{101\\(68, 150)} & \makecell[l]{19.90\\(13.43, 29.49)}\\
\hspace{1em}Age $<$ 65 Not at-risk & D57 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 218 & \makecell[l]{10\\(10, 10)} & \makecell[l]{730590\\(572430, 932450)} & \makecell[l]{72557.28\\(56856.08, 92594.47)}\\
\hspace{1em}Age $<$ 65 Not at-risk & D57 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 218 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1685764\\(1382036, 2056240)} & \makecell[l]{168576.35\\(138203.64, 205624.01)}\\
\hspace{1em}Age $<$ 65 Not at-risk & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 218 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1118\\(830, 1506)} & \makecell[l]{222.65\\(165.28, 299.92)}\\
\hspace{1em}Age $<$ 65 Not at-risk & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 218 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1671\\(1216, 2295)} & \makecell[l]{330.08\\(240.60, 452.85)}\\
\hspace{1em}Age $<$ 65 Not at-risk & D57 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 73 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1679359\\(1144789, 2463552)} & \makecell[l]{167935.92\\(114478.90, 246355.20)}\\
\hspace{1em}Age $<$ 65 Not at-risk & D57 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 73 & \makecell[l]{10\\(10, 10)} & \makecell[l]{4192147\\(3040678, 5779665)} & \makecell[l]{419214.74\\(304067.80, 577966.50)}\\
\hspace{1em}Age $<$ 65 Not at-risk & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 73 & \makecell[l]{5\\(5, 5)} & \makecell[l]{4435\\(2453, 8017)} & \makecell[l]{871.87\\(485.49, 1565.77)}\\
\hspace{1em}Age $<$ 65 Not at-risk & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 73 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5833\\(3464, 9821)} & \makecell[l]{1141.93\\(678.45, 1922.04)}\\
\hspace{1em}Age $<$ 65 Not at-risk & D57 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 40 & \makecell[l]{10\\(10, 11)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.97\\(0.91, 1.03)}\\
\hspace{1em}Age $<$ 65 Not at-risk & D57 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 40 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $<$ 65 Not at-risk & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 40 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $<$ 65 Not at-risk & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 40 & \makecell[l]{5\\(5, 6)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.97\\(0.90, 1.03)}\\
\hspace{1em}Age $<$ 65 Not at-risk & D57 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 72 & \makecell[l]{10\\(10, 10)} & \makecell[l]{241209\\(168681, 344922)} & \makecell[l]{24120.91\\(16868.12, 34492.19)}\\
\hspace{1em}Age $<$ 65 Not at-risk & D57 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 72 & \makecell[l]{10\\(10, 10)} & \makecell[l]{463469\\(322830, 665378)} & \makecell[l]{46346.93\\(32282.95, 66537.83)}\\
\hspace{1em}Age $<$ 65 Not at-risk & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 72 & \makecell[l]{5\\(5, 5)} & \makecell[l]{362\\(224, 583)} & \makecell[l]{69.97\\(43.74, 111.92)}\\
\hspace{1em}Age $<$ 65 Not at-risk & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 72 & \makecell[l]{5\\(5, 5)} & \makecell[l]{930\\(559, 1549)} & \makecell[l]{183.66\\(110.80, 304.42)}\\
\hspace{1em}Age $\geq$ 65 At-risk & D29 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 255 & \makecell[l]{10\\(10, 10)} & \makecell[l]{54232\\(44615, 65922)} & \makecell[l]{5389.56\\(4435.12, 6549.39)}\\
\hspace{1em}Age $\geq$ 65 At-risk & D29 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 255 & \makecell[l]{10\\(10, 10)} & \makecell[l]{84391\\(70325, 101269)} & \makecell[l]{8352.45\\(6975.06, 10001.82)}\\
\hspace{1em}Age $\geq$ 65 At-risk & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 255 & \makecell[l]{5\\(5, 5)} & \makecell[l]{199\\(157, 252)} & \makecell[l]{39.22\\(30.90, 49.78)}\\
\hspace{1em}Age $\geq$ 65 At-risk & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 255 & \makecell[l]{5\\(5, 5)} & \makecell[l]{348\\(276, 438)} & \makecell[l]{68.12\\(54.16, 85.68)}\\
\hspace{1em}Age $\geq$ 65 At-risk & D29 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 52 & \makecell[l]{10\\(10, 10)} & \makecell[l]{188670\\(129392, 275106)} & \makecell[l]{18867.03\\(12939.21, 27510.55)}\\
\hspace{1em}Age $\geq$ 65 At-risk & D29 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 52 & \makecell[l]{10\\(10, 10)} & \makecell[l]{293282\\(210942, 407763)} & \makecell[l]{29328.19\\(21094.20, 40776.26)}\\
\hspace{1em}Age $\geq$ 65 At-risk & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 52 & \makecell[l]{5\\(5, 6)} & \makecell[l]{541\\(337, 870)} & \makecell[l]{100.78\\(63.88, 159.01)}\\
\hspace{1em}Age $\geq$ 65 At-risk & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 52 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1052\\(680, 1627)} & \makecell[l]{210.47\\(136.09, 325.50)}\\
\hspace{1em}Age $\geq$ 65 At-risk & D29 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 44 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $\geq$ 65 At-risk & D29 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 44 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $\geq$ 65 At-risk & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 44 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.03\\(0.99, 1.08)}\\
\hspace{1em}Age $\geq$ 65 At-risk & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 44 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.02\\(0.98, 1.06)}\\
\hspace{1em}Age $\geq$ 65 At-risk & D29 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 48 & \makecell[l]{10\\(10, 11)} & \makecell[l]{48060\\(30237, 76388)} & \makecell[l]{4715.92\\(2980.60, 7461.57)}\\
\hspace{1em}Age $\geq$ 65 At-risk & D29 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 48 & \makecell[l]{10\\(10, 10)} & \makecell[l]{79058\\(52125, 119908)} & \makecell[l]{7905.78\\(5212.45, 11990.78)}\\
\hspace{1em}Age $\geq$ 65 At-risk & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 48 & \makecell[l]{5\\(5, 5)} & \makecell[l]{155\\(89, 270)} & \makecell[l]{29.89\\(17.24, 51.82)}\\
\hspace{1em}Age $\geq$ 65 At-risk & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 48 & \makecell[l]{5\\(5, 5)} & \makecell[l]{378\\(233, 613)} & \makecell[l]{74.62\\(45.91, 121.29)}\\
\hspace{1em}Age $\geq$ 65 At-risk & D57 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 255 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2156196\\(1736284, 2677662)} & \makecell[l]{214282.06\\(172705.04, 265868.34)}\\
\hspace{1em}Age $\geq$ 65 At-risk & D57 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 255 & \makecell[l]{10\\(10, 10)} & \makecell[l]{3754377\\(3053564, 4616033)} & \makecell[l]{371583.87\\(302329.22, 456702.71)}\\
\hspace{1em}Age $\geq$ 65 At-risk & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 255 & \makecell[l]{5\\(5, 5)} & \makecell[l]{3359\\(2423, 4656)} & \makecell[l]{662.04\\(477.45, 917.99)}\\
\hspace{1em}Age $\geq$ 65 At-risk & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 255 & \makecell[l]{5\\(5, 5)} & \makecell[l]{4361\\(3299, 5763)} & \makecell[l]{854.58\\(648.16, 1126.74)}\\
\hspace{1em}Age $\geq$ 65 At-risk & D57 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 52 & \makecell[l]{10\\(10, 10)} & \makecell[l]{7826271\\(5853680, 10463591)} & \makecell[l]{782627.11\\(585368.05, 1046359.11)}\\
\hspace{1em}Age $\geq$ 65 At-risk & D57 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 52 & \makecell[l]{10\\(10, 10)} & \makecell[l]{12884976\\(10641883, 15600868)} & \makecell[l]{1288497.62\\(1064188.30, 1560086.81)}\\
\hspace{1em}Age $\geq$ 65 At-risk & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 52 & \makecell[l]{5\\(5, 6)} & \makecell[l]{27431\\(17819, 42227)} & \makecell[l]{5108.47\\(3366.93, 7750.83)}\\
\hspace{1em}Age $\geq$ 65 At-risk & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 52 & \makecell[l]{5\\(5, 5)} & \makecell[l]{22502\\(13237, 38254)} & \makecell[l]{4500.48\\(2647.36, 7650.76)}\\
\hspace{1em}Age $\geq$ 65 At-risk & D57 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 44 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $\geq$ 65 At-risk & D57 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 44 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $\geq$ 65 At-risk & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 44 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $\geq$ 65 At-risk & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 44 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 6)} & \makecell[l]{1.04\\(0.97, 1.11)}\\
\hspace{1em}Age $\geq$ 65 At-risk & D57 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 48 & \makecell[l]{10\\(10, 11)} & \makecell[l]{1793880\\(1112795, 2891824)} & \makecell[l]{176025.95\\(109237.32, 283649.72)}\\
\hspace{1em}Age $\geq$ 65 At-risk & D57 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 48 & \makecell[l]{10\\(10, 10)} & \makecell[l]{3402410\\(2325361, 4978321)} & \makecell[l]{340240.98\\(232536.09, 497832.07)}\\
\hspace{1em}Age $\geq$ 65 At-risk & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 48 & \makecell[l]{5\\(5, 5)} & \makecell[l]{3501\\(1863, 6577)} & \makecell[l]{675.29\\(361.89, 1260.11)}\\
\hspace{1em}Age $\geq$ 65 At-risk & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 48 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5048\\(2709, 9408)} & \makecell[l]{997.20\\(534.99, 1858.76)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & D29 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 227 & \makecell[l]{10\\(10, 10)} & \makecell[l]{80069\\(65707, 97571)} & \makecell[l]{7979.90\\(6548.33, 9724.45)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & D29 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 227 & \makecell[l]{10\\(10, 10)} & \makecell[l]{153593\\(130667, 180543)} & \makecell[l]{15359.34\\(13066.69, 18054.25)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 227 & \makecell[l]{5\\(5, 5)} & \makecell[l]{332\\(263, 418)} & \makecell[l]{65.09\\(51.60, 82.12)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 227 & \makecell[l]{5\\(5, 5)} & \makecell[l]{421\\(328, 540)} & \makecell[l]{81.90\\(63.99, 104.83)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & D29 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 76 & \makecell[l]{10\\(10, 10)} & \makecell[l]{139826\\(99996, 195520)} & \makecell[l]{13982.56\\(9999.60, 19552.00)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & D29 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 76 & \makecell[l]{10\\(10, 10)} & \makecell[l]{241494\\(182978, 318724)} & \makecell[l]{24149.39\\(18297.76, 31872.38)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 76 & \makecell[l]{5\\(5, 5)} & \makecell[l]{508\\(317, 815)} & \makecell[l]{99.68\\(62.60, 158.74)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 76 & \makecell[l]{5\\(5, 5)} & \makecell[l]{944\\(626, 1422)} & \makecell[l]{188.75\\(125.29, 284.35)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & D29 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 39 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & D29 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 39 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 39 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 39 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.96, 1.01)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & D29 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 75 & \makecell[l]{10\\(10, 10)} & \makecell[l]{38048\\(27669, 52321)} & \makecell[l]{3804.83\\(2766.90, 5232.12)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & D29 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 75 & \makecell[l]{10\\(10, 10)} & \makecell[l]{59664\\(45819, 77691)} & \makecell[l]{5966.37\\(4581.94, 7769.08)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 75 & \makecell[l]{5\\(5, 5)} & \makecell[l]{156\\(105, 232)} & \makecell[l]{30.49\\(20.53, 45.27)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 75 & \makecell[l]{5\\(5, 5)} & \makecell[l]{257\\(170, 390)} & \makecell[l]{50.29\\(33.38, 75.76)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & D57 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 227 & \makecell[l]{10\\(10, 10)} & \makecell[l]{3441017\\(2860842, 4138850)} & \makecell[l]{342939.68\\(285103.95, 412507.88)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & D57 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 227 & \makecell[l]{10\\(10, 10)} & \makecell[l]{7365218\\(6408010, 8465410)} & \makecell[l]{736521.80\\(640801.04, 846541.01)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 227 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5534\\(4137, 7404)} & \makecell[l]{1085.68\\(812.27, 1451.14)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 227 & \makecell[l]{5\\(5, 5)} & \makecell[l]{7125\\(5468, 9285)} & \makecell[l]{1386.74\\(1065.57, 1804.72)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & D57 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 76 & \makecell[l]{10\\(10, 10)} & \makecell[l]{7305563\\(5522547, 9664247)} & \makecell[l]{730556.35\\(552254.70, 966424.70)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & D57 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 76 & \makecell[l]{10\\(10, 10)} & \makecell[l]{13343347\\(11421210, 15588971)} & \makecell[l]{1334334.72\\(1142121.04, 1558897.08)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 76 & \makecell[l]{5\\(5, 5)} & \makecell[l]{18240\\(11134, 29880)} & \makecell[l]{3577.07\\(2192.53, 5835.90)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 76 & \makecell[l]{5\\(5, 5)} & \makecell[l]{17541\\(10280, 29932)} & \makecell[l]{3508.28\\(2056.01, 5986.35)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & D57 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 39 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & D57 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 39 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 39 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 6)} & \makecell[l]{1.05\\(0.98, 1.11)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 39 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.96, 1.01)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & D57 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 75 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1599200\\(1156266, 2211811)} & \makecell[l]{159920.02\\(115626.58, 221181.10)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & D57 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 75 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2437171\\(1815977, 3270859)} & \makecell[l]{243717.12\\(181597.68, 327085.88)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 75 & \makecell[l]{5\\(5, 5)} & \makecell[l]{2442\\(1442, 4134)} & \makecell[l]{476.56\\(282.81, 803.04)}\\
\hspace{1em}Age $\geq$ 65 Not at-risk & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 75 & \makecell[l]{5\\(5, 5)} & \makecell[l]{3681\\(2278, 5949)} & \makecell[l]{719.25\\(447.61, 1155.75)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item  
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{2.7cm}llllllll}
\caption{\label{tab:tabs}Table 6e. Geometric mean titer ratios (GMTRs) or geometric mean
      concentration ratios (GMCRs) between post-vaccinations/pre-vaccination by Sex}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & \makecell[l]{Baseline\\GMT/GMC} & \makecell[l]{Post Baseline\\GMT/GMC} & GMTR/GMCR\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & \makecell[l]{Baseline\\GMT/GMC} & \makecell[l]{Post Baseline\\GMT/GMC} & GMTR/GMCR\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{9}{l}{\textbf{Sex}}\\
\hspace{1em}Male & D29 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 395 & \makecell[l]{10\\(10, 10)} & \makecell[l]{25738\\(20110, 32941)} & \makecell[l]{2547.65\\(1992.51, 3257.47)}\\
\hspace{1em}Male & D29 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 395 & \makecell[l]{10\\(10, 10)} & \makecell[l]{40290\\(34397, 47193)} & \makecell[l]{4021.73\\(3433.73, 4710.40)}\\
\hspace{1em}Male & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 395 & \makecell[l]{5\\(5, 5)} & \makecell[l]{121\\(93, 157)} & \makecell[l]{23.94\\(18.44, 31.08)}\\
\hspace{1em}Male & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 395 & \makecell[l]{5\\(5, 5)} & \makecell[l]{207\\(158, 272)} & \makecell[l]{41.19\\(31.36, 54.12)}\\
\hspace{1em}Male & D29 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 121 & \makecell[l]{10\\(10, 10)} & \makecell[l]{43301\\(30763, 60949)} & \makecell[l]{4330.07\\(3076.26, 6094.90)}\\
\hspace{1em}Male & D29 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 121 & \makecell[l]{10\\(10, 10)} & \makecell[l]{83762\\(65541, 107048)} & \makecell[l]{8376.20\\(6554.14, 10704.79)}\\
\hspace{1em}Male & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 121 & \makecell[l]{5\\(5, 5)} & \makecell[l]{223\\(158, 315)} & \makecell[l]{44.26\\(31.35, 62.49)}\\
\hspace{1em}Male & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 121 & \makecell[l]{5\\(5, 5)} & \makecell[l]{449\\(303, 666)} & \makecell[l]{88.19\\(59.60, 130.49)}\\
\hspace{1em}Male & D29 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 76 & \makecell[l]{11\\(9, 12)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.95\\(0.85, 1.05)}\\
\hspace{1em}Male & D29 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 76 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Male & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 76 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.02\\(0.98, 1.07)}\\
\hspace{1em}Male & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 76 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(0.99, 1.00)}\\
\hspace{1em}Male & D29 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 115 & \makecell[l]{10\\(10, 10)} & \makecell[l]{12838\\(8743, 18852)} & \makecell[l]{1283.80\\(874.26, 1885.18)}\\
\hspace{1em}Male & D29 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 115 & \makecell[l]{10\\(10, 10)} & \makecell[l]{16359\\(12044, 22219)} & \makecell[l]{1635.88\\(1204.42, 2221.91)}\\
\hspace{1em}Male & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 115 & \makecell[l]{5\\(5, 5)} & \makecell[l]{43\\(29, 63)} & \makecell[l]{8.45\\(5.76, 12.39)}\\
\hspace{1em}Male & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 115 & \makecell[l]{5\\(5, 5)} & \makecell[l]{100\\(68, 146)} & \makecell[l]{19.80\\(13.54, 28.93)}\\
\hspace{1em}Male & D57 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 395 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1032572\\(803692, 1326633)} & \makecell[l]{102207.86\\(79582.66, 131265.36)}\\
\hspace{1em}Male & D57 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 395 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2448348\\(1992531, 3008439)} & \makecell[l]{244392.84\\(198889.12, 300307.33)}\\
\hspace{1em}Male & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 395 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1983\\(1427, 2754)} & \makecell[l]{392.99\\(282.86, 546.00)}\\
\hspace{1em}Male & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 395 & \makecell[l]{5\\(5, 5)} & \makecell[l]{2322\\(1694, 3181)} & \makecell[l]{461.27\\(336.67, 631.96)}\\
\hspace{1em}Male & D57 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 121 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2628794\\(1842173, 3751308)} & \makecell[l]{262879.40\\(184217.30, 375130.79)}\\
\hspace{1em}Male & D57 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 121 & \makecell[l]{10\\(10, 10)} & \makecell[l]{5518909\\(4222583, 7213204)} & \makecell[l]{551890.89\\(422258.33, 721320.40)}\\
\hspace{1em}Male & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 121 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5567\\(3235, 9581)} & \makecell[l]{1105.10\\(642.29, 1901.37)}\\
\hspace{1em}Male & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 121 & \makecell[l]{5\\(5, 5)} & \makecell[l]{9590\\(6259, 14696)} & \makecell[l]{1881.91\\(1235.71, 2866.05)}\\
\hspace{1em}Male & D57 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 76 & \makecell[l]{11\\(9, 12)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.96\\(0.86, 1.07)}\\
\hspace{1em}Male & D57 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 76 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Male & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 76 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.01\\(0.99, 1.02)}\\
\hspace{1em}Male & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 76 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(0.99, 1.00)}\\
\hspace{1em}Male & D57 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 115 & \makecell[l]{10\\(10, 10)} & \makecell[l]{361345\\(243436, 536364)} & \makecell[l]{36134.52\\(24343.59, 53636.45)}\\
\hspace{1em}Male & D57 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 115 & \makecell[l]{10\\(10, 10)} & \makecell[l]{578439\\(406742, 822616)} & \makecell[l]{57843.93\\(40674.16, 82261.55)}\\
\hspace{1em}Male & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 115 & \makecell[l]{5\\(5, 5)} & \makecell[l]{606\\(358, 1023)} & \makecell[l]{120.00\\(71.07, 202.60)}\\
\hspace{1em}Male & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 115 & \makecell[l]{5\\(5, 5)} & \makecell[l]{930\\(554, 1559)} & \makecell[l]{184.20\\(109.85, 308.87)}\\
\hspace{1em}Female & D29 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 519 & \makecell[l]{10\\(10, 10)} & \makecell[l]{21234\\(17837, 25278)} & \makecell[l]{2116.93\\(1778.05, 2520.39)}\\
\hspace{1em}Female & D29 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 519 & \makecell[l]{10\\(10, 10)} & \makecell[l]{41415\\(35725, 48012)} & \makecell[l]{4138.70\\(3570.16, 4797.78)}\\
\hspace{1em}Female & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 519 & \makecell[l]{5\\(5, 5)} & \makecell[l]{98\\(80, 120)} & \makecell[l]{19.27\\(15.73, 23.62)}\\
\hspace{1em}Female & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 519 & \makecell[l]{5\\(5, 5)} & \makecell[l]{178\\(145, 218)} & \makecell[l]{34.90\\(28.55, 42.66)}\\
\hspace{1em}Female & D29 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 153 & \makecell[l]{10\\(10, 10)} & \makecell[l]{32117\\(22658, 45526)} & \makecell[l]{3211.74\\(2265.79, 4552.63)}\\
\hspace{1em}Female & D29 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 153 & \makecell[l]{10\\(10, 10)} & \makecell[l]{77611\\(57216, 105276)} & \makecell[l]{7761.12\\(5721.63, 10527.59)}\\
\hspace{1em}Female & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 153 & \makecell[l]{5\\(5, 5)} & \makecell[l]{165\\(113, 242)} & \makecell[l]{32.19\\(21.92, 47.27)}\\
\hspace{1em}Female & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 153 & \makecell[l]{5\\(5, 5)} & \makecell[l]{401\\(268, 602)} & \makecell[l]{79.18\\(52.69, 118.97)}\\
\hspace{1em}Female & D29 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 87 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Female & D29 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 87 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.99\\(0.97, 1.01)}\\
\hspace{1em}Female & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 87 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(0.98, 1.01)}\\
\hspace{1em}Female & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 87 & \makecell[l]{5\\(5, 6)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.92, 1.07)}\\
\hspace{1em}Female & D29 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 155 & \makecell[l]{10\\(10, 10)} & \makecell[l]{12876\\(9489, 17472)} & \makecell[l]{1284.49\\(946.73, 1742.74)}\\
\hspace{1em}Female & D29 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 155 & \makecell[l]{10\\(10, 10)} & \makecell[l]{19468\\(15496, 24459)} & \makecell[l]{1946.81\\(1549.59, 2445.85)}\\
\hspace{1em}Female & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 155 & \makecell[l]{5\\(5, 5)} & \makecell[l]{58\\(42, 81)} & \makecell[l]{11.13\\(8.13, 15.24)}\\
\hspace{1em}Female & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 155 & \makecell[l]{5\\(5, 5)} & \makecell[l]{152\\(105, 219)} & \makecell[l]{29.90\\(20.91, 42.76)}\\
\hspace{1em}Female & D57 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 519 & \makecell[l]{10\\(10, 10)} & \makecell[l]{924524\\(750510, 1138886)} & \makecell[l]{92171.55\\(74822.64, 113543.10)}\\
\hspace{1em}Female & D57 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 519 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1878895\\(1586011, 2225864)} & \makecell[l]{187761.05\\(158494.70, 222431.47)}\\
\hspace{1em}Female & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 519 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1243\\(972, 1588)} & \makecell[l]{244.86\\(191.72, 312.74)}\\
\hspace{1em}Female & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 519 & \makecell[l]{5\\(5, 5)} & \makecell[l]{2160\\(1643, 2840)} & \makecell[l]{424.30\\(323.30, 556.85)}\\
\hspace{1em}Female & D57 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 153 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2106655\\(1490680, 2977161)} & \makecell[l]{210665.51\\(149068.03, 297716.12)}\\
\hspace{1em}Female & D57 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 153 & \makecell[l]{10\\(10, 10)} & \makecell[l]{5236885\\(3880756, 7066912)} & \makecell[l]{523688.47\\(388075.59, 706691.20)}\\
\hspace{1em}Female & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 153 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5754\\(3356, 9868)} & \makecell[l]{1120.71\\(659.00, 1905.91)}\\
\hspace{1em}Female & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 153 & \makecell[l]{5\\(5, 5)} & \makecell[l]{6872\\(4174, 11314)} & \makecell[l]{1355.55\\(821.91, 2235.68)}\\
\hspace{1em}Female & D57 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 87 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Female & D57 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 87 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.99\\(0.97, 1.01)}\\
\hspace{1em}Female & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 87 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(0.98, 1.02)}\\
\hspace{1em}Female & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 87 & \makecell[l]{5\\(5, 6)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.98\\(0.92, 1.04)}\\
\hspace{1em}Female & D57 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 155 & \makecell[l]{10\\(10, 10)} & \makecell[l]{396863\\(289955, 543189)} & \makecell[l]{39591.01\\(28926.67, 54186.94)}\\
\hspace{1em}Female & D57 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 155 & \makecell[l]{10\\(10, 10)} & \makecell[l]{748414\\(540245, 1036794)} & \makecell[l]{74841.37\\(54024.52, 103679.41)}\\
\hspace{1em}Female & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 155 & \makecell[l]{5\\(5, 5)} & \makecell[l]{541\\(355, 825)} & \makecell[l]{103.77\\(68.77, 156.56)}\\
\hspace{1em}Female & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 155 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1659\\(1064, 2588)} & \makecell[l]{326.50\\(210.44, 506.55)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item  
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{2.7cm}llllllll}
\caption{\label{tab:tabs}Table 6f. Geometric mean titer ratios (GMTRs) or geometric mean
      concentration ratios (GMCRs) between post-vaccinations/pre-vaccination by Age, sex}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & \makecell[l]{Baseline\\GMT/GMC} & \makecell[l]{Post Baseline\\GMT/GMC} & GMTR/GMCR\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & \makecell[l]{Baseline\\GMT/GMC} & \makecell[l]{Post Baseline\\GMT/GMC} & GMTR/GMCR\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{9}{l}{\textbf{Age, sex}}\\
\hspace{1em}Age $<$ 65 Female & D29 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 269 & \makecell[l]{10\\(10, 10)} & \makecell[l]{16543\\(13418, 20396)} & \makecell[l]{1649.23\\(1337.49, 2033.63)}\\
\hspace{1em}Age $<$ 65 Female & D29 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 269 & \makecell[l]{10\\(10, 10)} & \makecell[l]{32705\\(27399, 39039)} & \makecell[l]{3270.52\\(2739.91, 3903.89)}\\
\hspace{1em}Age $<$ 65 Female & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 269 & \makecell[l]{5\\(5, 5)} & \makecell[l]{79\\(62, 101)} & \makecell[l]{15.62\\(12.24, 19.92)}\\
\hspace{1em}Age $<$ 65 Female & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 269 & \makecell[l]{5\\(5, 5)} & \makecell[l]{150\\(118, 191)} & \makecell[l]{29.60\\(23.28, 37.64)}\\
\hspace{1em}Age $<$ 65 Female & D29 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 79 & \makecell[l]{10\\(10, 10)} & \makecell[l]{21789\\(14248, 33321)} & \makecell[l]{2178.91\\(1424.83, 3332.11)}\\
\hspace{1em}Age $<$ 65 Female & D29 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 79 & \makecell[l]{10\\(10, 10)} & \makecell[l]{56962\\(39317, 82526)} & \makecell[l]{5696.22\\(3931.72, 8252.62)}\\
\hspace{1em}Age $<$ 65 Female & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 79 & \makecell[l]{5\\(5, 5)} & \makecell[l]{124\\(78, 197)} & \makecell[l]{24.32\\(15.30, 38.67)}\\
\hspace{1em}Age $<$ 65 Female & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 79 & \makecell[l]{5\\(5, 5)} & \makecell[l]{319\\(195, 522)} & \makecell[l]{62.74\\(38.25, 102.90)}\\
\hspace{1em}Age $<$ 65 Female & D29 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 52 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $<$ 65 Female & D29 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 52 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.99\\(0.97, 1.01)}\\
\hspace{1em}Age $<$ 65 Female & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 52 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.97, 1.01)}\\
\hspace{1em}Age $<$ 65 Female & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 52 & \makecell[l]{5\\(5, 6)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.90, 1.08)}\\
\hspace{1em}Age $<$ 65 Female & D29 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 83 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10100\\(6984, 14608)} & \makecell[l]{1010.05\\(698.40, 1460.75)}\\
\hspace{1em}Age $<$ 65 Female & D29 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 83 & \makecell[l]{10\\(10, 10)} & \makecell[l]{14961\\(11369, 19689)} & \makecell[l]{1496.11\\(1136.86, 1968.90)}\\
\hspace{1em}Age $<$ 65 Female & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 83 & \makecell[l]{5\\(5, 6)} & \makecell[l]{46\\(31, 69)} & \makecell[l]{8.74\\(6.00, 12.74)}\\
\hspace{1em}Age $<$ 65 Female & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 83 & \makecell[l]{5\\(5, 5)} & \makecell[l]{133\\(86, 207)} & \makecell[l]{26.17\\(16.99, 40.31)}\\
\hspace{1em}Age $<$ 65 Female & D57 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 269 & \makecell[l]{10\\(10, 10)} & \makecell[l]{725439\\(563976, 933126)} & \makecell[l]{72323.27\\(56225.78, 93029.48)}\\
\hspace{1em}Age $<$ 65 Female & D57 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 269 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1494002\\(1218429, 1831901)} & \makecell[l]{149400.21\\(121842.92, 183190.15)}\\
\hspace{1em}Age $<$ 65 Female & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 269 & \makecell[l]{5\\(5, 5)} & \makecell[l]{946\\(706, 1267)} & \makecell[l]{186.45\\(139.19, 249.76)}\\
\hspace{1em}Age $<$ 65 Female & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 269 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1691\\(1216, 2352)} & \makecell[l]{332.97\\(239.88, 462.17)}\\
\hspace{1em}Age $<$ 65 Female & D57 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 79 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1557246\\(1019727, 2378101)} & \makecell[l]{155724.56\\(101972.70, 237810.10)}\\
\hspace{1em}Age $<$ 65 Female & D57 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 79 & \makecell[l]{10\\(10, 10)} & \makecell[l]{4234642\\(2930914, 6118296)} & \makecell[l]{423464.24\\(293091.36, 611829.57)}\\
\hspace{1em}Age $<$ 65 Female & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 79 & \makecell[l]{5\\(5, 5)} & \makecell[l]{4195\\(2173, 8100)} & \makecell[l]{820.85\\(429.44, 1568.99)}\\
\hspace{1em}Age $<$ 65 Female & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 79 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5422\\(2964, 9918)} & \makecell[l]{1066.04\\(581.49, 1954.38)}\\
\hspace{1em}Age $<$ 65 Female & D57 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 52 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $<$ 65 Female & D57 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 52 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.99\\(0.97, 1.01)}\\
\hspace{1em}Age $<$ 65 Female & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 52 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(0.97, 1.02)}\\
\hspace{1em}Age $<$ 65 Female & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 52 & \makecell[l]{5\\(5, 6)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.97\\(0.90, 1.04)}\\
\hspace{1em}Age $<$ 65 Female & D57 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 83 & \makecell[l]{10\\(10, 10)} & \makecell[l]{293632\\(201048, 428852)} & \makecell[l]{29363.18\\(20104.77, 42885.16)}\\
\hspace{1em}Age $<$ 65 Female & D57 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 83 & \makecell[l]{10\\(10, 10)} & \makecell[l]{571578\\(384900, 848795)} & \makecell[l]{57157.76\\(38489.96, 84879.54)}\\
\hspace{1em}Age $<$ 65 Female & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 83 & \makecell[l]{5\\(5, 6)} & \makecell[l]{387\\(233, 641)} & \makecell[l]{73.68\\(45.02, 120.60)}\\
\hspace{1em}Age $<$ 65 Female & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 83 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1375\\(804, 2349)} & \makecell[l]{270.38\\(159.26, 459.03)}\\
\hspace{1em}Age $<$ 65 Male & D29 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 163 & \makecell[l]{10\\(10, 10)} & \makecell[l]{18877\\(13705, 26001)} & \makecell[l]{1866.53\\(1356.91, 2567.57)}\\
\hspace{1em}Age $<$ 65 Male & D29 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 163 & \makecell[l]{10\\(10, 10)} & \makecell[l]{29372\\(24030, 35901)} & \makecell[l]{2937.19\\(2402.98, 3590.15)}\\
\hspace{1em}Age $<$ 65 Male & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 163 & \makecell[l]{5\\(5, 5)} & \makecell[l]{94\\(67, 132)} & \makecell[l]{18.70\\(13.35, 26.21)}\\
\hspace{1em}Age $<$ 65 Male & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 163 & \makecell[l]{5\\(5, 5)} & \makecell[l]{169\\(118, 240)} & \makecell[l]{33.64\\(23.62, 47.90)}\\
\hspace{1em}Age $<$ 65 Male & D29 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 67 & \makecell[l]{10\\(10, 10)} & \makecell[l]{30884\\(20281, 47031)} & \makecell[l]{3088.44\\(2028.11, 4703.13)}\\
\hspace{1em}Age $<$ 65 Male & D29 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 67 & \makecell[l]{10\\(10, 10)} & \makecell[l]{63477\\(47023, 85688)} & \makecell[l]{6347.70\\(4702.33, 8568.81)}\\
\hspace{1em}Age $<$ 65 Male & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 67 & \makecell[l]{5\\(5, 5)} & \makecell[l]{180\\(119, 274)} & \makecell[l]{36.09\\(23.79, 54.76)}\\
\hspace{1em}Age $<$ 65 Male & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 67 & \makecell[l]{5\\(5, 5)} & \makecell[l]{372\\(229, 604)} & \makecell[l]{72.62\\(44.83, 117.63)}\\
\hspace{1em}Age $<$ 65 Male & D29 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 28 & \makecell[l]{11\\(9, 13)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.92\\(0.78, 1.08)}\\
\hspace{1em}Age $<$ 65 Male & D29 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 28 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $<$ 65 Male & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 28 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.03\\(0.97, 1.10)}\\
\hspace{1em}Age $<$ 65 Male & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 28 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $<$ 65 Male & D29 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 64 & \makecell[l]{10\\(10, 10)} & \makecell[l]{9188\\(5784, 14598)} & \makecell[l]{918.85\\(578.36, 1459.77)}\\
\hspace{1em}Age $<$ 65 Male & D29 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 64 & \makecell[l]{10\\(10, 10)} & \makecell[l]{11210\\(7775, 16161)} & \makecell[l]{1120.96\\(777.52, 1616.12)}\\
\hspace{1em}Age $<$ 65 Male & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 64 & \makecell[l]{5\\(5, 5)} & \makecell[l]{31\\(20, 50)} & \makecell[l]{6.29\\(3.99, 9.92)}\\
\hspace{1em}Age $<$ 65 Male & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 64 & \makecell[l]{5\\(5, 5)} & \makecell[l]{73\\(47, 115)} & \makecell[l]{14.60\\(9.30, 22.92)}\\
\hspace{1em}Age $<$ 65 Male & D57 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 163 & \makecell[l]{10\\(10, 10)} & \makecell[l]{756600\\(546757, 1046981)} & \makecell[l]{74811.32\\(54086.35, 103477.74)}\\
\hspace{1em}Age $<$ 65 Male & D57 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 163 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1920202\\(1472176, 2504576)} & \makecell[l]{192020.23\\(147217.61, 250457.60)}\\
\hspace{1em}Age $<$ 65 Male & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 163 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1532\\(1004, 2337)} & \makecell[l]{304.47\\(199.53, 464.60)}\\
\hspace{1em}Age $<$ 65 Male & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 163 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1850\\(1231, 2781)} & \makecell[l]{368.88\\(245.44, 554.40)}\\
\hspace{1em}Age $<$ 65 Male & D57 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 67 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1977267\\(1268954, 3080952)} & \makecell[l]{197726.73\\(126895.40, 308095.19)}\\
\hspace{1em}Age $<$ 65 Male & D57 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 67 & \makecell[l]{10\\(10, 10)} & \makecell[l]{4318054\\(3077671, 6058343)} & \makecell[l]{431805.36\\(307767.09, 605834.32)}\\
\hspace{1em}Age $<$ 65 Male & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 67 & \makecell[l]{5\\(5, 5)} & \makecell[l]{3857\\(1960, 7590)} & \makecell[l]{771.41\\(392.00, 1518.05)}\\
\hspace{1em}Age $<$ 65 Male & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 67 & \makecell[l]{5\\(5, 5)} & \makecell[l]{7789\\(4625, 13117)} & \makecell[l]{1520.50\\(910.33, 2539.66)}\\
\hspace{1em}Age $<$ 65 Male & D57 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 28 & \makecell[l]{11\\(9, 13)} & \makecell[l]{10\\(10, 11)} & \makecell[l]{0.94\\(0.79, 1.11)}\\
\hspace{1em}Age $<$ 65 Male & D57 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 28 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $<$ 65 Male & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 28 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $<$ 65 Male & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 28 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $<$ 65 Male & D57 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 64 & \makecell[l]{10\\(10, 10)} & \makecell[l]{236528\\(146661, 381460)} & \makecell[l]{23652.81\\(14666.14, 38146.03)}\\
\hspace{1em}Age $<$ 65 Male & D57 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 64 & \makecell[l]{10\\(10, 10)} & \makecell[l]{373064\\(243212, 572245)} & \makecell[l]{37306.38\\(24321.16, 57224.48)}\\
\hspace{1em}Age $<$ 65 Male & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 64 & \makecell[l]{5\\(5, 5)} & \makecell[l]{387\\(206, 728)} & \makecell[l]{77.48\\(41.21, 145.66)}\\
\hspace{1em}Age $<$ 65 Male & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 64 & \makecell[l]{5\\(5, 5)} & \makecell[l]{618\\(331, 1154)} & \makecell[l]{122.95\\(65.86, 229.52)}\\
\hspace{1em}Age $\geq$ 65 Male & D29 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 232 & \makecell[l]{10\\(10, 10)} & \makecell[l]{66467\\(53933, 81913)} & \makecell[l]{6600.68\\(5356.98, 8133.11)}\\
\hspace{1em}Age $\geq$ 65 Male & D29 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 232 & \makecell[l]{10\\(10, 10)} & \makecell[l]{105989\\(87935, 127749)} & \makecell[l]{10521.42\\(8738.17, 12668.58)}\\
\hspace{1em}Age $\geq$ 65 Male & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 232 & \makecell[l]{5\\(5, 5)} & \makecell[l]{259\\(203, 330)} & \makecell[l]{50.93\\(39.90, 65.01)}\\
\hspace{1em}Age $\geq$ 65 Male & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 232 & \makecell[l]{5\\(5, 5)} & \makecell[l]{390\\(306, 496)} & \makecell[l]{76.59\\(60.31, 97.27)}\\
\hspace{1em}Age $\geq$ 65 Male & D29 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 54 & \makecell[l]{10\\(10, 10)} & \makecell[l]{148457\\(98119, 224620)} & \makecell[l]{14845.72\\(9811.94, 22461.95)}\\
\hspace{1em}Age $\geq$ 65 Male & D29 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 54 & \makecell[l]{10\\(10, 10)} & \makecell[l]{230231\\(167261, 316907)} & \makecell[l]{23023.06\\(16726.06, 31690.75)}\\
\hspace{1em}Age $\geq$ 65 Male & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 54 & \makecell[l]{5\\(5, 6)} & \makecell[l]{482\\(286, 812)} & \makecell[l]{93.10\\(56.09, 154.53)}\\
\hspace{1em}Age $\geq$ 65 Male & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 54 & \makecell[l]{5\\(5, 5)} & \makecell[l]{895\\(560, 1432)} & \makecell[l]{179.10\\(111.99, 286.42)}\\
\hspace{1em}Age $\geq$ 65 Male & D29 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 48 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $\geq$ 65 Male & D29 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 48 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $\geq$ 65 Male & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 48 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.01\\(0.99, 1.04)}\\
\hspace{1em}Age $\geq$ 65 Male & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 48 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.96, 1.01)}\\
\hspace{1em}Age $\geq$ 65 Male & D29 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 51 & \makecell[l]{10\\(10, 10)} & \makecell[l]{50082\\(30542, 82125)} & \makecell[l]{5008.22\\(3054.16, 8212.50)}\\
\hspace{1em}Age $\geq$ 65 Male & D29 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 51 & \makecell[l]{10\\(10, 10)} & \makecell[l]{76189\\(49115, 118188)} & \makecell[l]{7618.89\\(4911.45, 11818.80)}\\
\hspace{1em}Age $\geq$ 65 Male & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 51 & \makecell[l]{5\\(5, 6)} & \makecell[l]{147\\(82, 263)} & \makecell[l]{28.06\\(15.81, 49.79)}\\
\hspace{1em}Age $\geq$ 65 Male & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 51 & \makecell[l]{5\\(5, 5)} & \makecell[l]{350\\(196, 626)} & \makecell[l]{68.37\\(38.37, 121.82)}\\
\hspace{1em}Age $\geq$ 65 Male & D57 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 232 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2674328\\(2152728, 3322311)} & \makecell[l]{265580.56\\(213995.04, 329601.25)}\\
\hspace{1em}Age $\geq$ 65 Male & D57 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 232 & \makecell[l]{10\\(10, 10)} & \makecell[l]{5149990\\(4231902, 6267253)} & \makecell[l]{511235.06\\(419941.28, 622375.80)}\\
\hspace{1em}Age $\geq$ 65 Male & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 232 & \makecell[l]{5\\(5, 5)} & \makecell[l]{4362\\(3133, 6074)} & \makecell[l]{858.16\\(615.90, 1195.72)}\\
\hspace{1em}Age $\geq$ 65 Male & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 232 & \makecell[l]{5\\(5, 5)} & \makecell[l]{4649\\(3501, 6173)} & \makecell[l]{914.10\\(689.08, 1212.60)}\\
\hspace{1em}Age $\geq$ 65 Male & D57 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 54 & \makecell[l]{10\\(10, 10)} & \makecell[l]{7426127\\(5296972, 10411111)} & \makecell[l]{742612.73\\(529697.25, 1041111.05)}\\
\hspace{1em}Age $\geq$ 65 Male & D57 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 54 & \makecell[l]{10\\(10, 10)} & \makecell[l]{13502491\\(11607977, 15706205)} & \makecell[l]{1350249.15\\(1160797.74, 1570620.53)}\\
\hspace{1em}Age $\geq$ 65 Male & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 54 & \makecell[l]{5\\(5, 6)} & \makecell[l]{21221\\(12633, 35647)} & \makecell[l]{4098.51\\(2451.98, 6850.70)}\\
\hspace{1em}Age $\geq$ 65 Male & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 54 & \makecell[l]{5\\(5, 5)} & \makecell[l]{20477\\(11619, 36087)} & \makecell[l]{4095.32\\(2323.81, 7217.31)}\\
\hspace{1em}Age $\geq$ 65 Male & D57 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 48 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $\geq$ 65 Male & D57 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 48 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $\geq$ 65 Male & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 48 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.02\\(0.98, 1.06)}\\
\hspace{1em}Age $\geq$ 65 Male & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 48 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.96, 1.01)}\\
\hspace{1em}Age $\geq$ 65 Male & D57 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 51 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2027539\\(1259961, 3262731)} & \makecell[l]{202753.90\\(125996.11, 326273.11)}\\
\hspace{1em}Age $\geq$ 65 Male & D57 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 51 & \makecell[l]{10\\(10, 10)} & \makecell[l]{3447429\\(2322804, 5116559)} & \makecell[l]{344742.86\\(232280.42, 511655.88)}\\
\hspace{1em}Age $\geq$ 65 Male & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 51 & \makecell[l]{5\\(5, 6)} & \makecell[l]{3730\\(1880, 7401)} & \makecell[l]{712.08\\(364.28, 1391.96)}\\
\hspace{1em}Age $\geq$ 65 Male & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 51 & \makecell[l]{5\\(5, 5)} & \makecell[l]{4892\\(2560, 9348)} & \makecell[l]{954.53\\(501.47, 1816.94)}\\
\hspace{1em}Age $\geq$ 65 Female & D29 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 250 & \makecell[l]{10\\(10, 10)} & \makecell[l]{64209\\(53151, 77567)} & \makecell[l]{6401.45\\(5299.06, 7733.16)}\\
\hspace{1em}Age $\geq$ 65 Female & D29 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 250 & \makecell[l]{10\\(10, 10)} & \makecell[l]{117943\\(99447, 139878)} & \makecell[l]{11750.53\\(9917.62, 13922.19)}\\
\hspace{1em}Age $\geq$ 65 Female & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 250 & \makecell[l]{5\\(5, 5)} & \makecell[l]{249\\(197, 315)} & \makecell[l]{48.99\\(38.78, 61.89)}\\
\hspace{1em}Age $\geq$ 65 Female & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 250 & \makecell[l]{5\\(5, 5)} & \makecell[l]{373\\(294, 474)} & \makecell[l]{72.42\\(57.16, 91.75)}\\
\hspace{1em}Age $\geq$ 65 Female & D29 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 74 & \makecell[l]{10\\(10, 10)} & \makecell[l]{166523\\(121761, 227741)} & \makecell[l]{16652.29\\(12176.06, 22774.10)}\\
\hspace{1em}Age $\geq$ 65 Female & D29 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 74 & \makecell[l]{10\\(10, 10)} & \makecell[l]{288235\\(216852, 383115)} & \makecell[l]{28823.47\\(21685.20, 38311.49)}\\
\hspace{1em}Age $\geq$ 65 Female & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 74 & \makecell[l]{5\\(5, 6)} & \makecell[l]{553\\(354, 864)} & \makecell[l]{105.66\\(68.26, 163.53)}\\
\hspace{1em}Age $\geq$ 65 Female & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 74 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1062\\(720, 1566)} & \makecell[l]{212.40\\(144.04, 313.21)}\\
\hspace{1em}Age $\geq$ 65 Female & D29 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 35 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $\geq$ 65 Female & D29 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 35 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $\geq$ 65 Female & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 35 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.02\\(0.98, 1.07)}\\
\hspace{1em}Age $\geq$ 65 Female & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 35 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.02\\(0.98, 1.07)}\\
\hspace{1em}Age $\geq$ 65 Female & D29 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 72 & \makecell[l]{10\\(10, 10)} & \makecell[l]{37051\\(27449, 50013)} & \makecell[l]{3657.70\\(2719.73, 4919.14)}\\
\hspace{1em}Age $\geq$ 65 Female & D29 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 72 & \makecell[l]{10\\(10, 10)} & \makecell[l]{61265\\(47638, 78789)} & \makecell[l]{6126.46\\(4763.78, 7878.92)}\\
\hspace{1em}Age $\geq$ 65 Female & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 72 & \makecell[l]{5\\(5, 5)} & \makecell[l]{162\\(110, 238)} & \makecell[l]{31.81\\(21.63, 46.78)}\\
\hspace{1em}Age $\geq$ 65 Female & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 72 & \makecell[l]{5\\(5, 5)} & \makecell[l]{271\\(188, 392)} & \makecell[l]{53.46\\(37.23, 76.76)}\\
\hspace{1em}Age $\geq$ 65 Female & D57 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 250 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2708471\\(2228982, 3291105)} & \makecell[l]{270027.12\\(222227.95, 328107.44)}\\
\hspace{1em}Age $\geq$ 65 Female & D57 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 250 & \makecell[l]{10\\(10, 10)} & \makecell[l]{5189777\\(4355492, 6183867)} & \makecell[l]{517053.81\\(434090.43, 615873.16)}\\
\hspace{1em}Age $\geq$ 65 Female & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 250 & \makecell[l]{5\\(5, 5)} & \makecell[l]{4169\\(3097, 5612)} & \makecell[l]{819.46\\(609.36, 1102.00)}\\
\hspace{1em}Age $\geq$ 65 Female & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 250 & \makecell[l]{5\\(5, 5)} & \makecell[l]{6397\\(4907, 8340)} & \makecell[l]{1242.43\\(955.63, 1615.30)}\\
\hspace{1em}Age $\geq$ 65 Female & D57 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 74 & \makecell[l]{10\\(10, 10)} & \makecell[l]{7590360\\(5921961, 9728799)} & \makecell[l]{759036.03\\(592196.09, 972879.93)}\\
\hspace{1em}Age $\geq$ 65 Female & D57 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 74 & \makecell[l]{10\\(10, 10)} & \makecell[l]{12894340\\(10799304, 15395807)} & \makecell[l]{1289433.98\\(1079930.42, 1539580.67)}\\
\hspace{1em}Age $\geq$ 65 Female & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 74 & \makecell[l]{5\\(5, 6)} & \makecell[l]{21984\\(13986, 34558)} & \makecell[l]{4198.62\\(2698.65, 6532.30)}\\
\hspace{1em}Age $\geq$ 65 Female & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 74 & \makecell[l]{5\\(5, 5)} & \makecell[l]{18779\\(11189, 31518)} & \makecell[l]{3755.84\\(2237.83, 6303.56)}\\
\hspace{1em}Age $\geq$ 65 Female & D57 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 35 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $\geq$ 65 Female & D57 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 35 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $\geq$ 65 Female & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 35 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.02\\(0.98, 1.07)}\\
\hspace{1em}Age $\geq$ 65 Female & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 35 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 6)} & \makecell[l]{1.04\\(0.96, 1.13)}\\
\hspace{1em}Age $\geq$ 65 Female & D57 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 72 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1473236\\(1067157, 2033836)} & \makecell[l]{145438.84\\(105433.61, 200623.47)}\\
\hspace{1em}Age $\geq$ 65 Female & D57 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 72 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2420004\\(1820068, 3217693)} & \makecell[l]{242000.40\\(182006.75, 321769.35)}\\
\hspace{1em}Age $\geq$ 65 Female & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 72 & \makecell[l]{5\\(5, 5)} & \makecell[l]{2344\\(1427, 3849)} & \makecell[l]{460.66\\(280.22, 757.28)}\\
\hspace{1em}Age $\geq$ 65 Female & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 72 & \makecell[l]{5\\(5, 5)} & \makecell[l]{3767\\(2352, 6032)} & \makecell[l]{742.12\\(464.89, 1184.66)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item  
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{2.7cm}llllllll}
\caption{\label{tab:tabs}Table 6g. Geometric mean titer ratios (GMTRs) or geometric mean
      concentration ratios (GMCRs) between post-vaccinations/pre-vaccination by Hispanic or Latino ethnicity}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & \makecell[l]{Baseline\\GMT/GMC} & \makecell[l]{Post Baseline\\GMT/GMC} & GMTR/GMCR\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & \makecell[l]{Baseline\\GMT/GMC} & \makecell[l]{Post Baseline\\GMT/GMC} & GMTR/GMCR\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{9}{l}{\textbf{Hispanic or Latino ethnicity}}\\
\hspace{1em}Hispanic or Latino & D29 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 136 & \makecell[l]{10\\(10, 10)} & \makecell[l]{22266\\(15847, 31284)} & \makecell[l]{2226.58\\(1584.75, 3128.36)}\\
\hspace{1em}Hispanic or Latino & D29 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 136 & \makecell[l]{10\\(10, 10)} & \makecell[l]{41773\\(31562, 55289)} & \makecell[l]{4177.34\\(3156.18, 5528.90)}\\
\hspace{1em}Hispanic or Latino & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 136 & \makecell[l]{5\\(5, 5)} & \makecell[l]{101\\(67, 152)} & \makecell[l]{20.07\\(13.32, 30.26)}\\
\hspace{1em}Hispanic or Latino & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 136 & \makecell[l]{5\\(5, 6)} & \makecell[l]{190\\(126, 284)} & \makecell[l]{35.82\\(24.42, 52.53)}\\
\hspace{1em}Hispanic or Latino & D29 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 35 & \makecell[l]{10\\(10, 10)} & \makecell[l]{57339\\(30559, 107588)} & \makecell[l]{5733.92\\(3055.89, 10758.85)}\\
\hspace{1em}Hispanic or Latino & D29 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 35 & \makecell[l]{10\\(10, 10)} & \makecell[l]{90332\\(50343, 162084)} & \makecell[l]{9033.16\\(5034.32, 16208.37)}\\
\hspace{1em}Hispanic or Latino & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 35 & \makecell[l]{5\\(5, 5)} & \makecell[l]{254\\(155, 417)} & \makecell[l]{50.85\\(31.04, 83.31)}\\
\hspace{1em}Hispanic or Latino & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 35 & \makecell[l]{5\\(5, 5)} & \makecell[l]{498\\(236, 1049)} & \makecell[l]{97.19\\(45.87, 205.93)}\\
\hspace{1em}Hispanic or Latino & D29 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 20 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Hispanic or Latino & D29 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 20 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Hispanic or Latino & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 20 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.02\\(0.98, 1.05)}\\
\hspace{1em}Hispanic or Latino & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 20 & \makecell[l]{5\\(5, 5)} & \makecell[l]{6\\(4, 8)} & \makecell[l]{1.21\\(0.87, 1.67)}\\
\hspace{1em}Hispanic or Latino & D29 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 38 & \makecell[l]{10\\(10, 10)} & \makecell[l]{34815\\(16110, 75239)} & \makecell[l]{3481.54\\(1611.02, 7523.86)}\\
\hspace{1em}Hispanic or Latino & D29 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 38 & \makecell[l]{10\\(10, 10)} & \makecell[l]{26708\\(12585, 56680)} & \makecell[l]{2670.83\\(1258.52, 5668.01)}\\
\hspace{1em}Hispanic or Latino & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 38 & \makecell[l]{6\\(5, 7)} & \makecell[l]{118\\(42, 327)} & \makecell[l]{21.01\\(8.52, 51.83)}\\
\hspace{1em}Hispanic or Latino & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 38 & \makecell[l]{5\\(5, 5)} & \makecell[l]{351\\(151, 818)} & \makecell[l]{70.21\\(30.13, 163.62)}\\
\hspace{1em}Hispanic or Latino & D57 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 136 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1087406\\(737091, 1604213)} & \makecell[l]{108740.60\\(73709.14, 160421.34)}\\
\hspace{1em}Hispanic or Latino & D57 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 136 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2082654\\(1564176, 2772993)} & \makecell[l]{208265.41\\(156417.59, 277299.26)}\\
\hspace{1em}Hispanic or Latino & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 136 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1727\\(1013, 2946)} & \makecell[l]{344.71\\(202.11, 587.93)}\\
\hspace{1em}Hispanic or Latino & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 136 & \makecell[l]{5\\(5, 6)} & \makecell[l]{2444\\(1373, 4350)} & \makecell[l]{461.92\\(266.06, 801.97)}\\
\hspace{1em}Hispanic or Latino & D57 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 35 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2735111\\(1368395, 5466868)} & \makecell[l]{273511.13\\(136839.49, 546686.78)}\\
\hspace{1em}Hispanic or Latino & D57 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 35 & \makecell[l]{10\\(10, 10)} & \makecell[l]{7578287\\(5040721, 11393296)} & \makecell[l]{757828.67\\(504072.13, 1139329.58)}\\
\hspace{1em}Hispanic or Latino & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 35 & \makecell[l]{5\\(5, 5)} & \makecell[l]{7727\\(2908, 20532)} & \makecell[l]{1545.45\\(581.63, 4106.42)}\\
\hspace{1em}Hispanic or Latino & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 35 & \makecell[l]{5\\(5, 5)} & \makecell[l]{10208\\(4492, 23195)} & \makecell[l]{1991.90\\(877.85, 4519.79)}\\
\hspace{1em}Hispanic or Latino & D57 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 20 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Hispanic or Latino & D57 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 20 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Hispanic or Latino & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 20 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Hispanic or Latino & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 20 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Hispanic or Latino & D57 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 38 & \makecell[l]{10\\(10, 10)} & \makecell[l]{747435\\(391924, 1425424)} & \makecell[l]{74743.46\\(39192.45, 142542.38)}\\
\hspace{1em}Hispanic or Latino & D57 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 38 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1403460\\(609038, 3234119)} & \makecell[l]{140346.03\\(60903.77, 323411.95)}\\
\hspace{1em}Hispanic or Latino & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 38 & \makecell[l]{6\\(5, 7)} & \makecell[l]{1522\\(466, 4976)} & \makecell[l]{271.27\\(88.81, 828.62)}\\
\hspace{1em}Hispanic or Latino & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 38 & \makecell[l]{5\\(5, 5)} & \makecell[l]{3063\\(1057, 8877)} & \makecell[l]{612.54\\(211.34, 1775.33)}\\
\hspace{1em}Not Hispanic or Latino & D29 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 690 & \makecell[l]{10\\(10, 10)} & \makecell[l]{23020\\(19425, 27280)} & \makecell[l]{2286.61\\(1930.10, 2708.97)}\\
\hspace{1em}Not Hispanic or Latino & D29 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 690 & \makecell[l]{10\\(10, 10)} & \makecell[l]{39694\\(35055, 44946)} & \makecell[l]{3963.68\\(3500.65, 4487.96)}\\
\hspace{1em}Not Hispanic or Latino & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 690 & \makecell[l]{5\\(5, 5)} & \makecell[l]{104\\(86, 125)} & \makecell[l]{20.56\\(17.07, 24.76)}\\
\hspace{1em}Not Hispanic or Latino & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 690 & \makecell[l]{5\\(5, 5)} & \makecell[l]{191\\(158, 230)} & \makecell[l]{37.96\\(31.48, 45.77)}\\
\hspace{1em}Not Hispanic or Latino & D29 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 217 & \makecell[l]{10\\(10, 10)} & \makecell[l]{35344\\(26390, 47337)} & \makecell[l]{3534.42\\(2639.00, 4733.66)}\\
\hspace{1em}Not Hispanic or Latino & D29 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 217 & \makecell[l]{10\\(10, 10)} & \makecell[l]{83383\\(65546, 106075)} & \makecell[l]{8338.33\\(6554.59, 10607.48)}\\
\hspace{1em}Not Hispanic or Latino & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 217 & \makecell[l]{5\\(5, 5)} & \makecell[l]{183\\(133, 251)} & \makecell[l]{36.13\\(26.25, 49.73)}\\
\hspace{1em}Not Hispanic or Latino & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 217 & \makecell[l]{5\\(5, 5)} & \makecell[l]{411\\(294, 575)} & \makecell[l]{80.81\\(57.70, 113.17)}\\
\hspace{1em}Not Hispanic or Latino & D29 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 130 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Not Hispanic or Latino & D29 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 130 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.99\\(0.98, 1.01)}\\
\hspace{1em}Not Hispanic or Latino & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 130 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.01\\(0.98, 1.03)}\\
\hspace{1em}Not Hispanic or Latino & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 130 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.97\\(0.93, 1.02)}\\
\hspace{1em}Not Hispanic or Latino & D29 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 214 & \makecell[l]{10\\(10, 10)} & \makecell[l]{11608\\(9046, 14896)} & \makecell[l]{1158.76\\(903.07, 1486.86)}\\
\hspace{1em}Not Hispanic or Latino & D29 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 214 & \makecell[l]{10\\(10, 10)} & \makecell[l]{18056\\(14910, 21865)} & \makecell[l]{1805.57\\(1490.99, 2186.53)}\\
\hspace{1em}Not Hispanic or Latino & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 214 & \makecell[l]{5\\(5, 5)} & \makecell[l]{48\\(37, 63)} & \makecell[l]{9.40\\(7.28, 12.15)}\\
\hspace{1em}Not Hispanic or Latino & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 214 & \makecell[l]{5\\(5, 5)} & \makecell[l]{123\\(92, 165)} & \makecell[l]{24.28\\(18.23, 32.35)}\\
\hspace{1em}Not Hispanic or Latino & D57 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 690 & \makecell[l]{10\\(10, 10)} & \makecell[l]{987977\\(822264, 1187086)} & \makecell[l]{98137.11\\(81690.28, 117895.20)}\\
\hspace{1em}Not Hispanic or Latino & D57 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 690 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2063432\\(1775937, 2397468)} & \makecell[l]{206047.30\\(177339.03, 239402.97)}\\
\hspace{1em}Not Hispanic or Latino & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 690 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1500\\(1191, 1888)} & \makecell[l]{296.84\\(235.74, 373.77)}\\
\hspace{1em}Not Hispanic or Latino & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 690 & \makecell[l]{5\\(5, 5)} & \makecell[l]{2270\\(1788, 2883)} & \makecell[l]{451.12\\(355.29, 572.80)}\\
\hspace{1em}Not Hispanic or Latino & D57 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 217 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2315554\\(1731123, 3097290)} & \makecell[l]{231555.38\\(173112.28, 309728.99)}\\
\hspace{1em}Not Hispanic or Latino & D57 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 217 & \makecell[l]{10\\(10, 10)} & \makecell[l]{5301268\\(4150604, 6770929)} & \makecell[l]{530126.82\\(415060.39, 677092.90)}\\
\hspace{1em}Not Hispanic or Latino & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 217 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5224\\(3348, 8151)} & \makecell[l]{1034.14\\(662.98, 1613.08)}\\
\hspace{1em}Not Hispanic or Latino & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 217 & \makecell[l]{5\\(5, 5)} & \makecell[l]{7937\\(5300, 11886)} & \makecell[l]{1561.42\\(1043.13, 2337.23)}\\
\hspace{1em}Not Hispanic or Latino & D57 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 130 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.01\\(1.00, 1.02)}\\
\hspace{1em}Not Hispanic or Latino & D57 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 130 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.99\\(0.98, 1.01)}\\
\hspace{1em}Not Hispanic or Latino & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 130 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(0.99, 1.02)}\\
\hspace{1em}Not Hispanic or Latino & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 130 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.98\\(0.93, 1.03)}\\
\hspace{1em}Not Hispanic or Latino & D57 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 214 & \makecell[l]{10\\(10, 10)} & \makecell[l]{381696\\(293138, 497006)} & \makecell[l]{38101.89\\(29262.14, 49612.02)}\\
\hspace{1em}Not Hispanic or Latino & D57 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 214 & \makecell[l]{10\\(10, 10)} & \makecell[l]{648311\\(505732, 831086)} & \makecell[l]{64831.06\\(50573.21, 83108.56)}\\
\hspace{1em}Not Hispanic or Latino & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 214 & \makecell[l]{5\\(5, 5)} & \makecell[l]{555\\(395, 782)} & \makecell[l]{108.64\\(77.40, 152.49)}\\
\hspace{1em}Not Hispanic or Latino & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 214 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1324\\(921, 1904)} & \makecell[l]{261.10\\(182.28, 374.00)}\\
\hspace{1em}Not reported and unknown & D29 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 88 & \makecell[l]{10\\(10, 10)} & \makecell[l]{22876\\(15904, 32905)} & \makecell[l]{2274.83\\(1582.12, 3270.83)}\\
\hspace{1em}Not reported and unknown & D29 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 88 & \makecell[l]{10\\(10, 10)} & \makecell[l]{50488\\(35885, 71034)} & \makecell[l]{5048.79\\(3588.47, 7103.37)}\\
\hspace{1em}Not reported and unknown & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 88 & \makecell[l]{5\\(5, 5)} & \makecell[l]{133\\(84, 213)} & \makecell[l]{25.71\\(16.13, 40.96)}\\
\hspace{1em}Not reported and unknown & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 88 & \makecell[l]{5\\(5, 5)} & \makecell[l]{174\\(106, 287)} & \makecell[l]{34.02\\(20.65, 56.04)}\\
\hspace{1em}Not reported and unknown & D29 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 22 & \makecell[l]{10\\(10, 10)} & \makecell[l]{25827\\(18334, 36382)} & \makecell[l]{2582.70\\(1833.44, 3638.16)}\\
\hspace{1em}Not reported and unknown & D29 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 22 & \makecell[l]{10\\(10, 10)} & \makecell[l]{46903\\(33825, 65038)} & \makecell[l]{4690.32\\(3382.48, 6503.83)}\\
\hspace{1em}Not reported and unknown & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 22 & \makecell[l]{6\\(4, 7)} & \makecell[l]{154\\(91, 259)} & \makecell[l]{27.15\\(16.58, 44.47)}\\
\hspace{1em}Not reported and unknown & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 22 & \makecell[l]{5\\(5, 5)} & \makecell[l]{420\\(198, 891)} & \makecell[l]{83.98\\(39.57, 178.24)}\\
\hspace{1em}Not reported and unknown & D29 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 13 & \makecell[l]{12\\(8, 18)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.82\\(0.56, 1.21)}\\
\hspace{1em}Not reported and unknown & D29 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 13 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Not reported and unknown & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 13 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Not reported and unknown & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 13 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Not reported and unknown & D29 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 18 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10750\\(3611, 32001)} & \makecell[l]{1075.02\\(361.13, 3200.07)}\\
\hspace{1em}Not reported and unknown & D29 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 18 & \makecell[l]{10\\(10, 10)} & \makecell[l]{11909\\(5649, 25107)} & \makecell[l]{1190.89\\(564.87, 2510.66)}\\
\hspace{1em}Not reported and unknown & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 18 & \makecell[l]{5\\(5, 5)} & \makecell[l]{37\\(15, 93)} & \makecell[l]{7.39\\(2.93, 18.63)}\\
\hspace{1em}Not reported and unknown & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 18 & \makecell[l]{5\\(5, 5)} & \makecell[l]{58\\(19, 177)} & \makecell[l]{11.28\\(3.70, 34.45)}\\
\hspace{1em}Not reported and unknown & D57 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 88 & \makecell[l]{10\\(10, 10)} & \makecell[l]{735710\\(462524, 1170251)} & \makecell[l]{73159.15\\(46013.55, 116319.24)}\\
\hspace{1em}Not reported and unknown & D57 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 88 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2279592\\(1446853, 3591615)} & \makecell[l]{227959.19\\(144685.30, 359161.52)}\\
\hspace{1em}Not reported and unknown & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 88 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1291\\(765, 2178)} & \makecell[l]{248.75\\(147.56, 419.33)}\\
\hspace{1em}Not reported and unknown & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 88 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1748\\(990, 3088)} & \makecell[l]{341.31\\(194.13, 600.06)}\\
\hspace{1em}Not reported and unknown & D57 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 22 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1751283\\(872333, 3515850)} & \makecell[l]{175128.31\\(87233.31, 351585.01)}\\
\hspace{1em}Not reported and unknown & D57 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 22 & \makecell[l]{10\\(10, 10)} & \makecell[l]{3840709\\(2197166, 6713669)} & \makecell[l]{384070.92\\(219716.64, 671366.86)}\\
\hspace{1em}Not reported and unknown & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 22 & \makecell[l]{6\\(4, 7)} & \makecell[l]{8669\\(2979, 25223)} & \makecell[l]{1531.30\\(641.99, 3652.47)}\\
\hspace{1em}Not reported and unknown & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 22 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5104\\(2140, 12175)} & \makecell[l]{1020.81\\(427.96, 2434.92)}\\
\hspace{1em}Not reported and unknown & D57 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 13 & \makecell[l]{12\\(8, 18)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.82\\(0.56, 1.21)}\\
\hspace{1em}Not reported and unknown & D57 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 13 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Not reported and unknown & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 13 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.03\\(0.97, 1.08)}\\
\hspace{1em}Not reported and unknown & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 13 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Not reported and unknown & D57 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 18 & \makecell[l]{10\\(10, 10)} & \makecell[l]{162620\\(55659, 475135)} & \makecell[l]{16262.02\\(5565.86, 47513.49)}\\
\hspace{1em}Not reported and unknown & D57 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 18 & \makecell[l]{10\\(10, 10)} & \makecell[l]{417076\\(107739, 1614570)} & \makecell[l]{41707.62\\(10773.92, 161457.03)}\\
\hspace{1em}Not reported and unknown & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 18 & \makecell[l]{5\\(5, 5)} & \makecell[l]{188\\(46, 766)} & \makecell[l]{37.59\\(9.22, 153.25)}\\
\hspace{1em}Not reported and unknown & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 18 & \makecell[l]{5\\(5, 5)} & \makecell[l]{437\\(69, 2773)} & \makecell[l]{85.21\\(13.47, 538.99)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item  
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{2.7cm}llllllll}
\caption{\label{tab:tabs}Table 6h. Geometric mean titer ratios (GMTRs) or geometric mean
      concentration ratios (GMCRs) between post-vaccinations/pre-vaccination by Race}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & \makecell[l]{Baseline\\GMT/GMC} & \makecell[l]{Post Baseline\\GMT/GMC} & GMTR/GMCR\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & \makecell[l]{Baseline\\GMT/GMC} & \makecell[l]{Post Baseline\\GMT/GMC} & GMTR/GMCR\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{9}{l}{\textbf{Race}}\\
\hspace{1em}White Non-Hispanic & D29 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 362 & \makecell[l]{10\\(10, 10)} & \makecell[l]{23438\\(18669, 29425)} & \makecell[l]{2343.79\\(1866.88, 2942.53)}\\
\hspace{1em}White Non-Hispanic & D29 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 362 & \makecell[l]{10\\(10, 10)} & \makecell[l]{40376\\(34349, 47460)} & \makecell[l]{4031.72\\(3430.05, 4738.93)}\\
\hspace{1em}White Non-Hispanic & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 362 & \makecell[l]{5\\(5, 5)} & \makecell[l]{115\\(90, 147)} & \makecell[l]{22.83\\(17.82, 29.23)}\\
\hspace{1em}White Non-Hispanic & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 362 & \makecell[l]{5\\(5, 5)} & \makecell[l]{188\\(146, 241)} & \makecell[l]{37.41\\(29.16, 48.00)}\\
\hspace{1em}White Non-Hispanic & D29 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 125 & \makecell[l]{10\\(10, 10)} & \makecell[l]{30985\\(21434, 44793)} & \makecell[l]{3098.50\\(2143.36, 4479.29)}\\
\hspace{1em}White Non-Hispanic & D29 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 125 & \makecell[l]{10\\(10, 10)} & \makecell[l]{72481\\(53061, 99008)} & \makecell[l]{7248.12\\(5306.15, 9900.82)}\\
\hspace{1em}White Non-Hispanic & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 125 & \makecell[l]{5\\(5, 5)} & \makecell[l]{148\\(104, 211)} & \makecell[l]{29.21\\(20.49, 41.65)}\\
\hspace{1em}White Non-Hispanic & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 125 & \makecell[l]{5\\(5, 5)} & \makecell[l]{348\\(226, 535)} & \makecell[l]{69.53\\(45.18, 106.99)}\\
\hspace{1em}White Non-Hispanic & D29 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 67 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}White Non-Hispanic & D29 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 67 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.99\\(0.96, 1.01)}\\
\hspace{1em}White Non-Hispanic & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 67 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.01\\(1.00, 1.02)}\\
\hspace{1em}White Non-Hispanic & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 67 & \makecell[l]{5\\(5, 6)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.96\\(0.89, 1.04)}\\
\hspace{1em}White Non-Hispanic & D29 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 121 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10931\\(7560, 15804)} & \makecell[l]{1089.81\\(753.88, 1575.44)}\\
\hspace{1em}White Non-Hispanic & D29 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 121 & \makecell[l]{10\\(10, 10)} & \makecell[l]{18868\\(14808, 24043)} & \makecell[l]{1886.83\\(1480.76, 2404.27)}\\
\hspace{1em}White Non-Hispanic & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 121 & \makecell[l]{5\\(5, 5)} & \makecell[l]{52\\(37, 74)} & \makecell[l]{10.37\\(7.32, 14.70)}\\
\hspace{1em}White Non-Hispanic & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 121 & \makecell[l]{5\\(5, 5)} & \makecell[l]{107\\(76, 150)} & \makecell[l]{21.32\\(15.15, 29.99)}\\
\hspace{1em}White Non-Hispanic & D57 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 362 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1035293\\(809568, 1323956)} & \makecell[l]{103529.30\\(80956.76, 132395.58)}\\
\hspace{1em}White Non-Hispanic & D57 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 362 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2145772\\(1770774, 2600184)} & \makecell[l]{214266.04\\(176817.71, 259645.59)}\\
\hspace{1em}White Non-Hispanic & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 362 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1376\\(1010, 1874)} & \makecell[l]{273.04\\(200.41, 371.99)}\\
\hspace{1em}White Non-Hispanic & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 362 & \makecell[l]{5\\(5, 5)} & \makecell[l]{2011\\(1465, 2761)} & \makecell[l]{400.97\\(292.11, 550.40)}\\
\hspace{1em}White Non-Hispanic & D57 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 125 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1943813\\(1349835, 2799166)} & \makecell[l]{194381.34\\(134983.46, 279916.55)}\\
\hspace{1em}White Non-Hispanic & D57 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 125 & \makecell[l]{10\\(10, 10)} & \makecell[l]{4608987\\(3338577, 6362819)} & \makecell[l]{460898.73\\(333857.72, 636281.94)}\\
\hspace{1em}White Non-Hispanic & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 125 & \makecell[l]{5\\(5, 5)} & \makecell[l]{4550\\(2471, 8378)} & \makecell[l]{899.93\\(488.90, 1656.55)}\\
\hspace{1em}White Non-Hispanic & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 125 & \makecell[l]{5\\(5, 5)} & \makecell[l]{7994\\(4646, 13757)} & \makecell[l]{1598.88\\(929.14, 2751.39)}\\
\hspace{1em}White Non-Hispanic & D57 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 67 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.01\\(0.99, 1.03)}\\
\hspace{1em}White Non-Hispanic & D57 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 67 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.99\\(0.96, 1.01)}\\
\hspace{1em}White Non-Hispanic & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 67 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}White Non-Hispanic & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 67 & \makecell[l]{5\\(5, 6)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.98\\(0.90, 1.06)}\\
\hspace{1em}White Non-Hispanic & D57 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 121 & \makecell[l]{10\\(10, 10)} & \makecell[l]{393045\\(287516, 537306)} & \makecell[l]{39187.22\\(28666.35, 53569.39)}\\
\hspace{1em}White Non-Hispanic & D57 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 121 & \makecell[l]{10\\(10, 10)} & \makecell[l]{674526\\(485396, 937351)} & \makecell[l]{67452.65\\(48539.56, 93735.08)}\\
\hspace{1em}White Non-Hispanic & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 121 & \makecell[l]{5\\(5, 5)} & \makecell[l]{575\\(371, 892)} & \makecell[l]{114.01\\(73.52, 176.80)}\\
\hspace{1em}White Non-Hispanic & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 121 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1478\\(953, 2292)} & \makecell[l]{295.55\\(190.57, 458.35)}\\
\hspace{1em}Black or African American & D29 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 195 & \makecell[l]{10\\(10, 11)} & \makecell[l]{18966\\(14305, 25146)} & \makecell[l]{1843.84\\(1399.25, 2429.70)}\\
\hspace{1em}Black or African American & D29 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 195 & \makecell[l]{10\\(10, 10)} & \makecell[l]{33478\\(26923, 41629)} & \makecell[l]{3347.79\\(2692.25, 4162.95)}\\
\hspace{1em}Black or African American & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 195 & \makecell[l]{5\\(5, 5)} & \makecell[l]{80\\(57, 111)} & \makecell[l]{15.88\\(11.38, 22.16)}\\
\hspace{1em}Black or African American & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 195 & \makecell[l]{5\\(5, 5)} & \makecell[l]{168\\(116, 244)} & \makecell[l]{33.41\\(23.02, 48.50)}\\
\hspace{1em}Black or African American & D29 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 52 & \makecell[l]{10\\(10, 10)} & \makecell[l]{49806\\(32279, 76849)} & \makecell[l]{4980.58\\(3227.90, 7684.92)}\\
\hspace{1em}Black or African American & D29 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 52 & \makecell[l]{10\\(10, 10)} & \makecell[l]{92510\\(63827, 134083)} & \makecell[l]{9251.02\\(6382.72, 13408.29)}\\
\hspace{1em}Black or African American & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 52 & \makecell[l]{5\\(5, 5)} & \makecell[l]{240\\(126, 455)} & \makecell[l]{47.20\\(24.97, 89.23)}\\
\hspace{1em}Black or African American & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 52 & \makecell[l]{5\\(5, 5)} & \makecell[l]{595\\(282, 1255)} & \makecell[l]{116.76\\(55.14, 247.22)}\\
\hspace{1em}Black or African American & D29 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 39 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Black or African American & D29 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 39 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Black or African American & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 39 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.97\\(0.92, 1.03)}\\
\hspace{1em}Black or African American & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 39 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Black or African American & D29 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 60 & \makecell[l]{10\\(10, 10)} & \makecell[l]{13142\\(8909, 19387)} & \makecell[l]{1314.25\\(890.92, 1938.73)}\\
\hspace{1em}Black or African American & D29 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 60 & \makecell[l]{10\\(10, 10)} & \makecell[l]{17281\\(11001, 27148)} & \makecell[l]{1728.13\\(1100.06, 2714.79)}\\
\hspace{1em}Black or African American & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 60 & \makecell[l]{5\\(5, 6)} & \makecell[l]{44\\(24, 81)} & \makecell[l]{8.34\\(4.87, 14.28)}\\
\hspace{1em}Black or African American & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 60 & \makecell[l]{5\\(5, 5)} & \makecell[l]{170\\(88, 328)} & \makecell[l]{33.37\\(17.33, 64.24)}\\
\hspace{1em}Black or African American & D57 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 195 & \makecell[l]{10\\(10, 11)} & \makecell[l]{700976\\(482795, 1017755)} & \makecell[l]{68147.28\\(47075.98, 98650.13)}\\
\hspace{1em}Black or African American & D57 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 195 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1698222\\(1265203, 2279444)} & \makecell[l]{169822.23\\(126520.28, 227944.40)}\\
\hspace{1em}Black or African American & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 195 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1634\\(1060, 2520)} & \makecell[l]{325.53\\(211.14, 501.88)}\\
\hspace{1em}Black or African American & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 195 & \makecell[l]{5\\(5, 5)} & \makecell[l]{2461\\(1568, 3861)} & \makecell[l]{488.47\\(311.61, 765.72)}\\
\hspace{1em}Black or African American & D57 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 52 & \makecell[l]{10\\(10, 10)} & \makecell[l]{3863173\\(2496394, 5978266)} & \makecell[l]{386317.31\\(249639.38, 597826.60)}\\
\hspace{1em}Black or African American & D57 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 52 & \makecell[l]{10\\(10, 10)} & \makecell[l]{5233980\\(3292870, 8319352)} & \makecell[l]{523397.96\\(329286.96, 831935.23)}\\
\hspace{1em}Black or African American & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 52 & \makecell[l]{5\\(5, 5)} & \makecell[l]{9353\\(5430, 16111)} & \makecell[l]{1839.68\\(1070.22, 3162.36)}\\
\hspace{1em}Black or African American & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 52 & \makecell[l]{5\\(5, 5)} & \makecell[l]{10207\\(5426, 19200)} & \makecell[l]{2004.31\\(1066.53, 3766.66)}\\
\hspace{1em}Black or African American & D57 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 39 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Black or African American & D57 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 39 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Black or African American & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 39 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.92, 1.06)}\\
\hspace{1em}Black or African American & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 39 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Black or African American & D57 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 60 & \makecell[l]{10\\(10, 10)} & \makecell[l]{304404\\(168043, 551417)} & \makecell[l]{30440.40\\(16804.30, 55141.74)}\\
\hspace{1em}Black or African American & D57 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 60 & \makecell[l]{10\\(10, 10)} & \makecell[l]{604842\\(358324, 1020956)} & \makecell[l]{60484.17\\(35832.44, 102095.63)}\\
\hspace{1em}Black or African American & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 60 & \makecell[l]{5\\(5, 6)} & \makecell[l]{572\\(270, 1213)} & \makecell[l]{107.39\\(52.57, 219.36)}\\
\hspace{1em}Black or African American & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 60 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1276\\(599, 2723)} & \makecell[l]{250.63\\(117.65, 533.90)}\\
\hspace{1em}Asian & D29 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 67 & \makecell[l]{10\\(10, 10)} & \makecell[l]{33349\\(22259, 49964)} & \makecell[l]{3334.89\\(2225.89, 4996.41)}\\
\hspace{1em}Asian & D29 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 67 & \makecell[l]{10\\(10, 10)} & \makecell[l]{63758\\(45931, 88504)} & \makecell[l]{6375.81\\(4593.12, 8850.40)}\\
\hspace{1em}Asian & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 67 & \makecell[l]{5\\(5, 5)} & \makecell[l]{144\\(92, 225)} & \makecell[l]{28.35\\(18.13, 44.32)}\\
\hspace{1em}Asian & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 67 & \makecell[l]{5\\(5, 6)} & \makecell[l]{330\\(204, 534)} & \makecell[l]{62.08\\(38.25, 100.73)}\\
\hspace{1em}Asian & D29 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 24 & \makecell[l]{10\\(10, 10)} & \makecell[l]{24553\\(12536, 48091)} & \makecell[l]{2455.34\\(1253.59, 4809.13)}\\
\hspace{1em}Asian & D29 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 24 & \makecell[l]{10\\(10, 10)} & \makecell[l]{49522\\(26709, 91821)} & \makecell[l]{4952.19\\(2670.86, 9182.14)}\\
\hspace{1em}Asian & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 24 & \makecell[l]{5\\(5, 5)} & \makecell[l]{174\\(94, 325)} & \makecell[l]{34.87\\(18.71, 64.97)}\\
\hspace{1em}Asian & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 24 & \makecell[l]{6\\(5, 7)} & \makecell[l]{368\\(184, 735)} & \makecell[l]{66.35\\(30.44, 144.62)}\\
\hspace{1em}Asian & D29 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 12 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Asian & D29 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 12 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Asian & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 12 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 6)} & \makecell[l]{1.03\\(0.97, 1.11)}\\
\hspace{1em}Asian & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 12 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Asian & D29 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 13 & \makecell[l]{10\\(10, 10)} & \makecell[l]{27396\\(5431, 138186)} & \makecell[l]{2739.55\\(543.12, 13818.59)}\\
\hspace{1em}Asian & D29 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 13 & \makecell[l]{10\\(10, 10)} & \makecell[l]{12500\\(4740, 32962)} & \makecell[l]{1250.02\\(474.04, 3296.21)}\\
\hspace{1em}Asian & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 13 & \makecell[l]{5\\(5, 5)} & \makecell[l]{65\\(17, 245)} & \makecell[l]{12.91\\(3.40, 49.02)}\\
\hspace{1em}Asian & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 13 & \makecell[l]{5\\(5, 5)} & \makecell[l]{146\\(18, 1215)} & \makecell[l]{29.22\\(3.51, 243.00)}\\
\hspace{1em}Asian & D57 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 67 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1685637\\(1167594, 2433528)} & \makecell[l]{168563.68\\(116759.36, 243352.76)}\\
\hspace{1em}Asian & D57 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 67 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2633046\\(1864450, 3718486)} & \makecell[l]{263304.56\\(186444.95, 371848.60)}\\
\hspace{1em}Asian & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 67 & \makecell[l]{5\\(5, 5)} & \makecell[l]{2850\\(1578, 5149)} & \makecell[l]{562.24\\(311.66, 1014.28)}\\
\hspace{1em}Asian & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 67 & \makecell[l]{5\\(5, 6)} & \makecell[l]{3805\\(1835, 7889)} & \makecell[l]{715.18\\(348.74, 1466.64)}\\
\hspace{1em}Asian & D57 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 24 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2094481\\(742718, 5906481)} & \makecell[l]{209448.13\\(74271.83, 590648.10)}\\
\hspace{1em}Asian & D57 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 24 & \makecell[l]{10\\(10, 10)} & \makecell[l]{4848443\\(2478358, 9485072)} & \makecell[l]{484844.34\\(247835.80, 948507.20)}\\
\hspace{1em}Asian & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 24 & \makecell[l]{5\\(5, 5)} & \makecell[l]{6020\\(2360, 15360)} & \makecell[l]{1204.08\\(471.94, 3072.01)}\\
\hspace{1em}Asian & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 24 & \makecell[l]{6\\(5, 7)} & \makecell[l]{8404\\(2608, 27081)} & \makecell[l]{1516.02\\(420.28, 5468.58)}\\
\hspace{1em}Asian & D57 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 12 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Asian & D57 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 12 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Asian & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 12 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Asian & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 12 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Asian & D57 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 13 & \makecell[l]{10\\(10, 10)} & \makecell[l]{750472\\(176753, 3186420)} & \makecell[l]{75047.23\\(17675.28, 318642.03)}\\
\hspace{1em}Asian & D57 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 13 & \makecell[l]{10\\(10, 10)} & \makecell[l]{859200\\(168867, 4371633)} & \makecell[l]{85919.98\\(16886.69, 437163.32)}\\
\hspace{1em}Asian & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 13 & \makecell[l]{5\\(5, 5)} & \makecell[l]{482\\(269, 862)} & \makecell[l]{96.37\\(53.86, 172.43)}\\
\hspace{1em}Asian & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 13 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1167\\(203, 6693)} & \makecell[l]{233.34\\(40.67, 1338.57)}\\
\hspace{1em}American Indian or Alaska Native & D29 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 13 & \makecell[l]{10\\(10, 10)} & \makecell[l]{42283\\(20288, 88120)} & \makecell[l]{4228.26\\(2028.84, 8812.00)}\\
\hspace{1em}American Indian or Alaska Native & D29 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 13 & \makecell[l]{10\\(10, 10)} & \makecell[l]{30785\\(13439, 70516)} & \makecell[l]{3078.46\\(1343.94, 7051.60)}\\
\hspace{1em}American Indian or Alaska Native & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 13 & \makecell[l]{5\\(5, 5)} & \makecell[l]{186\\(63, 554)} & \makecell[l]{37.27\\(12.54, 110.76)}\\
\hspace{1em}American Indian or Alaska Native & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 13 & \makecell[l]{5\\(5, 5)} & \makecell[l]{309\\(55, 1753)} & \makecell[l]{61.82\\(10.90, 350.55)}\\
\hspace{1em}American Indian or Alaska Native & D29 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 6 & \makecell[l]{10\\(10, 10)} & \makecell[l]{22761\\(8134, 63689)} & \makecell[l]{2276.11\\(813.43, 6368.93)}\\
\hspace{1em}American Indian or Alaska Native & D29 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 6 & \makecell[l]{10\\(10, 10)} & \makecell[l]{85898\\(68138, 108288)} & \makecell[l]{8589.81\\(6813.79, 10828.76)}\\
\hspace{1em}American Indian or Alaska Native & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 6 & \makecell[l]{5\\(5, 5)} & \makecell[l]{244\\(182, 327)} & \makecell[l]{48.86\\(36.48, 65.43)}\\
\hspace{1em}American Indian or Alaska Native & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 6 & \makecell[l]{7\\(4, 14)} & \makecell[l]{1338\\(620, 2888)} & \makecell[l]{189.36\\(70.73, 506.98)}\\
\hspace{1em}American Indian or Alaska Native & D29 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 5 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}American Indian or Alaska Native & D29 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 5 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}American Indian or Alaska Native & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 5 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}American Indian or Alaska Native & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 5 & \makecell[l]{5\\(5, 7)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.92\\(0.76, 1.11)}\\
\hspace{1em}American Indian or Alaska Native & D29 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 4 & \makecell[l]{10\\(10, 10)} & \makecell[l]{7559\\(3837, 14892)} & \makecell[l]{755.89\\(383.69, 1489.16)}\\
\hspace{1em}American Indian or Alaska Native & D29 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 4 & \makecell[l]{10\\(10, 10)} & \makecell[l]{5348\\(1735, 16488)} & \makecell[l]{534.82\\(173.48, 1648.79)}\\
\hspace{1em}American Indian or Alaska Native & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 4 & \makecell[l]{5\\(5, 5)} & \makecell[l]{13\\(4, 46)} & \makecell[l]{2.68\\(0.78, 9.17)}\\
\hspace{1em}American Indian or Alaska Native & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 4 & \makecell[l]{5\\(5, 5)} & \makecell[l]{79\\(32, 190)} & \makecell[l]{15.71\\(6.48, 38.08)}\\
\hspace{1em}American Indian or Alaska Native & D57 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 13 & \makecell[l]{10\\(10, 10)} & \makecell[l]{836025\\(283249, 2467576)} & \makecell[l]{83602.47\\(28324.85, 246757.62)}\\
\hspace{1em}American Indian or Alaska Native & D57 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 13 & \makecell[l]{10\\(10, 10)} & \makecell[l]{4760602\\(2359191, 9606399)} & \makecell[l]{476060.17\\(235919.09, 960639.89)}\\
\hspace{1em}American Indian or Alaska Native & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 13 & \makecell[l]{5\\(5, 5)} & \makecell[l]{3381\\(548, 20856)} & \makecell[l]{676.29\\(109.65, 4171.15)}\\
\hspace{1em}American Indian or Alaska Native & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 13 & \makecell[l]{5\\(5, 5)} & \makecell[l]{4097\\(1137, 14766)} & \makecell[l]{819.48\\(227.39, 2953.28)}\\
\hspace{1em}American Indian or Alaska Native & D57 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 6 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2320038\\(501453, 10733961)} & \makecell[l]{232003.84\\(50145.31, 1073396.08)}\\
\hspace{1em}American Indian or Alaska Native & D57 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 6 & \makecell[l]{10\\(10, 10)} & \makecell[l]{7507181\\(3379449, 16676615)} & \makecell[l]{750718.10\\(337944.88, 1667661.53)}\\
\hspace{1em}American Indian or Alaska Native & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 6 & \makecell[l]{5\\(5, 5)} & \makecell[l]{8919\\(1502, 52953)} & \makecell[l]{1783.72\\(300.42, 10590.56)}\\
\hspace{1em}American Indian or Alaska Native & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 6 & \makecell[l]{7\\(4, 14)} & \makecell[l]{9789\\(1020, 93964)} & \makecell[l]{1385.06\\(263.35, 7284.52)}\\
\hspace{1em}American Indian or Alaska Native & D57 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 5 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}American Indian or Alaska Native & D57 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 5 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}American Indian or Alaska Native & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 5 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}American Indian or Alaska Native & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 5 & \makecell[l]{5\\(5, 7)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.92\\(0.76, 1.11)}\\
\hspace{1em}American Indian or Alaska Native & D57 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 4 & \makecell[l]{10\\(10, 10)} & \makecell[l]{272152\\(65917, 1123631)} & \makecell[l]{27215.15\\(6591.71, 112363.10)}\\
\hspace{1em}American Indian or Alaska Native & D57 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 4 & \makecell[l]{10\\(10, 10)} & \makecell[l]{677711\\(214540, 2140827)} & \makecell[l]{67771.11\\(21453.97, 214082.67)}\\
\hspace{1em}American Indian or Alaska Native & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 4 & \makecell[l]{5\\(5, 5)} & \makecell[l]{126\\(26, 608)} & \makecell[l]{25.11\\(5.18, 121.64)}\\
\hspace{1em}American Indian or Alaska Native & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 4 & \makecell[l]{5\\(5, 5)} & \makecell[l]{520\\(61, 4436)} & \makecell[l]{104.04\\(12.20, 887.23)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & D29 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 17 & \makecell[l]{11\\(9, 14)} & \makecell[l]{114776\\(53301, 247155)} & \makecell[l]{10095.55\\(4569.91, 22302.43)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & D29 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 17 & \makecell[l]{10\\(10, 10)} & \makecell[l]{116196\\(67714, 199391)} & \makecell[l]{11619.59\\(6771.36, 19939.11)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 17 & \makecell[l]{6\\(4, 8)} & \makecell[l]{381\\(198, 736)} & \makecell[l]{66.42\\(37.70, 117.02)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 17 & \makecell[l]{5\\(5, 5)} & \makecell[l]{982\\(339, 2849)} & \makecell[l]{196.48\\(67.76, 569.73)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & D29 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 5 & \makecell[l]{10\\(10, 10)} & \makecell[l]{44998\\(2885, 701952)} & \makecell[l]{4499.84\\(288.46, 70195.19)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & D29 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 5 & \makecell[l]{10\\(10, 10)} & \makecell[l]{107953\\(71167, 163752)} & \makecell[l]{10795.26\\(7116.74, 16375.16)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 5 & \makecell[l]{5\\(5, 5)} & \makecell[l]{227\\(17, 2989)} & \makecell[l]{45.50\\(3.46, 597.82)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 5 & \makecell[l]{5\\(5, 5)} & \makecell[l]{489\\(239, 1000)} & \makecell[l]{97.88\\(47.90, 200.01)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & D29 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 1 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & D29 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 1 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 1 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 1 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & D29 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 1 & \makecell[l]{10\\(10, 10)} & \makecell[l]{6237\\(6237, 6237)} & \makecell[l]{623.73\\(623.73, 623.73)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & D29 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 1 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10844\\(10844, 10844)} & \makecell[l]{1084.43\\(1084.43, 1084.43)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 1 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 1 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & D57 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 17 & \makecell[l]{11\\(9, 14)} & \makecell[l]{5533419\\(2490433, 12294540)} & \makecell[l]{486710.15\\(203427.87, 1164475.48)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & D57 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 17 & \makecell[l]{10\\(10, 10)} & \makecell[l]{7662810\\(3323463, 17667914)} & \makecell[l]{766281.01\\(332346.29, 1766791.43)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 17 & \makecell[l]{6\\(4, 8)} & \makecell[l]{10464\\(2274, 48150)} & \makecell[l]{1821.72\\(378.83, 8760.18)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 17 & \makecell[l]{5\\(5, 5)} & \makecell[l]{4635\\(2089, 10284)} & \makecell[l]{927.06\\(417.84, 2056.86)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & D57 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 5 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1828480\\(947016, 3530396)} & \makecell[l]{182848.03\\(94701.55, 353039.63)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & D57 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 5 & \makecell[l]{10\\(10, 10)} & \makecell[l]{5139344\\(595014, 44390337)} & \makecell[l]{513934.43\\(59501.37, 4439033.72)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 5 & \makecell[l]{5\\(5, 5)} & \makecell[l]{2545\\(185, 35084)} & \makecell[l]{509.01\\(36.92, 7016.90)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 5 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1804\\(213, 15248)} & \makecell[l]{360.81\\(42.69, 3049.51)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & D57 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 1 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & D57 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 1 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 1 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 1 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & D57 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 1 & \makecell[l]{10\\(10, 10)} & \makecell[l]{4780\\(4780, 4780)} & \makecell[l]{477.97\\(477.97, 477.97)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & D57 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 1 & \makecell[l]{10\\(10, 10)} & \makecell[l]{61376\\(61376, 61376)} & \makecell[l]{6137.62\\(6137.62, 6137.62)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 1 & \makecell[l]{5\\(5, 5)} & \makecell[l]{44\\(44, 44)} & \makecell[l]{8.78\\(8.78, 8.78)}\\
\hspace{1em}Native Hawaiian or Other Pacific Islander & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 1 & \makecell[l]{5\\(5, 5)} & \makecell[l]{144\\(144, 144)} & \makecell[l]{28.88\\(28.88, 28.88)}\\
\hspace{1em}Multiracial & D29 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 52 & \makecell[l]{10\\(10, 10)} & \makecell[l]{21505\\(13701, 33755)} & \makecell[l]{2150.54\\(1370.10, 3375.53)}\\
\hspace{1em}Multiracial & D29 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 52 & \makecell[l]{10\\(10, 10)} & \makecell[l]{45067\\(27165, 74765)} & \makecell[l]{4506.67\\(2716.51, 7476.53)}\\
\hspace{1em}Multiracial & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 52 & \makecell[l]{5\\(5, 5)} & \makecell[l]{71\\(38, 130)} & \makecell[l]{14.15\\(7.67, 26.10)}\\
\hspace{1em}Multiracial & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 52 & \makecell[l]{5\\(5, 5)} & \makecell[l]{135\\(82, 222)} & \makecell[l]{27.01\\(16.44, 44.37)}\\
\hspace{1em}Multiracial & D29 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 12 & \makecell[l]{10\\(10, 10)} & \makecell[l]{55196\\(16260, 187371)} & \makecell[l]{5519.61\\(1625.98, 18737.06)}\\
\hspace{1em}Multiracial & D29 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 12 & \makecell[l]{10\\(10, 10)} & \makecell[l]{155885\\(67996, 357377)} & \makecell[l]{15588.50\\(6799.58, 35737.70)}\\
\hspace{1em}Multiracial & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 12 & \makecell[l]{5\\(5, 5)} & \makecell[l]{398\\(197, 804)} & \makecell[l]{79.65\\(39.46, 160.77)}\\
\hspace{1em}Multiracial & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 12 & \makecell[l]{5\\(5, 5)} & \makecell[l]{277\\(153, 502)} & \makecell[l]{55.46\\(30.62, 100.45)}\\
\hspace{1em}Multiracial & D29 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 8 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Multiracial & D29 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 8 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Multiracial & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 8 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Multiracial & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 8 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Multiracial & D29 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 19 & \makecell[l]{10\\(10, 10)} & \makecell[l]{24792\\(13458, 45670)} & \makecell[l]{2479.22\\(1345.85, 4567.01)}\\
\hspace{1em}Multiracial & D29 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 19 & \makecell[l]{10\\(10, 10)} & \makecell[l]{25261\\(11298, 56479)} & \makecell[l]{2526.08\\(1129.81, 5647.92)}\\
\hspace{1em}Multiracial & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 19 & \makecell[l]{5\\(5, 5)} & \makecell[l]{51\\(28, 93)} & \makecell[l]{10.28\\(5.69, 18.57)}\\
\hspace{1em}Multiracial & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 19 & \makecell[l]{5\\(5, 5)} & \makecell[l]{190\\(60, 600)} & \makecell[l]{38.04\\(12.06, 119.98)}\\
\hspace{1em}Multiracial & D57 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 52 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1262157\\(710446, 2242309)} & \makecell[l]{126215.68\\(71044.61, 224230.92)}\\
\hspace{1em}Multiracial & D57 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 52 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2195866\\(1476648, 3265387)} & \makecell[l]{219586.59\\(147664.79, 326538.73)}\\
\hspace{1em}Multiracial & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 52 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1524\\(697, 3334)} & \makecell[l]{304.82\\(139.36, 666.71)}\\
\hspace{1em}Multiracial & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 52 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1963\\(778, 4953)} & \makecell[l]{392.69\\(155.66, 990.65)}\\
\hspace{1em}Multiracial & D57 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 12 & \makecell[l]{10\\(10, 10)} & \makecell[l]{3777504\\(1786314, 7988255)} & \makecell[l]{377750.36\\(178631.43, 798825.46)}\\
\hspace{1em}Multiracial & D57 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 12 & \makecell[l]{10\\(10, 10)} & \makecell[l]{8118223\\(3167974, 20803689)} & \makecell[l]{811822.28\\(316797.37, 2080368.91)}\\
\hspace{1em}Multiracial & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 12 & \makecell[l]{5\\(5, 5)} & \makecell[l]{2411\\(687, 8455)} & \makecell[l]{482.14\\(137.47, 1690.96)}\\
\hspace{1em}Multiracial & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 12 & \makecell[l]{5\\(5, 5)} & \makecell[l]{10135\\(6049, 16979)} & \makecell[l]{2026.93\\(1209.86, 3395.82)}\\
\hspace{1em}Multiracial & D57 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 8 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Multiracial & D57 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 8 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Multiracial & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 8 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Multiracial & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 8 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Multiracial & D57 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 19 & \makecell[l]{10\\(10, 10)} & \makecell[l]{693982\\(285837, 1684912)} & \makecell[l]{69398.16\\(28583.71, 168491.21)}\\
\hspace{1em}Multiracial & D57 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 19 & \makecell[l]{10\\(10, 10)} & \makecell[l]{791515\\(327732, 1911609)} & \makecell[l]{79151.46\\(32773.19, 191160.91)}\\
\hspace{1em}Multiracial & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 19 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1034\\(211, 5057)} & \makecell[l]{206.71\\(42.25, 1011.44)}\\
\hspace{1em}Multiracial & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 19 & \makecell[l]{5\\(5, 5)} & \makecell[l]{2744\\(676, 11140)} & \makecell[l]{548.80\\(135.18, 2227.99)}\\
\hspace{1em}Other & D29 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 34 & \makecell[l]{10\\(10, 10)} & \makecell[l]{22295\\(11570, 42963)} & \makecell[l]{2229.51\\(1156.96, 4296.34)}\\
\hspace{1em}Other & D29 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 34 & \makecell[l]{10\\(10, 10)} & \makecell[l]{38007\\(21259, 67950)} & \makecell[l]{3800.73\\(2125.91, 6794.99)}\\
\hspace{1em}Other & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 34 & \makecell[l]{5\\(5, 5)} & \makecell[l]{118\\(54, 259)} & \makecell[l]{23.46\\(10.69, 51.49)}\\
\hspace{1em}Other & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 34 & \makecell[l]{6\\(5, 7)} & \makecell[l]{254\\(100, 650)} & \makecell[l]{45.07\\(19.22, 105.68)}\\
\hspace{1em}Other & D29 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 7 & \makecell[l]{10\\(10, 10)} & \makecell[l]{18039\\(7489, 43449)} & \makecell[l]{1803.88\\(748.91, 4344.93)}\\
\hspace{1em}Other & D29 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 7 & \makecell[l]{10\\(10, 10)} & \makecell[l]{75844\\(32129, 179037)} & \makecell[l]{7584.42\\(3212.93, 17903.73)}\\
\hspace{1em}Other & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 7 & \makecell[l]{5\\(5, 5)} & \makecell[l]{63\\(18, 221)} & \makecell[l]{12.67\\(3.62, 44.29)}\\
\hspace{1em}Other & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 7 & \makecell[l]{5\\(5, 5)} & \makecell[l]{283\\(86, 936)} & \makecell[l]{56.63\\(17.13, 187.20)}\\
\hspace{1em}Other & D29 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 4 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Other & D29 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 4 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Other & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 4 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Other & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 4 & \makecell[l]{6\\(4, 8)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.87\\(0.67, 1.14)}\\
\hspace{1em}Other & D29 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 5 & \makecell[l]{10\\(10, 10)} & \makecell[l]{49870\\(993, 2505753)} & \makecell[l]{4987.05\\(99.25, 250575.29)}\\
\hspace{1em}Other & D29 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 5 & \makecell[l]{10\\(10, 10)} & \makecell[l]{40496\\(1871, 876366)} & \makecell[l]{4049.58\\(187.13, 87636.61)}\\
\hspace{1em}Other & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 5 & \makecell[l]{5\\(5, 5)} & \makecell[l]{221\\(12, 4185)} & \makecell[l]{44.21\\(2.34, 836.92)}\\
\hspace{1em}Other & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 5 & \makecell[l]{5\\(5, 5)} & \makecell[l]{295\\(27, 3229)} & \makecell[l]{58.92\\(5.37, 645.90)}\\
\hspace{1em}Other & D57 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 34 & \makecell[l]{10\\(10, 10)} & \makecell[l]{959325\\(467189, 1969877)} & \makecell[l]{95932.51\\(46718.88, 196987.75)}\\
\hspace{1em}Other & D57 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 34 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2238776\\(1221484, 4103302)} & \makecell[l]{223877.62\\(122148.43, 410330.20)}\\
\hspace{1em}Other & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 34 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1974\\(715, 5452)} & \makecell[l]{392.38\\(142.10, 1083.45)}\\
\hspace{1em}Other & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 34 & \makecell[l]{6\\(5, 7)} & \makecell[l]{3391\\(1017, 11315)} & \makecell[l]{600.81\\(201.25, 1793.66)}\\
\hspace{1em}Other & D57 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 7 & \makecell[l]{10\\(10, 10)} & \makecell[l]{4612046\\(1663462, 12787169)} & \makecell[l]{461204.60\\(166346.19, 1278716.85)}\\
\hspace{1em}Other & D57 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 7 & \makecell[l]{10\\(10, 10)} & \makecell[l]{5745695\\(3340937, 9881364)} & \makecell[l]{574569.52\\(334093.70, 988136.36)}\\
\hspace{1em}Other & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 7 & \makecell[l]{5\\(5, 5)} & \makecell[l]{2543\\(573, 11275)} & \makecell[l]{508.53\\(114.67, 2255.10)}\\
\hspace{1em}Other & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 7 & \makecell[l]{5\\(5, 5)} & \makecell[l]{4503\\(1467, 13817)} & \makecell[l]{900.51\\(293.45, 2763.40)}\\
\hspace{1em}Other & D57 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 4 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Other & D57 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 4 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Other & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 4 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Other & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 4 & \makecell[l]{6\\(4, 8)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.87\\(0.67, 1.14)}\\
\hspace{1em}Other & D57 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 5 & \makecell[l]{10\\(10, 10)} & \makecell[l]{390164\\(12362, 12313729)} & \makecell[l]{39016.41\\(1236.25, 1231372.90)}\\
\hspace{1em}Other & D57 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 5 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1950467\\(62864, 60516607)} & \makecell[l]{195046.73\\(6286.41, 6051660.72)}\\
\hspace{1em}Other & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 5 & \makecell[l]{5\\(5, 5)} & \makecell[l]{6112\\(27, 1395272)} & \makecell[l]{1222.45\\(5.36, 279054.32)}\\
\hspace{1em}Other & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 5 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1609\\(34, 75283)} & \makecell[l]{321.73\\(6.87, 15056.61)}\\
\hspace{1em}Not reported and unknown & D29 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 87 & \makecell[l]{10\\(10, 10)} & \makecell[l]{19972\\(12070, 33047)} & \makecell[l]{1984.44\\(1199.39, 3283.33)}\\
\hspace{1em}Not reported and unknown & D29 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 87 & \makecell[l]{10\\(10, 10)} & \makecell[l]{41499\\(27382, 62895)} & \makecell[l]{4133.86\\(2728.77, 6262.46)}\\
\hspace{1em}Not reported and unknown & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 87 & \makecell[l]{5\\(5, 5)} & \makecell[l]{85\\(51, 144)} & \makecell[l]{16.41\\(9.71, 27.74)}\\
\hspace{1em}Not reported and unknown & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 87 & \makecell[l]{5\\(5, 5)} & \makecell[l]{167\\(114, 245)} & \makecell[l]{32.87\\(22.41, 48.19)}\\
\hspace{1em}Not reported and unknown & D29 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 20 & \makecell[l]{10\\(10, 10)} & \makecell[l]{57668\\(23639, 140684)} & \makecell[l]{5766.80\\(2363.88, 14068.40)}\\
\hspace{1em}Not reported and unknown & D29 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 20 & \makecell[l]{10\\(10, 10)} & \makecell[l]{112437\\(52711, 239834)} & \makecell[l]{11243.65\\(5271.13, 23983.41)}\\
\hspace{1em}Not reported and unknown & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 20 & \makecell[l]{6\\(5, 7)} & \makecell[l]{348\\(94, 1295)} & \makecell[l]{63.04\\(16.08, 247.10)}\\
\hspace{1em}Not reported and unknown & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 20 & \makecell[l]{5\\(5, 5)} & \makecell[l]{581\\(199, 1695)} & \makecell[l]{116.20\\(39.84, 338.93)}\\
\hspace{1em}Not reported and unknown & D29 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 14 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Not reported and unknown & D29 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 14 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Not reported and unknown & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 14 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 6)} & \makecell[l]{1.07\\(0.93, 1.23)}\\
\hspace{1em}Not reported and unknown & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 14 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Not reported and unknown & D29 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 24 & \makecell[l]{10\\(10, 10)} & \makecell[l]{11890\\(6465, 21867)} & \makecell[l]{1188.99\\(646.49, 2186.73)}\\
\hspace{1em}Not reported and unknown & D29 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 24 & \makecell[l]{10\\(10, 10)} & \makecell[l]{17779\\(10512, 30069)} & \makecell[l]{1777.89\\(1051.21, 3006.90)}\\
\hspace{1em}Not reported and unknown & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 24 & \makecell[l]{6\\(5, 7)} & \makecell[l]{46\\(19, 111)} & \makecell[l]{8.22\\(3.79, 17.84)}\\
\hspace{1em}Not reported and unknown & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 24 & \makecell[l]{5\\(5, 6)} & \makecell[l]{168\\(59, 476)} & \makecell[l]{31.45\\(11.89, 83.22)}\\
\hspace{1em}Not reported and unknown & D57 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 87 & \makecell[l]{10\\(10, 10)} & \makecell[l]{958206\\(602856, 1523015)} & \makecell[l]{95207.62\\(59917.16, 151283.72)}\\
\hspace{1em}Not reported and unknown & D57 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 87 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1898203\\(1201387, 2999181)} & \makecell[l]{189087.45\\(119691.94, 298717.41)}\\
\hspace{1em}Not reported and unknown & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 87 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1331\\(758, 2339)} & \makecell[l]{256.28\\(146.58, 448.08)}\\
\hspace{1em}Not reported and unknown & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 87 & \makecell[l]{5\\(5, 5)} & \makecell[l]{2345\\(1156, 4755)} & \makecell[l]{461.94\\(227.90, 936.32)}\\
\hspace{1em}Not reported and unknown & D57 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 20 & \makecell[l]{10\\(10, 10)} & \makecell[l]{3239260\\(1199389, 8748461)} & \makecell[l]{323926.04\\(119938.90, 874846.13)}\\
\hspace{1em}Not reported and unknown & D57 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 20 & \makecell[l]{10\\(10, 10)} & \makecell[l]{9280577\\(5784309, 14890128)} & \makecell[l]{928057.68\\(578430.93, 1489012.80)}\\
\hspace{1em}Not reported and unknown & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 20 & \makecell[l]{6\\(5, 7)} & \makecell[l]{11045\\(3104, 39295)} & \makecell[l]{2000.02\\(606.29, 6597.67)}\\
\hspace{1em}Not reported and unknown & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 20 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5210\\(1481, 18320)} & \makecell[l]{1041.90\\(296.28, 3663.93)}\\
\hspace{1em}Not reported and unknown & D57 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 14 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Not reported and unknown & D57 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 14 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Not reported and unknown & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 14 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.02\\(0.98, 1.07)}\\
\hspace{1em}Not reported and unknown & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 14 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Not reported and unknown & D57 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 24 & \makecell[l]{10\\(10, 10)} & \makecell[l]{401782\\(153583, 1051084)} & \makecell[l]{40178.22\\(15358.33, 105108.37)}\\
\hspace{1em}Not reported and unknown & D57 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 24 & \makecell[l]{10\\(10, 10)} & \makecell[l]{645039\\(295340, 1408800)} & \makecell[l]{64503.88\\(29533.99, 140880.03)}\\
\hspace{1em}Not reported and unknown & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 24 & \makecell[l]{6\\(5, 7)} & \makecell[l]{485\\(159, 1481)} & \makecell[l]{87.38\\(29.73, 256.78)}\\
\hspace{1em}Not reported and unknown & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 24 & \makecell[l]{5\\(5, 6)} & \makecell[l]{1124\\(299, 4219)} & \makecell[l]{209.99\\(58.57, 752.84)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item  
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{2.7cm}llllllll}
\caption{\label{tab:tabs}Table 6i. Geometric mean titer ratios (GMTRs) or geometric mean
      concentration ratios (GMCRs) between post-vaccinations/pre-vaccination by Underrepresented minority status}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & \makecell[l]{Baseline\\GMT/GMC} & \makecell[l]{Post Baseline\\GMT/GMC} & GMTR/GMCR\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & \makecell[l]{Baseline\\GMT/GMC} & \makecell[l]{Post Baseline\\GMT/GMC} & GMTR/GMCR\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{9}{l}{\textbf{Underrepresented minority status}}\\
\hspace{1em}Communities of Color & D29 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 420 & \makecell[l]{10\\(10, 10)} & \makecell[l]{23355\\(19242, 28347)} & \makecell[l]{2298.01\\(1896.26, 2784.86)}\\
\hspace{1em}Communities of Color & D29 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 420 & \makecell[l]{10\\(10, 10)} & \makecell[l]{40216\\(34320, 47124)} & \makecell[l]{4021.60\\(3432.03, 4712.44)}\\
\hspace{1em}Communities of Color & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 420 & \makecell[l]{5\\(5, 5)} & \makecell[l]{99\\(79, 124)} & \makecell[l]{19.66\\(15.68, 24.64)}\\
\hspace{1em}Communities of Color & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 420 & \makecell[l]{5\\(5, 5)} & \makecell[l]{208\\(163, 266)} & \makecell[l]{40.35\\(31.69, 51.38)}\\
\hspace{1em}Communities of Color & D29 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 120 & \makecell[l]{10\\(10, 10)} & \makecell[l]{44605\\(32113, 61955)} & \makecell[l]{4460.46\\(3211.32, 6195.47)}\\
\hspace{1em}Communities of Color & D29 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 120 & \makecell[l]{10\\(10, 10)} & \makecell[l]{90964\\(70627, 117156)} & \makecell[l]{9096.36\\(7062.72, 11715.57)}\\
\hspace{1em}Communities of Color & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 120 & \makecell[l]{5\\(5, 5)} & \makecell[l]{238\\(171, 332)} & \makecell[l]{47.22\\(33.91, 65.75)}\\
\hspace{1em}Communities of Color & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 120 & \makecell[l]{5\\(5, 6)} & \makecell[l]{545\\(371, 802)} & \makecell[l]{103.86\\(70.31, 153.42)}\\
\hspace{1em}Communities of Color & D29 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 73 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Communities of Color & D29 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 73 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Communities of Color & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 73 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.96, 1.02)}\\
\hspace{1em}Communities of Color & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 73 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 6)} & \makecell[l]{1.04\\(0.95, 1.15)}\\
\hspace{1em}Communities of Color & D29 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 111 & \makecell[l]{10\\(10, 10)} & \makecell[l]{17596\\(12331, 25109)} & \makecell[l]{1759.61\\(1233.11, 2510.90)}\\
\hspace{1em}Communities of Color & D29 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 111 & \makecell[l]{10\\(10, 10)} & \makecell[l]{18884\\(13334, 26743)} & \makecell[l]{1888.39\\(1333.43, 2674.32)}\\
\hspace{1em}Communities of Color & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 111 & \makecell[l]{5\\(5, 6)} & \makecell[l]{54\\(34, 84)} & \makecell[l]{10.35\\(6.82, 15.71)}\\
\hspace{1em}Communities of Color & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 111 & \makecell[l]{5\\(5, 5)} & \makecell[l]{178\\(110, 288)} & \makecell[l]{35.18\\(21.73, 56.94)}\\
\hspace{1em}Communities of Color & D57 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 420 & \makecell[l]{10\\(10, 10)} & \makecell[l]{977894\\(775549, 1233031)} & \makecell[l]{96220.17\\(76347.07, 121266.24)}\\
\hspace{1em}Communities of Color & D57 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 420 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2083276\\(1732503, 2505069)} & \makecell[l]{208327.61\\(173250.30, 250506.88)}\\
\hspace{1em}Communities of Color & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 420 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1903\\(1416, 2557)} & \makecell[l]{377.51\\(280.96, 507.24)}\\
\hspace{1em}Communities of Color & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 420 & \makecell[l]{5\\(5, 5)} & \makecell[l]{2744\\(2021, 3725)} & \makecell[l]{531.46\\(393.63, 717.56)}\\
\hspace{1em}Communities of Color & D57 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 120 & \makecell[l]{10\\(10, 10)} & \makecell[l]{3146770\\(2273084, 4356267)} & \makecell[l]{314676.99\\(227308.38, 435626.74)}\\
\hspace{1em}Communities of Color & D57 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 120 & \makecell[l]{10\\(10, 10)} & \makecell[l]{5991417\\(4527248, 7929117)} & \makecell[l]{599141.71\\(452724.79, 792911.71)}\\
\hspace{1em}Communities of Color & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 120 & \makecell[l]{5\\(5, 5)} & \makecell[l]{7086\\(4582, 10956)} & \makecell[l]{1407.15\\(910.55, 2174.59)}\\
\hspace{1em}Communities of Color & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 120 & \makecell[l]{5\\(5, 6)} & \makecell[l]{8885\\(5903, 13374)} & \makecell[l]{1691.75\\(1126.45, 2540.74)}\\
\hspace{1em}Communities of Color & D57 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 73 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Communities of Color & D57 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 73 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Communities of Color & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 73 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.96, 1.03)}\\
\hspace{1em}Communities of Color & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 73 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.97, 1.01)}\\
\hspace{1em}Communities of Color & D57 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 111 & \makecell[l]{10\\(10, 10)} & \makecell[l]{397884\\(256621, 616908)} & \makecell[l]{39788.42\\(25662.15, 61690.79)}\\
\hspace{1em}Communities of Color & D57 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 111 & \makecell[l]{10\\(10, 10)} & \makecell[l]{734879\\(489927, 1102301)} & \makecell[l]{73487.92\\(48992.72, 110230.12)}\\
\hspace{1em}Communities of Color & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 111 & \makecell[l]{5\\(5, 6)} & \makecell[l]{684\\(382, 1222)} & \makecell[l]{131.54\\(74.79, 231.36)}\\
\hspace{1em}Communities of Color & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 111 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1409\\(809, 2454)} & \makecell[l]{278.73\\(160.13, 485.18)}\\
\hspace{1em}White Non-Hispanic & D29 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 362 & \makecell[l]{10\\(10, 10)} & \makecell[l]{23438\\(18669, 29425)} & \makecell[l]{2343.79\\(1866.88, 2942.53)}\\
\hspace{1em}White Non-Hispanic & D29 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 362 & \makecell[l]{10\\(10, 10)} & \makecell[l]{40376\\(34349, 47460)} & \makecell[l]{4031.72\\(3430.05, 4738.93)}\\
\hspace{1em}White Non-Hispanic & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 362 & \makecell[l]{5\\(5, 5)} & \makecell[l]{115\\(90, 147)} & \makecell[l]{22.83\\(17.82, 29.23)}\\
\hspace{1em}White Non-Hispanic & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 362 & \makecell[l]{5\\(5, 5)} & \makecell[l]{188\\(146, 241)} & \makecell[l]{37.41\\(29.16, 48.00)}\\
\hspace{1em}White Non-Hispanic & D29 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 125 & \makecell[l]{10\\(10, 10)} & \makecell[l]{30985\\(21434, 44793)} & \makecell[l]{3098.50\\(2143.36, 4479.29)}\\
\hspace{1em}White Non-Hispanic & D29 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 125 & \makecell[l]{10\\(10, 10)} & \makecell[l]{72481\\(53061, 99008)} & \makecell[l]{7248.12\\(5306.15, 9900.82)}\\
\hspace{1em}White Non-Hispanic & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 125 & \makecell[l]{5\\(5, 5)} & \makecell[l]{148\\(104, 211)} & \makecell[l]{29.21\\(20.49, 41.65)}\\
\hspace{1em}White Non-Hispanic & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 125 & \makecell[l]{5\\(5, 5)} & \makecell[l]{348\\(226, 535)} & \makecell[l]{69.53\\(45.18, 106.99)}\\
\hspace{1em}White Non-Hispanic & D29 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 67 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}White Non-Hispanic & D29 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 67 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.99\\(0.96, 1.01)}\\
\hspace{1em}White Non-Hispanic & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 67 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.01\\(1.00, 1.02)}\\
\hspace{1em}White Non-Hispanic & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 67 & \makecell[l]{5\\(5, 6)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.96\\(0.89, 1.04)}\\
\hspace{1em}White Non-Hispanic & D29 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 121 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10931\\(7560, 15804)} & \makecell[l]{1089.81\\(753.88, 1575.44)}\\
\hspace{1em}White Non-Hispanic & D29 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 121 & \makecell[l]{10\\(10, 10)} & \makecell[l]{18868\\(14808, 24043)} & \makecell[l]{1886.83\\(1480.76, 2404.27)}\\
\hspace{1em}White Non-Hispanic & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 121 & \makecell[l]{5\\(5, 5)} & \makecell[l]{52\\(37, 74)} & \makecell[l]{10.37\\(7.32, 14.70)}\\
\hspace{1em}White Non-Hispanic & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 121 & \makecell[l]{5\\(5, 5)} & \makecell[l]{107\\(76, 150)} & \makecell[l]{21.32\\(15.15, 29.99)}\\
\hspace{1em}White Non-Hispanic & D57 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 362 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1035293\\(809568, 1323956)} & \makecell[l]{103529.30\\(80956.76, 132395.58)}\\
\hspace{1em}White Non-Hispanic & D57 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 362 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2145772\\(1770774, 2600184)} & \makecell[l]{214266.04\\(176817.71, 259645.59)}\\
\hspace{1em}White Non-Hispanic & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 362 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1376\\(1010, 1874)} & \makecell[l]{273.04\\(200.41, 371.99)}\\
\hspace{1em}White Non-Hispanic & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 362 & \makecell[l]{5\\(5, 5)} & \makecell[l]{2011\\(1465, 2761)} & \makecell[l]{400.97\\(292.11, 550.40)}\\
\hspace{1em}White Non-Hispanic & D57 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 125 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1943813\\(1349835, 2799166)} & \makecell[l]{194381.34\\(134983.46, 279916.55)}\\
\hspace{1em}White Non-Hispanic & D57 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 125 & \makecell[l]{10\\(10, 10)} & \makecell[l]{4608987\\(3338577, 6362819)} & \makecell[l]{460898.73\\(333857.72, 636281.94)}\\
\hspace{1em}White Non-Hispanic & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 125 & \makecell[l]{5\\(5, 5)} & \makecell[l]{4550\\(2471, 8378)} & \makecell[l]{899.93\\(488.90, 1656.55)}\\
\hspace{1em}White Non-Hispanic & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 125 & \makecell[l]{5\\(5, 5)} & \makecell[l]{7994\\(4646, 13757)} & \makecell[l]{1598.88\\(929.14, 2751.39)}\\
\hspace{1em}White Non-Hispanic & D57 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 67 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.01\\(0.99, 1.03)}\\
\hspace{1em}White Non-Hispanic & D57 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 67 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.99\\(0.96, 1.01)}\\
\hspace{1em}White Non-Hispanic & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 67 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}White Non-Hispanic & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 67 & \makecell[l]{5\\(5, 6)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.98\\(0.90, 1.06)}\\
\hspace{1em}White Non-Hispanic & D57 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 121 & \makecell[l]{10\\(10, 10)} & \makecell[l]{393045\\(287516, 537306)} & \makecell[l]{39187.22\\(28666.35, 53569.39)}\\
\hspace{1em}White Non-Hispanic & D57 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 121 & \makecell[l]{10\\(10, 10)} & \makecell[l]{674526\\(485396, 937351)} & \makecell[l]{67452.65\\(48539.56, 93735.08)}\\
\hspace{1em}White Non-Hispanic & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 121 & \makecell[l]{5\\(5, 5)} & \makecell[l]{575\\(371, 892)} & \makecell[l]{114.01\\(73.52, 176.80)}\\
\hspace{1em}White Non-Hispanic & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 121 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1478\\(953, 2292)} & \makecell[l]{295.55\\(190.57, 458.35)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item  
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{2.7cm}llllllll}
\caption{\label{tab:tabs}Table 6j. Geometric mean titer ratios (GMTRs) or geometric mean
      concentration ratios (GMCRs) between post-vaccinations/pre-vaccination by Age, Underrepresented minority status}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & \makecell[l]{Baseline\\GMT/GMC} & \makecell[l]{Post Baseline\\GMT/GMC} & GMTR/GMCR\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & N & \makecell[l]{Baseline\\GMT/GMC} & \makecell[l]{Post Baseline\\GMT/GMC} & GMTR/GMCR\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
\addlinespace[0.3em]
\multicolumn{9}{l}{\textbf{Age, Underrepresented minority status}}\\
\hspace{1em}Age $<$ 65 Communities of Color & D29 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 192 & \makecell[l]{10\\(10, 10)} & \makecell[l]{17593\\(13852, 22344)} & \makecell[l]{1725.89\\(1361.64, 2187.59)}\\
\hspace{1em}Age $<$ 65 Communities of Color & D29 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 192 & \makecell[l]{10\\(10, 10)} & \makecell[l]{30531\\(25113, 37119)} & \makecell[l]{3053.10\\(2511.25, 3711.87)}\\
\hspace{1em}Age $<$ 65 Communities of Color & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 192 & \makecell[l]{5\\(5, 5)} & \makecell[l]{76\\(58, 101)} & \makecell[l]{15.18\\(11.48, 20.07)}\\
\hspace{1em}Age $<$ 65 Communities of Color & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 192 & \makecell[l]{5\\(5, 5)} & \makecell[l]{174\\(128, 236)} & \makecell[l]{33.64\\(24.93, 45.38)}\\
\hspace{1em}Age $<$ 65 Communities of Color & D29 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 69 & \makecell[l]{10\\(10, 10)} & \makecell[l]{34937\\(23612, 51692)} & \makecell[l]{3493.66\\(2361.25, 5169.16)}\\
\hspace{1em}Age $<$ 65 Communities of Color & D29 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 69 & \makecell[l]{10\\(10, 10)} & \makecell[l]{70998\\(52424, 96153)} & \makecell[l]{7099.81\\(5242.39, 9615.33)}\\
\hspace{1em}Age $<$ 65 Communities of Color & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 69 & \makecell[l]{5\\(5, 5)} & \makecell[l]{209\\(141, 310)} & \makecell[l]{41.82\\(28.22, 61.98)}\\
\hspace{1em}Age $<$ 65 Communities of Color & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 69 & \makecell[l]{5\\(5, 6)} & \makecell[l]{484\\(305, 768)} & \makecell[l]{91.16\\(57.15, 145.40)}\\
\hspace{1em}Age $<$ 65 Communities of Color & D29 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 37 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $<$ 65 Communities of Color & D29 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 37 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $<$ 65 Communities of Color & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 37 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.98\\(0.94, 1.02)}\\
\hspace{1em}Age $<$ 65 Communities of Color & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 37 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 6)} & \makecell[l]{1.05\\(0.93, 1.19)}\\
\hspace{1em}Age $<$ 65 Communities of Color & D29 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 61 & \makecell[l]{10\\(10, 10)} & \makecell[l]{13618\\(8923, 20783)} & \makecell[l]{1361.81\\(892.33, 2078.29)}\\
\hspace{1em}Age $<$ 65 Communities of Color & D29 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 61 & \makecell[l]{10\\(10, 10)} & \makecell[l]{13717\\(9065, 20756)} & \makecell[l]{1371.71\\(906.53, 2075.61)}\\
\hspace{1em}Age $<$ 65 Communities of Color & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 61 & \makecell[l]{5\\(5, 6)} & \makecell[l]{42\\(25, 72)} & \makecell[l]{8.09\\(4.93, 13.29)}\\
\hspace{1em}Age $<$ 65 Communities of Color & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 61 & \makecell[l]{5\\(5, 5)} & \makecell[l]{150\\(84, 267)} & \makecell[l]{30.02\\(16.87, 53.39)}\\
\hspace{1em}Age $<$ 65 Communities of Color & D57 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 192 & \makecell[l]{10\\(10, 10)} & \makecell[l]{741900\\(555661, 990562)} & \makecell[l]{72781.13\\(54544.47, 97115.13)}\\
\hspace{1em}Age $<$ 65 Communities of Color & D57 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 192 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1629402\\(1297120, 2046806)} & \makecell[l]{162940.23\\(129711.97, 204680.56)}\\
\hspace{1em}Age $<$ 65 Communities of Color & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 192 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1435\\(996, 2067)} & \makecell[l]{285.33\\(198.09, 411.00)}\\
\hspace{1em}Age $<$ 65 Communities of Color & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 192 & \makecell[l]{5\\(5, 5)} & \makecell[l]{2230\\(1526, 3260)} & \makecell[l]{431.29\\(297.10, 626.08)}\\
\hspace{1em}Age $<$ 65 Communities of Color & D57 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 69 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2542683\\(1712040, 3776334)} & \makecell[l]{254268.26\\(171204.01, 377633.36)}\\
\hspace{1em}Age $<$ 65 Communities of Color & D57 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 69 & \makecell[l]{10\\(10, 10)} & \makecell[l]{5081700\\(3610831, 7151727)} & \makecell[l]{508170.01\\(361083.05, 715172.74)}\\
\hspace{1em}Age $<$ 65 Communities of Color & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 69 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5550\\(3299, 9337)} & \makecell[l]{1109.99\\(659.78, 1867.40)}\\
\hspace{1em}Age $<$ 65 Communities of Color & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 69 & \makecell[l]{5\\(5, 6)} & \makecell[l]{7380\\(4562, 11940)} & \makecell[l]{1389.33\\(861.24, 2241.22)}\\
\hspace{1em}Age $<$ 65 Communities of Color & D57 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 37 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $<$ 65 Communities of Color & D57 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 37 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $<$ 65 Communities of Color & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 37 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.95, 1.04)}\\
\hspace{1em}Age $<$ 65 Communities of Color & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 37 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.97, 1.01)}\\
\hspace{1em}Age $<$ 65 Communities of Color & D57 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 61 & \makecell[l]{10\\(10, 10)} & \makecell[l]{277278\\(163947, 468952)} & \makecell[l]{27727.83\\(16394.70, 46895.20)}\\
\hspace{1em}Age $<$ 65 Communities of Color & D57 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 61 & \makecell[l]{10\\(10, 10)} & \makecell[l]{543679\\(333997, 884998)} & \makecell[l]{54367.88\\(33399.71, 88499.76)}\\
\hspace{1em}Age $<$ 65 Communities of Color & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 61 & \makecell[l]{5\\(5, 6)} & \makecell[l]{466\\(233, 933)} & \makecell[l]{89.60\\(45.67, 175.78)}\\
\hspace{1em}Age $<$ 65 Communities of Color & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 61 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1073\\(554, 2078)} & \makecell[l]{214.52\\(110.72, 415.67)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & D29 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 175 & \makecell[l]{10\\(10, 10)} & \makecell[l]{18239\\(13758, 24181)} & \makecell[l]{1823.94\\(1375.79, 2418.07)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & D29 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 175 & \makecell[l]{10\\(10, 10)} & \makecell[l]{31442\\(25791, 38330)} & \makecell[l]{3144.18\\(2579.11, 3833.04)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 175 & \makecell[l]{5\\(5, 5)} & \makecell[l]{98\\(72, 132)} & \makecell[l]{19.42\\(14.32, 26.34)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 175 & \makecell[l]{5\\(5, 5)} & \makecell[l]{163\\(120, 222)} & \makecell[l]{32.68\\(24.04, 44.44)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & D29 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 59 & \makecell[l]{10\\(10, 10)} & \makecell[l]{19045\\(11981, 30275)} & \makecell[l]{1904.54\\(1198.08, 3027.54)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & D29 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 59 & \makecell[l]{10\\(10, 10)} & \makecell[l]{50450\\(34089, 74664)} & \makecell[l]{5044.99\\(3408.87, 7466.38)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 59 & \makecell[l]{5\\(5, 5)} & \makecell[l]{100\\(65, 155)} & \makecell[l]{20.06\\(12.98, 31.00)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 59 & \makecell[l]{5\\(5, 5)} & \makecell[l]{255\\(148, 438)} & \makecell[l]{50.94\\(29.59, 87.68)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & D29 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 31 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & D29 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 31 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.98\\(0.95, 1.02)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 31 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 31 & \makecell[l]{5\\(5, 6)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.95\\(0.85, 1.05)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & D29 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 61 & \makecell[l]{10\\(10, 10)} & \makecell[l]{7844\\(4943, 12447)} & \makecell[l]{784.36\\(494.26, 1244.74)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & D29 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 61 & \makecell[l]{10\\(10, 10)} & \makecell[l]{13337\\(9897, 17972)} & \makecell[l]{1333.71\\(989.74, 1797.23)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 61 & \makecell[l]{5\\(5, 5)} & \makecell[l]{38\\(25, 58)} & \makecell[l]{7.54\\(4.91, 11.57)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 61 & \makecell[l]{5\\(5, 5)} & \makecell[l]{78\\(51, 118)} & \makecell[l]{15.51\\(10.18, 23.62)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & D57 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 175 & \makecell[l]{10\\(10, 10)} & \makecell[l]{821667\\(605817, 1114423)} & \makecell[l]{82166.69\\(60581.70, 111442.32)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & D57 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 175 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1724310\\(1360533, 2185355)} & \makecell[l]{172431.05\\(136053.26, 218535.49)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 175 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1085\\(742, 1587)} & \makecell[l]{215.99\\(147.67, 315.94)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 175 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1624\\(1097, 2405)} & \makecell[l]{324.87\\(219.40, 481.06)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & D57 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 59 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1330657\\(839177, 2109982)} & \makecell[l]{133065.71\\(83917.71, 210998.18)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & D57 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 59 & \makecell[l]{10\\(10, 10)} & \makecell[l]{3419951\\(2265916, 5161739)} & \makecell[l]{341995.14\\(226591.60, 516173.95)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 59 & \makecell[l]{5\\(5, 5)} & \makecell[l]{2838\\(1308, 6159)} & \makecell[l]{567.69\\(261.64, 1231.71)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 59 & \makecell[l]{5\\(5, 5)} & \makecell[l]{6125\\(3095, 12121)} & \makecell[l]{1224.99\\(619.02, 2424.13)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & D57 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 31 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.01\\(0.99, 1.03)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & D57 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 31 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.98\\(0.95, 1.02)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 31 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 31 & \makecell[l]{5\\(5, 6)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.96\\(0.86, 1.07)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & D57 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 61 & \makecell[l]{10\\(10, 10)} & \makecell[l]{264698\\(179593, 390131)} & \makecell[l]{26469.79\\(17959.33, 39013.14)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & D57 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 61 & \makecell[l]{10\\(10, 10)} & \makecell[l]{451492\\(299075, 681584)} & \makecell[l]{45149.17\\(29907.49, 68158.43)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 61 & \makecell[l]{5\\(5, 5)} & \makecell[l]{376\\(219, 646)} & \makecell[l]{74.74\\(43.50, 128.41)}\\
\hspace{1em}Age $<$ 65 White Non-Hispanic & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 61 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1102\\(639, 1903)} & \makecell[l]{220.47\\(127.72, 380.58)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & D29 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 228 & \makecell[l]{10\\(10, 10)} & \makecell[l]{67566\\(54928, 83111)} & \makecell[l]{6723.29\\(5465.75, 8270.15)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & D29 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 228 & \makecell[l]{10\\(10, 10)} & \makecell[l]{113000\\(94968, 134457)} & \makecell[l]{11300.05\\(9496.80, 13445.69)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 228 & \makecell[l]{5\\(5, 5)} & \makecell[l]{263\\(208, 334)} & \makecell[l]{51.85\\(40.91, 65.71)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 228 & \makecell[l]{5\\(5, 5)} & \makecell[l]{409\\(322, 520)} & \makecell[l]{79.83\\(63.06, 101.06)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & D29 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 51 & \makecell[l]{10\\(10, 10)} & \makecell[l]{127850\\(82403, 198362)} & \makecell[l]{12784.98\\(8240.28, 19836.18)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & D29 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 51 & \makecell[l]{10\\(10, 10)} & \makecell[l]{264698\\(193965, 361225)} & \makecell[l]{26469.82\\(19396.51, 36122.55)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 51 & \makecell[l]{5\\(5, 6)} & \makecell[l]{414\\(254, 674)} & \makecell[l]{79.73\\(50.17, 126.69)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 51 & \makecell[l]{5\\(5, 5)} & \makecell[l]{911\\(557, 1491)} & \makecell[l]{182.23\\(111.38, 298.14)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & D29 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 36 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & D29 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 36 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 36 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.02\\(0.98, 1.06)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 36 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.01\\(0.94, 1.09)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & D29 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 50 & \makecell[l]{10\\(10, 10)} & \makecell[l]{57615\\(37847, 87707)} & \makecell[l]{5761.48\\(3784.71, 8770.72)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & D29 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 50 & \makecell[l]{10\\(10, 10)} & \makecell[l]{82913\\(55530, 123801)} & \makecell[l]{8291.33\\(5552.97, 12380.06)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{167\\(101, 276)} & \makecell[l]{32.28\\(19.55, 53.29)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 50 & \makecell[l]{5\\(5, 6)} & \makecell[l]{390\\(234, 650)} & \makecell[l]{73.32\\(44.82, 119.94)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & D57 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 228 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2754587\\(2268630, 3344640)} & \makecell[l]{274100.63\\(225748.76, 332808.72)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & D57 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 228 & \makecell[l]{10\\(10, 10)} & \makecell[l]{5234940\\(4335352, 6321193)} & \makecell[l]{523493.98\\(433535.17, 632119.29)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 228 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5478\\(4015, 7473)} & \makecell[l]{1078.45\\(791.36, 1469.70)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 228 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5966\\(4475, 7954)} & \makecell[l]{1163.05\\(875.98, 1544.19)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & D57 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 51 & \makecell[l]{10\\(10, 10)} & \makecell[l]{7886529\\(5982602, 10396367)} & \makecell[l]{788652.86\\(598260.24, 1039636.74)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & D57 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 51 & \makecell[l]{10\\(10, 10)} & \makecell[l]{12184499\\(9858697, 15058989)} & \makecell[l]{1218449.89\\(985869.74, 1505898.89)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 51 & \makecell[l]{5\\(5, 6)} & \makecell[l]{20307\\(11438, 36054)} & \makecell[l]{3912.01\\(2231.34, 6858.57)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 51 & \makecell[l]{5\\(5, 5)} & \makecell[l]{19769\\(10376, 37665)} & \makecell[l]{3953.73\\(2075.11, 7533.05)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & D57 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 36 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & D57 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 36 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 36 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 36 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.98\\(0.94, 1.02)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & D57 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 50 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2116643\\(1388474, 3226693)} & \makecell[l]{211664.33\\(138847.41, 322669.26)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & D57 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 50 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2964324\\(2089369, 4205680)} & \makecell[l]{296432.41\\(208936.91, 420567.97)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{4026\\(2199, 7373)} & \makecell[l]{777.87\\(423.25, 1429.59)}\\
\hspace{1em}Age $\geq$ 65 Communities of Color & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 50 & \makecell[l]{5\\(5, 6)} & \makecell[l]{4985\\(2691, 9234)} & \makecell[l]{936.31\\(513.96, 1705.72)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & D29 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 187 & \makecell[l]{10\\(10, 10)} & \makecell[l]{60501\\(48781, 75037)} & \makecell[l]{6050.09\\(4878.07, 7503.69)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & D29 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 187 & \makecell[l]{10\\(10, 10)} & \makecell[l]{103956\\(85919, 125780)} & \makecell[l]{10323.75\\(8540.15, 12479.85)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 187 & \makecell[l]{5\\(5, 5)} & \makecell[l]{214\\(164, 280)} & \makecell[l]{42.04\\(32.14, 54.99)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & D29 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 187 & \makecell[l]{5\\(5, 5)} & \makecell[l]{317\\(243, 412)} & \makecell[l]{62.39\\(47.99, 81.11)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & D29 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 66 & \makecell[l]{10\\(10, 10)} & \makecell[l]{171330\\(122104, 240402)} & \makecell[l]{17133.00\\(12210.38, 24040.16)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & D29 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 66 & \makecell[l]{10\\(10, 10)} & \makecell[l]{258922\\(193660, 346179)} & \makecell[l]{25892.24\\(19365.96, 34617.87)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 66 & \makecell[l]{5\\(5, 6)} & \makecell[l]{575\\(355, 932)} & \makecell[l]{109.39\\(68.12, 175.65)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & D29 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 66 & \makecell[l]{5\\(5, 5)} & \makecell[l]{1037\\(709, 1518)} & \makecell[l]{207.43\\(141.72, 303.60)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & D29 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 36 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & D29 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 36 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 36 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.02\\(0.98, 1.06)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & D29 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 36 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & D29 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 60 & \makecell[l]{10\\(10, 10)} & \makecell[l]{34684\\(23682, 50795)} & \makecell[l]{3422.26\\(2343.82, 4996.92)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & D29 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 60 & \makecell[l]{10\\(10, 10)} & \makecell[l]{63090\\(45886, 86746)} & \makecell[l]{6309.04\\(4588.59, 8674.56)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 60 & \makecell[l]{5\\(5, 5)} & \makecell[l]{160\\(99, 257)} & \makecell[l]{31.48\\(19.58, 50.61)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & D29 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 60 & \makecell[l]{5\\(5, 5)} & \makecell[l]{323\\(207, 502)} & \makecell[l]{64.50\\(41.47, 100.34)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & D57 fold-rise over D1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & 187 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2480906\\(1963293, 3134986)} & \makecell[l]{248090.62\\(196329.26, 313498.63)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & D57 fold-rise over D1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & 187 & \makecell[l]{10\\(10, 10)} & \makecell[l]{4905828\\(4009921, 6001900)} & \makecell[l]{487190.64\\(398077.65, 596252.31)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID50 & 187 & \makecell[l]{5\\(5, 5)} & \makecell[l]{3376\\(2393, 4763)} & \makecell[l]{662.37\\(469.40, 934.65)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & D57 fold-rise over D1 & Vaccine & Negative & Pseudovirus-nAb ID80 & 187 & \makecell[l]{5\\(5, 5)} & \makecell[l]{4511\\(3339, 6096)} & \makecell[l]{888.68\\(657.99, 1200.26)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & D57 fold-rise over D1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & 66 & \makecell[l]{10\\(10, 10)} & \makecell[l]{7361735\\(5495760, 9861264)} & \makecell[l]{736173.49\\(549575.99, 986126.43)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & D57 fold-rise over D1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & 66 & \makecell[l]{10\\(10, 10)} & \makecell[l]{13150407\\(11178796, 15469753)} & \makecell[l]{1315040.71\\(1117879.58, 1546975.29)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID50 & 66 & \makecell[l]{5\\(5, 6)} & \makecell[l]{23885\\(15539, 36713)} & \makecell[l]{4542.74\\(2980.14, 6924.67)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & D57 fold-rise over D1 & Vaccine & Positive & Pseudovirus-nAb ID80 & 66 & \makecell[l]{5\\(5, 5)} & \makecell[l]{20383\\(12350, 33642)} & \makecell[l]{4076.69\\(2470.01, 6728.46)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & D57 fold-rise over D1 & Placebo & Negative & Anti RBD IgG (IU/ml) & 36 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & D57 fold-rise over D1 & Placebo & Negative & Anti Spike IgG (IU/ml) & 36 & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID50 & 36 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & D57 fold-rise over D1 & Placebo & Negative & Pseudovirus-nAb ID80 & 36 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 6)} & \makecell[l]{1.04\\(0.96, 1.12)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & D57 fold-rise over D1 & Placebo & Positive & Anti RBD IgG (IU/ml) & 60 & \makecell[l]{10\\(10, 10)} & \makecell[l]{1555275\\(1070146, 2260326)} & \makecell[l]{153460.09\\(105621.81, 222965.32)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & D57 fold-rise over D1 & Placebo & Positive & Anti Spike IgG (IU/ml) & 60 & \makecell[l]{10\\(10, 10)} & \makecell[l]{2726537\\(1931325, 3849174)} & \makecell[l]{272653.70\\(193132.47, 384917.37)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID50 & 60 & \makecell[l]{5\\(5, 5)} & \makecell[l]{2516\\(1427, 4435)} & \makecell[l]{495.52\\(282.39, 869.51)}\\
\hspace{1em}Age $\geq$ 65 White Non-Hispanic & D57 fold-rise over D1 & Placebo & Positive & Pseudovirus-nAb ID80 & 60 & \makecell[l]{5\\(5, 5)} & \makecell[l]{4096\\(2471, 6792)} & \makecell[l]{819.28\\(494.12, 1358.43)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item  
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{2.7cm}lllllll}
\caption{\label{tab:tabs}Table 7. The ratios of GMTs/GMCs between groups}\\
\toprule
Group 1 vs 2 & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & Group 1 GMT/GMC & Group 2 GMT/GMC & Ratios of GMT/GMC\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group 1 vs 2 & Visit & Arm & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & Group 1 GMT/GMC & Group 2 GMT/GMC & Ratios of GMT/GMC\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
Age $\geq$ 65 vs Age $<$ 65 & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(0.99, 1.01)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.01\\(1.00, 1.01)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.01\\(0.99, 1.02)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.01\\(0.99, 1.04)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\addlinespace
Age $\geq$ 65 vs Age $<$ 65 & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.03\\(0.98, 1.08)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.98\\(0.96, 1.00)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 11)} & \makecell[l]{0.98\\(0.93, 1.02)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.99\\(0.98, 1.01)}\\
\addlinespace
Age $\geq$ 65 vs Age $<$ 65 & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.98, 1.01)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.98\\(0.93, 1.03)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.01\\(0.99, 1.02)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(0.95, 1.05)}\\
\addlinespace
Age $\geq$ 65 vs Age $<$ 65 & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.01\\(0.98, 1.04)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{65260\\(56734, 75068)} & \makecell[l]{17393\\(14565, 20770)} & \makecell[l]{3.75\\(2.99, 4.70)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{112166\\(98902, 127209)} & \makecell[l]{31397\\(27475, 35879)} & \makecell[l]{3.57\\(2.97, 4.29)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & \makecell[l]{254\\(214, 300)} & \makecell[l]{85\\(69, 103)} & \makecell[l]{3.00\\(2.32, 3.89)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & \makecell[l]{381\\(321, 451)} & \makecell[l]{157\\(129, 192)} & \makecell[l]{2.42\\(1.86, 3.15)}\\
\addlinespace
Age $\geq$ 65 vs Age $<$ 65 & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{158619\\(123545, 203649)} & \makecell[l]{24939\\(18393, 33814)} & \makecell[l]{6.36\\(4.29, 9.43)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{262073\\(211994, 323982)} & \makecell[l]{59400\\(46119, 76506)} & \makecell[l]{4.41\\(3.17, 6.14)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & \makecell[l]{522\\(373, 731)} & \makecell[l]{144\\(104, 198)} & \makecell[l]{3.63\\(2.28, 5.80)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & \makecell[l]{988\\(733, 1331)} & \makecell[l]{339\\(238, 482)} & \makecell[l]{2.92\\(1.84, 4.63)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\addlinespace
Age $\geq$ 65 vs Age $<$ 65 & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.01\\(0.98, 1.04)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.95, 1.03)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{41836\\(32047, 54614)} & \makecell[l]{9737\\(7318, 12957)} & \makecell[l]{4.30\\(2.91, 6.35)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{66891\\(53117, 84238)} & \makecell[l]{13380\\(10752, 16650)} & \makecell[l]{5.00\\(3.64, 6.87)}\\
\addlinespace
Age $\geq$ 65 vs Age $<$ 65 & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & \makecell[l]{156\\(112, 216)} & \makecell[l]{40\\(29, 54)} & \makecell[l]{3.93\\(2.51, 6.13)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & \makecell[l]{301\\(219, 413)} & \makecell[l]{106\\(76, 147)} & \makecell[l]{2.85\\(1.80, 4.49)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{2692372\\(2329146, 3112243)} & \makecell[l]{737116\\(604473, 898866)} & \makecell[l]{3.65\\(2.86, 4.67)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{5171042\\(4536102, 5894857)} & \makecell[l]{1643373\\(1397160, 1932976)} & \makecell[l]{3.15\\(2.55, 3.88)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & \makecell[l]{4259\\(3414, 5312)} & \makecell[l]{1136\\(890, 1449)} & \makecell[l]{3.75\\(2.70, 5.21)}\\
\addlinespace
Age $\geq$ 65 vs Age $<$ 65 & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & \makecell[l]{5506\\(4535, 6685)} & \makecell[l]{1750\\(1355, 2260)} & \makecell[l]{3.15\\(2.28, 4.34)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{7520373\\(6146909, 9200723)} & \makecell[l]{1708031\\(1250384, 2333179)} & \makecell[l]{4.40\\(3.04, 6.38)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{13148461\\(11661345, 14825221)} & \makecell[l]{4266733\\(3292306, 5529560)} & \makecell[l]{3.08\\(2.32, 4.10)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & \makecell[l]{21658\\(15437, 30385)} & \makecell[l]{4061\\(2527, 6527)} & \makecell[l]{5.33\\(2.98, 9.55)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & \makecell[l]{19480\\(13318, 28494)} & \makecell[l]{6238\\(4090, 9513)} & \makecell[l]{3.12\\(1.77, 5.51)}\\
\addlinespace
Age $\geq$ 65 vs Age $<$ 65 & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.99\\(0.98, 1.01)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.02\\(0.99, 1.05)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.01\\(0.97, 1.05)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{1675605\\(1276999, 2198632)} & \makecell[l]{270061\\(201183, 362521)} & \makecell[l]{6.20\\(4.16, 9.26)}\\
\addlinespace
Age $\geq$ 65 vs Age $<$ 65 & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{2790960\\(2209589, 3525298)} & \makecell[l]{484596\\(361146, 650244)} & \makecell[l]{5.76\\(3.96, 8.38)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & \makecell[l]{2827\\(1887, 4233)} & \makecell[l]{387\\(262, 572)} & \makecell[l]{7.30\\(4.17, 12.81)}\\
Age $\geq$ 65 vs Age $<$ 65 & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & \makecell[l]{4185\\(2859, 6127)} & \makecell[l]{1009\\(665, 1531)} & \makecell[l]{4.15\\(2.36, 7.30)}\\
At-risk vs Not at-risk & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(0.99, 1.01)}\\
At-risk vs Not at-risk & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.01)}\\
\addlinespace
At-risk vs Not at-risk & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.02\\(1.00, 1.04)}\\
At-risk vs Not at-risk & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(0.98, 1.02)}\\
At-risk vs Not at-risk & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
At-risk vs Not at-risk & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
At-risk vs Not at-risk & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.01\\(0.97, 1.05)}\\
\addlinespace
At-risk vs Not at-risk & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.96, 1.02)}\\
At-risk vs Not at-risk & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 11)} & \makecell[l]{0.97\\(0.92, 1.03)}\\
At-risk vs Not at-risk & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 11)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.02\\(0.98, 1.06)}\\
At-risk vs Not at-risk & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.02\\(0.98, 1.05)}\\
At-risk vs Not at-risk & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.98\\(0.92, 1.04)}\\
\addlinespace
At-risk vs Not at-risk & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.01\\(0.99, 1.02)}\\
At-risk vs Not at-risk & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
At-risk vs Not at-risk & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.94, 1.04)}\\
At-risk vs Not at-risk & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(0.97, 1.03)}\\
At-risk vs Not at-risk & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{26276\\(22610, 30535)} & \makecell[l]{21736\\(17965, 26298)} & \makecell[l]{1.21\\(0.95, 1.55)}\\
\addlinespace
At-risk vs Not at-risk & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{45842\\(40067, 52448)} & \makecell[l]{39200\\(34023, 45165)} & \makecell[l]{1.17\\(0.96, 1.43)}\\
At-risk vs Not at-risk & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & \makecell[l]{103\\(87, 122)} & \makecell[l]{108\\(87, 133)} & \makecell[l]{0.96\\(0.73, 1.26)}\\
At-risk vs Not at-risk & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & \makecell[l]{215\\(180, 258)} & \makecell[l]{180\\(145, 223)} & \makecell[l]{1.20\\(0.91, 1.59)}\\
At-risk vs Not at-risk & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{55528\\(43641, 70653)} & \makecell[l]{31130\\(22510, 43050)} & \makecell[l]{1.78\\(1.17, 2.72)}\\
At-risk vs Not at-risk & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{103862\\(82479, 130788)} & \makecell[l]{73051\\(55946, 95386)} & \makecell[l]{1.42\\(0.99, 2.05)}\\
\addlinespace
At-risk vs Not at-risk & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & \makecell[l]{220\\(161, 302)} & \makecell[l]{175\\(124, 247)} & \makecell[l]{1.26\\(0.78, 2.02)}\\
At-risk vs Not at-risk & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & \makecell[l]{443\\(318, 617)} & \makecell[l]{412\\(284, 597)} & \makecell[l]{1.08\\(0.65, 1.78)}\\
At-risk vs Not at-risk & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
At-risk vs Not at-risk & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
At-risk vs Not at-risk & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.04\\(0.99, 1.09)}\\
\addlinespace
At-risk vs Not at-risk & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.94, 1.03)}\\
At-risk vs Not at-risk & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{16713\\(12642, 22096)} & \makecell[l]{11818\\(8756, 15950)} & \makecell[l]{1.41\\(0.93, 2.16)}\\
At-risk vs Not at-risk & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{26705\\(21285, 33505)} & \makecell[l]{16070\\(12770, 20222)} & \makecell[l]{1.66\\(1.18, 2.33)}\\
At-risk vs Not at-risk & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & \makecell[l]{69\\(52, 93)} & \makecell[l]{47\\(34, 64)} & \makecell[l]{1.48\\(0.96, 2.30)}\\
At-risk vs Not at-risk & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & \makecell[l]{180\\(133, 243)} & \makecell[l]{116\\(82, 164)} & \makecell[l]{1.55\\(0.97, 2.47)}\\
\addlinespace
At-risk vs Not at-risk & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{1142597\\(961925, 1357205)} & \makecell[l]{904842\\(732112, 1118324)} & \makecell[l]{1.26\\(0.96, 1.66)}\\
At-risk vs Not at-risk & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{2144439\\(1840509, 2498559)} & \makecell[l]{2066294\\(1739231, 2454861)} & \makecell[l]{1.04\\(0.82, 1.31)}\\
At-risk vs Not at-risk & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & \makecell[l]{1796\\(1424, 2264)} & \makecell[l]{1394\\(1075, 1808)} & \makecell[l]{1.29\\(0.91, 1.83)}\\
At-risk vs Not at-risk & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & \makecell[l]{2766\\(2265, 3377)} & \makecell[l]{2041\\(1549, 2690)} & \makecell[l]{1.35\\(0.96, 1.91)}\\
At-risk vs Not at-risk & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{2930270\\(2216035, 3874704)} & \makecell[l]{2113273\\(1525010, 2928453)} & \makecell[l]{1.39\\(0.89, 2.15)}\\
\addlinespace
At-risk vs Not at-risk & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{6396516\\(5214355, 7846688)} & \makecell[l]{5023873\\(3827375, 6594416)} & \makecell[l]{1.27\\(0.90, 1.80)}\\
At-risk vs Not at-risk & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & \makecell[l]{6128\\(4355, 8625)} & \makecell[l]{5532\\(3337, 9171)} & \makecell[l]{1.11\\(0.59, 2.07)}\\
At-risk vs Not at-risk & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & \makecell[l]{11182\\(7684, 16271)} & \makecell[l]{6928\\(4429, 10838)} & \makecell[l]{1.61\\(0.90, 2.90)}\\
At-risk vs Not at-risk & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.01\\(0.99, 1.04)}\\
At-risk vs Not at-risk & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\addlinespace
At-risk vs Not at-risk & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(0.98, 1.02)}\\
At-risk vs Not at-risk & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.03\\(0.99, 1.07)}\\
At-risk vs Not at-risk & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{663561\\(492320, 894363)} & \makecell[l]{320294\\(235413, 435781)} & \makecell[l]{2.07\\(1.33, 3.22)}\\
At-risk vs Not at-risk & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{1012116\\(794913, 1288669)} & \makecell[l]{594413\\(435730, 810886)} & \makecell[l]{1.70\\(1.13, 2.56)}\\
At-risk vs Not at-risk & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & \makecell[l]{931\\(651, 1331)} & \makecell[l]{482\\(318, 728)} & \makecell[l]{1.93\\(1.10, 3.39)}\\
\addlinespace
At-risk vs Not at-risk & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & \makecell[l]{2086\\(1418, 3067)} & \makecell[l]{1143\\(737, 1774)} & \makecell[l]{1.82\\(1.01, 3.29)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(0.98, 1.01)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.03\\(1.00, 1.07)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.98, 1.01)}\\
\addlinespace
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.98\\(0.95, 1.02)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.95, 1.03)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 11)} & \makecell[l]{0.97\\(0.91, 1.03)}\\
\addlinespace
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 11)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.03\\(0.97, 1.10)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.03\\(0.97, 1.08)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 6)} & \makecell[l]{0.98\\(0.91, 1.05)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\addlinespace
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.98\\(0.93, 1.04)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(0.97, 1.03)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{16530\\(13368, 20441)} & \makecell[l]{17639\\(14174, 21953)} & \makecell[l]{0.94\\(0.69, 1.27)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{31028\\(25725, 37423)} & \makecell[l]{31500\\(26782, 37050)} & \makecell[l]{0.98\\(0.77, 1.26)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & \makecell[l]{68\\(54, 85)} & \makecell[l]{90\\(70, 115)} & \makecell[l]{0.75\\(0.54, 1.05)}\\
\addlinespace
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & \makecell[l]{159\\(123, 204)} & \makecell[l]{157\\(122, 200)} & \makecell[l]{1.01\\(0.71, 1.44)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{30603\\(22501, 41623)} & \makecell[l]{23567\\(16129, 34434)} & \makecell[l]{1.30\\(0.80, 2.12)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{62641\\(46271, 84801)} & \makecell[l]{58534\\(42846, 79967)} & \makecell[l]{1.07\\(0.69, 1.65)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & \makecell[l]{142\\(95, 213)} & \makecell[l]{144\\(97, 214)} & \makecell[l]{0.99\\(0.56, 1.74)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & \makecell[l]{291\\(187, 453)} & \makecell[l]{353\\(229, 545)} & \makecell[l]{0.82\\(0.44, 1.53)}\\
\addlinespace
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 6)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.04\\(0.96, 1.12)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.97\\(0.93, 1.03)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{10221\\(7219, 14470)} & \makecell[l]{9616\\(6788, 13622)} & \makecell[l]{1.06\\(0.65, 1.74)}\\
\addlinespace
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{16112\\(12299, 21107)} & \makecell[l]{12751\\(9770, 16642)} & \makecell[l]{1.26\\(0.86, 1.85)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & \makecell[l]{48\\(34, 67)} & \makecell[l]{38\\(26, 55)} & \makecell[l]{1.26\\(0.77, 2.08)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & \makecell[l]{127\\(87, 186)} & \makecell[l]{101\\(68, 150)} & \makecell[l]{1.26\\(0.72, 2.19)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{761200\\(595277, 973370)} & \makecell[l]{730590\\(572430, 932450)} & \makecell[l]{1.04\\(0.74, 1.47)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{1498825\\(1211392, 1854460)} & \makecell[l]{1685764\\(1382036, 2056240)} & \makecell[l]{0.89\\(0.66, 1.19)}\\
\addlinespace
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & \makecell[l]{1203\\(876, 1652)} & \makecell[l]{1118\\(830, 1506)} & \makecell[l]{1.08\\(0.70, 1.66)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & \makecell[l]{2067\\(1571, 2720)} & \makecell[l]{1671\\(1216, 2295)} & \makecell[l]{1.24\\(0.81, 1.88)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{1815884\\(1228679, 2683724)} & \makecell[l]{1679359\\(1144789, 2463552)} & \makecell[l]{1.08\\(0.63, 1.87)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{4547755\\(3405518, 6073108)} & \makecell[l]{4192147\\(3040678, 5779665)} & \makecell[l]{1.08\\(0.70, 1.67)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & \makecell[l]{2953\\(1859, 4690)} & \makecell[l]{4435\\(2453, 8017)} & \makecell[l]{0.67\\(0.31, 1.41)}\\
\addlinespace
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & \makecell[l]{7954\\(4852, 13039)} & \makecell[l]{5833\\(3464, 9821)} & \makecell[l]{1.36\\(0.66, 2.80)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 11)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.02\\(0.98, 1.07)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.02\\(0.98, 1.05)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.02\\(0.98, 1.07)}\\
\addlinespace
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{417627\\(286526, 608715)} & \makecell[l]{241209\\(168681, 344922)} & \makecell[l]{1.73\\(1.03, 2.91)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{575539\\(423609, 781958)} & \makecell[l]{463469\\(322830, 665378)} & \makecell[l]{1.24\\(0.77, 1.99)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & \makecell[l]{502\\(325, 776)} & \makecell[l]{362\\(224, 583)} & \makecell[l]{1.39\\(0.73, 2.65)}\\
Age $<$ 65 At-risk vs Age $<$ 65 Not at-risk & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & \makecell[l]{1382\\(851, 2245)} & \makecell[l]{930\\(559, 1549)} & \makecell[l]{1.49\\(0.73, 3.00)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(0.99, 1.02)}\\
\addlinespace
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.01\\(1.00, 1.03)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(0.97, 1.02)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.96, 1.03)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\addlinespace
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 6)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.05\\(0.96, 1.15)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\addlinespace
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.96, 1.01)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 11)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.02\\(0.98, 1.06)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.01\\(0.95, 1.08)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.95, 1.03)}\\
\addlinespace
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{54232\\(44615, 65922)} & \makecell[l]{80069\\(65707, 97571)} & \makecell[l]{0.68\\(0.51, 0.89)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{84391\\(70325, 101269)} & \makecell[l]{153593\\(130667, 180543)} & \makecell[l]{0.55\\(0.43, 0.70)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & \makecell[l]{199\\(157, 252)} & \makecell[l]{332\\(263, 418)} & \makecell[l]{0.60\\(0.43, 0.84)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & \makecell[l]{348\\(276, 438)} & \makecell[l]{421\\(328, 540)} & \makecell[l]{0.83\\(0.59, 1.16)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{188670\\(129392, 275106)} & \makecell[l]{139826\\(99996, 195520)} & \makecell[l]{1.35\\(0.82, 2.23)}\\
\addlinespace
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{293282\\(210942, 407763)} & \makecell[l]{241494\\(182978, 318724)} & \makecell[l]{1.21\\(0.79, 1.86)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & \makecell[l]{541\\(337, 870)} & \makecell[l]{508\\(317, 815)} & \makecell[l]{1.06\\(0.55, 2.08)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & \makecell[l]{1052\\(680, 1627)} & \makecell[l]{944\\(626, 1422)} & \makecell[l]{1.12\\(0.62, 2.02)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\addlinespace
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.03\\(0.99, 1.08)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.02\\(0.98, 1.06)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{48060\\(30237, 76388)} & \makecell[l]{38048\\(27669, 52321)} & \makecell[l]{1.26\\(0.72, 2.22)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{79058\\(52125, 119908)} & \makecell[l]{59664\\(45819, 77691)} & \makecell[l]{1.33\\(0.81, 2.17)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & \makecell[l]{155\\(89, 270)} & \makecell[l]{156\\(105, 232)} & \makecell[l]{0.99\\(0.50, 1.96)}\\
\addlinespace
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & \makecell[l]{378\\(233, 613)} & \makecell[l]{257\\(170, 390)} & \makecell[l]{1.47\\(0.77, 2.79)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{2156196\\(1736284, 2677662)} & \makecell[l]{3441017\\(2860842, 4138850)} & \makecell[l]{0.63\\(0.47, 0.83)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{3754377\\(3053564, 4616033)} & \makecell[l]{7365218\\(6408010, 8465410)} & \makecell[l]{0.51\\(0.40, 0.65)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & \makecell[l]{3359\\(2423, 4656)} & \makecell[l]{5534\\(4137, 7404)} & \makecell[l]{0.61\\(0.39, 0.94)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & \makecell[l]{4361\\(3299, 5763)} & \makecell[l]{7125\\(5468, 9285)} & \makecell[l]{0.61\\(0.42, 0.90)}\\
\addlinespace
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{7826271\\(5853680, 10463591)} & \makecell[l]{7305563\\(5522547, 9664247)} & \makecell[l]{1.07\\(0.72, 1.60)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{12884976\\(10641883, 15600868)} & \makecell[l]{13343347\\(11421210, 15588971)} & \makecell[l]{0.97\\(0.76, 1.23)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & \makecell[l]{27431\\(17819, 42227)} & \makecell[l]{18240\\(11134, 29880)} & \makecell[l]{1.50\\(0.78, 2.88)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & \makecell[l]{22502\\(13237, 38254)} & \makecell[l]{17541\\(10280, 29932)} & \makecell[l]{1.28\\(0.61, 2.71)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\addlinespace
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 6)} & \makecell[l]{0.96\\(0.90, 1.02)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 6)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.04\\(0.97, 1.11)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{1793880\\(1112795, 2891824)} & \makecell[l]{1599200\\(1156266, 2211811)} & \makecell[l]{1.12\\(0.63, 1.99)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{3402410\\(2325361, 4978321)} & \makecell[l]{2437171\\(1815977, 3270859)} & \makecell[l]{1.40\\(0.87, 2.25)}\\
\addlinespace
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & \makecell[l]{3501\\(1863, 6577)} & \makecell[l]{2442\\(1442, 4134)} & \makecell[l]{1.43\\(0.63, 3.27)}\\
Age $\geq$ 65 At-risk vs Age $\geq$ 65 Not at-risk & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & \makecell[l]{5048\\(2709, 9408)} & \makecell[l]{3681\\(2278, 5949)} & \makecell[l]{1.37\\(0.63, 3.00)}\\
Male vs Female & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.01\\(0.99, 1.02)}\\
Male vs Female & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Male vs Female & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.98, 1.01)}\\
\addlinespace
Male vs Female & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.97, 1.01)}\\
Male vs Female & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Male vs Female & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Male vs Female & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.98\\(0.94, 1.02)}\\
Male vs Female & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.01\\(0.96, 1.05)}\\
\addlinespace
Male vs Female & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{11\\(9, 12)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.05\\(0.95, 1.17)}\\
Male vs Female & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.99\\(0.97, 1.01)}\\
Male vs Female & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.98, 1.01)}\\
Male vs Female & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 6)} & \makecell[l]{0.97\\(0.91, 1.03)}\\
Male vs Female & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(0.99, 1.00)}\\
\addlinespace
Male vs Female & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Male vs Female & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.97\\(0.92, 1.02)}\\
Male vs Female & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.96, 1.02)}\\
Male vs Female & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{25738\\(20110, 32941)} & \makecell[l]{21234\\(17837, 25278)} & \makecell[l]{1.21\\(0.89, 1.65)}\\
Male vs Female & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{40290\\(34397, 47193)} & \makecell[l]{41415\\(35725, 48012)} & \makecell[l]{0.97\\(0.78, 1.22)}\\
\addlinespace
Male vs Female & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & \makecell[l]{121\\(93, 157)} & \makecell[l]{98\\(80, 120)} & \makecell[l]{1.23\\(0.89, 1.72)}\\
Male vs Female & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & \makecell[l]{207\\(158, 272)} & \makecell[l]{178\\(145, 218)} & \makecell[l]{1.17\\(0.83, 1.64)}\\
Male vs Female & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{43301\\(30763, 60949)} & \makecell[l]{32117\\(22658, 45526)} & \makecell[l]{1.35\\(0.81, 2.24)}\\
Male vs Female & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{83762\\(65541, 107048)} & \makecell[l]{77611\\(57216, 105276)} & \makecell[l]{1.08\\(0.72, 1.62)}\\
Male vs Female & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & \makecell[l]{223\\(158, 315)} & \makecell[l]{165\\(113, 242)} & \makecell[l]{1.35\\(0.80, 2.27)}\\
\addlinespace
Male vs Female & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & \makecell[l]{449\\(303, 666)} & \makecell[l]{401\\(268, 602)} & \makecell[l]{1.12\\(0.64, 1.97)}\\
Male vs Female & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Male vs Female & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Male vs Female & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.02\\(0.98, 1.06)}\\
Male vs Female & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.97\\(0.93, 1.02)}\\
\addlinespace
Male vs Female & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{12838\\(8743, 18852)} & \makecell[l]{12876\\(9489, 17472)} & \makecell[l]{1.00\\(0.60, 1.65)}\\
Male vs Female & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{16359\\(12044, 22219)} & \makecell[l]{19468\\(15496, 24459)} & \makecell[l]{0.84\\(0.56, 1.26)}\\
Male vs Female & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & \makecell[l]{43\\(29, 63)} & \makecell[l]{58\\(42, 81)} & \makecell[l]{0.73\\(0.44, 1.23)}\\
Male vs Female & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & \makecell[l]{100\\(68, 146)} & \makecell[l]{152\\(105, 219)} & \makecell[l]{0.66\\(0.38, 1.14)}\\
Male vs Female & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{1032572\\(803692, 1326633)} & \makecell[l]{924524\\(750510, 1138886)} & \makecell[l]{1.12\\(0.80, 1.56)}\\
\addlinespace
Male vs Female & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{2448348\\(1992531, 3008439)} & \makecell[l]{1878895\\(1586011, 2225864)} & \makecell[l]{1.30\\(0.99, 1.71)}\\
Male vs Female & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & \makecell[l]{1983\\(1427, 2754)} & \makecell[l]{1243\\(972, 1588)} & \makecell[l]{1.60\\(1.05, 2.41)}\\
Male vs Female & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & \makecell[l]{2322\\(1694, 3181)} & \makecell[l]{2160\\(1643, 2840)} & \makecell[l]{1.07\\(0.70, 1.64)}\\
Male vs Female & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{2628794\\(1842173, 3751308)} & \makecell[l]{2106655\\(1490680, 2977161)} & \makecell[l]{1.25\\(0.76, 2.06)}\\
Male vs Female & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{5518909\\(4222583, 7213204)} & \makecell[l]{5236885\\(3880756, 7066912)} & \makecell[l]{1.05\\(0.70, 1.59)}\\
\addlinespace
Male vs Female & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & \makecell[l]{5567\\(3235, 9581)} & \makecell[l]{5754\\(3356, 9868)} & \makecell[l]{0.97\\(0.45, 2.07)}\\
Male vs Female & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & \makecell[l]{9590\\(6259, 14696)} & \makecell[l]{6872\\(4174, 11314)} & \makecell[l]{1.40\\(0.73, 2.67)}\\
Male vs Female & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.01\\(0.99, 1.03)}\\
Male vs Female & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Male vs Female & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(0.98, 1.02)}\\
\addlinespace
Male vs Female & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.97, 1.01)}\\
Male vs Female & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{361345\\(243436, 536364)} & \makecell[l]{396863\\(289955, 543189)} & \makecell[l]{0.91\\(0.54, 1.55)}\\
Male vs Female & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{578439\\(406742, 822616)} & \makecell[l]{748414\\(540245, 1036794)} & \makecell[l]{0.77\\(0.47, 1.28)}\\
Male vs Female & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & \makecell[l]{606\\(358, 1023)} & \makecell[l]{541\\(355, 825)} & \makecell[l]{1.12\\(0.56, 2.23)}\\
Male vs Female & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & \makecell[l]{930\\(554, 1559)} & \makecell[l]{1659\\(1064, 2588)} & \makecell[l]{0.56\\(0.28, 1.12)}\\
\addlinespace
Hispanic or Latino vs Not Hispanic or Latino & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.99\\(0.99, 1.00)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.98, 1.00)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 6)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.05\\(0.97, 1.14)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\addlinespace
Hispanic or Latino vs Not Hispanic or Latino & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.98, 1.00)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.01\\(0.96, 1.06)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.99\\(0.98, 1.01)}\\
\addlinespace
Hispanic or Latino vs Not Hispanic or Latino & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.98, 1.01)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.97\\(0.93, 1.02)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(0.99, 1.00)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & \makecell[l]{6\\(5, 7)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.10\\(0.90, 1.34)}\\
\addlinespace
Hispanic or Latino vs Not Hispanic or Latino & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.97, 1.01)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{22266\\(15847, 31284)} & \makecell[l]{23020\\(19425, 27280)} & \makecell[l]{0.97\\(0.66, 1.42)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{41773\\(31562, 55289)} & \makecell[l]{39694\\(35055, 44946)} & \makecell[l]{1.05\\(0.77, 1.44)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & \makecell[l]{101\\(67, 152)} & \makecell[l]{104\\(86, 125)} & \makecell[l]{0.97\\(0.62, 1.52)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & \makecell[l]{190\\(126, 284)} & \makecell[l]{191\\(158, 230)} & \makecell[l]{0.99\\(0.63, 1.55)}\\
\addlinespace
Hispanic or Latino vs Not Hispanic or Latino & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{57339\\(30559, 107588)} & \makecell[l]{35344\\(26390, 47337)} & \makecell[l]{1.62\\(0.82, 3.20)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{90332\\(50343, 162084)} & \makecell[l]{83383\\(65546, 106075)} & \makecell[l]{1.08\\(0.58, 2.02)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & \makecell[l]{254\\(155, 417)} & \makecell[l]{183\\(133, 251)} & \makecell[l]{1.39\\(0.78, 2.48)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & \makecell[l]{498\\(236, 1049)} & \makecell[l]{411\\(294, 575)} & \makecell[l]{1.21\\(0.55, 2.69)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\addlinespace
Hispanic or Latino vs Not Hispanic or Latino & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(0.97, 1.04)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & \makecell[l]{6\\(4, 8)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.21\\(0.89, 1.64)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{34815\\(16110, 75239)} & \makecell[l]{11608\\(9046, 14896)} & \makecell[l]{3.00\\(1.35, 6.66)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{26708\\(12585, 56680)} & \makecell[l]{18056\\(14910, 21865)} & \makecell[l]{1.48\\(0.70, 3.14)}\\
\addlinespace
Hispanic or Latino vs Not Hispanic or Latino & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & \makecell[l]{118\\(42, 327)} & \makecell[l]{48\\(37, 63)} & \makecell[l]{2.45\\(0.88, 6.82)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & \makecell[l]{351\\(151, 818)} & \makecell[l]{123\\(92, 165)} & \makecell[l]{2.85\\(1.19, 6.80)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{1087406\\(737091, 1604213)} & \makecell[l]{987977\\(822264, 1187086)} & \makecell[l]{1.10\\(0.71, 1.70)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{2082654\\(1564176, 2772993)} & \makecell[l]{2063432\\(1775937, 2397468)} & \makecell[l]{1.01\\(0.73, 1.40)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & \makecell[l]{1727\\(1013, 2946)} & \makecell[l]{1500\\(1191, 1888)} & \makecell[l]{1.15\\(0.64, 2.06)}\\
\addlinespace
Hispanic or Latino vs Not Hispanic or Latino & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & \makecell[l]{2444\\(1373, 4350)} & \makecell[l]{2270\\(1788, 2883)} & \makecell[l]{1.08\\(0.58, 2.00)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{2735111\\(1368395, 5466868)} & \makecell[l]{2315554\\(1731123, 3097290)} & \makecell[l]{1.18\\(0.56, 2.47)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{7578287\\(5040721, 11393296)} & \makecell[l]{5301268\\(4150604, 6770929)} & \makecell[l]{1.43\\(0.90, 2.28)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & \makecell[l]{7727\\(2908, 20532)} & \makecell[l]{5224\\(3348, 8151)} & \makecell[l]{1.48\\(0.52, 4.24)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & \makecell[l]{10208\\(4492, 23195)} & \makecell[l]{7937\\(5300, 11886)} & \makecell[l]{1.29\\(0.53, 3.14)}\\
\addlinespace
Hispanic or Latino vs Not Hispanic or Latino & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.99\\(0.98, 1.00)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.98, 1.00)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.99\\(0.97, 1.00)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{747435\\(391924, 1425424)} & \makecell[l]{381696\\(293138, 497006)} & \makecell[l]{1.96\\(0.99, 3.89)}\\
\addlinespace
Hispanic or Latino vs Not Hispanic or Latino & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{1403460\\(609038, 3234119)} & \makecell[l]{648311\\(505732, 831086)} & \makecell[l]{2.16\\(0.93, 5.02)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & \makecell[l]{1522\\(466, 4976)} & \makecell[l]{555\\(395, 782)} & \makecell[l]{2.74\\(0.84, 8.96)}\\
Hispanic or Latino vs Not Hispanic or Latino & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & \makecell[l]{3063\\(1057, 8877)} & \makecell[l]{1324\\(921, 1904)} & \makecell[l]{2.31\\(0.78, 6.86)}\\
Communities of Color vs White Non-Hispanic & Day 1 & Vaccine & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.02\\(1.00, 1.04)}\\
Communities of Color vs White Non-Hispanic & Day 1 & Vaccine & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\addlinespace
Communities of Color vs White Non-Hispanic & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(0.99, 1.01)}\\
Communities of Color vs White Non-Hispanic & Day 1 & Vaccine & Negative & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.03\\(1.00, 1.06)}\\
Communities of Color vs White Non-Hispanic & Day 1 & Vaccine & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Communities of Color vs White Non-Hispanic & Day 1 & Vaccine & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Communities of Color vs White Non-Hispanic & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(0.98, 1.02)}\\
\addlinespace
Communities of Color vs White Non-Hispanic & Day 1 & Vaccine & Positive & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 6)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.05\\(0.99, 1.11)}\\
Communities of Color vs White Non-Hispanic & Day 1 & Placebo & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Communities of Color vs White Non-Hispanic & Day 1 & Placebo & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.99\\(0.96, 1.01)}\\
Communities of Color vs White Non-Hispanic & Day 1 & Placebo & Negative & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.02\\(0.99, 1.05)}\\
Communities of Color vs White Non-Hispanic & Day 1 & Placebo & Negative & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 6)} & \makecell[l]{0.97\\(0.90, 1.05)}\\
\addlinespace
Communities of Color vs White Non-Hispanic & Day 1 & Placebo & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(0.99, 1.00)}\\
Communities of Color vs White Non-Hispanic & Day 1 & Placebo & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Communities of Color vs White Non-Hispanic & Day 1 & Placebo & Positive & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 6)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.03\\(0.97, 1.10)}\\
Communities of Color vs White Non-Hispanic & Day 1 & Placebo & Positive & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.01\\(1.00, 1.02)}\\
Communities of Color vs White Non-Hispanic & Day 29 & Vaccine & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{23355\\(19242, 28347)} & \makecell[l]{23438\\(18669, 29425)} & \makecell[l]{1.00\\(0.74, 1.34)}\\
\addlinespace
Communities of Color vs White Non-Hispanic & Day 29 & Vaccine & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{40216\\(34320, 47124)} & \makecell[l]{40376\\(34349, 47460)} & \makecell[l]{1.00\\(0.79, 1.25)}\\
Communities of Color vs White Non-Hispanic & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID50 & \makecell[l]{99\\(79, 124)} & \makecell[l]{115\\(90, 147)} & \makecell[l]{0.86\\(0.62, 1.20)}\\
Communities of Color vs White Non-Hispanic & Day 29 & Vaccine & Negative & Pseudovirus-nAb ID80 & \makecell[l]{208\\(163, 266)} & \makecell[l]{188\\(146, 241)} & \makecell[l]{1.11\\(0.78, 1.57)}\\
Communities of Color vs White Non-Hispanic & Day 29 & Vaccine & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{44605\\(32113, 61955)} & \makecell[l]{30985\\(21434, 44793)} & \makecell[l]{1.44\\(0.88, 2.36)}\\
Communities of Color vs White Non-Hispanic & Day 29 & Vaccine & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{90964\\(70627, 117156)} & \makecell[l]{72481\\(53061, 99008)} & \makecell[l]{1.25\\(0.84, 1.88)}\\
\addlinespace
Communities of Color vs White Non-Hispanic & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID50 & \makecell[l]{238\\(171, 332)} & \makecell[l]{148\\(104, 211)} & \makecell[l]{1.61\\(0.99, 2.62)}\\
Communities of Color vs White Non-Hispanic & Day 29 & Vaccine & Positive & Pseudovirus-nAb ID80 & \makecell[l]{545\\(371, 802)} & \makecell[l]{348\\(226, 535)} & \makecell[l]{1.57\\(0.88, 2.80)}\\
Communities of Color vs White Non-Hispanic & Day 29 & Placebo & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Communities of Color vs White Non-Hispanic & Day 29 & Placebo & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
Communities of Color vs White Non-Hispanic & Day 29 & Placebo & Negative & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.00\\(0.99, 1.01)}\\
\addlinespace
Communities of Color vs White Non-Hispanic & Day 29 & Placebo & Negative & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 6)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.06\\(0.96, 1.16)}\\
Communities of Color vs White Non-Hispanic & Day 29 & Placebo & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{17596\\(12331, 25109)} & \makecell[l]{10931\\(7560, 15804)} & \makecell[l]{1.61\\(0.96, 2.69)}\\
Communities of Color vs White Non-Hispanic & Day 29 & Placebo & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{18884\\(13334, 26743)} & \makecell[l]{18868\\(14808, 24043)} & \makecell[l]{1.00\\(0.65, 1.53)}\\
Communities of Color vs White Non-Hispanic & Day 29 & Placebo & Positive & Pseudovirus-nAb ID50 & \makecell[l]{54\\(34, 84)} & \makecell[l]{52\\(37, 74)} & \makecell[l]{1.03\\(0.58, 1.81)}\\
Communities of Color vs White Non-Hispanic & Day 29 & Placebo & Positive & Pseudovirus-nAb ID80 & \makecell[l]{178\\(110, 288)} & \makecell[l]{107\\(76, 150)} & \makecell[l]{1.67\\(0.92, 3.01)}\\
\addlinespace
Communities of Color vs White Non-Hispanic & Day 57 & Vaccine & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{977894\\(775549, 1233031)} & \makecell[l]{1035293\\(809568, 1323956)} & \makecell[l]{0.94\\(0.67, 1.32)}\\
Communities of Color vs White Non-Hispanic & Day 57 & Vaccine & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{2083276\\(1732503, 2505069)} & \makecell[l]{2145772\\(1770774, 2600184)} & \makecell[l]{0.97\\(0.74, 1.27)}\\
Communities of Color vs White Non-Hispanic & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID50 & \makecell[l]{1903\\(1416, 2557)} & \makecell[l]{1376\\(1010, 1874)} & \makecell[l]{1.38\\(0.90, 2.12)}\\
Communities of Color vs White Non-Hispanic & Day 57 & Vaccine & Negative & Pseudovirus-nAb ID80 & \makecell[l]{2744\\(2021, 3725)} & \makecell[l]{2011\\(1465, 2761)} & \makecell[l]{1.36\\(0.88, 2.12)}\\
Communities of Color vs White Non-Hispanic & Day 57 & Vaccine & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{3146770\\(2273084, 4356267)} & \makecell[l]{1943813\\(1349835, 2799166)} & \makecell[l]{1.62\\(0.99, 2.64)}\\
\addlinespace
Communities of Color vs White Non-Hispanic & Day 57 & Vaccine & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{5991417\\(4527248, 7929117)} & \makecell[l]{4608987\\(3338577, 6362819)} & \makecell[l]{1.30\\(0.85, 1.99)}\\
Communities of Color vs White Non-Hispanic & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID50 & \makecell[l]{7086\\(4582, 10956)} & \makecell[l]{4550\\(2471, 8378)} & \makecell[l]{1.56\\(0.74, 3.30)}\\
Communities of Color vs White Non-Hispanic & Day 57 & Vaccine & Positive & Pseudovirus-nAb ID80 & \makecell[l]{8885\\(5903, 13374)} & \makecell[l]{7994\\(4646, 13757)} & \makecell[l]{1.11\\(0.56, 2.19)}\\
Communities of Color vs White Non-Hispanic & Day 57 & Placebo & Negative & Anti RBD IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{0.99\\(0.98, 1.01)}\\
Communities of Color vs White Non-Hispanic & Day 57 & Placebo & Negative & Anti Spike IgG (IU/ml) & \makecell[l]{10\\(10, 10)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{1.00\\(1.00, 1.00)}\\
\addlinespace
Communities of Color vs White Non-Hispanic & Day 57 & Placebo & Negative & Pseudovirus-nAb ID50 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{1.01\\(0.99, 1.03)}\\
Communities of Color vs White Non-Hispanic & Day 57 & Placebo & Negative & Pseudovirus-nAb ID80 & \makecell[l]{5\\(5, 5)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{0.98\\(0.96, 1.01)}\\
Communities of Color vs White Non-Hispanic & Day 57 & Placebo & Positive & Anti RBD IgG (IU/ml) & \makecell[l]{397884\\(256621, 616908)} & \makecell[l]{393045\\(287516, 537306)} & \makecell[l]{1.01\\(0.59, 1.73)}\\
Communities of Color vs White Non-Hispanic & Day 57 & Placebo & Positive & Anti Spike IgG (IU/ml) & \makecell[l]{734879\\(489927, 1102301)} & \makecell[l]{674526\\(485396, 937351)} & \makecell[l]{1.09\\(0.65, 1.84)}\\
Communities of Color vs White Non-Hispanic & Day 57 & Placebo & Positive & Pseudovirus-nAb ID50 & \makecell[l]{684\\(382, 1222)} & \makecell[l]{575\\(371, 892)} & \makecell[l]{1.19\\(0.57, 2.46)}\\
\addlinespace
Communities of Color vs White Non-Hispanic & Day 57 & Placebo & Positive & Pseudovirus-nAb ID80 & \makecell[l]{1409\\(809, 2454)} & \makecell[l]{1478\\(953, 2292)} & \makecell[l]{0.95\\(0.47, 1.93)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item  
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{2.7cm}lllllll}
\caption{\label{tab:tabs}Table 8a. Differences in the responder rates, 2FRs, 4FRs between 
      the vaccine arm and the placebo arm by All participants}\\
\toprule
Group & Visit & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & Comparison & Responder & \% 2-Fold Rise & \% 4-Fold Rise\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Group & Visit & \makecell[l]{Baseline\\SARS-CoV-2} & Marker & Comparison & Responder & \% 2-Fold Rise & \% 4-Fold Rise\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
 & Day 29 & Negative & Anti RBD IgG (IU/ml) & Vaccine vs Placebo & \makecell[l]{100\%\\(100\%, 100\%)} & \makecell[l]{100\%\\(100\%, 100\%)} & \makecell[l]{100\%\\(100\%, 100\%)}\\
 & Day 29 & Negative & Anti Spike IgG (IU/ml) & Vaccine vs Placebo & \makecell[l]{100\%\\(100\%, 100\%)} & \makecell[l]{100\%\\(100\%, 100\%)} & \makecell[l]{100\%\\(100\%, 100\%)}\\
 & Day 29 & Negative & Pseudovirus-nAb ID50 & Vaccine vs Placebo & \makecell[l]{87.1\%\\(82.7\%, 90\%)} & \makecell[l]{87.5\%\\(83.2\%, 90.4\%)} & \makecell[l]{81.8\%\\(77.9\%, 85.1\%)}\\
 & Day 29 & Negative & Pseudovirus-nAb ID80 & Vaccine vs Placebo & \makecell[l]{93\%\\(87.4\%, 95.1\%)} & \makecell[l]{93\%\\(87.4\%, 95.1\%)} & \makecell[l]{87.3\%\\(80.6\%, 90.2\%)}\\
 & Day 29 & Positive & Anti RBD IgG (IU/ml) & Vaccine vs Placebo & \makecell[l]{0\%\\(0\%, 0\%)} & \makecell[l]{0\%\\(0\%, 0\%)} & \makecell[l]{0\%\\(0\%, 0\%)}\\
\addlinespace
 & Day 29 & Positive & Anti Spike IgG (IU/ml) & Vaccine vs Placebo & \makecell[l]{0\%\\(0\%, 0\%)} & \makecell[l]{0\%\\(0\%, 0\%)} & \makecell[l]{0\%\\(0\%, 0\%)}\\
 & Day 29 & Positive & Pseudovirus-nAb ID50 & Vaccine vs Placebo & \makecell[l]{12.6\%\\(5.3\%, 20.1\%)} & \makecell[l]{12.3\%\\(5.1\%, 19.9\%)} & \makecell[l]{23.2\%\\(13.3\%, 32.3\%)}\\
 & Day 29 & Positive & Pseudovirus-nAb ID80 & Vaccine vs Placebo & \makecell[l]{5.5\%\\(-0.1\%, 11.6\%)} & \makecell[l]{5.4\%\\(-0.4\%, 11.5\%)} & \makecell[l]{9.9\%\\(3.5\%, 17\%)}\\
 & Day 57 & Negative & Anti RBD IgG (IU/ml) & Vaccine vs Placebo & \makecell[l]{99.4\%\\(96\%, 99.9\%)} & \makecell[l]{99.4\%\\(96\%, 99.9\%)} & \makecell[l]{100\%\\(100\%, 100\%)}\\
 & Day 57 & Negative & Anti Spike IgG (IU/ml) & Vaccine vs Placebo & \makecell[l]{100\%\\(100\%, 100\%)} & \makecell[l]{100\%\\(100\%, 100\%)} & \makecell[l]{100\%\\(100\%, 100\%)}\\
\addlinespace
 & Day 57 & Negative & Pseudovirus-nAb ID50 & Vaccine vs Placebo & \makecell[l]{98\%\\(95.7\%, 98.8\%)} & \makecell[l]{98\%\\(95.7\%, 98.8\%)} & \makecell[l]{97.4\%\\(95.6\%, 98.5\%)}\\
 & Day 57 & Negative & Pseudovirus-nAb ID80 & Vaccine vs Placebo & \makecell[l]{98.2\%\\(94.7\%, 99.1\%)} & \makecell[l]{98.2\%\\(94.7\%, 99.1\%)} & \makecell[l]{98.3\%\\(96.4\%, 99.2\%)}\\
 & Day 57 & Positive & Anti RBD IgG (IU/ml) & Vaccine vs Placebo & \makecell[l]{0\%\\(0\%, 0\%)} & \makecell[l]{0\%\\(0\%, 0\%)} & \makecell[l]{0\%\\(0\%, 0\%)}\\
 & Day 57 & Positive & Anti Spike IgG (IU/ml) & Vaccine vs Placebo & \makecell[l]{0\%\\(0\%, 0\%)} & \makecell[l]{0\%\\(0\%, 0\%)} & \makecell[l]{0\%\\(0\%, 0\%)}\\
 & Day 57 & Positive & Pseudovirus-nAb ID50 & Vaccine vs Placebo & \makecell[l]{4.1\%\\(1.7\%, 9.4\%)} & \makecell[l]{4.1\%\\(1.7\%, 9.4\%)} & \makecell[l]{7.7\%\\(4.1\%, 14\%)}\\
\addlinespace
 & Day 57 & Positive & Pseudovirus-nAb ID80 & Vaccine vs Placebo & \makecell[l]{2\%\\(0.6\%, 6.8\%)} & \makecell[l]{2\%\\(0.6\%, 6.8\%)} & \makecell[l]{2.5\%\\(0.9\%, 6.8\%)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item 
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{1cm}lllllllll}
\caption{\label{tab:tabs}Table 9. Antibody levels in the baseline SARS-CoV-2
      negative per-protocol cohort (vaccine vs. placebo)}\\
\toprule
\multicolumn{2}{c}{ } & \multicolumn{8}{c}{Baseline SARS-CoV-2 Negative} \\
\cmidrule(l{3pt}r{3pt}){3-10}
\multicolumn{2}{c}{ } & \multicolumn{3}{c}{Vaccine} & \multicolumn{3}{c}{Placebo} & \multicolumn{2}{c}{Comparison} \\
\cmidrule(l{3pt}r{3pt}){3-5} \cmidrule(l{3pt}r{3pt}){6-8} \cmidrule(l{3pt}r{3pt}){9-10}
Visit & Marker & N & Resp rate & GMT/GMC & N & Resp rate & GMT/GMC & \makecell[l]{Resp Rate\\Difference} & \makecell[l]{GMTR/\\GMCR}\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Visit & Marker & N & Resp rate & GMT/GMC & N & Resp rate & GMT/GMC & \makecell[l]{Resp Rate\\Difference} & \makecell[l]{GMTR/\\GMCR}\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
Day 29 & Anti RBD IgG (IU/ml) & 914 & \makecell[l]{13295/13295 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{22926\\(19863, 26460)} & 163 & \makecell[l]{0/13359 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{100\%\\(100\%, 100\%)} & \makecell[l]{2292.58\\(1986.35, 2646.03)}\\
Day 29 & Anti Spike IgG (IU/ml) & 914 & \makecell[l]{13295/13295 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{40963\\(36741, 45671)} & 163 & \makecell[l]{0/13359 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{100\%\\(100\%, 100\%)} & \makecell[l]{4096.31\\(3674.06, 4567.08)}\\
Day 29 & Pseudovirus-nAb ID50 & 914 & \makecell[l]{11733.1/13295 = 88.3\%\\(84.7\%, 91.0\%)} & \makecell[l]{106\\(91, 125)} & 163 & \makecell[l]{149.5/13359 = 1.1\%\\(0.3\%, 3.8\%)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{87.1\%\\(82.7\%, 90\%)} & \makecell[l]{21.04\\(17.92, 24.71)}\\
Day 29 & Pseudovirus-nAb ID80 & 914 & \makecell[l]{12521.7/13295 = 94.2\%\\(91.6\%, 96.0\%)} & \makecell[l]{189\\(161, 222)} & 163 & \makecell[l]{160.7/13359 = 1.2\%\\(0.2\%, 6.1\%)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{93\%\\(87.4\%, 95.1\%)} & \makecell[l]{37.14\\(31.48, 43.81)}\\
Day 57 & Anti RBD IgG (IU/ml) & 914 & \makecell[l]{13295/13295 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{966160\\(823437, 1133621)} & 163 & \makecell[l]{76.3/13359 = 0.6\%\\(0.1\%, 4.0\%)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{99.4\%\\(96\%, 99.9\%)} & \makecell[l]{96216.76\\(81986.55, 112916.89)}\\
\addlinespace
Day 57 & Anti Spike IgG (IU/ml) & 914 & \makecell[l]{13295/13295 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{2087965\\(1831068, 2380904)} & 163 & \makecell[l]{0/13359 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{100\%\\(100\%, 100\%)} & \makecell[l]{208796.50\\(183106.81, 238090.43)}\\
Day 57 & Pseudovirus-nAb ID50 & 914 & \makecell[l]{13159.4/13295 = 99.0\%\\(98.0\%, 99.5\%)} & \makecell[l]{1497\\(1228, 1825)} & 163 & \makecell[l]{131.9/13359 = 1.0\%\\(0.3\%, 3.0\%)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{98\%\\(95.7\%, 98.8\%)} & \makecell[l]{297.04\\(243.64, 362.15)}\\
Day 57 & Pseudovirus-nAb ID80 & 914 & \makecell[l]{13174.8/13295 = 99.1\%\\(97.1\%, 99.7\%)} & \makecell[l]{2223\\(1809, 2733)} & 163 & \makecell[l]{120.7/13359 = 0.9\%\\(0.2\%, 3.8\%)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{98.2\%\\(94.7\%, 99.1\%)} & \makecell[l]{440.71\\(358.41, 541.91)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item 
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{1cm}lllllllll}
\caption{\label{tab:tabs}Table 10. Antibody levels in the baseline SARS-CoV-2
      positive per-protocol cohort (vaccine vs. placebo)}\\
\toprule
\multicolumn{2}{c}{ } & \multicolumn{8}{c}{Baseline SARS-CoV-2 Positive} \\
\cmidrule(l{3pt}r{3pt}){3-10}
\multicolumn{2}{c}{ } & \multicolumn{3}{c}{Vaccine} & \multicolumn{3}{c}{Placebo} & \multicolumn{2}{c}{Comparison} \\
\cmidrule(l{3pt}r{3pt}){3-5} \cmidrule(l{3pt}r{3pt}){6-8} \cmidrule(l{3pt}r{3pt}){9-10}
Visit & Marker & N & Resp rate & GMT/GMC & N & Resp rate & GMT/GMC & \makecell[l]{Resp Rate\\Difference} & \makecell[l]{GMTR/\\GMCR}\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Visit & Marker & N & Resp rate & GMT/GMC & N & Resp rate & GMT/GMC & \makecell[l]{Resp Rate\\Difference} & \makecell[l]{GMTR/\\GMCR}\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
Day 29 & Anti RBD IgG (IU/ml) & 274 & \makecell[l]{1432/1432 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{36133\\(28182, 46328)} & 270 & \makecell[l]{1357/1357 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{12861\\(10150, 16296)} & \makecell[l]{0\%\\(0\%, 0\%)} & \makecell[l]{2.81\\(1.99, 3.96)}\\
Day 29 & Anti Spike IgG (IU/ml) & 274 & \makecell[l]{1432/1432 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{79981\\(65041, 98352)} & 270 & \makecell[l]{1357/1357 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{18191\\(15159, 21829)} & \makecell[l]{0\%\\(0\%, 0\%)} & \makecell[l]{4.40\\(3.34, 5.79)}\\
Day 29 & Pseudovirus-nAb ID50 & 274 & \makecell[l]{1383.1/1432 = 96.6\%\\(91.6\%, 98.7\%)} & \makecell[l]{186\\(142, 243)} & 270 & \makecell[l]{1139.8/1357 = 84.0\%\\(76.8\%, 89.3\%)} & \makecell[l]{51\\(40, 66)} & \makecell[l]{12.6\%\\(5.3\%, 20.1\%)} & \makecell[l]{3.61\\(2.50, 5.22)}\\
Day 29 & Pseudovirus-nAb ID80 & 274 & \makecell[l]{1407.2/1432 = 98.3\%\\(93.8\%, 99.5\%)} & \makecell[l]{420\\(314, 560)} & 270 & \makecell[l]{1258.5/1357 = 92.7\%\\(86.8\%, 96.1\%)} & \makecell[l]{129\\(98, 169)} & \makecell[l]{5.5\%\\(-0.1\%, 11.6\%)} & \makecell[l]{3.25\\(2.19, 4.83)}\\
Day 57 & Anti RBD IgG (IU/ml) & 274 & \makecell[l]{1432/1432 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{2298869\\(1785648, 2959596)} & 270 & \makecell[l]{1357/1357 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{382614\\(299829, 488256)} & \makecell[l]{0\%\\(0\%, 0\%)} & \makecell[l]{6.01\\(4.23, 8.54)}\\
\addlinespace
Day 57 & Anti Spike IgG (IU/ml) & 274 & \makecell[l]{1432/1432 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{5346334\\(4339333, 6587023)} & 270 & \makecell[l]{1357/1357 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{676872\\(531354, 862241)} & \makecell[l]{0\%\\(0\%, 0\%)} & \makecell[l]{7.90\\(5.74, 10.87)}\\
Day 57 & Pseudovirus-nAb ID50 & 274 & \makecell[l]{1432/1432 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{5680\\(3863, 8351)} & 270 & \makecell[l]{1301.8/1357 = 95.9\%\\(90.6\%, 98.3\%)} & \makecell[l]{566\\(409, 783)} & \makecell[l]{4.1\%\\(1.7\%, 9.4\%)} & \makecell[l]{10.04\\(6.07, 16.62)}\\
Day 57 & Pseudovirus-nAb ID80 & 274 & \makecell[l]{1432/1432 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{7837\\(5545, 11076)} & 270 & \makecell[l]{1330.1/1357 = 98.0\%\\(93.2\%, 99.4\%)} & \makecell[l]{1324\\(937, 1870)} & \makecell[l]{2\%\\(0.6\%, 6.8\%)} & \makecell[l]{5.92\\(3.63, 9.65)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item 
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{1cm}lllllllll}
\caption{\label{tab:tabs}Table 11. Antibody levels in the per-protocol cohort
      (vaccine recipients)}\\
\toprule
\multicolumn{2}{c}{ } & \multicolumn{8}{c}{Vaccine Recipients} \\
\cmidrule(l{3pt}r{3pt}){3-10}
\multicolumn{2}{c}{ } & \multicolumn{3}{c}{Baseline SARS-CoV-2 Positive} & \multicolumn{3}{c}{Baseline SARS-CoV-2 Negative} & \multicolumn{2}{c}{Comparison} \\
\cmidrule(l{3pt}r{3pt}){3-5} \cmidrule(l{3pt}r{3pt}){6-8} \cmidrule(l{3pt}r{3pt}){9-10}
Visit & Marker & N & Resp rate & GMT/GMC & N & Resp rate & GMT/GMC & \makecell[l]{Resp Rate\\Difference} & \makecell[l]{GMTR/\\GMCR}\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Visit & Marker & N & Resp rate & GMT/GMC & N & Resp rate & GMT/GMC & \makecell[l]{Resp Rate\\Difference} & \makecell[l]{GMTR/\\GMCR}\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
Day 29 & Anti RBD IgG (IU/ml) & 274 & \makecell[l]{1432/1432 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{36133\\(28182, 46328)} & 914 & \makecell[l]{13295/13295 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{22926\\(19863, 26460)} & \makecell[l]{0\%\\(0\%, 0\%)} & \makecell[l]{1.58\\(1.18, 2.10)}\\
Day 29 & Anti Spike IgG (IU/ml) & 274 & \makecell[l]{1432/1432 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{79981\\(65041, 98352)} & 914 & \makecell[l]{13295/13295 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{40963\\(36741, 45671)} & \makecell[l]{0\%\\(0\%, 0\%)} & \makecell[l]{1.95\\(1.55, 2.47)}\\
Day 29 & Pseudovirus-nAb ID50 & 274 & \makecell[l]{1383.1/1432 = 96.6\%\\(91.6\%, 98.7\%)} & \makecell[l]{186\\(142, 243)} & 914 & \makecell[l]{11733.1/13295 = 88.3\%\\(84.7\%, 91.0\%)} & \makecell[l]{106\\(91, 125)} & \makecell[l]{8.3\%\\(2.6\%, 12.4\%)} & \makecell[l]{1.75\\(1.28, 2.39)}\\
Day 29 & Pseudovirus-nAb ID80 & 274 & \makecell[l]{1407.2/1432 = 98.3\%\\(93.8\%, 99.5\%)} & \makecell[l]{420\\(314, 560)} & 914 & \makecell[l]{12521.7/13295 = 94.2\%\\(91.6\%, 96.0\%)} & \makecell[l]{189\\(161, 222)} & \makecell[l]{4.1\%\\(-0.8\%, 7\%)} & \makecell[l]{2.22\\(1.59, 3.09)}\\
Day 57 & Anti RBD IgG (IU/ml) & 274 & \makecell[l]{1432/1432 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{2298869\\(1785648, 2959596)} & 914 & \makecell[l]{13295/13295 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{966160\\(823437, 1133621)} & \makecell[l]{0\%\\(0\%, 0\%)} & \makecell[l]{2.38\\(1.76, 3.21)}\\
\addlinespace
Day 57 & Anti Spike IgG (IU/ml) & 274 & \makecell[l]{1432/1432 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{5346334\\(4339333, 6587023)} & 914 & \makecell[l]{13295/13295 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{2087965\\(1831068, 2380904)} & \makecell[l]{0\%\\(0\%, 0\%)} & \makecell[l]{2.56\\(2.00, 3.28)}\\
Day 57 & Pseudovirus-nAb ID50 & 274 & \makecell[l]{1432/1432 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{5680\\(3863, 8351)} & 914 & \makecell[l]{13159.4/13295 = 99.0\%\\(98.0\%, 99.5\%)} & \makecell[l]{1497\\(1228, 1825)} & \makecell[l]{1\%\\(0.5\%, 2\%)} & \makecell[l]{3.79\\(2.46, 5.85)}\\
Day 57 & Pseudovirus-nAb ID80 & 274 & \makecell[l]{1432/1432 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{7837\\(5545, 11076)} & 914 & \makecell[l]{13174.8/13295 = 99.1\%\\(97.1\%, 99.7\%)} & \makecell[l]{2223\\(1809, 2733)} & \makecell[l]{0.9\%\\(0.3\%, 2.9\%)} & \makecell[l]{3.53\\(2.36, 5.27)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage

\begin{ThreePartTable}
\begin{TableNotes}
\item 
\end{TableNotes}
\begin{longtable}[t]{>{\raggedright\arraybackslash}p{1cm}lllllllll}
\caption{\label{tab:tabs}Table 12. Antibody levels in the per-protocol cohort
      (placebo recipients)}\\
\toprule
\multicolumn{2}{c}{ } & \multicolumn{8}{c}{Placebo Recipients} \\
\cmidrule(l{3pt}r{3pt}){3-10}
\multicolumn{2}{c}{ } & \multicolumn{3}{c}{Baseline SARS-CoV-2 Positive} & \multicolumn{3}{c}{Baseline SARS-CoV-2 Negative} & \multicolumn{2}{c}{Comparison} \\
\cmidrule(l{3pt}r{3pt}){3-5} \cmidrule(l{3pt}r{3pt}){6-8} \cmidrule(l{3pt}r{3pt}){9-10}
Visit & Marker & N & Resp rate & GMT/GMC & N & Resp rate & GMT/GMC & \makecell[l]{Resp Rate\\Difference} & GMTR/GMCR\\
\midrule
\endfirsthead
\caption[]{\textit{(continued)}}\\
\toprule
Visit & Marker & N & Resp rate & GMT/GMC & N & Resp rate & GMT/GMC & \makecell[l]{Resp Rate\\Difference} & GMTR/GMCR\\
\midrule
\endhead

\endfoot
\bottomrule
\insertTableNotes
\endlastfoot
Day 29 & Anti RBD IgG (IU/ml) & 270 & \makecell[l]{1357/1357 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{12861\\(10150, 16296)} & 163 & \makecell[l]{0/13359 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{100\%\\(100\%, 100\%)} & \makecell[l]{1286.10\\(1015.03, 1629.57)}\\
Day 29 & Anti Spike IgG (IU/ml) & 270 & \makecell[l]{1357/1357 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{18191\\(15159, 21829)} & 163 & \makecell[l]{0/13359 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{100\%\\(100\%, 100\%)} & \makecell[l]{1819.07\\(1515.87, 2182.92)}\\
Day 29 & Pseudovirus-nAb ID50 & 270 & \makecell[l]{1139.8/1357 = 84.0\%\\(76.8\%, 89.3\%)} & \makecell[l]{51\\(40, 66)} & 163 & \makecell[l]{149.5/13359 = 1.1\%\\(0.3\%, 3.8\%)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{82.9\%\\(75.2\%, 88.2\%)} & \makecell[l]{10.18\\(7.90, 13.11)}\\
Day 29 & Pseudovirus-nAb ID80 & 270 & \makecell[l]{1258.5/1357 = 92.7\%\\(86.8\%, 96.1\%)} & \makecell[l]{129\\(98, 169)} & 163 & \makecell[l]{160.7/13359 = 1.2\%\\(0.2\%, 6.1\%)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{91.5\%\\(83.8\%, 95.1\%)} & \makecell[l]{25.36\\(19.29, 33.34)}\\
Day 57 & Anti RBD IgG (IU/ml) & 270 & \makecell[l]{1357/1357 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{382614\\(299829, 488256)} & 163 & \makecell[l]{76.3/13359 = 0.6\%\\(0.1\%, 4.0\%)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{99.4\%\\(96\%, 99.9\%)} & \makecell[l]{38103.25\\(29854.93, 48630.43)}\\
\addlinespace
Day 57 & Anti Spike IgG (IU/ml) & 270 & \makecell[l]{1357/1357 = 100.0\%\\(100.0\%, 100.0\%)} & \makecell[l]{676872\\(531354, 862241)} & 163 & \makecell[l]{0/13359 = 0.0\%\\(0.0\%, 0.0\%)} & \makecell[l]{10\\(10, 10)} & \makecell[l]{100\%\\(100\%, 100\%)} & \makecell[l]{67687.19\\(53135.41, 86224.15)}\\
Day 57 & Pseudovirus-nAb ID50 & 270 & \makecell[l]{1301.8/1357 = 95.9\%\\(90.6\%, 98.3\%)} & \makecell[l]{566\\(409, 783)} & 163 & \makecell[l]{131.9/13359 = 1.0\%\\(0.3\%, 3.0\%)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{94.9\%\\(89.3\%, 97.4\%)} & \makecell[l]{112.24\\(81.10, 155.32)}\\
Day 57 & Pseudovirus-nAb ID80 & 270 & \makecell[l]{1330.1/1357 = 98.0\%\\(93.2\%, 99.4\%)} & \makecell[l]{1324\\(937, 1870)} & 163 & \makecell[l]{120.7/13359 = 0.9\%\\(0.2\%, 3.8\%)} & \makecell[l]{5\\(5, 5)} & \makecell[l]{97.1\%\\(91.5\%, 98.7\%)} & \makecell[l]{262.45\\(185.80, 370.71)}\\*
\end{longtable}
\end{ThreePartTable}


\clearpage
\end{landscape}
\newgeometry{margin=1in}

\hypertarget{immuno-graphical}{%
\chapter{Graphical Description of Immunogenicity Data}\label{immuno-graphical}}

\hypertarget{pairs-plots-of-antibody-markers-for-overall-per-protocal-cohort}{%
\section{Pairs plots of antibody markers for overall per-protocal cohort}\label{pairs-plots-of-antibody-markers-for-overall-per-protocal-cohort}}

\hypertarget{baseline-sars-cov-2-negative}{%
\subsection{Baseline SARS-CoV-2 Negative}\label{baseline-sars-cov-2-negative}}

\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/pairs_Day29_Markers_BaselineNeg_vaccine_arm_mock} 

}

\caption{Pair plots of D29 Ab markers: baseline negative vaccine arm}\label{fig:unnamed-chunk-5}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/pairs_Day57_Markers_BaselineNeg_vaccine_arm_mock} 

}

\caption{Pair plots of D57 Ab markers: baseline negative vaccine arm}\label{fig:unnamed-chunk-6}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/pairs_Delta29overB_Markers_BaselineNeg_vaccine_arm_mock} 

}

\caption{Pair plots of D29 fold-rise over D1 Ab markers: baseline negative vaccine arm}\label{fig:unnamed-chunk-7}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/pairs_Delta57overB_Markers_BaselineNeg_vaccine_arm_mock} 

}

\caption{Pair plots of D57 fold-rise over D1 Ab markers: baseline negative vaccine arm}\label{fig:unnamed-chunk-8}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/pairs_bindSpike_by_times_BaselineNeg_vaccine_mock} 

}

\caption{Pair plots of D1, D29 and D57 Binding Antibody to Spike: baseline negative vaccine arm}\label{fig:unnamed-chunk-9}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/pairs_bindRBD_by_times_BaselineNeg_vaccine_mock} 

}

\caption{Pair plots of D1, D29 and D57 Binding Antibody to RBD: baseline negative vaccine arm}\label{fig:unnamed-chunk-10}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/pairs_pseudoneutid50_by_times_BaselineNeg_vaccine_mock} 

}

\caption{Pair plots of D1, D29 and D57 PsV Neutralization 50\% Titer: baseline negative vaccine arm}\label{fig:unnamed-chunk-11}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/pairs_pseudoneutid80_by_times_BaselineNeg_vaccine_mock} 

}

\caption{Pair plots of D1, D29 and D57 PsV Neutralization 80\% Titer: Baseline negative vaccine arm}\label{fig:unnamed-chunk-12}
\end{figure}

\clearpage

\hypertarget{baseline-sars-cov-2-positive}{%
\subsection{Baseline SARS-CoV-2 Positive}\label{baseline-sars-cov-2-positive}}

\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/pairs_Day29_Markers_BaselinePos_vaccine_arm_mock} 

}

\caption{Pair plots of D29 Ab markers: baseline positive vaccine arm}\label{fig:unnamed-chunk-13}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/pairs_Day57_Markers_BaselinePos_vaccine_arm_mock} 

}

\caption{Pair plots of D57 Ab markers: baseline positive vaccine arm}\label{fig:unnamed-chunk-14}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/pairs_Delta29overB_Markers_BaselinePos_vaccine_arm_mock} 

}

\caption{Pair plots of D29 fold-rise over D1 Ab markers: baseline positive vaccine arm}\label{fig:unnamed-chunk-15}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/pairs_Delta57overB_Markers_BaselinePos_vaccine_arm_mock} 

}

\caption{Pair plots of D57 fold-rise over D1 Ab markers: baseline positive vaccine arm}\label{fig:unnamed-chunk-16}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/pairs_bindSpike_by_times_BaselineNeg_placebo_mock} 

}

\caption{Pair plots of D1, D29 and D57 Binding Antibody to Spike: baseline negative placebo arm}\label{fig:unnamed-chunk-17}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/pairs_bindRBD_by_times_BaselineNeg_placebo_mock} 

}

\caption{Pair plots of D1, D29 and D57 Binding Antibody to RBD: baseline negative placebo arm}\label{fig:unnamed-chunk-18}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/pairs_pseudoneutid50_by_times_BaselineNeg_placebo_mock} 

}

\caption{Pair plots of D1, D29 and D57 PsV Neutralization 50\% Titer: baseline negative placebo arm}\label{fig:unnamed-chunk-19}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/pairs_pseudoneutid80_by_times_BaselineNeg_placebo_mock} 

}

\caption{Pair plots of D1, D29 and D57 PsV Neutralization 80\% Titer: Baseline negative placebo arm}\label{fig:unnamed-chunk-20}
\end{figure}

\clearpage

\hypertarget{rcdf-plots-of-antibody-markers-for-overall-per-protocol-cohort}{%
\section{RCDF plots of antibody markers for overall per-protocol cohort}\label{rcdf-plots-of-antibody-markers-for-overall-per-protocol-cohort}}

\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/Marker_RCDF_Day29_trt_both_bstatus_both_mock} 

}

\caption{RCDF plots for D29 Ab markers: by baseline status x randomization arm}\label{fig:unnamed-chunk-21}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/Marker_RCDF_Day57_trt_both_bstatus_both_mock} 

}

\caption{RCDF plots for D57 Ab markers: by baseline status x randomization arm}\label{fig:unnamed-chunk-22}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/Marker_RCDF_Delta29overB_trt_both_bstatus_both_mock} 

}

\caption{RCDF plots for D29 fold-rise over D1 Ab markers: by baseline status x randomization arm}\label{fig:unnamed-chunk-23}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/Marker_RCDF_Delta57overB_trt_both_bstatus_both_mock} 

}

\caption{RCDF plots for D57 fold-rise over D1 Ab markers: by baseline status x randomization arm}\label{fig:unnamed-chunk-24}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/Marker_Rcdf_Day29_trt_vaccine_bstatus_both_mock} 

}

\caption{RCDF plots for D29 Ab markers: by baseline status for the vaccine arm}\label{fig:unnamed-chunk-25}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/Marker_Rcdf_Day57_trt_vaccine_bstatus_both_mock} 

}

\caption{RCDF plots for D57 Ab markers: by baseline status for the vaccine arm}\label{fig:unnamed-chunk-26}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/Marker_Rcdf_Delta29overB_trt_vaccine_bstatus_both_mock} 

}

\caption{RCDF plots for D29 over D1 fold-rise Ab markers: by baseline status for the vaccine arm}\label{fig:unnamed-chunk-27}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/Marker_Rcdf_Delta57overB_trt_vaccine_bstatus_both_mock} 

}

\caption{RCDF plots for D57 fold-rise over D1 Ab markers: by baseline status for the vaccine arm}\label{fig:unnamed-chunk-28}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/Marker_Rcdf_Day29_trt_vaccine_bstatus_Neg_mock} 

}

\caption{RCDF plots for D29 Ab markers: baseline negative vaccine arm}\label{fig:unnamed-chunk-29}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/Marker_Rcdf_Day57_trt_vaccine_bstatus_Neg_mock} 

}

\caption{RCDF plots for D57 Ab markers: baseline negative vaccine arm}\label{fig:unnamed-chunk-30}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/Marker_Rcdf_Delta29overB_trt_vaccine_bstatus_Neg_mock} 

}

\caption{RCDF plots for D29 fold-rise over D1 Ab markers: baseline negative vaccine arm}\label{fig:unnamed-chunk-31}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/Marker_Rcdf_Delta57overB_trt_vaccine_bstatus_Neg_mock} 

}

\caption{RCDF plots for D57 fold-rise over D1 Ab markers: baseline negative vaccine arm}\label{fig:unnamed-chunk-32}
\end{figure}

\clearpage

\hypertarget{scatter-plots-of-antibody-markers-versus-age-for-overall-per-protocol-cohort}{%
\section{Scatter plots of antibody markers versus age for overall per-protocol cohort}\label{scatter-plots-of-antibody-markers-versus-age-for-overall-per-protocol-cohort}}

\hypertarget{baseline-sars-cov-2-negative-1}{%
\subsection{Baseline SARS-CoV-2 negative}\label{baseline-sars-cov-2-negative-1}}

\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/scatter_Day29_vs_age_trt_Vaccine_BaselineNeg_mock} 

}

\caption{Scatter plots for D29 Ab markers vs. age: baseline negative vaccine arm}\label{fig:unnamed-chunk-33}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/scatter_Day57_vs_age_trt_Vaccine_BaselineNeg_mock} 

}

\caption{Scatter plots for D57 Ab markers vs. age: baseline negative vaccine arm}\label{fig:unnamed-chunk-34}
\end{figure}

\clearpage

\hypertarget{baseline-sars-cov-2-positive-1}{%
\subsection{Baseline SARS-CoV-2 positive}\label{baseline-sars-cov-2-positive-1}}

\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/scatter_Day29_vs_age_trt_Vaccine_BaselinePos_mock} 

}

\caption{Scatter plots for D29 Ab markers vs. age: baseline positive vaccine arm}\label{fig:unnamed-chunk-35}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/scatter_Day57_vs_age_trt_Vaccine_BaselinePos_mock} 

}

\caption{Scatter plots for D57 Ab markers vs. age: baseline positive vaccine arm}\label{fig:unnamed-chunk-36}
\end{figure}

\clearpage

\hypertarget{box-plots-of-antibody-markers-for-overall-per-protocol-cohort}{%
\section{Box plots of antibody markers for overall per-protocol cohort}\label{box-plots-of-antibody-markers-for-overall-per-protocol-cohort}}

\hypertarget{baseline-sars-cov-2-negative-2}{%
\subsection{Baseline SARS-CoV-2 negative}\label{baseline-sars-cov-2-negative-2}}

\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/boxplots_Day29_x_trt_BaselineNeg_mock} 

}

\caption{Boxplots of D29 Ab markers: baseline negative vaccine + placebo arms}\label{fig:unnamed-chunk-37}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/boxplots_Day57_x_trt_BaselineNeg_mock} 

}

\caption{Boxplots of D57 Ab markers: baseline negative vaccine + placebo arms}\label{fig:unnamed-chunk-38}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/boxplots_Delta29overB_x_trt_BaselineNeg_mock} 

}

\caption{Boxplots of D29 fold-rise over D1 Ab markers: baseline negative vaccine + placebo arms}\label{fig:unnamed-chunk-39}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/boxplots_Delta57overB_x_trt_BaselineNeg_mock} 

}

\caption{Boxplots of D57 fold-rise over D1 Ab markers: baseline negative vaccine + placebo arms}\label{fig:unnamed-chunk-40}
\end{figure}

\clearpage

\hypertarget{baseline-sars-cov-2-positive-2}{%
\subsection{Baseline SARS-CoV-2 positive}\label{baseline-sars-cov-2-positive-2}}

\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/boxplots_Day29_x_trt_BaselinePos_mock} 

}

\caption{Boxplots of D29 Ab markers: baseline positive vaccine + placebo arms}\label{fig:unnamed-chunk-41}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/boxplots_Day57_x_trt_BaselinePos_mock} 

}

\caption{Boxplots of D57 Ab markers: baseline positive vaccine + placebo arms}\label{fig:unnamed-chunk-42}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/boxplots_Delta29overB_x_trt_BaselinePos_mock} 

}

\caption{Boxplots of D29 fold-rise over D1 Ab markers: baseline positive vaccine + placebo arms}\label{fig:unnamed-chunk-43}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/boxplots_Delta57overB_x_trt_BaselinePos_mock} 

}

\caption{Boxplots of D57 fold-rise over D1 Ab markers: baseline positive vaccine + placebo arms}\label{fig:unnamed-chunk-44}
\end{figure}

\clearpage

\hypertarget{baseline-negative-vs.positive-vaccine-recipients}{%
\subsection{Baseline negative vs.~positive vaccine recipients}\label{baseline-negative-vs.positive-vaccine-recipients}}

\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/boxplots_Day29_x_bstatus_vaccine_arm_mock} 

}

\caption{Boxplots of D29 Ab markers: baseline positive + negative vaccine arm}\label{fig:unnamed-chunk-45}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/boxplots_Day57_x_bstatus_vaccine_arm_mock} 

}

\caption{Boxplots of D57 Ab markers: baseline positive + negative vaccine arm}\label{fig:unnamed-chunk-46}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/boxplots_Delta29overB_x_bstatus_vaccine_arm_mock} 

}

\caption{Boxplots of D29 fold-rise over D1 Ab markers: baseline positive + negative vaccine arm}\label{fig:unnamed-chunk-47}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/boxplots_Delta57overB_x_bstatus_vaccine_arm_mock} 

}

\caption{Boxplots of D57 fold-rise over D1 Ab markers: baseline positive + negative vaccine arm}\label{fig:unnamed-chunk-48}
\end{figure}

\clearpage

\hypertarget{baseline-negative-vs.positive-placebo-recipients}{%
\subsection{Baseline negative vs.~positive placebo recipients}\label{baseline-negative-vs.positive-placebo-recipients}}

\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/boxplots_Day29_x_bstatus_placebo_arm_mock} 

}

\caption{Boxplots of D29 Ab markers: baseline positive + negative placebo arm}\label{fig:unnamed-chunk-49}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/boxplots_Day57_x_bstatus_placebo_arm_mock} 

}

\caption{Boxplots of D57 Ab markers: baseline positive + negative placebo arm}\label{fig:unnamed-chunk-50}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/boxplots_Delta29overB_x_bstatus_placebo_arm_mock} 

}

\caption{Boxplots of D29 fold-rise over D1 Ab markers: baseline positive + negative placebo arm}\label{fig:unnamed-chunk-51}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/boxplots_Delta57overB_x_bstatus_placebo_arm_mock} 

}

\caption{Boxplots of D57 fold-rise over D1 Ab markers: baseline positive + negative placebo arm}\label{fig:unnamed-chunk-52}
\end{figure}

\clearpage

\hypertarget{spaghetti-plots-of-antibody-markers-over-time-for-the-overall-per-protocol-cohort}{%
\section{Spaghetti plots of antibody markers over time for the overall per-protocol cohort}\label{spaghetti-plots-of-antibody-markers-over-time-for-the-overall-per-protocol-cohort}}

\hypertarget{baseline-sars-cov-2-negative-3}{%
\subsection{Baseline SARS-CoV-2 negative}\label{baseline-sars-cov-2-negative-3}}

\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/spaghetti_plot_BaselineNeg_mock} 

}

\caption{Spaghetti plots of Ab markers over time: baseline negative vaccine + placebo arm}\label{fig:unnamed-chunk-53}
\end{figure}

\clearpage

\hypertarget{baseline-sars-cov-2-positive-3}{%
\subsection{Baseline SARS-CoV-2 positive}\label{baseline-sars-cov-2-positive-3}}

\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/spaghetti_plot_BaselinePos_mock} 

}

\caption{Spaghetti plots of Ab markers over time: baseline positive vaccine + placebo arm}\label{fig:unnamed-chunk-54}
\end{figure}

\clearpage

\hypertarget{rcdf-plots-of-antibody-markers-by-demographics-for-per-protocol-cohort}{%
\section{RCDF plots of antibody markers by demographics for per-protocol cohort}\label{rcdf-plots-of-antibody-markers-by-demographics-for-per-protocol-cohort}}

\hypertarget{baseline-sars-cov-2-negative-4}{%
\subsection{Baseline SARS-CoV-2 negative}\label{baseline-sars-cov-2-negative-4}}

\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day29_trt_vaccine_BaselineNeg_by_age_group_mock} 

}

\caption{RCDF plots for D29 Ab markers: baseline negative vaccine arm by age groups.}\label{fig:unnamed-chunk-55}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day57_trt_vaccine_BaselineNeg_by_age_group_mock} 

}

\caption{RCDF plots for D57 Ab markers: baseline negative vaccine arm by age groups.}\label{fig:unnamed-chunk-56}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta29overB_trt_vaccine_BaselineNeg_by_age_group_mock} 

}

\caption{RCDF plots for D29 fold-rise over D1 Ab markers: baseline negative vaccine arm by age groups.}\label{fig:unnamed-chunk-57}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta57overB_trt_vaccine_BaselineNeg_by_age_group_mock} 

}

\caption{RCDF plots for D57 fold-rise over D1 Ab markers: baseline negative vaccine arm by age groups.}\label{fig:unnamed-chunk-58}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day29_trt_vaccine_BaselineNeg_by_risk_group_mock} 

}

\caption{RCDF plots for D29 Ab markers: baseline negative vaccine arm by high-risk condition.}\label{fig:unnamed-chunk-59}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day57_trt_vaccine_BaselineNeg_by_risk_group_mock} 

}

\caption{RCDF plots for D57 Ab markers: baseline negative vaccine arm by high-risk condition.}\label{fig:unnamed-chunk-60}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta29overB_trt_vaccine_BaselineNeg_by_risk_group_mock} 

}

\caption{RCDF plots for D29 fold-rise over D1 Ab markers: baseline negative vaccine arm by high-risk condition.}\label{fig:unnamed-chunk-61}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta57overB_trt_vaccine_BaselineNeg_by_risk_group_mock} 

}

\caption{RCDF plots for D57 fold-rise over D1 Ab markers: baseline negative vaccine arm by high-risk condition.}\label{fig:unnamed-chunk-62}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day29_trt_vaccine_BaselineNeg_by_age_risk_group_mock} 

}

\caption{RCDF plots for D29 Ab markers: baseline negative vaccine arm by age and high-risk condition.}\label{fig:unnamed-chunk-63}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day57_trt_vaccine_BaselineNeg_by_age_risk_group_mock} 

}

\caption{RCDF plots for D57 Ab markers: baseline negative vaccine arm by age and high-risk condition.}\label{fig:unnamed-chunk-64}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta29overB_trt_vaccine_BaselineNeg_by_age_risk_group_mock} 

}

\caption{RCDF plots for D29 fold-rise over D1 Ab markers: baseline negative vaccine arm by age and high-risk condition.}\label{fig:unnamed-chunk-65}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta57overB_trt_vaccine_BaselineNeg_by_age_risk_group_mock} 

}

\caption{RCDF plots for D57 fold-rise over D1 Ab markers: baseline negative vaccine arm by age and high-risk condition.}\label{fig:unnamed-chunk-66}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day29_trt_vaccine_BaselineNeg_by_sex_group_mock} 

}

\caption{RCDF plots for D29 Ab markers: baseline negative vaccine arm by sex assigned at birth.}\label{fig:unnamed-chunk-67}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day57_trt_vaccine_BaselineNeg_by_sex_group_mock} 

}

\caption{RCDF plots for D57 Ab markers: baseline negative vaccine arm by sex assigned at birth.}\label{fig:unnamed-chunk-68}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta29overB_trt_vaccine_BaselineNeg_by_sex_group_mock} 

}

\caption{RCDF plots for D29 fold-rise over D1 Ab markers: baseline negative vaccine arm by sex assigned at birth.}\label{fig:unnamed-chunk-69}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta57overB_trt_vaccine_BaselineNeg_by_sex_group_mock} 

}

\caption{RCDF plots for D57 fold-rise over D1 Ab markers: baseline negative vaccine arm by sex assigned at birth.}\label{fig:unnamed-chunk-70}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day29_trt_vaccine_BaselineNeg_by_age_sex_group_mock} 

}

\caption{RCDF plots for D29 Ab markers: baseline negative vaccine arm by age and sex assigned at birth.}\label{fig:unnamed-chunk-71}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day57_trt_vaccine_BaselineNeg_by_age_sex_group_mock} 

}

\caption{RCDF plots for D57 Ab markers: baseline negative vaccine arm by age and sex assigned at birth.}\label{fig:unnamed-chunk-72}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta29overB_trt_vaccine_BaselineNeg_by_age_sex_group_mock} 

}

\caption{RCDF plots for D29 fold-rise over D1 Ab markers: baseline negative vaccine arm by age and sex assigned at birth.}\label{fig:unnamed-chunk-73}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta57overB_trt_vaccine_BaselineNeg_by_age_sex_group_mock} 

}

\caption{RCDF plots for D57 fold-rise over D1 Ab markers: baseline negative vaccine arm by age and sex at birth.}\label{fig:unnamed-chunk-74}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day29_trt_vaccine_BaselineNeg_by_ethnicity_mock} 

}

\caption{RCDF plots for D29 Ab markers: baseline negative vaccine arm by ethnicity.}\label{fig:unnamed-chunk-75}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day57_trt_vaccine_BaselineNeg_by_ethnicity_mock} 

}

\caption{RCDF plots for D57 Ab markers: baseline negative vaccine arm by ethnicity.}\label{fig:unnamed-chunk-76}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta29overB_trt_vaccine_BaselineNeg_by_ethnicity_mock} 

}

\caption{RCDF plots for D29 fold-rise over D1 Ab markers: baseline negative vaccine arm by ethnicity.}\label{fig:unnamed-chunk-77}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta29overB_trt_vaccine_BaselineNeg_by_ethnicity_mock} 

}

\caption{RCDF plots for D29 fold-rise over D1 Ab markers: baseline negative vaccine arm by ethnicity.}\label{fig:unnamed-chunk-78}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta57overB_trt_vaccine_BaselineNeg_by_ethnicity_mock} 

}

\caption{RCDF plots for D57 fold-rise over D1 Ab markers: baseline negative vaccine arm by ethnicity.}\label{fig:unnamed-chunk-79}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day29_trt_vaccine_BaselineNeg_by_race_mock} 

}

\caption{RCDF plots for D29 Ab markers: baseline negative vaccine arm by race.}\label{fig:unnamed-chunk-80}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day57_trt_vaccine_BaselineNeg_by_race_mock} 

}

\caption{RCDF plots for D57 Ab markers: baseline negative vaccine arm by race.}\label{fig:unnamed-chunk-81}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta29overB_trt_vaccine_BaselineNeg_by_race_mock} 

}

\caption{RCDF plots for D29 fold-rise over D1 Ab markers: baseline negative vaccine arm by race.}\label{fig:unnamed-chunk-82}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta57overB_trt_vaccine_BaselineNeg_by_race_mock} 

}

\caption{RCDF plots for D57 fold-rise over D1 Ab markers: baseline negative vaccine arm by race.}\label{fig:unnamed-chunk-83}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day29_trt_vaccine_BaselineNeg_by_minority_group_mock} 

}

\caption{RCDF plots for D29 Ab markers: baseline negative vaccine arm by dichotomous classification of race and ethnic group.}\label{fig:unnamed-chunk-84}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day57_trt_vaccine_BaselineNeg_by_minority_group_mock} 

}

\caption{RCDF plots for D57 Ab markers: baseline negative vaccine arm by dichotomous classification of race and ethnic group.}\label{fig:unnamed-chunk-85}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta29overB_trt_vaccine_BaselineNeg_by_minority_group_mock} 

}

\caption{RCDF plots for D29 fold-rise over D1 Ab markers: baseline negative vaccine arm by dichotomous classification of race and ethnic group.}\label{fig:unnamed-chunk-86}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta57overB_trt_vaccine_BaselineNeg_by_minority_group_mock} 

}

\caption{RCDF plots for D57 fold-rise over D1 Ab markers: baseline negative vaccine arm by dichotomous classification of race and ethnic group.}\label{fig:unnamed-chunk-87}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day29_trt_vaccine_BaselineNeg_by_age_minority_group_mock} 

}

\caption{RCDF plots for D29 Ab markers: baseline negative vaccine arm by age and dichotomous classification of race and ethnic group.}\label{fig:unnamed-chunk-88}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day57_trt_vaccine_BaselineNeg_by_age_minority_group_mock} 

}

\caption{RCDF plots for D57 Ab markers: baseline negative vaccine arm by age and dichotomous classification of race and ethnic group.}\label{fig:unnamed-chunk-89}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta29overB_trt_vaccine_BaselineNeg_by_age_minority_group_mock} 

}

\caption{RCDF plots for D29 fold-rise over D1 Ab markers: baseline negative vaccine arm by age and dichotomous classification of race and ethnic group.}\label{fig:unnamed-chunk-90}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta57overB_trt_vaccine_BaselineNeg_by_age_minority_group_mock} 

}

\caption{RCDF plots for D57 fold-rise over D1 Ab markers: baseline negative vaccine arm by age and dichotomous classification of race and ethnic group.}\label{fig:unnamed-chunk-91}
\end{figure}

\clearpage

\hypertarget{baseline-sars-cov-2-positive-4}{%
\subsection{Baseline SARS-CoV-2 positive}\label{baseline-sars-cov-2-positive-4}}

\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day29_trt_vaccine_BaselinePos_by_age_group_mock} 

}

\caption{RCDF plots for D29 Ab markers: baseline positive vaccine arm by age groups.}\label{fig:unnamed-chunk-92}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day57_trt_vaccine_BaselinePos_by_age_group_mock} 

}

\caption{RCDF plots for D57 Ab markers: baseline positive vaccine arm by age groups.}\label{fig:unnamed-chunk-93}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta29overB_trt_vaccine_BaselinePos_by_age_group_mock} 

}

\caption{RCDF plots for D29 fold-rise over D1 Ab markers: baseline positive vaccine arm by age groups.}\label{fig:unnamed-chunk-94}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta57overB_trt_vaccine_BaselinePos_by_age_group_mock} 

}

\caption{RCDF plots for D57 fold-rise over D1 Ab markers: baseline positive vaccine arm by age groups.}\label{fig:unnamed-chunk-95}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day29_trt_vaccine_BaselinePos_by_risk_group_mock} 

}

\caption{RCDF plots for D29 Ab markers: baseline positive vaccine arm by high-risk condition.}\label{fig:unnamed-chunk-96}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day57_trt_vaccine_BaselinePos_by_risk_group_mock} 

}

\caption{RCDF plots for D57 Ab markers: baseline positive vaccine arm by high-risk condition.}\label{fig:unnamed-chunk-97}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta29overB_trt_vaccine_BaselinePos_by_risk_group_mock} 

}

\caption{RCDF plots for D29 fold-rise over D1 Ab markers: baseline positive vaccine arm by high-risk condition.}\label{fig:unnamed-chunk-98}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta57overB_trt_vaccine_BaselinePos_by_risk_group_mock} 

}

\caption{RCDF plots for D57 fold-rise over D1 Ab markers: baseline positive vaccine arm by high-risk condition.}\label{fig:unnamed-chunk-99}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day29_trt_vaccine_BaselinePos_by_age_risk_group_mock} 

}

\caption{RCDF plots for D29 Ab markers: baseline positive vaccine arm by age and high-risk condition.}\label{fig:unnamed-chunk-100}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day57_trt_vaccine_BaselinePos_by_age_risk_group_mock} 

}

\caption{RCDF plots for D57 Ab markers: baseline positive vaccine arm by age and high-risk condition.}\label{fig:unnamed-chunk-101}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta29overB_trt_vaccine_BaselinePos_by_age_risk_group_mock} 

}

\caption{RCDF plots for D29 fold-rise over D1 Ab markers: baseline positive vaccine arm by age and high-risk condition.}\label{fig:unnamed-chunk-102}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta57overB_trt_vaccine_BaselinePos_by_age_risk_group_mock} 

}

\caption{RCDF plots for D57 fold-rise over D1 Ab markers: baseline positive vaccine arm by age and high-risk condition.}\label{fig:unnamed-chunk-103}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day29_trt_vaccine_BaselinePos_by_sex_group_mock} 

}

\caption{RCDF plots for D29 Ab markers: baseline positive vaccine arm by sex assigned at birth.}\label{fig:unnamed-chunk-104}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day57_trt_vaccine_BaselinePos_by_sex_group_mock} 

}

\caption{RCDF plots for D57 Ab markers: baseline positive vaccine arm by sex assigned at birth.}\label{fig:unnamed-chunk-105}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta29overB_trt_vaccine_BaselinePos_by_sex_group_mock} 

}

\caption{RCDF plots for D29 fold-rise over D1 Ab markers: baseline positive vaccine arm by sex assigned at birth.}\label{fig:unnamed-chunk-106}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta57overB_trt_vaccine_BaselinePos_by_sex_group_mock} 

}

\caption{RCDF plots for D57 fold-rise over D1 Ab markers: baseline positive vaccine arm by sex assigned at birth.}\label{fig:unnamed-chunk-107}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day29_trt_vaccine_BaselinePos_by_age_sex_group_mock} 

}

\caption{RCDF plots for D29 Ab markers: baseline positive vaccine arm by age and sex assigned at birth.}\label{fig:unnamed-chunk-108}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day57_trt_vaccine_BaselinePos_by_age_sex_group_mock} 

}

\caption{RCDF plots for D57 Ab markers: baseline positive vaccine arm by age and sex assigned at birth.}\label{fig:unnamed-chunk-109}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta29overB_trt_vaccine_BaselinePos_by_age_sex_group_mock} 

}

\caption{RCDF plots for D29 fold-rise over D1 Ab markers: baseline positive vaccine arm by age and sex assigned at birth.}\label{fig:unnamed-chunk-110}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta57overB_trt_vaccine_BaselinePos_by_age_sex_group_mock} 

}

\caption{RCDF plots for D57 fold-rise over D1 Ab markers: baseline positive vaccine arm by age and sex assigned at birth.}\label{fig:unnamed-chunk-111}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day29_trt_vaccine_BaselinePos_by_ethnicity_mock} 

}

\caption{RCDF plots for D29 Ab markers: baseline positive vaccine arm by ethnicity.}\label{fig:unnamed-chunk-112}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day57_trt_vaccine_BaselinePos_by_ethnicity_mock} 

}

\caption{RCDF plots for D57 Ab markers: baseline positive vaccine arm by ethnicity.}\label{fig:unnamed-chunk-113}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta29overB_trt_vaccine_BaselinePos_by_ethnicity_mock} 

}

\caption{RCDF plots for D29 fold-rise over D1 Ab markers: baseline positive vaccine arm by ethnicity.}\label{fig:unnamed-chunk-114}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta57overB_trt_vaccine_BaselinePos_by_ethnicity_mock} 

}

\caption{RCDF plots for D57 fold-rise over D1 Ab markers: baseline positive vaccine arm by ethnicity.}\label{fig:unnamed-chunk-115}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day29_trt_vaccine_BaselinePos_by_race_mock} 

}

\caption{RCDF plots for D29 Ab markers: baseline positive vaccine arm by race.}\label{fig:unnamed-chunk-116}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day57_trt_vaccine_BaselinePos_by_race_mock} 

}

\caption{RCDF plots for D57 Ab markers: baseline positive vaccine arm by race.}\label{fig:unnamed-chunk-117}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta29overB_trt_vaccine_BaselinePos_by_race_mock} 

}

\caption{RCDF plots for D29 fold-rise over D1 Ab markers: baseline positive vaccine arm by race.}\label{fig:unnamed-chunk-118}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta57overB_trt_vaccine_BaselinePos_by_race_mock} 

}

\caption{RCDF plots for D57 fold-rise over D1 Ab markers: baseline positive vaccine arm by race.}\label{fig:unnamed-chunk-119}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day29_trt_vaccine_BaselinePos_by_minority_group_mock} 

}

\caption{RCDF plots for D29 Ab markers: baseline positive vaccine arm by dichotomous classification of race and ethnic group.}\label{fig:unnamed-chunk-120}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day57_trt_vaccine_BaselinePos_by_minority_group_mock} 

}

\caption{RCDF plots for D57 Ab markers: baseline positive vaccine arm by dichotomous classification of race and ethnic group.}\label{fig:unnamed-chunk-121}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta29overB_trt_vaccine_BaselinePos_by_minority_group_mock} 

}

\caption{RCDF plots for D29 fold-rise over D1 Ab markers: baseline positive vaccine arm by dichotomous classification of race and ethnic group.}\label{fig:unnamed-chunk-122}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta57overB_trt_vaccine_BaselinePos_by_minority_group_mock} 

}

\caption{RCDF plots for D57 fold-rise over D1 Ab markers: baseline positive vaccine arm by dichotomous classification of race and ethnic group.}\label{fig:unnamed-chunk-123}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day29_trt_vaccine_BaselinePos_by_age_minority_group_mock} 

}

\caption{RCDF plots for D29 Ab markers: baseline positive vaccine arm by age and dichotomous classification of race and ethnic group.}\label{fig:unnamed-chunk-124}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Day57_trt_vaccine_BaselinePos_by_age_minority_group_mock} 

}

\caption{RCDF plots for D57 Ab markers: baseline positive vaccine arm by age and dichotomous classification of race and ethnic group.}\label{fig:unnamed-chunk-125}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta29overB_trt_vaccine_BaselinePos_by_age_minority_group_mock} 

}

\caption{RCDF plots for D29 fold-rise over D1 Ab markers: baseline positive vaccine arm by age and dichotomous classification of race and ethnic group.}\label{fig:unnamed-chunk-126}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/Marker_Rcdf_Delta57overB_trt_vaccine_BaselinePos_by_age_minority_group_mock} 

}

\caption{RCDF plots for D57 fold-rise over D1 Ab markers: baseline positive vaccine arm by age and dichotomous classification of race and ethnic group.}\label{fig:unnamed-chunk-127}
\end{figure}

\clearpage

\hypertarget{boxplots-of-antibody-markers-by-demographics-for-per-protocol-cohort}{%
\section{Boxplots of antibody markers by demographics for per-protocol cohort}\label{boxplots-of-antibody-markers-by-demographics-for-per-protocol-cohort}}

\hypertarget{baseline-sars-cov-2-negative-5}{%
\subsection{Baseline SARS-CoV-2 negative}\label{baseline-sars-cov-2-negative-5}}

\clearpage

\clearpage

\clearpage

\clearpage

\clearpage

\clearpage

\clearpage

\clearpage

\clearpage

\clearpage

\clearpage

\clearpage

\clearpage

\clearpage

\clearpage

\clearpage

\clearpage

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/boxplots_Delta29overB_BaselineNeg_trt_Vaccine_by_age_x_sex_group_mock} 

}

\caption{Boxplots of D29 fold-rise over D1 Ab markers: Baseline negative vaccine arm by age and sex assigned at birth.}\label{fig:unnamed-chunk-146}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/boxplots_Delta57overB_BaselineNeg_trt_Vaccine_by_age_x_sex_group_mock} 

}

\caption{Boxplots of D57 fold-rise over D1 Ab markers: Baseline negative vaccine arm by age and sex assigned at birth.}\label{fig:unnamed-chunk-147}
\end{figure}

\clearpage

\clearpage

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/boxplots_Delta29overB_BaselineNeg_trt_Vaccine_by_ethnicity_mock} 

}

\caption{Boxplots of D29 fold-rise over D1 Ab markers: Baseline negative vaccine arm by ethnicity.}\label{fig:unnamed-chunk-150}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/boxplots_Delta57overB_BaselineNeg_trt_Vaccine_by_ethnicity_mock} 

}

\caption{Boxplots of D57 fold-rise over D1 Ab markers: Baseline negative vaccine arm by ethnicity.}\label{fig:unnamed-chunk-151}
\end{figure}

\clearpage

\clearpage

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/boxplots_Delta29overB_BaselineNeg_trt_Vaccine_by_race_mock} 

}

\caption{Boxplots of D29 fold-rise over D1 Ab markers: Baseline negative vaccine arm by race.}\label{fig:unnamed-chunk-154}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/boxplots_Delta57overB_BaselineNeg_trt_Vaccine_by_race_mock} 

}

\caption{Boxplots of D57 fold-rise over D1 Ab markers: Baseline negative vaccine arm by race.}\label{fig:unnamed-chunk-155}
\end{figure}

\clearpage

\clearpage

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/boxplots_Delta29overB_BaselineNeg_trt_Vaccine_by_minority_group_mock} 

}

\caption{Boxplots of D29 fold-rise over D1 Ab markers: Baseline negative vaccine arm by dichotomous classification of race and ethnic group.}\label{fig:unnamed-chunk-158}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/boxplots_Delta57overB_BaselineNeg_trt_Vaccine_by_minority_group_mock} 

}

\caption{Boxplots of D57 fold-rise over D1 Ab markers: Baseline negative vaccine arm by dichotomous classification of race and ethnic group.}\label{fig:unnamed-chunk-159}
\end{figure}

\clearpage

\clearpage

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/boxplots_Delta29overB_BaselineNeg_trt_Vaccine_by_age_x_minority_mock} 

}

\caption{Boxplots of D29 fold-rise over D1 Ab markers: Baseline negative vaccine arm by age and dichotomous classification of race and ethnic group.}\label{fig:unnamed-chunk-162}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/boxplots_Delta57overB_BaselineNeg_trt_Vaccine_by_age_x_minority_mock} 

}

\caption{Boxplots of D57 fold-rise over D1 Ab markers: Baseline negative vaccine arm by age and dichotomous classification of race and ethnic group.}\label{fig:unnamed-chunk-163}
\end{figure}

\clearpage

\hypertarget{baseline-sars-cov-2-positive-5}{%
\subsection{Baseline SARS-CoV-2 positive}\label{baseline-sars-cov-2-positive-5}}

\clearpage

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/boxplots_Delta29overB_BaselinePos_trt_Vaccine_by_age_group_mock} 

}

\caption{Boxplots of D29 fold-rise over D1 Ab markers: baseline positive vaccine arm by age group.}\label{fig:unnamed-chunk-166}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/boxplots_Delta57overB_BaselinePos_trt_Vaccine_by_age_group_mock} 

}

\caption{Boxplots of D57 fold-rise over D1 Ab markers: baseline positive vaccine arm by age group.}\label{fig:unnamed-chunk-167}
\end{figure}

\clearpage

\clearpage

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/boxplots_Delta29overB_BaselinePos_trt_Vaccine_by_risk_group_mock} 

}

\caption{Boxplots of D29 fold-rise over D1 Ab markers: baseline positive vaccine arm by high-risk condition.}\label{fig:unnamed-chunk-170}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/boxplots_Delta57overB_BaselinePos_trt_Vaccine_by_risk_group_mock} 

}

\caption{Boxplots of D57 fold-rise over D1 Ab markers: baseline positive vaccine arm by high-risk condition.}\label{fig:unnamed-chunk-171}
\end{figure}

\clearpage

\clearpage

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/boxplots_Delta29overB_BaselinePos_trt_Vaccine_by_age_x_risk_group_mock} 

}

\caption{Boxplots of D29 fold-rise over D1 Ab markers: baseline positive vaccine arm by age and high-risk condition.}\label{fig:unnamed-chunk-174}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/boxplots_Delta57overB_BaselinePos_trt_Vaccine_by_age_x_risk_group_mock} 

}

\caption{Boxplots of D57 fold-rise over D1 Ab markers: baseline positive vaccine arm by age and high-risk condition.}\label{fig:unnamed-chunk-175}
\end{figure}

\clearpage

\clearpage

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/boxplots_Delta29overB_BaselinePos_trt_Vaccine_by_sex_mock} 

}

\caption{Boxplots of D29 fold-rise over D1 Ab markers: baseline positive vaccine arm by sex assigned at birth.}\label{fig:unnamed-chunk-178}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/boxplots_Delta57overB_BaselinePos_trt_Vaccine_by_sex_mock} 

}

\caption{Boxplots of D57 fold-rise over D1 Ab markers: baseline positive vaccine arm by sex assigned at birth.}\label{fig:unnamed-chunk-179}
\end{figure}

\clearpage

\clearpage

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/boxplots_Delta29overB_BaselinePos_trt_Vaccine_by_age_x_sex_group_mock} 

}

\caption{Boxplots of D29 fold-rise over D1 Ab markers: baseline positive vaccine arm by age and sex assigned at birth.}\label{fig:unnamed-chunk-182}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/boxplots_Delta57overB_BaselinePos_trt_Vaccine_by_age_x_sex_group_mock} 

}

\caption{Boxplots of D57 fold-rise over D1 Ab markers: baseline positive vaccine arm by age and sex assigned at birth.}\label{fig:unnamed-chunk-183}
\end{figure}

\clearpage

\clearpage

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/boxplots_Delta29overB_BaselinePos_trt_Vaccine_by_ethnicity_mock} 

}

\caption{Boxplots of D29 fold-rise over D1 Ab markers: baseline positive vaccine arm by ethnicity.}\label{fig:unnamed-chunk-186}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/boxplots_Delta57overB_BaselinePos_trt_Vaccine_by_ethnicity_mock} 

}

\caption{Boxplots of D57 fold-rise over D1 Ab markers: baseline positive vaccine arm by ethnicity.}\label{fig:unnamed-chunk-187}
\end{figure}

\clearpage

\clearpage

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/boxplots_Delta29overB_BaselinePos_trt_Vaccine_by_race_mock} 

}

\caption{Boxplots of D29 fold-rise over D1 Ab markers: baseline positive vaccine arm by race.}\label{fig:unnamed-chunk-190}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/boxplots_Delta57overB_BaselinePos_trt_Vaccine_by_race_mock} 

}

\caption{Boxplots of D57 fold-rise over D1 Ab markers: baseline positive vaccine arm by race.}\label{fig:unnamed-chunk-191}
\end{figure}

\clearpage

\clearpage

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/boxplots_Delta29overB_BaselinePos_trt_Vaccine_by_minority_group_mock} 

}

\caption{Boxplots of D29 fold-rise over D1 Ab markers: baseline positive vaccine arm by dichotomous classification of race and ethnic group.}\label{fig:unnamed-chunk-194}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/boxplots_Delta57overB_BaselinePos_trt_Vaccine_by_minority_group_mock} 

}

\caption{Boxplots of D57 fold-rise over D1 Ab markers: baseline positive vaccine arm by dichotomous classification of race and ethnic group.}\label{fig:unnamed-chunk-195}
\end{figure}

\clearpage

\clearpage

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/boxplots_Delta29overB_BaselinePos_trt_Vaccine_by_age_x_minority_mock} 

}

\caption{Boxplots of D29 fold-rise over D1 Ab markers: baseline positive vaccine arm by age and dichotomous classification of race and ethnic group.}\label{fig:unnamed-chunk-198}
\end{figure}

\clearpage
\begin{figure}[H]

{\centering \includegraphics[width=0.8\linewidth,]{/home/travis/build/CoVPN/correlates_reporting/immuno_graphical/figs/demographics/boxplots_Delta57overB_BaselinePos_trt_Vaccine_by_age_x_minority_mock} 

}

\caption{Boxplots of D57 fold-rise over D1 Ab markers: baseline positive vaccine arm by age and dichotomous classification of race and ethnic group.}\label{fig:unnamed-chunk-199}
\end{figure}

\bibliography{book.bib,packages.bib}

\end{document}
